,date,title,stock,close,volume,1_past_close,2_past_close,3_past_close,4_past_close,5_past_close,next_close,next_volume
0,2009-09-18,Sanofi-aventis (SNY) Completes Acquisition of Merial ,MRK,-0.004061184352521341,0.3361922481064197,-0.004973748125307265,-0.01620803060760667,-0.005776631563948698,0.010755563693445769,0.0181479316871056,-0.0018819977159921786,-0.3320394117049259
1,2009-11-04,Merck Says It Won't Seek Another Larger Merger,MRK,0.0642320791869826,-0.4668800422671491,-0.01887388305962967,0.010669480173789658,-0.012137086402663422,-0.02308903928581918,-0.01171714002803892,0.002144133459157871,-0.3720195033821023
2,2009-11-13,Merck (MRK) Drugs Under Scanner Of Cholesterol Study,MRK,0.003638645414370645,0.029534483405075695,-0.0072246194649645545,-0.011603743135623401,0.005384307388847764,0.025774928768814043,-0.00366809860340489,0.021449960545911972,0.7290495025943453
3,2009-12-02,"Google's Most Popular Stock Searches Today, SNTS, MRK, ITVI, DYAX, SNDA",MRK,-0.00216935765926618,-0.27664287637603424,0.018503450387395315,-0.0022048019756483184,-0.00765633343482075,0.00966313845015132,-0.0054914582311769156,-0.0008150617607562971,0.08232160158832058
4,2009-12-10,SEC On Trail Of Insider Trading Transactions,MRK,0.010498030410448944,-0.17596048085657834,0.0220083975878691,-0.009536669783095197,0.0,-0.0019040826884287876,-0.0008150617607562971,-0.002422138647047656,-0.06089162151662664
5,2009-12-21,"Health Brings Wealth To The Street (PFE, MRK, AET, UNH, SNY, CHTT)",MRK,0.007753967360379255,-0.41835639589187923,0.003219377146972624,-0.012450478540700916,-0.006579296088200959,0.006089830520479067,0.018883182277213972,0.001591634553825827,-0.04683072757530604
6,2009-12-23,Merck & Co. Inc (MRK) Gets A Hold Rating,MRK,-0.013244656017607603,-0.09564515091714709,0.001591634553825827,0.007753967360379255,0.003219377146972624,-0.012450478540700916,-0.006579296088200959,-0.006979762389665467,-0.5069155002095289
7,2009-12-24,Merck Decides To Discontinue Its Collaboration With ARNA For Dyslipidemia,MRK,-0.006979762389665467,-0.5069155002095289,-0.013244656017607603,0.001591634553825827,0.007753967360379255,0.003219377146972624,-0.012450478540700916,0.008109707885966877,0.5855182035831781
8,2009-12-28,"The World's Largest M&A Deals in 2009 (PFE, WLA, GM, SGP, MRK)",MRK,0.008109707885966877,0.5855182035831781,-0.006979762389665467,-0.013244656017607603,0.001591634553825827,0.007753967360379255,0.003219377146972624,-0.005095100812017472,-0.24652539527907624
9,2010-01-04,"Biotech Listings To Form A Major Chunk Of IPO Market (JNJ, PFE, MRK, CDXS,TNGN, MBGI)",MRK,0.012862769619812697,0.9672281993204983,-0.014031688171799228,-0.001077851392405682,-0.005095100812017472,0.008109707885966877,-0.006979762389665467,0.004052919507697039,0.06104412034113693
10,2010-01-14,Merck & Co (MRK) Submits New Data To FDA To Widen Gardasil Use,MRK,0.0272283050780866,-0.13206098095171592,0.0367510467468124,-0.007926360438824664,0.00397899141950675,-0.0005302341958086654,0.0015934043572551904,-0.013003298693704646,-0.05316854657325487
11,2010-01-25,"Merck (MRK) Doing Well, But Becoming More Transparent",MRK,-0.002830047750426612,-0.11943129474376168,-0.030189683745257656,-0.023153716345785114,0.010093496987539696,0.029136331604062704,-0.013003298693704646,-0.004643576722501486,0.2917043697896238
12,2010-02-05,"Market Round-up (UBS, GOOG¸ AAPL, MOT¸ PG, PFE, MRK, LLY, CVS, WAG)",MRK,-0.009972967188476511,-0.09312948390584397,-0.0418387857930701,-0.0207387824616313,0.032376363412406794,0.0031428281744196873,0.005530928615636643,-0.0038115098979041306,-0.5553078986183575
13,2010-02-10,Merck & Co. To Change Safety Procedures (MRK),MRK,-0.007403205774757615,-0.018812343230473094,-0.003279827837422644,-0.0038115098979041306,-0.009972967188476511,-0.0418387857930701,-0.0207387824616313,0.018784679480163158,-0.14207071024520013
14,2010-02-10,Merck & Co. (MRK) Agrees To Changes In Vioxx Settlement,MRK,-0.007403205774757615,-0.018812343230473094,-0.003279827837422644,-0.0038115098979041306,-0.009972967188476511,-0.0418387857930701,-0.0207387824616313,0.018784679480163158,-0.14207071024520013
15,2010-02-10,"Market Roundup (AAPL, MRK, FITB, PNC, TTWO, GOOG)",MRK,-0.007403205774757615,-0.018812343230473094,-0.003279827837422644,-0.0038115098979041306,-0.009972967188476511,-0.0418387857930701,-0.0207387824616313,0.018784679480163158,-0.14207071024520013
16,2010-02-11,"Credit Suisse Lowers Estimates, Price Targets On Merck, Pfizer",MRK,0.018784679480163158,-0.14207071024520013,-0.007403205774757615,-0.003279827837422644,-0.0038115098979041306,-0.009972967188476511,-0.0418387857930701,0.0010844515353078954,0.24091528416942198
17,2010-02-16,"Merck & Co. (MRK) Reports Bigger Profit, Helped By Schering-Ploug Deal ",MRK,0.02004326287601632,0.15996180520494674,0.0010844515353078954,0.018784679480163158,-0.007403205774757615,-0.003279827837422644,-0.0038115098979041306,-0.008497014466493646,-0.42418364578063494
18,2010-02-16,Merck & Co. (MRK) Reports Schering Fueled Profit Jump,MRK,0.02004326287601632,0.15996180520494674,0.0010844515353078954,0.018784679480163158,-0.007403205774757615,-0.003279827837422644,-0.0038115098979041306,-0.008497014466493646,-0.42418364578063494
19,2010-02-16,"Merck Reports Inline, Stock Off To Good Start In Premarket (MRK)",MRK,0.02004326287601632,0.15996180520494674,0.0010844515353078954,0.018784679480163158,-0.007403205774757615,-0.003279827837422644,-0.0038115098979041306,-0.008497014466493646,-0.42418364578063494
20,2010-02-16,MRK Shares Up As 4Q Earnings Match Expectations,MRK,0.02004326287601632,0.15996180520494674,0.0010844515353078954,0.018784679480163158,-0.007403205774757615,-0.003279827837422644,-0.0038115098979041306,-0.008497014466493646,-0.42418364578063494
21,2010-02-16,Merck Posts Bigger Profit (MRK),MRK,0.02004326287601632,0.15996180520494674,0.0010844515353078954,0.018784679480163158,-0.007403205774757615,-0.003279827837422644,-0.0038115098979041306,-0.008497014466493646,-0.42418364578063494
22,2010-02-25,Eli Lilly Banks On Its Restructured Development Process To Offset Sales Loss (LLY),MRK,-0.009748214031878644,-0.003334600871676363,0.011503863785922386,-0.0164334191577451,-0.009868970302257751,0.005363317316582572,-0.0013392022572161766,0.008477035531569088,-0.22704782031753556
23,2010-03-08,"ThinkEquity Reiterates Buy on OraSure Technologies (OSUR, MRK, PFE)",MRK,-0.0037340756544663734,0.2207461985504089,0.009423455460771502,-0.0018813820901457667,-0.004813973249250925,0.0032198177969877673,0.01057476784732625,-0.008299920523801352,0.21984179724162956
24,2010-03-09,Sonofi-Merck (MRK) Deal Positive,MRK,-0.008299920523801352,0.21984179724162956,-0.0037340756544663734,0.009423455460771502,-0.0018813820901457667,-0.004813973249250925,0.0032198177969877673,-0.009989121608319662,0.3218130823329457
25,2010-03-12,Overhang On Merck & Company (MRK) Lifted By IMPROVE-IT Update,MRK,0.007592134832409503,0.07000739041011261,0.016257884405790568,-0.009989121608319662,-0.008299920523801352,-0.0037340756544663734,0.009423455460771502,0.015877419512195567,0.0628394260717191
26,2010-03-12,"Merck To Continue Its M&A Spree (MRK, MIL)",MRK,0.007592134832409503,0.07000739041011261,0.016257884405790568,-0.009989121608319662,-0.008299920523801352,-0.0037340756544663734,0.009423455460771502,0.015877419512195567,0.0628394260717191
27,2010-03-15,"Benzinga’s News Roundup (PEP, ALKS, MRK)",MRK,0.015877419512195567,0.0628394260717191,0.007592134832409503,0.016257884405790568,-0.009989121608319662,-0.008299920523801352,-0.0037340756544663734,0.005033001380647217,0.05128649059002899
28,2010-03-22,FDA Asks Doctors To Suspend Use Of GlaxoSmithKline (GSK) Rotavirus Vaccine,MRK,0.006305680538045477,-0.4972267019180333,-0.010142850442712348,0.00971622368236491,0.0036901329272061023,0.005033001380647217,0.015877419512195567,0.0052223353212725865,-0.20280873467878535
29,2010-04-23,"Market Roundup (MS, C, HLS, UBS, HBC, USB, MRK)",MRK,0.050044445297052986,0.08136582168186757,-0.027921518224260478,-0.036605770772181745,0.00445662978011474,0.005320695214017013,-0.009156305605991344,-0.012972423466320326,-0.3565904113847017
30,2010-04-23,Merck & Co. (MRK) Says U.S. Health-Care Legislation To Reduce 2010 Revenue By $170 Million,MRK,0.050044445297052986,0.08136582168186757,-0.027921518224260478,-0.036605770772181745,0.00445662978011474,0.005320695214017013,-0.009156305605991344,-0.012972423466320326,-0.3565904113847017
31,2010-04-23,Merck To Lose $170 Million In Revenue (MRK),MRK,0.050044445297052986,0.08136582168186757,-0.027921518224260478,-0.036605770772181745,0.00445662978011474,0.005320695214017013,-0.009156305605991344,-0.012972423466320326,-0.3565904113847017
32,2010-04-23,US Stock Ended In Positive Territory After Losing 100 Points,MRK,0.050044445297052986,0.08136582168186757,-0.027921518224260478,-0.036605770772181745,0.00445662978011474,0.005320695214017013,-0.009156305605991344,-0.012972423466320326,-0.3565904113847017
33,2010-04-28,"Afternoon Market Update - Goldman Sachs (NYSE: GS), Merck (NYSE: MRK), AstraZeneca (NYSE: AZN)",MRK,0.002320400856293592,-0.13530254191894742,-0.014857185673129991,-0.012972423466320326,0.050044445297052986,-0.027921518224260478,-0.036605770772181745,0.01996523310841236,0.08076658777337076
34,2010-04-28,Investors Allowed To Sue Merck Over Vioxx (MRK),MRK,0.002320400856293592,-0.13530254191894742,-0.014857185673129991,-0.012972423466320326,0.050044445297052986,-0.027921518224260478,-0.036605770772181745,0.01996523310841236,0.08076658777337076
35,2010-04-30,"DOW Gains The Highest Since March 5, Led By Q1 Gains",MRK,-0.0059576450289002825,-0.13819694835157692,0.01996523310841236,0.002320400856293592,-0.014857185673129991,-0.012972423466320326,0.050044445297052986,0.006563824964667564,-0.20970382867750625
36,2010-05-04,Merck & Co.’s (MRK) First-Quarter Profit Down By 77%,MRK,0.015310736483858056,1.6108187500527986,0.006563824964667564,-0.0059576450289002825,0.01996523310841236,0.002320400856293592,-0.014857185673129991,-0.00614384346684671,-0.3384609121429021
37,2010-05-04,"MRK Shares Rise As Q1 Profits, Sales Exceeds Expectations",MRK,0.015310736483858056,1.6108187500527986,0.006563824964667564,-0.0059576450289002825,0.01996523310841236,0.002320400856293592,-0.014857185673129991,-0.00614384346684671,-0.3384609121429021
38,2010-05-05,"Merck And Ariad Re-Write Ridaforolimus Contract (MRK, ARIA)",MRK,-0.00614384346684671,-0.3384609121429021,0.015310736483858056,0.006563824964667564,-0.0059576450289002825,0.01996523310841236,0.002320400856293592,-0.03708857889292161,0.43384775786526975
39,2010-05-05,"US Stocks Dive, Hit By Europe Crisis, Investors Take Refuge In Dollar & Bonds",MRK,-0.00614384346684671,-0.3384609121429021,0.015310736483858056,0.006563824964667564,-0.0059576450289002825,0.01996523310841236,0.002320400856293592,-0.03708857889292161,0.43384775786526975
40,2010-05-05,"Benzinga’s Top Pre-Market Gainers (AMMD, HNSN, ACAS, ARIA, ERTS)",MRK,-0.00614384346684671,-0.3384609121429021,0.015310736483858056,0.006563824964667564,-0.0059576450289002825,0.01996523310841236,0.002320400856293592,-0.03708857889292161,0.43384775786526975
41,2010-05-11,Five New Drugs On Cards for Merck (MRK),MRK,-0.021605842867672087,0.051209642090685126,0.022693401555952564,-0.022760808791720155,-0.03708857889292161,-0.00614384346684671,0.015310736483858056,0.0038795199916572543,-0.2253056628742004
42,2010-05-12,"US Stocks End Lower Yesterday After Soaring On Monday, Dow And S&P Down, Nasdaq Bucks Trend",MRK,0.0038795199916572543,-0.2253056628742004,-0.021605842867672087,0.022693401555952564,-0.022760808791720155,-0.03708857889292161,-0.00614384346684671,-0.009809733591104264,-0.2323760768810128
43,2010-05-27,"Citigroup Outlook For U.S. Major Pharmaceuticals (MRK, PFE, BMY)",MRK,0.037014350330835555,0.1646254381049932,0.011228818457914347,0.0062778513790195944,-0.005618109688940165,0.006913846339067664,-0.024524999873487996,0.002081730648085145,-0.18273974512480817
44,2010-06-22,Late Market Roundup,MRK,0.0002846236315150463,0.05326060705151847,-0.015418886633478901,-0.005298658700510495,-0.004165546401723286,-0.00027785398546431583,0.02855551500511444,0.008255331820566036,-0.20727563325855825
45,2010-07-08,Late Market Roundup,MRK,0.012136951097377002,-0.07827487211496664,0.022510761934852797,0.012565837147859638,-0.006388216673082758,-0.015155403022870884,-0.012983525063745227,0.012269904395130204,-0.22957246549771348
46,2010-07-08,Merck Details Global Restructuring Program,MRK,0.012136951097377002,-0.07827487211496664,0.022510761934852797,0.012565837147859638,-0.006388216673082758,-0.015155403022870884,-0.012983525063745227,0.012269904395130204,-0.22957246549771348
47,2010-07-08,"News Summary (HRB, BP, MRK)",MRK,0.012136951097377002,-0.07827487211496664,0.022510761934852797,0.012565837147859638,-0.006388216673082758,-0.015155403022870884,-0.012983525063745227,0.012269904395130204,-0.22957246549771348
48,2010-07-13,GlaxoSmithKline: Another Drug Company Runs Afoul Of The Truth ,MRK,0.009975067239756275,0.02270637804865605,-0.005785260374479684,0.012269904395130204,0.012136951097377002,0.022510761934852797,0.012565837147859638,-0.006858828924196869,-0.13212854633679438
49,2010-07-14,10 Firms Expecting Clinical Trial Results,MRK,-0.006858828924196869,-0.13212854633679438,0.009975067239756275,-0.005785260374479684,0.012269904395130204,0.012136951097377002,0.022510761934852797,0.008011066390086308,-0.0185729207218035
50,2010-07-26,Corporate Catalysts For The Week Starting July 26 ,MRK,0.011470987897202356,-0.3855235110549653,-0.008811874928746577,-0.00028396999862212446,-0.013180437346124507,-0.0039104201778575876,-0.0030630984731945254,-0.0025515052256336324,0.31582330357783084
51,2010-07-27,Merk and Sinopharm Sign Statement of Mutual Intent,MRK,-0.0025515052256336324,0.31582330357783084,0.011470987897202356,-0.008811874928746577,-0.00028396999862212446,-0.013180437346124507,-0.0039104201778575876,-0.012507510618188444,-0.23407981899485242
52,2010-07-27,A Peek Into The Market At The Start Of The Trading Day,MRK,-0.0025515052256336324,0.31582330357783084,0.011470987897202356,-0.008811874928746577,-0.00028396999862212446,-0.013180437346124507,-0.0039104201778575876,-0.012507510618188444,-0.23407981899485242
53,2010-07-27,Sanofi-aventis and Merck Appoint CEO for Joint Venture,MRK,-0.0025515052256336324,0.31582330357783084,0.011470987897202356,-0.008811874928746577,-0.00028396999862212446,-0.013180437346124507,-0.0039104201778575876,-0.012507510618188444,-0.23407981899485242
54,2010-07-30,US Stock Futures Point To Weak Day Today,MRK,-0.017113327116833665,0.4907386828206288,0.009211399957579802,-0.012507510618188444,-0.0025515052256336324,0.011470987897202356,-0.008811874928746577,0.0177013672319688,-0.4426434117871142
55,2010-07-30,"Merck’s Q2 Earnings Beat Targets, Revenue Misses",MRK,-0.017113327116833665,0.4907386828206288,0.009211399957579802,-0.012507510618188444,-0.0025515052256336324,0.011470987897202356,-0.008811874928746577,0.0177013672319688,-0.4426434117871142
56,2010-07-30,"Earnings Scheduled For July 30 (MRK, AON, CVX, CVH, WY, PPC)",MRK,-0.017113327116833665,0.4907386828206288,0.009211399957579802,-0.012507510618188444,-0.0025515052256336324,0.011470987897202356,-0.008811874928746577,0.0177013672319688,-0.4426434117871142
57,2010-07-30,"Stocks To Watch For July 30 (FSLR, MRK, CVX, AON, CSTR)",MRK,-0.017113327116833665,0.4907386828206288,0.009211399957579802,-0.012507510618188444,-0.0025515052256336324,0.011470987897202356,-0.008811874928746577,0.0177013672319688,-0.4426434117871142
58,2010-07-30,"ETFs To Watch July 30, 2010 (HAO, PPH, YCS, PALL)",MRK,-0.017113327116833665,0.4907386828206288,0.009211399957579802,-0.012507510618188444,-0.0025515052256336324,0.011470987897202356,-0.008811874928746577,0.0177013672319688,-0.4426434117871142
59,2010-07-30,Merck Posts Mixed Results (MRK),MRK,-0.017113327116833665,0.4907386828206288,0.009211399957579802,-0.012507510618188444,-0.0025515052256336324,0.011470987897202356,-0.008811874928746577,0.0177013672319688,-0.4426434117871142
60,2010-08-06,Oncothyreon Phase 3 Breast Cancer Trial Shut Down,MRK,-0.0025657930796052497,0.15861539905800548,-0.0034102660931942808,0.010626056463813427,-0.0071283741527287114,0.0177013672319688,-0.017113327116833665,0.010863212274712986,-0.11637558434305184
61,2010-08-09,Finally There Is A Cure For Tobacco Addiction (CIGX),MRK,0.010863212274712986,-0.11637558434305184,-0.0025657930796052497,-0.0034102660931942808,0.010626056463813427,-0.0071283741527287114,0.0177013672319688,0.011594982145985533,0.151689029477712
62,2010-08-12,Merck Announces Mandatory Conversion of its 6.00% Mandatory Convertible Preferred Stock,MRK,0.00429917732565821,-0.26395868312468107,-0.024601729809665462,0.011594982145985533,0.010863212274712986,-0.0025657930796052497,-0.0034102660931942808,-0.0011414458331469035,-0.04430048765931138
63,2010-08-13,All Is Not Well In The Pharmaceutical Industry,MRK,-0.0011414458331469035,-0.04430048765931138,0.00429917732565821,-0.024601729809665462,0.011594982145985533,0.010863212274712986,-0.0025657930796052497,-0.0008574147142116351,-0.21316929461359013
64,2010-08-13,"U.S. Probing Pharmaceutical Corruption (GSK, PFE, BMY, LLY)",MRK,-0.0011414458331469035,-0.04430048765931138,0.00429917732565821,-0.024601729809665462,0.011594982145985533,0.010863212274712986,-0.0025657930796052497,-0.0008574147142116351,-0.21316929461359013
65,2010-08-26,A New Round Of Corporate Layoffs?,MRK,-0.0017371322406410927,-0.19899489675010373,0.002903417734380742,-0.015155403022870884,0.015388623818812341,-0.007778719093014641,-0.018659703526578975,0.015081225255745512,0.12369199671933528
66,2010-09-09,Top 10 'Buy'-Rated Stocks Under $5,MRK,0.007539345110522344,-0.4777780698258125,0.009870483083192827,-0.003652629965414267,0.006789226121811431,-0.007579909283925157,0.013082522202763736,0.01579863156618555,-0.02961649876778072
67,2010-09-16,Unconfirmed Chatter that Merck & Co. Inc. (MRK) will buy Medicines Co. (MDCO) at $23.00 a share,MRK,-0.002191303903475106,-0.2089928307858534,-0.00027379625435042243,0.008282762973516045,-0.001378669363433449,0.01579863156618555,0.007539345110522344,-0.0027447269235201244,0.8041738583830411
68,2010-09-23,Travelers Mad As Hell ,MRK,-0.00811700844470431,-0.144792996731264,0.006536233126948732,0.004926219749763705,0.005780042218986425,-0.0027447269235201244,-0.002191303903475106,0.018548705569609414,0.09751379761103895
69,2010-10-01,Merck Announces Pivotal Phase III Data for Boceprevir will be Presented at Liver Diseases Meeting  ,MRK,-0.005705167346689355,-0.14267670785920672,-0.008350902654681192,-0.003490333268762691,0.0032322345941548924,-0.005624108425573704,0.018548705569609414,-0.002185832129624976,-0.21350889044754018
70,2010-10-04,Merck to Appeal Reduced Jury Verdict in Federal FOSAMAX Case ,MRK,-0.002185832129624976,-0.21350889044754018,-0.005705167346689355,-0.008350902654681192,-0.003490333268762691,0.0032322345941548924,-0.005624108425573704,0.013691231783471203,0.15531306263835898
71,2010-10-27,"Merck In Talks To Acquire InterMune (MRK, ITMN)",MRK,-0.01645508994642164,0.7061407403158604,-0.009353204065063347,0.008624999301559688,0.0,0.00297398541571936,0.012869676071484593,0.013165182166736678,-0.1855785126537156
72,2010-10-29,News Summary,MRK,-0.017055267560405207,0.5430737444453704,0.013165182166736678,-0.01645508994642164,-0.009353204065063347,0.008624999301559688,0.0,-0.0016518592631019624,-0.36525810678068815
73,2010-10-29,"Stocks To Watch For October 29 (MSFT, MRK, EXPE, CVX, MXIM)",MRK,-0.017055267560405207,0.5430737444453704,0.013165182166736678,-0.01645508994642164,-0.009353204065063347,0.008624999301559688,0.0,-0.0016518592631019624,-0.36525810678068815
74,2010-10-29,"Earnings Scheduled For October 29 (CVX, POM, CEG, MRK, PGN, NEE, SNE, D, EL, ITT, CI, WY, EIX, LNT)",MRK,-0.017055267560405207,0.5430737444453704,0.013165182166736678,-0.01645508994642164,-0.009353204065063347,0.008624999301559688,0.0,-0.0016518592631019624,-0.36525810678068815
75,2010-10-29,US Stock Futures Down As Investors Await Q3 GDP Data,MRK,-0.017055267560405207,0.5430737444453704,0.013165182166736678,-0.01645508994642164,-0.009353204065063347,0.008624999301559688,0.0,-0.0016518592631019624,-0.36525810678068815
76,2010-11-09,Merck Wins TEMODAR Patent Infringement Lawsuit ,MRK,-0.016002247082541277,0.5560961772246957,-0.0022409368777873695,-0.025920792896167777,0.0038346148364232224,-0.0027313153747050567,0.009930581964093355,-0.0025681221649286323,-0.10477684781366436
77,2010-11-30,Merck Board Elects Kenneth C. Frazier as Next CEO,MRK,-0.006342153792615823,1.9027574563871692,-0.0028742881422602062,-0.010241962271612781,0.0097675968072235,-0.021916305606313746,0.007359516052195758,0.017116282525053705,-0.14386673340000744
78,2010-11-30,Merck Down Slightly On New CEO (MRK),MRK,-0.006342153792615823,1.9027574563871692,-0.0028742881422602062,-0.010241962271612781,0.0097675968072235,-0.021916305606313746,0.007359516052195758,0.017116282525053705,-0.14386673340000744
79,2010-11-30,News Summary,MRK,-0.006342153792615823,1.9027574563871692,-0.0028742881422602062,-0.010241962271612781,0.0097675968072235,-0.021916305606313746,0.007359516052195758,0.017116282525053705,-0.14386673340000744
80,2010-12-02,A Peek Into The Market Before The Trading Starts,MRK,0.0045636023216855115,0.13810355557688747,0.017116282525053705,-0.006342153792615823,-0.0028742881422602062,-0.010241962271612781,0.0097675968072235,0.002271738178323268,-0.7126189571224669
81,2010-12-02,"Merck to Acquire SmartCells, Inc; Transaction May Exceed $500M",MRK,0.0045636023216855115,0.13810355557688747,0.017116282525053705,-0.006342153792615823,-0.0028742881422602062,-0.010241962271612781,0.0097675968072235,0.002271738178323268,-0.7126189571224669
82,2010-12-06,ETFs For Biotech M&A Mania,MRK,-0.0014166397657103813,-0.015563773224059552,0.002271738178323268,0.0045636023216855115,0.017116282525053705,-0.006342153792615823,-0.0028742881422602062,0.003404274455574674,0.7076104130230969
83,2010-12-10,"Mad Money Lightning Round: Cramer Advises Investors To Buy BlackRock (LLY, DECK, CMI, OXPS, AXP, V, MRK, ABT, BLK)",MRK,0.008971117820766095,0.3622446097598824,0.007626901676900388,0.0008483535494239192,0.003404274455574674,-0.0014166397657103813,0.002271738178323268,0.01376037800911134,0.5663669981418074
84,2010-12-22,FDA's Approves Gardasil to Prevent Anal Cancer ,MRK,0.0011053929989330857,-0.1331197022393209,-0.008767348471463543,0.0005486061311428259,-0.00977218832615101,0.00491008530221082,0.0030096982098772873,0.0019326973619779864,-0.1603875223826
85,2011-01-11,Merck Announces FDA Acceptance of New Drug Application for JANUMET®   ,MRK,-0.006720430870407856,-0.04560927417137506,-0.004016241664493658,0.00782504290454189,0.013676397342784696,0.005776939870668407,0.008601643699322814,0.005412851121451512,0.25934570660574474
86,2011-01-19,Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar (MRK),MRK,0.0011811394919238882,-0.49560660973565585,-0.010517308212715903,-0.013260328848851644,-0.06621797545941532,0.005412851121451512,-0.006720430870407856,0.004128888790055463,-0.27359765951827775
87,2011-02-03,"US Stock Futures Mixed As Investors Await Earnings Reports, Economic Data; Merck Earnings In Focus",MRK,-0.02720271313636291,1.9176594140710077,-0.005294227653297234,0.025022278965383116,0.0030244183542491587,-0.005413827262633064,0.0015062423337588449,-0.00030419706689122084,-0.3719311477654439
88,2011-02-03,Merck Reports Q4 EPS of $0.88,MRK,-0.02720271313636291,1.9176594140710077,-0.005294227653297234,0.025022278965383116,0.0030244183542491587,-0.005413827262633064,0.0015062423337588449,-0.00030419706689122084,-0.3719311477654439
89,2011-02-03,A Peek Into The Market Before The Trading Starts,MRK,-0.02720271313636291,1.9176594140710077,-0.005294227653297234,0.025022278965383116,0.0030244183542491587,-0.005413827262633064,0.0015062423337588449,-0.00030419706689122084,-0.3719311477654439
91,2011-02-14,Merck Wins First FOSAMAX State Court Trial ,MRK,-0.00755972334676025,0.1627387103780784,0.000907902780181713,-0.0015111581224885873,-0.005410210942470073,0.008181759683877132,0.0033447098037111544,-0.0009138968381043888,0.3645342687873636
92,2011-03-07,Merck Announces New Data Analyses for VICTRELIS Will Be Presented at The International Liver Congress,MRK,-0.006957105498141547,-0.006669955796437033,-0.0012084336108754146,0.01596055665444429,0.00369687175551503,-0.003377292403898169,0.011804796431190479,0.004568642461050931,-0.7003424884759404
93,2011-03-17,ARIAD Announces Election to Co-Promote Ridaforolimus in Sarcoma Indication in U.S. upon Approval ,MRK,0.011583092696398012,-0.40785886061260124,-0.024482139540063286,-0.01605928522640787,-0.010693454457376239,0.006457449128816517,-0.011715186604691619,0.014949220804036711,0.4209911549785603
94,2011-03-18,Committee for Medicinal Products for Human Use (CHMP) Issues Positive Opinion for New Contraception Offering,MRK,0.014949220804036711,0.4209911549785603,0.011583092696398012,-0.024482139540063286,-0.01605928522640787,-0.010693454457376239,0.006457449128816517,0.015042315534606887,-0.21646009298142577
95,2011-03-22,"Zings Of The Day (SNY, MRK, AAPL, AMZN)",MRK,0.0043222437227776744,0.07985873071701044,0.015042315534606887,0.014949220804036711,0.011583092696398012,-0.024482139540063286,-0.01605928522640787,0.003073663626303569,-0.2528622161874543
96,2011-03-24,Merck Announces FDA Approves Zostavax Vaccine to Prevent Shingles in Individuals 50 to 59 Years of Age ,MRK,0.0027586978200695444,-0.06741696228372873,0.003073663626303569,0.0043222437227776744,0.015042315534606887,0.014949220804036711,0.011583092696398012,-0.004584269368059668,-0.08054544236929562
97,2011-03-24,Portola Pharmaceuticals to Regain Global Rights for Investigational Medicine Betrixaban from Merck   ,MRK,0.0027586978200695444,-0.06741696228372873,0.003073663626303569,0.0043222437227776744,0.015042315534606887,0.014949220804036711,0.011583092696398012,-0.004584269368059668,-0.08054544236929562
98,2011-03-31,"VICTRELIS, Merck's Investigational Medicine, Added to Peginterferon Alfa-2a and Ribavirin Achieved Significantly Higher SVR Rates In Treatment-Failure Patients with Chronic HCV Genotype 1 Compared to Control   ",MRK,-0.008708286503637752,-0.268773451342218,0.015863324251910393,0.010169310259792397,-0.0036846715029124066,-0.004584269368059668,0.0027586978200695444,0.0018171465876137827,-0.09268215333386187
99,2011-04-05,"Merck to Acquire Inspire Pharmaceuticals, Inc. for $5.00 per Share Totaling $430M",MRK,-0.003306133656230892,-0.1975777376002248,0.00604794158750277,0.0018171465876137827,-0.008708286503637752,0.015863324251910393,0.010169310259792397,0.005729692414078169,0.41110982631507764
100,2011-04-06,Experts Think Merck's Gardasil Could Be Widely Distributed (MRK),MRK,0.005729692414078169,0.41110982631507764,-0.003306133656230892,0.00604794158750277,0.0018171465876137827,-0.008708286503637752,0.015863324251910393,-0.0005995106827064722,-0.035792302130149944
101,2011-04-08,Merck Loses U.K. Appeal Against Teva to Reinstate Cosopt Patent (MRK),MRK,0.010201015593139351,0.4620241518419299,-0.0005995106827064722,0.005729692414078169,-0.003306133656230892,0.00604794158750277,0.0018171465876137827,-0.002375959666065741,-0.39175745169931775
102,2011-04-11,Merck & Co and Sun Pharma Establish Joint Venture (MRK),MRK,-0.002375959666065741,-0.39175745169931775,0.010201015593139351,-0.0005995106827064722,0.005729692414078169,-0.003306133656230892,0.00604794158750277,-0.000893195621024856,0.3038291750448936
103,2011-04-11,"FDA Approves Merck's SYLATRON for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement   ",MRK,-0.002375959666065741,-0.39175745169931775,0.010201015593139351,-0.0005995106827064722,0.005729692414078169,-0.003306133656230892,0.00604794158750277,-0.000893195621024856,0.3038291750448936
104,2011-04-12,"Inspire Pharmaceuticals Shareholder Sues Over Merck Deal (MRK, ISPH)",MRK,-0.000893195621024856,0.3038291750448936,-0.002375959666065741,0.010201015593139351,-0.0005995106827064722,0.005729692414078169,-0.003306133656230892,-0.0026818935582849646,-0.4633887323667134
105,2011-04-15,A Peek Into The Market Before The Trading Starts,MRK,0.019197058619454532,1.4570439160000408,0.011652018281071097,-0.0026818935582849646,-0.000893195621024856,-0.002375959666065741,0.010201015593139351,-0.016806766249135463,-0.5179840951406071
106,2011-04-15,Merck Reaffirms 2011 Non-GAAP EPS Target of $3.64 to $3.76,MRK,0.019197058619454532,1.4570439160000408,0.011652018281071097,-0.0026818935582849646,-0.000893195621024856,-0.002375959666065741,0.010201015593139351,-0.016806766249135463,-0.5179840951406071
107,2011-04-15,"Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck (JNJ, MRK)",MRK,0.019197058619454532,1.4570439160000408,0.011652018281071097,-0.0026818935582849646,-0.000893195621024856,-0.002375959666065741,0.010201015593139351,-0.016806766249135463,-0.5179840951406071
108,2011-04-15,"  Merck and Johnson & Johnson Reach Agreement on Distribution Rights for REMICADE® and SIMPONI® (MRK, JNJ)",MRK,0.019197058619454532,1.4570439160000408,0.011652018281071097,-0.0026818935582849646,-0.000893195621024856,-0.002375959666065741,0.010201015593139351,-0.016806766249135463,-0.5179840951406071
109,2011-04-15,Merck Commences Tender Offer for Inspire Pharmaceuticals at $5.00 per Share    ,MRK,0.019197058619454532,1.4570439160000408,0.011652018281071097,-0.0026818935582849646,-0.000893195621024856,-0.002375959666065741,0.010201015593139351,-0.016806766249135463,-0.5179840951406071
110,2011-04-18,Don't Fall For The 'Defensive Portfolio' Hype,MRK,-0.016806766249135463,-0.5179840951406071,0.019197058619454532,0.011652018281071097,-0.0026818935582849646,-0.000893195621024856,-0.002375959666065741,-0.005305296175171059,-0.14590723011294904
111,2011-04-21,Merck and Sanofi Pasteur Initiate Phase III Study in the United States of Pediatric Combination Vaccine to Help Prevent Six Infectious Diseases   ,MRK,0.0,0.11168926815776437,0.008592882477396202,-0.005305296175171059,-0.016806766249135463,0.019197058619454532,0.011652018281071097,0.008519148398721477,-0.3910936566715548
112,2011-04-25,"Merck's Hepatitis C Drug Increases Anemia Risk, FDA Staff Says -Bloomberg (MRK)",MRK,0.008519148398721477,-0.3910936566715548,0.0,0.008592882477396202,-0.005305296175171059,-0.016806766249135463,0.019197058619454532,0.021264084215309342,1.2334876843950662
113,2011-04-25,"Rwanda, Merck and QIAGEN Launch Africa's First Comprehensive Cervical Cancer Prevention Program Incorporating Both HPV Vaccination and HPV Testing   ",MRK,0.008519148398721477,-0.3910936566715548,0.0,0.008592882477396202,-0.005305296175171059,-0.016806766249135463,0.019197058619454532,0.021264084215309342,1.2334876843950662
114,2011-04-27,Hepatitis Treatment Wins Over the U.S. FDA Panel -Bloomberg (MRK),MRK,0.016257982703267837,-0.051976744186046475,0.021264084215309342,0.008519148398721477,0.0,0.008592882477396202,-0.005305296175171059,0.003929454415098732,-0.3400564396751816
115,2011-04-27,VICTRELIS Unanimously Recommended for Approval by FDA Advisory Committee for Treatment of Chronic HCV Genotype 1 Infection   ,MRK,0.016257982703267837,-0.051976744186046475,0.021264084215309342,0.008519148398721477,0.0,0.008592882477396202,-0.005305296175171059,0.003929454415098732,-0.3400564396751816
116,2011-04-27,VICTRELIS™ Unanimously Recommended for Approval by FDA Advisory Committee (MRK),MRK,0.016257982703267837,-0.051976744186046475,0.021264084215309342,0.008519148398721477,0.0,0.008592882477396202,-0.005305296175171059,0.003929454415098732,-0.3400564396751816
117,2011-04-27,Merck Announces New $5 Billion Share Repurchase Program (MRK),MRK,0.016257982703267837,-0.051976744186046475,0.021264084215309342,0.008519148398721477,0.0,0.008592882477396202,-0.005305296175171059,0.003929454415098732,-0.3400564396751816
118,2011-04-28,"  Merck and Inspire Announce Expiration of Hart-Scott-Rodino Act Waiting Period Relating to Tender Offer for Shares of Inspire (ISPH, MRK)",MRK,0.003929454415098732,-0.3400564396751816,0.016257982703267837,0.021264084215309342,0.008519148398721477,0.0,0.008592882477396202,0.005031809615241523,0.4076706740076337
119,2011-04-29,Merck Up On Strong Earnings Today (MRK),MRK,0.005031809615241523,0.4076706740076337,0.003929454415098732,0.016257982703267837,0.021264084215309342,0.008519148398721477,0.0,0.010014063876438328,-0.028925290820142058
120,2011-04-29,"Stocks To Watch For April 29 (CVX, RIMM, CAT, MSFT, MRK)",MRK,0.005031809615241523,0.4076706740076337,0.003929454415098732,0.016257982703267837,0.021264084215309342,0.008519148398721477,0.0,0.010014063876438328,-0.028925290820142058
121,2011-04-29,UPDATE: Merck Reports Upbeat Q1 Earnings; Shares Rise In Pre-Market trading,MRK,0.005031809615241523,0.4076706740076337,0.003929454415098732,0.016257982703267837,0.021264084215309342,0.008519148398721477,0.0,0.010014063876438328,-0.028925290820142058
122,2011-04-29,Merck Announces First Quarter 2011 Financial Results   ,MRK,0.005031809615241523,0.4076706740076337,0.003929454415098732,0.016257982703267837,0.021264084215309342,0.008519148398721477,0.0,0.010014063876438328,-0.028925290820142058
123,2011-04-29,Merck Guides FY 2011 EPS $3.66-3.76 vs. $3.69 Est. (MRK),MRK,0.005031809615241523,0.4076706740076337,0.003929454415098732,0.016257982703267837,0.021264084215309342,0.008519148398721477,0.0,0.010014063876438328,-0.028925290820142058
124,2011-04-29,Merck Reports EPS of $0.92 vs. $0.84 Estimate; Revenues $11.58B vs. $11.37B Estimate ,MRK,0.005031809615241523,0.4076706740076337,0.003929454415098732,0.016257982703267837,0.021264084215309342,0.008519148398721477,0.0,0.010014063876438328,-0.028925290820142058
125,2011-04-29,"US Stock Futures Mixed As Investors Await Economic Data, Earnings Reports; Research In Motion Shares Decline In Pre-Market trading",MRK,0.005031809615241523,0.4076706740076337,0.003929454415098732,0.016257982703267837,0.021264084215309342,0.008519148398721477,0.0,0.010014063876438328,-0.028925290820142058
126,2011-04-29,A Peek Into The Market Before The Trading Starts,MRK,0.005031809615241523,0.4076706740076337,0.003929454415098732,0.016257982703267837,0.021264084215309342,0.008519148398721477,0.0,0.010014063876438328,-0.028925290820142058
127,2011-04-29,Friday Morning Market Summary 4/29/2011,MRK,0.005031809615241523,0.4076706740076337,0.003929454415098732,0.016257982703267837,0.021264084215309342,0.008519148398721477,0.0,0.010014063876438328,-0.028925290820142058
128,2011-05-03,"Morning News Summary for May 3, 2011",MRK,0.0027542597295746596,-0.03623149898624223,0.010014063876438328,0.005031809615241523,0.003929454415098732,0.016257982703267837,0.021264084215309342,0.004119591557019575,-0.018170429405192756
129,2011-05-06,"UPDATE: FDA Approves New Treatment for Rare Type of Pancreatic Cancer (PFE, MRK, GSK)",MRK,0.0038618349070100866,-0.22526956376603702,-0.008478979961740074,0.004119591557019575,0.0027542597295746596,0.010014063876438328,0.005031809615241523,0.0024734087462596754,-0.15976706191122214
130,2011-05-17,Merck and Roche Establish Strategic Agreements in Fight Against Chronic Hepatitis C ,MRK,-0.0008041950831315647,0.08780523051394185,0.005933252417914314,-0.0032254292444100496,0.015560655521010158,-0.003807706909058295,0.007949745382576756,0.008317290750792905,-0.36316139339769704
131,2011-05-19,Exclusive – Merck Talks To Benzinga About Collaboration With Roche (MRK),MRK,-0.0053218851977014925,-0.1217560215047282,0.008317290750792905,-0.0008041950831315647,0.005933252417914314,-0.0032254292444100496,0.015560655521010158,-0.008560654473037443,-0.006499389497447883
132,2011-05-20,"CHMP Issues Positive Opinion for Merck's VICTRELISTM, Oral Hepatitis C Virus Protease Inhibitor   ",MRK,-0.008560654473037443,-0.006499389497447883,-0.0053218851977014925,0.008317290750792905,-0.0008041950831315647,0.005933252417914314,-0.0032254292444100496,-0.004317326255272813,0.11213032496156927
133,2011-05-23,Vertex Hepatitis C Drug Approved by the FDA -Bloomberg,MRK,-0.004317326255272813,0.11213032496156927,-0.008560654473037443,-0.0053218851977014925,0.008317290750792905,-0.0008041950831315647,0.005933252417914314,-0.0008132359421684221,-0.08536883829361852
134,2011-05-24,FTC Files Amicus Brief In K-dur Antitrust Litigation -Bloomberg,MRK,-0.0008132359421684221,-0.08536883829361852,-0.004317326255272813,-0.008560654473037443,-0.0053218851977014925,0.008317290750792905,-0.0008041950831315647,-0.004881769715512574,-0.022592201141854673
135,2011-05-26,InSite Vision Announces Joint Patent Infringement Lawsuit with Merck Against Sandoz   ,MRK,-0.008449098236013586,0.5104960223935933,-0.004881769715512574,-0.0008132359421684221,-0.004317326255272813,-0.008560654473037443,-0.0053218851977014925,-0.004672976851800237,-0.3831443275779145
136,2011-05-31,Health Canada Approves Gardasil to Prevent Anal Cancer,MRK,0.01491306912477608,0.4101440277817816,-0.004672976851800237,-0.008449098236013586,-0.004881769715512574,-0.0008132359421684221,-0.004317326255272813,-0.01360544052119339,-0.23600852842494469
137,2011-06-02,FDA Says that High Blood Pressure Drugs Do Not Increase Cancer Risk -Bloomberg,MRK,-0.002758653248200904,-0.06419619260925813,-0.01360544052119339,0.01491306912477608,-0.004672976851800237,-0.008449098236013586,-0.004881769715512574,-0.009128631526719166,-0.06555625691044531
138,2011-06-02,FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer ,MRK,-0.002758653248200904,-0.06419619260925813,-0.01360544052119339,0.01491306912477608,-0.004672976851800237,-0.008449098236013586,-0.004881769715512574,-0.009128631526719166,-0.06555625691044531
139,2011-06-03,"Pimco's Gross Likes P&G and Merck, Offer Better Yields and Conservative -Bloomberg",MRK,-0.009128631526719166,-0.06555625691044531,-0.002758653248200904,-0.01360544052119339,0.01491306912477608,-0.004672976851800237,-0.008449098236013586,-0.0072588837050421295,-0.025037428726149114
140,2011-06-06,Merck and ARIAD Announce Presentation of Results of Phase III SUCCEED Trial at American Society of Clinical Oncology Annual Meeting ,MRK,-0.0072588837050421295,-0.025037428726149114,-0.009128631526719166,-0.002758653248200904,-0.01360544052119339,0.01491306912477608,-0.004672976851800237,0.0002816291124851933,0.042686511602119115
141,2011-06-07,Roche and Merck Collaborate to Develop Diagnostic Tests for Merck's Investigational Cancer Therapies   ,MRK,0.0002816291124851933,0.042686511602119115,-0.0072588837050421295,-0.009128631526719166,-0.002758653248200904,-0.01360544052119339,0.01491306912477608,0.006184875887994545,0.20084381486816127
142,2011-06-08,Merck Announces U.S. Prescribing Information for Simvastatin Revised to Include New Limits on the Use of the Highest Dose and Updated Drug Interaction Information  ,MRK,0.006184875887994545,0.20084381486816127,0.0002816291124851933,-0.0072588837050421295,-0.009128631526719166,-0.002758653248200904,-0.01360544052119339,0.0058677888978848625,0.12662214098849223
143,2011-06-08,"UPDATE: Merck and Intercell AG Announce Termination of Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710 ",MRK,0.006184875887994545,0.20084381486816127,0.0002816291124851933,-0.0072588837050421295,-0.009128631526719166,-0.002758653248200904,-0.01360544052119339,0.0058677888978848625,0.12662214098849223
144,2011-06-09,FDA Urges Limits On Dosages Of Zocor -WSJ,MRK,0.0058677888978848625,0.12662214098849223,0.006184875887994545,0.0002816291124851933,-0.0072588837050421295,-0.009128631526719166,-0.002758653248200904,-0.015277914773128676,-0.12463037740299865
145,2011-06-09,5-Alpha Reductase Inhibitors May Increase Risk of Prostate Cancer -FDA,MRK,0.0058677888978848625,0.12662214098849223,0.006184875887994545,0.0002816291124851933,-0.0072588837050421295,-0.009128631526719166,-0.002758653248200904,-0.015277914773128676,-0.12463037740299865
146,2011-06-20,Ligand Enters into Captisol Commercial Supply Agreement with Merck   ,MRK,0.011302869034686136,-0.2834767457992694,0.005969093616827514,0.000284718842030518,-0.013187601663274262,0.008774624758625782,0.0074133669028735305,-0.00027962163969863507,-0.20231669183591572
147,2011-06-27,"Stocks Shrug Off Greece, Deficit Uncertainty",MRK,-0.0005785465020089475,-0.34610727614787773,-0.012010221795554998,-0.01409682332732598,-0.008664018159964093,-0.00027962163969863507,0.011302869034686136,0.011004896959194044,-0.0796763959061747
148,2011-06-28,A Peek Into The Market Before The Trading Starts,MRK,0.011004896959194044,-0.0796763959061747,-0.0005785465020089475,-0.012010221795554998,-0.01409682332732598,-0.008664018159964093,-0.00027962163969863507,0.00544242700341413,0.2820073826652849
149,2011-06-28,UPS and Merck Expand Their Distribution and Logistics Agreement,MRK,0.011004896959194044,-0.0796763959061747,-0.0005785465020089475,-0.012010221795554998,-0.01409682332732598,-0.008664018159964093,-0.00027962163969863507,0.00544242700341413,0.2820073826652849
150,2011-07-01,"Merck Receives Approval to Market GARDASIL, ZOLINZA and CUBICIN in Japan",MRK,0.008784149950036513,-0.22502199688129942,0.005413303449522955,0.00544242700341413,0.011004896959194044,-0.0005785465020089475,-0.012010221795554998,-0.003089355344796818,-0.09062022660560587
151,2011-07-08,Hottest and Coldest Sectors for Friday 7/8/11,MRK,0.010915471855238001,0.23060858177059274,0.005628875735715244,0.0011266112968295605,-0.003089355344796818,0.008784149950036513,0.005413303449522955,-0.012181639349884699,-0.31807809650133567
152,2011-07-11,Merck to Participate in New Research Efforts to Eradicate HIV   ,MRK,-0.012181639349884699,-0.31807809650133567,0.010915471855238001,0.005628875735715244,0.0011266112968295605,-0.003089355344796818,0.008784149950036513,-0.001401509487055308,0.15536737233048736
153,2011-07-18,"Merck Announces VICTRELIS First-in-Class Oral Hepatitis C Virus Protease Inhibitor, Approved in the EU for Treatment of Chronic Hepatitis C   ",MRK,-0.012245565403100844,-0.2723282384640827,-0.010465493342621812,0.0077712790860162695,0.011226652841062945,-0.001401509487055308,-0.012181639349884699,0.008452909044005974,0.06672807279517556
154,2011-07-18,Merck's ISENTRESS in Combination Therapy Demonstrated Efficacy in a Phase II Study Extending to Nearly Five Years in Previously Untreated Adults with HIV-1 ,MRK,-0.012245565403100844,-0.2723282384640827,-0.010465493342621812,0.0077712790860162695,0.011226652841062945,-0.001401509487055308,-0.012181639349884699,0.008452909044005974,0.06672807279517556
155,2011-07-19,Dow Jones Industrial Average Companies Increase Expected Dividend Distribution by 12.66% From a Year Ago,MRK,0.008452909044005974,0.06672807279517556,-0.012245565403100844,-0.010465493342621812,0.0077712790860162695,0.011226652841062945,-0.001401509487055308,-0.005588394638846306,-0.26530991207178367
156,2011-07-20,Merck and Roche Expand Agreement in Fight Against Chronic Hepatitis C,MRK,-0.005588394638846306,-0.26530991207178367,0.008452909044005974,-0.012245565403100844,-0.010465493342621812,0.0077712790860162695,0.011226652841062945,0.016577544848966674,0.3672658912211628
157,2011-07-21,"Earnings Preview: Gilead Sciences EPS, Revenue Expected to Rise from Previous Quarter",MRK,0.016577544848966674,0.3672658912211628,-0.005588394638846306,0.008452909044005974,-0.012245565403100844,-0.010465493342621812,0.0077712790860162695,-0.0024874301704442825,-0.33412666915600153
158,2011-07-22,"Earnings Preview: Mylan Laboratories EPS, Revenue Expected to Rise from Previous Quarter",MRK,-0.0024874301704442825,-0.33412666915600153,0.016577544848966674,-0.005588394638846306,0.008452909044005974,-0.012245565403100844,-0.010465493342621812,-0.005541860497616735,0.594186565990247
159,2011-07-25,Ratchet Back The Risk With These ETFs,MRK,-0.005541860497616735,0.594186565990247,-0.0024874301704442825,0.016577544848966674,-0.005588394638846306,0.008452909044005974,-0.012245565403100844,-0.002785878842910705,-0.20982664321087985
160,2011-07-26,"Earnings Preview: Merck EPS, Revenue Expected to Rise from Previous Quarter",MRK,-0.002785878842910705,-0.20982664321087985,-0.005541860497616735,-0.0024874301704442825,0.016577544848966674,-0.005588394638846306,0.008452909044005974,-0.01676468944856435,0.49647693921194125
161,2011-07-26,"Merck to Acquire Rights to Vernakalant i.v. in Canada, Mexico and the United States from Astellas ",MRK,-0.002785878842910705,-0.20982664321087985,-0.005541860497616735,-0.0024874301704442825,0.016577544848966674,-0.005588394638846306,0.008452909044005974,-0.01676468944856435,0.49647693921194125
162,2011-07-28,How to Profit from Exploding Government Healthcare Costs ,MRK,-0.007388507100136499,-0.03174911535045044,-0.01676468944856435,-0.002785878842910705,-0.005541860497616735,-0.0024874301704442825,0.016577544848966674,-0.02290276285528714,0.393728097113335
163,2011-07-29,US Stock Futures Down On Debt Worries,MRK,-0.02290276285528714,0.393728097113335,-0.007388507100136499,-0.01676468944856435,-0.002785878842910705,-0.005541860497616735,-0.0024874301704442825,-0.020216920167107855,0.3220831065142442
164,2011-07-29,"News Summary for July 29, 2011",MRK,-0.02290276285528714,0.393728097113335,-0.007388507100136499,-0.01676468944856435,-0.002785878842910705,-0.005541860497616735,-0.0024874301704442825,-0.020216920167107855,0.3220831065142442
165,2011-07-29,Merck Doubles Profits In Second Quarter,MRK,-0.02290276285528714,0.393728097113335,-0.007388507100136499,-0.01676468944856435,-0.002785878842910705,-0.005541860497616735,-0.0024874301704442825,-0.020216920167107855,0.3220831065142442
166,2011-07-29,Stocks To Watch For July 29,MRK,-0.02290276285528714,0.393728097113335,-0.007388507100136499,-0.01676468944856435,-0.002785878842910705,-0.005541860497616735,-0.0024874301704442825,-0.020216920167107855,0.3220831065142442
167,2011-07-29,Earnings Scheduled For July 29,MRK,-0.02290276285528714,0.393728097113335,-0.007388507100136499,-0.01676468944856435,-0.002785878842910705,-0.005541860497616735,-0.0024874301704442825,-0.020216920167107855,0.3220831065142442
168,2011-08-01,"ARIAD Announces That Merck Has Submitted for Approval of Ridaforolimus, an Investigational mTOR Inhibitor, in the EU",MRK,-0.020216920167107855,0.3220831065142442,-0.02290276285528714,-0.007388507100136499,-0.01676468944856435,-0.002785878842910705,-0.005541860497616735,-0.016148611859732487,0.031073283759864623
169,2011-08-03,Merck and Serum Institute Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine ,MRK,-0.00607875513406253,-0.16114691221344224,-0.016148611859732487,-0.020216920167107855,-0.02290276285528714,-0.007388507100136499,-0.01676468944856435,-0.03639162424389697,0.18720275256735874
170,2011-08-09,"News Summary for August 9, 2011",MRK,0.04275241989253331,-0.026309309467206998,-0.05581833816778303,0.0063471874465572675,-0.03639162424389697,-0.00607875513406253,-0.016148611859732487,-0.04516337425286998,-0.09581452440685012
171,2011-08-18,Merck and ARIAD Announce European Medicines Agency Accepts Marketing Authorization Application for Ridaforolimus,MRK,-0.035403737404159474,0.6480387073112857,0.003115170336499551,-0.0009334125620182876,0.025206848602775,0.004487497513720795,0.0466285490617151,0.006438955462134688,-0.10234734299177706
172,2011-08-29,Zymeworks Announces Collaboration with Merck to Develop Bi-specific Antibody Therapeutics,MRK,0.01691740821569354,-0.37420468160967746,0.00188329321819114,-0.011480177574087591,0.009079925060098137,0.020121143427099142,0.0015997703803480867,0.007393562835334322,0.10850632251129366
173,2011-08-30,Merck Millipore Strengthens Bioscience Business by acquiring Amnis Corporation,MRK,0.007393562835334322,0.10850632251129366,0.01691740821569354,0.00188329321819114,-0.011480177574087591,0.009079925060098137,0.020121143427099142,0.012232315773152536,0.12482318959338712
174,2011-09-13,Merck Issues Statement on HPV Vaccine,MRK,0.003795179923327785,-0.03060966306781865,0.005025084663867085,-0.028676122648530367,-0.005460964462253637,0.02201535771423746,-0.003707151353281146,0.01197194279067837,0.0673951913207107
175,2011-09-13,A Peek Into The Market Before The Trading Starts,MRK,0.003795179923327785,-0.03060966306781865,0.005025084663867085,-0.028676122648530367,-0.005460964462253637,0.02201535771423746,-0.003707151353281146,0.01197194279067837,0.0673951913207107
176,2011-09-13,Merck and BGI Establish Strategic Collaboration focused on Biomarkers and Genomic Technologies  ,MRK,0.003795179923327785,-0.03060966306781865,0.005025084663867085,-0.028676122648530367,-0.005460964462253637,0.02201535771423746,-0.003707151353281146,0.01197194279067837,0.0673951913207107
177,2011-09-14,S&P Likes Three Health Care ETFs,MRK,0.01197194279067837,0.0673951913207107,0.003795179923327785,0.005025084663867085,-0.028676122648530367,-0.005460964462253637,0.02201535771423746,0.011519354735386456,-0.18430066076407348
178,2011-09-19,"Merck's Iss=entress Combo Showed Efficacy, Tolerability",MRK,-0.01315768468912537,-0.3186915165031683,0.005848241212881966,0.011519354735386456,0.01197194279067837,0.003795179923327785,0.005025084663867085,0.007751873533611953,0.0325850274013646
179,2011-09-27,Merck Names Cuong Viet Do as Chief Strategy Officer,MRK,0.01676630529990253,-0.016194159618559634,0.018035492783503138,-0.0025694774724842606,-0.022606093370877822,-0.02000030131199848,0.007751873533611953,-0.006222328217883932,-0.030689816317274632
180,2011-09-28,Merck Sells Its Interest in Johnson & Johnson-Merck Consumer Pharmaceuticals for $175M   ,MRK,-0.006222328217883932,-0.030689816317274632,0.01676630529990253,0.018035492783503138,-0.0025694774724842606,-0.022606093370877822,-0.02000030131199848,0.022541932553323152,0.3072781706825569
181,2011-09-30,Merck Announces New Data Analyses for VICTRELIS will be Presented at The American Association for the Study of Liver Diseases 2011 Annual Meeting   ,MRK,0.00122486575646219,0.2550086425865665,0.022541932553323152,-0.006222328217883932,0.01676630529990253,0.018035492783503138,-0.0025694774724842606,-0.034556783814973624,-0.016945802526261877
182,2011-10-03,Merck Wins Another Federal Bellwether Trial Regarding FOSAMAX,MRK,-0.034556783814973624,-0.016945802526261877,0.00122486575646219,0.022541932553323152,-0.006222328217883932,0.01676630529990253,0.018035492783503138,-0.006968527888790099,0.20489008086026406
183,2011-10-05,"FDA Accepts New Drug Application Filing for Ridaforolimus, Investigational mTOR Inhibitor   ",MRK,0.0035088074851585827,-0.11937282229965152,-0.006968527888790099,-0.034556783814973624,0.00122486575646219,0.022541932553323152,-0.006222328217883932,-0.0012717718436865422,-0.2640183436860256
184,2011-10-06,Merck Announces Retirement of Chairman and Former CEO Richard T. Clark   ,MRK,-0.0012717718436865422,-0.2640183436860256,0.0035088074851585827,-0.006968527888790099,-0.034556783814973624,0.00122486575646219,0.022541932553323152,0.006047773879542362,0.17587574634280867
185,2011-10-13,Under The Hood: Emerging Markets Health Care,MRK,0.0039912309783880495,-0.16805287872790498,0.020043895139085777,-0.012982802062134535,0.023409946283651006,0.006047773879542362,-0.0012717718436865422,0.008562590665188718,-0.207071695457809
186,2011-10-21,"Mylan Laboratories Earnings Preview: Analysts Expect Higher EPS, Revenue",MRK,0.01676810169674048,0.3235761965400179,0.007990179271642361,-0.007623860851695863,0.014855894852236151,-0.020315267256590608,0.008562590665188718,0.005396981895374742,-0.20339748723057438
187,2011-10-24,Merck Announces Presentation of Phase III Investigational Studies Evaluating DULERA Inhalation Aerosol in Chronic Obstructive Pulmonary Disease ,MRK,0.005396981895374742,-0.20339748723057438,0.01676810169674048,0.007990179271642361,-0.007623860851695863,0.014855894852236151,-0.020315267256590608,-0.01849080987713303,0.09661505730606468
188,2011-10-25,"Merck Earnings Preview: Analysts Expect Higher EPS, Revenue",MRK,-0.01849080987713303,0.09661505730606468,0.005396981895374742,0.01676810169674048,0.007990179271642361,-0.007623860851695863,0.014855894852236151,0.0191430957967762,-0.025144044156735545
189,2011-10-25,What Does Novartis' Earnings Release Really Mean for the Company?,MRK,-0.01849080987713303,0.09661505730606468,0.005396981895374742,0.01676810169674048,0.007990179271642361,-0.007623860851695863,0.014855894852236151,0.0191430957967762,-0.025144044156735545
190,2011-10-25,Merck Announces CDC Advisory Committee on Immunization Practices Votes for Expanded Use of GARDASIL® in Boys and Young Men   ,MRK,-0.01849080987713303,0.09661505730606468,0.005396981895374742,0.01676810169674048,0.007990179271642361,-0.007623860851695863,0.014855894852236151,0.0191430957967762,-0.025144044156735545
191,2011-10-28,US Stock Futures Signal Lower Start On Wall Street,MRK,0.023316664496311645,0.24025036824828927,0.022957897530306193,0.0191430957967762,-0.01849080987713303,0.005396981895374742,0.01676810169674048,-0.01737355538922214,-0.32250382652994813
192,2011-10-28,Earnings Scheduled For October 28,MRK,0.023316664496311645,0.24025036824828927,0.022957897530306193,0.0191430957967762,-0.01849080987713303,0.005396981895374742,0.01676810169674048,-0.01737355538922214,-0.32250382652994813
193,2011-10-28,"Financial Breakfast: Morning News Summary for October 28, 2011",MRK,0.023316664496311645,0.24025036824828927,0.022957897530306193,0.0191430957967762,-0.01849080987713303,0.005396981895374742,0.01676810169674048,-0.01737355538922214,-0.32250382652994813
194,2011-10-28,Merck Announces Increased Earnings,MRK,0.023316664496311645,0.24025036824828927,0.022957897530306193,0.0191430957967762,-0.01849080987713303,0.005396981895374742,0.01676810169674048,-0.01737355538922214,-0.32250382652994813
195,2011-10-31,A Look at The New DRGS ETN,MRK,-0.01737355538922214,-0.32250382652994813,0.023316664496311645,0.022957897530306193,0.0191430957967762,-0.01849080987713303,0.005396981895374742,-0.012753747382673764,0.540463907750018
196,2011-11-01,Which Pharma Stock Should You Short?,MRK,-0.012753747382673764,0.540463907750018,-0.01737355538922214,0.023316664496311645,0.022957897530306193,0.0191430957967762,-0.01849080987713303,0.0038169715628901812,-0.5302724129118623
197,2011-11-01,"One Pill Makes You Stronger: Pfizer Earnings Are the ""White Knight""",MRK,-0.012753747382673764,0.540463907750018,-0.01737355538922214,0.023316664496311645,0.022957897530306193,0.0191430957967762,-0.01849080987713303,0.0038169715628901812,-0.5302724129118623
198,2011-11-02,"FDA Advisers Vote 16-0 Efficacy, Safety data Support Approval of Merck's Vytorin ",MRK,0.0038169715628901812,-0.5302724129118623,-0.012753747382673764,-0.01737355538922214,0.023316664496311645,0.022957897530306193,0.0191430957967762,0.009944082808283072,0.17855722941537167
199,2011-11-02,FDA Advisory Committee Unanimously Recommends Approval of Merck's VYTORIN for Use in Patients with Pre-Dialysis Chronic Kidney Disease,MRK,0.0038169715628901812,-0.5302724129118623,-0.012753747382673764,-0.01737355538922214,0.023316664496311645,0.022957897530306193,0.0191430957967762,0.009944082808283072,0.17855722941537167
200,2011-11-07,JP Morgan Maintains Overweight Rating and $44 PT on Merck & Co ,MRK,0.008817960642922174,-0.10635777096674792,-0.014769468503392003,0.009944082808283072,0.0038169715628901812,-0.012753747382673764,-0.01737355538922214,0.004370696698462906,0.49537343997496386
201,2011-11-09,Merck Launches NEXPLANON 68 mg in the United States,MRK,-0.019727128183296694,0.4969794053999004,0.004370696698462906,0.008817960642922174,-0.014769468503392003,0.009944082808283072,0.0038169715628901812,0.034921103423030564,0.2322579463217609
202,2011-11-10,Merck Increase Quarterly Dividend by 11%,MRK,0.034921103423030564,0.2322579463217609,-0.019727128183296694,0.004370696698462906,0.008817960642922174,-0.014769468503392003,0.009944082808283072,0.02859621931307843,0.14907593450225232
203,2011-11-15,"Merck Settles Vioxx Suits From NY, Florida, S Carolina -Reuters ",MRK,0.0016819317875138573,-0.3693223948319857,-0.008340249510668474,0.02859621931307843,0.034921103423030564,-0.019727128183296694,0.004370696698462906,-0.01791208572495029,0.43939604255806075
204,2011-11-22,"End-of-Day Market Summary for November 22, 2011",MRK,-0.009666517812667474,0.029133710275223157,-0.023175885711150257,0.003157322020746367,-0.007124397679547867,-0.01791208572495029,0.0016819317875138573,-0.018337504631183665,-0.19103676624129473
205,2011-11-22,UPDATE: Merck Resolves Previously Disclosed Seven-Year Investigation Led by U.S. Attorney's Office for the District of Massachusetts Related to Vioxx,MRK,-0.009666517812667474,0.029133710275223157,-0.023175885711150257,0.003157322020746367,-0.007124397679547867,-0.01791208572495029,0.0016819317875138573,-0.018337504631183665,-0.19103676624129473
206,2011-11-28,Is Arena Pharma Going to Cure Obesity?,MRK,0.03317238963813818,2.171714696512403,-0.000903847899952015,-0.018337504631183665,-0.009666517812667474,-0.023175885711150257,0.003157322020746367,0.006421632804797239,-0.21972538274445808
207,2011-12-01,Are the Samsung M&A Rumors True?,MRK,-0.001958528022383166,-0.31875263679705723,0.036833136992156845,0.006421632804797239,0.03317238963813818,-0.000903847899952015,-0.018337504631183665,-0.005605305068127953,0.15294060998159154
208,2011-12-01,These Stocks May Be Better Than Their Dow Equivalents,MRK,-0.001958528022383166,-0.31875263679705723,0.036833136992156845,0.006421632804797239,0.03317238963813818,-0.000903847899952015,-0.018337504631183665,-0.005605305068127953,0.15294060998159154
209,2011-12-09,Are You Guaranteed Profits if These Rumors are True?,MRK,0.013924311047865068,-0.048978686637940805,-0.011794668611069703,0.005932194947532388,0.00397049914834624,-0.006200411066175526,-0.005605305068127953,-0.0075669412957385385,-0.687296051707273
210,2011-12-13,Benzinga's Top Pre-Market Losers,MRK,0.0,0.4525932980555343,-0.0075669412957385385,0.013924311047865068,-0.011794668611069703,0.005932194947532388,0.00397049914834624,0.016290369123699744,0.23055549970512712
211,2011-12-21,Merck and the ADAP Crisis Task Force Announce New Agreement to Improve Access and Care for People with HIV   ,MRK,0.007013863882936011,-0.3563164974929681,0.016451884318789523,0.006068541485249046,-0.0030252497266621825,0.022497215454609476,0.016290369123699744,0.006161445993382086,-0.12326632974883156
212,2011-12-21,Exelixis Licenses PI3K-Delta Program to Merck   ,MRK,0.007013863882936011,-0.3563164974929681,0.016451884318789523,0.006068541485249046,-0.0030252497266621825,0.022497215454609476,0.016290369123699744,0.006161445993382086,-0.12326632974883156
213,2011-12-27,Inside: 2012's Best Value Investment,MRK,-0.0039577840421478605,-0.2079350512389213,0.009052158309374336,0.006161445993382086,0.007013863882936011,0.016451884318789523,0.006068541485249046,-0.008476923772913092,-0.03821890343172385
214,2011-12-30,ETF Showdown: Fun With Pharma,MRK,-0.00079497068645773,0.14565775450009166,0.008015039846683836,-0.008476923772913092,-0.0039577840421478605,0.009052158309374336,0.006161445993382086,0.015914660617383447,1.197407120766525
215,2012-01-03,Can Germany's Employers Turn Europe Around? ,MRK,0.015914660617383447,1.197407120766525,-0.00079497068645773,0.008015039846683836,-0.008476923772913092,-0.0039577840421478605,0.009052158309374336,0.0010446625772959628,-0.2058374092500691
216,2012-01-04,Bark At The Dow's Dogs With These ETFs,MRK,0.0010446625772959628,-0.2058374092500691,0.015914660617383447,-0.00079497068645773,0.008015039846683836,-0.008476923772913092,-0.0039577840421478605,0.01043294470846523,0.530121153288817
217,2012-01-04,Will Alnylam's Prospective Obesity Drug Change the World Forever?,MRK,0.0010446625772959628,-0.2058374092500691,0.015914660617383447,-0.00079497068645773,0.008015039846683836,-0.008476923772913092,-0.0039577840421478605,0.01043294470846523,0.530121153288817
218,2012-01-10,Going Nuc-lear on Hepatitis C -- Is Idenix the Next Target?,MRK,0.0033861238986170328,-0.18269344443018054,-0.002079791778272111,-0.006969244377915684,0.01043294470846523,0.0010446625772959628,0.015914660617383447,-0.0028556104090606826,0.05099322703965781
219,2012-01-10,"Feuerstein: Merck for Idenix Pharma was Just a Prediction, Not a Rumor",MRK,0.0033861238986170328,-0.18269344443018054,-0.002079791778272111,-0.006969244377915684,0.01043294470846523,0.0010446625772959628,0.015914660617383447,-0.0028556104090606826,0.05099322703965781
220,2012-01-11,How to Trade Biotechs Based on the JP Morgan Health Care Conference,MRK,-0.0028556104090606826,0.05099322703965781,0.0033861238986170328,-0.002079791778272111,-0.006969244377915684,0.01043294470846523,0.0010446625772959628,0.005207003643710406,-0.16864498828119823
221,2012-01-18,"Benzinga's M&A Chatter for Wednesday January 18, 2012",MRK,0.0012881692662132238,-0.11139435618421145,0.013048045021568422,-0.007511034054973775,0.005207003643710406,-0.0028556104090606826,0.0033861238986170328,0.010032852585534213,0.1248215167063218
222,2012-01-20,Merck Announces Remicade Receives Positive Opinion From CHMP In Europe for Treatment of Ulcerative Colitis in Pediatric Patients  ,MRK,-0.0015279072490099743,-0.073301172259159,0.010032852585534213,0.0012881692662132238,0.013048045021568422,-0.007511034054973775,0.005207003643710406,-0.0109696600892345,-0.11960427698271436
223,2012-01-20,What's the Future Like For Health Care?,MRK,-0.0015279072490099743,-0.073301172259159,0.010032852585534213,0.0012881692662132238,0.013048045021568422,-0.007511034054973775,0.005207003643710406,-0.0109696600892345,-0.11960427698271436
224,2012-01-25,"Benzinga's M&A Chatter for Wednesday January 25, 2012",MRK,-0.0025789212123120686,0.10121949997844015,0.00025842674344644934,-0.0109696600892345,-0.0015279072490099743,0.010032852585534213,0.0012881692662132238,0.002585589243257802,-0.14413622667354864
225,2012-01-25,Merck Announces New FDA Approved Labeling For VYTORIN Includes Results From the Study of Heart and Renal Protection in Patients With Moderate to Severe Chronic Kidney Disease   ,MRK,-0.0025789212123120686,0.10121949997844015,0.00025842674344644934,-0.0109696600892345,-0.0015279072490099743,0.010032852585534213,0.0012881692662132238,0.002585589243257802,-0.14413622667354864
226,2012-01-26,"Benzinga's M&A Chatter for Thursday January 26, 2012",MRK,0.002585589243257802,-0.14413622667354864,-0.0025789212123120686,0.00025842674344644934,-0.0109696600892345,-0.0015279072490099743,0.010032852585534213,-0.006704734723194661,-0.021648540273772943
227,2012-02-02,UPDATE: Merck Swings To Q4 Profit,MRK,-0.004918655471582101,0.425571623273747,0.009407148990749015,-0.01594242908457122,0.009605527271509207,-0.006704734723194661,0.002585589243257802,-0.0018214444971877963,-0.2776855396600284
228,2012-02-02,"Merck's Earnings Are Up, But a Huge Drop may be Coming",MRK,-0.004918655471582101,0.425571623273747,0.009407148990749015,-0.01594242908457122,0.009605527271509207,-0.006704734723194661,0.002585589243257802,-0.0018214444971877963,-0.2776855396600284
229,2012-02-02,FDA Approves JANUMET XR for Type 2 Diabetes,MRK,-0.004918655471582101,0.425571623273747,0.009407148990749015,-0.01594242908457122,0.009605527271509207,-0.006704734723194661,0.002585589243257802,-0.0018214444971877963,-0.2776855396600284
230,2012-02-02,Earnings Scheduled For February 2,MRK,-0.004918655471582101,0.425571623273747,0.009407148990749015,-0.01594242908457122,0.009605527271509207,-0.006704734723194661,0.002585589243257802,-0.0018214444971877963,-0.2776855396600284
231,2012-02-02,"Financial Breakfast: Morning News Summary for February 2, 2012",MRK,-0.004918655471582101,0.425571623273747,0.009407148990749015,-0.01594242908457122,0.009605527271509207,-0.006704734723194661,0.002585589243257802,-0.0018214444971877963,-0.2776855396600284
232,2012-02-03,Candlesticks – Bears Appeared on Merck ,MRK,-0.0018214444971877963,-0.2776855396600284,-0.004918655471582101,0.009407148990749015,-0.01594242908457122,0.009605527271509207,-0.006704734723194661,0.0007820113521117555,-0.26501316852598333
233,2012-02-03,From Earlier: Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302  ,MRK,-0.0018214444971877963,-0.2776855396600284,-0.004918655471582101,0.009407148990749015,-0.01594242908457122,0.009605527271509207,-0.006704734723194661,0.0007820113521117555,-0.26501316852598333
234,2012-02-06,"Benzinga's M&A Chatter for Monday February 6, 2012",MRK,0.0007820113521117555,-0.26501316852598333,-0.0018214444971877963,-0.004918655471582101,0.009407148990749015,-0.01594242908457122,0.009605527271509207,0.005990060564334598,0.12826883241003828
235,2012-02-06,Merck Confirms Plans to File NDA for Suvorexant in 2012   ,MRK,0.0007820113521117555,-0.26501316852598333,-0.0018214444971877963,-0.004918655471582101,0.009407148990749015,-0.01594242908457122,0.009605527271509207,0.005990060564334598,0.12826883241003828
236,2012-02-07,Merck Announces Top-Line Results of TRA-2P Study of Vorapaxar,MRK,0.005990060564334598,0.12826883241003828,0.0007820113521117555,-0.0018214444971877963,-0.004918655471582101,0.009407148990749015,-0.01594242908457122,-0.005436636256045624,-0.08951262468977284
237,2012-02-10,Grandpa's 2012 ETF Portfolio,MRK,-0.006290956591372909,0.09621052673439778,-0.00702721746235202,-0.005436636256045624,0.005990060564334598,0.0007820113521117555,-0.0018214444971877963,0.005275602083804287,0.10459932707020148
238,2012-02-13,"FDA Approves ZIOPTAN, Merck's Once-Daily, Preservative-Free Ophthalmic Medication",MRK,0.005275602083804287,0.10459932707020148,-0.006290956591372909,-0.00702721746235202,-0.005436636256045624,0.005990060564334598,0.0007820113521117555,0.002623958083170841,-0.03900500491114656
239,2012-02-15,Merck Establishes Joint Venture with Supera Farma to Commercialize Innovative Pharmaceutical Products and Branded Generics in Brazil  ,MRK,-0.004972495408992583,0.09101654099004652,0.002623958083170841,0.005275602083804287,-0.006290956591372909,-0.00702721746235202,-0.005436636256045624,0.003156082146608563,-0.14378570472063879
240,2012-02-23,"Viva Vivus, But Not In ETFs (VVUS, IBB, PJP)",MRK,0.007587676133466559,0.050361068003599074,0.002360346362380694,-0.01115128079003902,0.011011987259841094,0.003156082146608563,-0.004972495408992583,-0.00804983265349013,-0.17802717934684498
241,2012-02-28,"The Rick Santorum ETF Portfolio (KOL, PBS, IYZ)",MRK,0.006028481117769546,-0.42695092455801686,-0.0013088502962799176,-0.00804983265349013,0.007587676133466559,0.002360346362380694,-0.01115128079003902,-0.005471676607404441,0.6106701938701327
242,2012-03-05,Merck's Investigational Allergy Immunotherapy Tablet Significantly Reduced the Combination of Ragweed Allergy Symptoms,MRK,0.013709596900054688,0.43007880706763757,0.003704404819224294,-0.009955189762764771,-0.005471676607404441,0.006028481117769546,-0.0013088502962799176,-0.026267612944473995,-0.0036328676278747363
243,2012-03-06,Merck Down 2% After Reaffirming 2012 Guidance,MRK,-0.026267612944473995,-0.0036328676278747363,0.013709596900054688,0.003704404819224294,-0.009955189762764771,-0.005471676607404441,0.006028481117769546,-0.003472350423248005,-0.09278149068492536
244,2012-03-06,Merck Issues Q1 Profit Forecast,MRK,-0.026267612944473995,-0.0036328676278747363,0.013709596900054688,0.003704404819224294,-0.009955189762764771,-0.005471676607404441,0.006028481117769546,-0.003472350423248005,-0.09278149068492536
245,2012-03-06,UPDATE: Merck Confirms 2012 Full-Year Guidance,MRK,-0.026267612944473995,-0.0036328676278747363,0.013709596900054688,0.003704404819224294,-0.009955189762764771,-0.005471676607404441,0.006028481117769546,-0.003472350423248005,-0.09278149068492536
246,2012-03-06,Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy,MRK,-0.026267612944473995,-0.0036328676278747363,0.013709596900054688,0.003704404819224294,-0.009955189762764771,-0.005471676607404441,0.006028481117769546,-0.003472350423248005,-0.09278149068492536
247,2012-03-07,Merck Gives Weak Q1 Outlook,MRK,-0.003472350423248005,-0.09278149068492536,-0.026267612944473995,0.013709596900054688,0.003704404819224294,-0.009955189762764771,-0.005471676607404441,0.002412453800668457,1.425726141078838
248,2012-03-07,From Earlier: Merck Announces Results from Investigational Studies with VICTRELIS Presented at the Conference on Retroviruses and Opportunistic Infections to Understand Potential Use in Patients Coinfected with Chronic Hepatitis C and HIV-1  ,MRK,-0.003472350423248005,-0.09278149068492536,-0.026267612944473995,0.013709596900054688,0.003704404819224294,-0.009955189762764771,-0.005471676607404441,0.002412453800668457,1.425726141078838
249,2012-03-12,"Benzinga's M&A Chatter for  Monday March 12, 2012",MRK,0.013297820599213805,-0.7557691918609127,0.005347541698597302,0.002412453800668457,-0.003472350423248005,-0.026267612944473995,0.013709596900054688,0.015923471551272605,0.37975246511222194
250,2012-03-15,"A Look At The New Russell High Yield ETF (HDIV, ABT, KFT)",MRK,-0.004186617266753956,0.04150365708453818,-0.00156723263575953,0.015923471551272605,0.013297820599213805,0.005347541698597302,0.002412453800668457,-0.0007881460204388624,0.515229462681692
251,2012-03-16,"ETF Showdown: Dividend Dilemma (HDV, HDIV, JNJ)",MRK,-0.0007881460204388624,0.515229462681692,-0.004186617266753956,-0.00156723263575953,0.015923471551272605,0.013297820599213805,0.005347541698597302,-0.003681415144489275,-0.4746894554627843
252,2012-03-21,UPDATE: Merck and ARIAD Pharmaceuticals Provide Update on FDA Advisory Committee Vote; Voted 13 To 1 Against The Use of Ridaforolimus,MRK,-0.0015888908433121518,-0.1699516280412967,-0.003430873410678492,-0.003681415144489275,-0.0007881460204388624,-0.004186617266753956,-0.00156723263575953,-0.0026523405424545565,0.1299904322866834
253,2012-03-26,Merck Reports C$35M Investment and Start of Merck Lumira Fund,MRK,0.01710043113560844,0.1146333889081308,0.01090406145421463,-0.0026523405424545565,-0.0015888908433121518,-0.003430873410678492,-0.003681415144489275,0.0036214240132326214,0.05739661823172848
254,2012-03-27,"Benzinga's M&A Chatter for Tuesday March 27, 2012",MRK,0.0036214240132326214,0.05739661823172848,0.01710043113560844,0.01090406145421463,-0.0026523405424545565,-0.0015888908433121518,-0.003430873410678492,-0.012628514121376666,0.2833287062784673
255,2012-04-03,Codexis and Merck Develop Prototype Enzyme-Based Method for Production of Boceprevir  ,MRK,0.005452773935197719,-0.04307350178226754,0.0028649240171358947,0.010260348599631541,-0.007830992181423468,-0.012628514121376666,0.0036214240132326214,0.004649005662854089,0.38935517150706467
256,2012-04-16,Morning Market Movers,MRK,0.004499687478773495,-0.33176559402275163,-0.012803848790417294,-0.005457469515873337,0.0007804480287243454,-0.007229461799705628,-0.0038582031943062978,0.014756552384477706,-0.19641847484197617
257,2012-04-16,Merck and Endocyte Enter Exclusive Worldwide Agreement to Develop and Commercialize Phase III Cancer Candidate Vintafolide,MRK,0.004499687478773495,-0.33176559402275163,-0.012803848790417294,-0.005457469515873337,0.0007804480287243454,-0.007229461799705628,-0.0038582031943062978,0.014756552384477706,-0.19641847484197617
258,2012-04-16,Benzinga's Top Pre-Market Gainers,MRK,0.004499687478773495,-0.33176559402275163,-0.012803848790417294,-0.005457469515873337,0.0007804480287243454,-0.007229461799705628,-0.0038582031943062978,0.014756552384477706,-0.19641847484197617
259,2012-04-16,"Financial Breakfast: Morning News Summary for April 16, 2012",MRK,0.004499687478773495,-0.33176559402275163,-0.012803848790417294,-0.005457469515873337,0.0007804480287243454,-0.007229461799705628,-0.0038582031943062978,0.014756552384477706,-0.19641847484197617
260,2012-04-17,"Benzinga's Microcap Movers for Monday April 16, 2012",MRK,0.014756552384477706,-0.19641847484197617,0.004499687478773495,-0.012803848790417294,-0.005457469515873337,0.0007804480287243454,-0.007229461799705628,-0.0028567396750301954,-0.31561373345877186
261,2012-04-17,Benzinga's Top Pre-Market Gainers,MRK,0.014756552384477706,-0.19641847484197617,0.004499687478773495,-0.012803848790417294,-0.005457469515873337,0.0007804480287243454,-0.007229461799705628,-0.0028567396750301954,-0.31561373345877186
262,2012-04-18,Merck Wins Another FOSAMAX State Court Trial   ,MRK,-0.0028567396750301954,-0.31561373345877186,0.014756552384477706,0.004499687478773495,-0.012803848790417294,-0.005457469515873337,0.0007804480287243454,-0.0010414331829494694,0.40120540163934315
263,2012-04-19,S&P: Bullish On Pharma ETFs Long-Term,MRK,-0.0010414331829494694,0.40120540163934315,-0.0028567396750301954,0.014756552384477706,0.004499687478773495,-0.012803848790417294,-0.005457469515873337,0.009645211685685773,0.3851110634540942
264,2012-04-19,Merck Reports Phase III Study Results Evaluating Anaemia Management Strategies Used With VICTRELIS® (boceprevir) Combination Therapy   ,MRK,-0.0010414331829494694,0.40120540163934315,-0.0028567396750301954,0.014756552384477706,0.004499687478773495,-0.012803848790417294,-0.005457469515873337,0.009645211685685773,0.3851110634540942
265,2012-04-27,Earnings Scheduled For April 27,MRK,-0.00026001403868503026,0.5218649739496437,0.0010411389977629248,0.0041806268350339515,0.0,-0.011876899417763154,0.009645211685685773,0.020280667512327044,0.2767797989519285
266,2012-04-27,US Stock Futures Flat; GDP Data In Focus,MRK,-0.00026001403868503026,0.5218649739496437,0.0010411389977629248,0.0041806268350339515,0.0,-0.011876899417763154,0.009645211685685773,0.020280667512327044,0.2767797989519285
267,2012-04-30,FDA Considering Letting Patients Purchase Drugs Without Prescriptions,MRK,0.020280667512327044,0.2767797989519285,-0.00026001403868503026,0.0010411389977629248,0.0041806268350339515,0.0,-0.011876899417763154,0.003312983448873652,-0.2634512353504408
268,2012-04-30,New Kids: Do These New ETFs Have The Right Stuff?,MRK,0.020280667512327044,0.2767797989519285,-0.00026001403868503026,0.0010411389977629248,0.0041806268350339515,0.0,-0.011876899417763154,0.003312983448873652,-0.2634512353504408
269,2012-05-11,The Shorts Report: 10 Mega-Caps With Increased Short Selling,MRK,-0.009377637924354754,0.2812634824048623,0.007876223656845927,-0.01397928091008982,0.0023355063551151467,-0.007723985383158216,-0.008424363744507501,0.004996302557862986,0.34358543505200245
270,2012-05-15,"S&P Bullish On Biotech ETFs (FBT, IBB, XBI)",MRK,-0.012559181118796503,-0.3453636992129022,0.004996302557862986,-0.009377637924354754,0.007876223656845927,-0.01397928091008982,0.0023355063551151467,0.012983737480711355,0.4426013724434634
271,2012-05-21,"Merck: FDA Approves New Labeling for ISENTRESS to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety and Tolerability",MRK,-0.0058166659022870215,-0.5024236832930624,-0.005522047824245924,-0.005231586858556625,0.012983737480711355,-0.012559181118796503,0.004996302557862986,-0.003723666918834967,0.3255484076171715
272,2012-05-22,Health Care SPDR In Focus Ahead Of Obamacare Decision,MRK,-0.003723666918834967,0.3255484076171715,-0.0058166659022870215,-0.005522047824245924,-0.005231586858556625,0.012983737480711355,-0.012559181118796503,-0.0032035351870711715,-0.08848442159323344
273,2012-05-25,"Amylin Shares Jump as Sanofi, Merck Sumbit Bids",MRK,-0.0013300000765064102,-0.23811506408637406,0.006963427209524031,-0.0032035351870711715,-0.003723666918834967,-0.0058166659022870215,-0.005522047824245924,0.0010651591765591384,0.3338794154079685
274,2012-05-25,Government of Rwanda Introduces Merck's ROTATEQ,MRK,-0.0013300000765064102,-0.23811506408637406,0.006963427209524031,-0.0032035351870711715,-0.003723666918834967,-0.0058166659022870215,-0.005522047824245924,0.0010651591765591384,0.3338794154079685
275,2012-06-04,The US Economy and the United Nations: Bold Strategies Needed - Tax Reform and Benefits Reform,MRK,0.007530850418150381,-0.18365794201665164,-0.010644072369657587,0.00481278217922676,-0.005054255239510752,0.0010651591765591384,-0.0013300000765064102,0.0010676423101736443,-0.03254911511240011
276,2012-06-07,Pfizer Plans to IPO Part of its Animal Health Segment,MRK,0.011345600515584753,3.231118101191986,0.01066693543186914,0.0010676423101736443,0.007530850418150381,-0.010644072369657587,0.00481278217922676,0.003391711843669043,-0.04584146416095791
277,2012-06-13,Merck Announces New Phase III Data Showed Merck's Investigational Insomnia Medicine Suvorexant Improved Patients' Ability to Fall Asleep and Stay Asleep ,MRK,-0.0007807699227191378,0.1050444253367726,0.009877794142176821,0.0002600816635687231,0.003391711843669043,0.011345600515584753,0.01066693543186914,0.010156252522059761,0.11611984531532404
278,2012-06-14,"Believe In The Rally? Try These ETFs (HDV, IYZ, HYD)",MRK,0.010156252522059761,0.11611984531532404,-0.0007807699227191378,0.009877794142176821,0.0002600816635687231,0.003391711843669043,0.011345600515584753,0.003867183695365428,0.24349319596983166
279,2012-06-14,Johnson & Johnson to Complete Synthes Acquisition ,MRK,0.010156252522059761,0.11611984531532404,-0.0007807699227191378,0.009877794142176821,0.0002600816635687231,0.003391711843669043,0.011345600515584753,0.003867183695365428,0.24349319596983166
280,2012-06-15,US District Court Rules Against Merck in NASONEX Patent Lawsuit,MRK,0.003867183695365428,0.24349319596983166,0.010156252522059761,-0.0007807699227191378,0.009877794142176821,0.0002600816635687231,0.003391711843669043,-0.0023114874806848817,-0.4857721417080729
281,2012-06-18,From Earlier: U.S. District Court Rules Against Merck in NASONEX Patent Lawsuit  ,MRK,-0.0023114874806848817,-0.4857721417080729,0.003867183695365428,0.010156252522059761,-0.0007807699227191378,0.009877794142176821,0.0002600816635687231,0.00978131478002564,0.44170134901374203
282,2012-06-18,"Geisinger and Merck to Collaborate on Multi-year Effort to Improve Patient Adherence, Engagement and Care Delivery   ",MRK,-0.0023114874806848817,-0.4857721417080729,0.003867183695365428,0.010156252522059761,-0.0007807699227191378,0.009877794142176821,0.0002600816635687231,0.00978131478002564,0.44170134901374203
283,2012-06-20,Merck Statement on CDC Advisory Committee on Immunization Practices' Recommendation for Pneumococcal Vaccination in Immunocompromised Adults   ,MRK,-0.0005097550805661655,-0.04276073648653145,0.00978131478002564,-0.0023114874806848817,0.003867183695365428,0.010156252522059761,-0.0007807699227191378,0.006120827440161181,0.5216288162870237
284,2012-06-25,"Ahead of Obamacare Ruling, S&P Likes Health Care SPDR",MRK,-0.00970674186382936,-0.36441677656050797,0.018504657158929794,0.006120827440161181,-0.0005097550805661655,0.00978131478002564,-0.0023114874806848817,0.006785692487583095,-0.254684637031555
285,2012-06-27,A Peek Into The Market Before The Trading Starts,MRK,0.011732314935305022,0.1475990052532592,0.006785692487583095,-0.00970674186382936,0.018504657158929794,0.006120827440161181,-0.0005097550805661655,0.003700883526855714,-0.04303942106265468
286,2012-06-27,Merck and AstraZeneca Agree to Amend Partnership   ,MRK,0.011732314935305022,0.1475990052532592,0.006785692487583095,-0.00970674186382936,0.018504657158929794,0.006120827440161181,-0.0005097550805661655,0.003700883526855714,-0.04303942106265468
287,2012-06-28,Ultimate Stock Watch List for The Supreme Court's Health Care Ruling,MRK,0.003700883526855714,-0.04303942106265468,0.011732314935305022,0.006785692487583095,-0.00970674186382936,0.018504657158929794,0.006120827440161181,0.026303217523325984,0.8846169154228856
288,2012-06-29,ALPS Unveils Dogs of the Dow ETF,MRK,0.026303217523325984,0.8846169154228856,0.003700883526855714,0.011732314935305022,0.006785692487583095,-0.00970674186382936,0.018504657158929794,0.002394933026227619,-0.394559768924006
289,2012-07-11,Merck Announces Collaboration to Improve Maternal Health through Expanded Access to Family Planning   ,MRK,-0.0038670241647638104,-0.2602091797407098,-0.018039860868872104,0.014936132377694422,-0.002882407245547891,-0.004304964185832705,-0.0009558863723819755,0.04125207713508572,2.7173883913857697
292,2012-07-12,"From Earlier: Update on Phase III Trial for Odanacatib, Merck's Investigational Cat-K Inhibitor for Osteoporosis ",MRK,0.04125207713508572,2.7173883913857697,-0.0038670241647638104,-0.018039860868872104,0.014936132377694422,-0.002882407245547891,-0.004304964185832705,0.01305031208067331,-0.6307591555772005
295,2012-07-12,Benzinga's Top Pre-Market Gainers,MRK,0.04125207713508572,2.7173883913857697,-0.0038670241647638104,-0.018039860868872104,0.014936132377694422,-0.002882407245547891,-0.004304964185832705,0.01305031208067331,-0.6307591555772005
298,2012-07-12,Thursday Market Movers,MRK,0.04125207713508572,2.7173883913857697,-0.0038670241647638104,-0.018039860868872104,0.014936132377694422,-0.002882407245547891,-0.004304964185832705,0.01305031208067331,-0.6307591555772005
302,2012-07-13,"5 Market-Based ETFs Your Broker Forgot to Mention (HDIV, OFF, PDP)",MRK,0.01305031208067331,-0.6307591555772005,0.04125207713508572,-0.0038670241647638104,-0.018039860868872104,0.014936132377694422,-0.002882407245547891,-0.002760141756452672,-0.10225418810382148
304,2012-07-13,"Low Volume, High Returns for These ETFs (BIB, FHC, DRW)",MRK,0.01305031208067331,-0.6307591555772005,0.04125207713508572,-0.0038670241647638104,-0.018039860868872104,0.014936132377694422,-0.002882407245547891,-0.002760141756452672,-0.10225418810382148
308,2012-07-13,"Low Volume, High Returns for These ETFs (BIB, FHC)",MRK,0.01305031208067331,-0.6307591555772005,0.04125207713508572,-0.0038670241647638104,-0.018039860868872104,0.014936132377694422,-0.002882407245547891,-0.002760141756452672,-0.10225418810382148
313,2012-07-17,Popular Drug Manufacturing Stocks Among Hedge Funds,MRK,0.01937700323259839,0.32234431385484497,-0.002760141756452672,0.01305031208067331,0.04125207713508572,-0.0038670241647638104,-0.018039860868872104,-0.005657628279432392,-0.19523126232372567
318,2012-07-23,"From Earlier: Merck ISENTRESS in Combination Therapy Demonstrated Long-Term Efficacy, Safety and Tolerability in Previously Untreated Adult Patients with HIV-1 for up to 240 Weeks  ",MRK,-0.0032250154919643004,0.10465710562231445,-0.0120616035981298,0.0,-0.005657628279432392,0.01937700323259839,-0.002760141756452672,-0.013404741424130506,0.41711229130330363
321,2012-07-23,"Earnings Expectations for the Week of July 23 (MCD, AAPL, F, XOM)",MRK,-0.0032250154919643004,0.10465710562231445,-0.0120616035981298,0.0,-0.005657628279432392,0.01937700323259839,-0.002760141756452672,-0.013404741424130506,0.41711229130330363
322,2012-07-23,Earnings Expectations for the Week of July 23,MRK,-0.0032250154919643004,0.10465710562231445,-0.0120616035981298,0.0,-0.005657628279432392,0.01937700323259839,-0.002760141756452672,-0.013404741424130506,0.41711229130330363
326,2012-07-27,US Stock Futures Up; GDP Data In Focus,MRK,0.040849060069527265,0.8389467476552832,0.016659038217867517,-0.0016392757778739275,-0.013404741424130506,-0.0032250154919643004,-0.0120616035981298,-0.013747079008862961,-0.5680483340808937
327,2012-07-27,Earnings Scheduled For July 27,MRK,0.040849060069527265,0.8389467476552832,0.016659038217867517,-0.0016392757778739275,-0.013404741424130506,-0.0032250154919643004,-0.0120616035981298,-0.013747079008862961,-0.5680483340808937
330,2012-07-27,Stocks To Watch For July 27,MRK,0.040849060069527265,0.8389467476552832,0.016659038217867517,-0.0016392757778739275,-0.013404741424130506,-0.0032250154919643004,-0.0120616035981298,-0.013747079008862961,-0.5680483340808937
335,2012-07-27,"Benzinga Market Primer, Friday July 27",MRK,0.040849060069527265,0.8389467476552832,0.016659038217867517,-0.0016392757778739275,-0.013404741424130506,-0.0032250154919643004,-0.0120616035981298,-0.013747079008862961,-0.5680483340808937
339,2012-07-30,"Benzinga Market Primer, Monday July 30",MRK,-0.013747079008862961,-0.5680483340808937,0.040849060069527265,0.016659038217867517,-0.0016392757778739275,-0.013404741424130506,-0.0032250154919643004,-0.006969506027954764,-0.024277415845694317
343,2012-08-06,Teva Pharmaceutical Subpoenaed By SEC in Bribery Charge,MRK,0.007701025120797622,-0.09179861280419399,0.0054660596902880165,-0.008356415872812661,0.002490345708562769,-0.006969506027954764,-0.013747079008862961,-0.011014151381002257,0.19672381367197733
345,2012-08-09,Under The Hood: Tempting Technicals And a Dividend,MRK,0.004993447343272672,-0.07448796388848211,0.0013639920568049302,-0.011014151381002257,0.007701025120797622,0.0054660596902880165,-0.008356415872812661,0.006548858017154435,-0.06979935960015993
349,2012-08-16,S&P Still Bullish on Health Care ETFs,MRK,-0.0027235648498803444,0.12687563338626462,-0.007881340319514263,-0.00022522466810759312,-0.003365042083886105,0.006548858017154435,0.004993447343272672,-0.013655014567101498,0.7671601789450344
353,2012-09-10,"Merck Announces New Phase III Data for Suvorexant, Says Patients Normal Sleep Patterns Return After Stopping Use",MRK,0.004766887125042807,0.07881707443510577,-0.004294388745189948,0.018416292498101283,0.004392817627552725,0.004645551337318032,-0.0016228632540061794,0.0015815087791082316,-0.047912845311544716
356,2012-09-13,Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer ,MRK,0.012468684983141243,0.325350596095469,0.004511670417547409,0.0015815087791082316,0.004766887125042807,-0.004294388745189948,0.018416292498101283,-0.023286730460506666,0.3943962491476707
357,2012-09-25,S&P Highlights Election ETFs,MRK,-0.0006644992746336342,0.28189171122611545,0.005121060072919903,0.00044550796051723296,0.00853760883625121,0.009755066963321957,0.001818459052894239,-0.0022169241127586448,-0.01190147430858024
361,2012-09-26,Merck Returns Rights for Vernakalant to Cardiome,MRK,-0.0022169241127586448,-0.01190147430858024,-0.0006644992746336342,0.005121060072919903,0.00044550796051723296,0.00853760883625121,0.009755066963321957,0.004887895916189988,-0.22275702492900906
364,2012-10-08,Delphi Genetics Grants Merck License for the Use of the StabyExpress System,MRK,0.0012966235264868509,-0.4085848497705046,0.003468769066838462,0.007427068930012659,0.006817906599534407,0.005528271942890406,0.002660662967138183,-0.003668567689154023,0.42611986079015995
367,2012-10-09,Part I: Must Know ETFs For Q3 Earnings ,MRK,-0.003668567689154023,0.42611986079015995,0.0012966235264868509,0.003468769066838462,0.007427068930012659,0.006817906599534407,0.005528271942890406,-0.01234527454569001,-0.05538886853722891
371,2012-10-09,Merck to Move Global Headquarters Within New Jersey  ,MRK,-0.003668567689154023,0.42611986079015995,0.0012966235264868509,0.003468769066838462,0.007427068930012659,0.006817906599534407,0.005528271942890406,-0.01234527454569001,-0.05538886853722891
374,2012-10-15,"AiCuris, Merck Enter Exclusive Worldwide License Agreement ",MRK,0.021262676506361045,0.5021697166500345,0.0037401599823942977,-0.0032898960562987023,-0.01234527454569001,-0.003668567689154023,0.0012966235264868509,0.012449390954316408,0.1627129667904803
375,2012-10-15,A Peek Into The Market Before The Trading Starts,MRK,0.021262676506361045,0.5021697166500345,0.0037401599823942977,-0.0032898960562987023,-0.01234527454569001,-0.003668567689154023,0.0012966235264868509,0.012449390954316408,0.1627129667904803
378,2012-10-22,Earnings Expectations for the Week of October 22,MRK,-0.011694527366608698,0.08052246824338649,-0.019391382838671034,0.012027928935318233,0.004663950062187894,0.012449390954316408,0.021262676506361045,-0.012693683599984129,-0.10820598856968022
380,2012-10-24,S&P Likes a Trio of Biotech ETFs ,MRK,-0.0002178999022703909,-0.22908302111000567,-0.012693683599984129,-0.011694527366608698,-0.019391382838671034,0.012027928935318233,0.004663950062187894,0.009154033818160379,0.13815778142355395
385,2012-10-26,S&P Bullish on Select Dividend ETFs,MRK,-0.0032396764434408087,0.08831973750170907,0.009154033818160379,-0.0002178999022703909,-0.012693683599984129,-0.011694527366608698,-0.019391382838671034,-0.01126732456524937,0.13353712156107367
389,2012-10-26,"Earnings Scheduled For October 26, 2012",MRK,-0.0032396764434408087,0.08831973750170907,0.009154033818160379,-0.0002178999022703909,-0.012693683599984129,-0.011694527366608698,-0.019391382838671034,-0.01126732456524937,0.13353712156107367
390,2012-10-26,US Stock Futures Down After Apple Earnings,MRK,-0.0032396764434408087,0.08831973750170907,0.009154033818160379,-0.0002178999022703909,-0.012693683599984129,-0.011694527366608698,-0.019391382838671034,-0.01126732456524937,0.13353712156107367
392,2012-10-26,"Stocks To Watch For October 26, 2012",MRK,-0.0032396764434408087,0.08831973750170907,0.009154033818160379,-0.0002178999022703909,-0.012693683599984129,-0.011694527366608698,-0.019391382838671034,-0.01126732456524937,0.13353712156107367
400,2012-10-26,"Benzinga Market Primer, Friday October 26",MRK,-0.0032396764434408087,0.08831973750170907,0.009154033818160379,-0.0002178999022703909,-0.012693683599984129,-0.011694527366608698,-0.019391382838671034,-0.01126732456524937,0.13353712156107367
404,2012-10-26,"Benzinga Market Primer, Friday, October 26",MRK,-0.0032396764434408087,0.08831973750170907,0.009154033818160379,-0.0002178999022703909,-0.012693683599984129,-0.011694527366608698,-0.019391382838671034,-0.01126732456524937,0.13353712156107367
408,2012-11-08,"Futures Flat, Euro Falls Ahead of Central Banks",MRK,-0.013945198808531623,-0.32150707213160734,-0.03179436732948515,0.005473799324904549,-0.007173563718949172,0.001306037460233167,0.006793508176796692,0.004790444777634129,-0.14297083599810323
415,2012-11-12,Merck Presents Early-Stage Interim Data for MK-3475  Study for Treatment of Advanced Melanoma ,MRK,-0.0006814485761963418,-0.47626333182654634,0.004790444777634129,-0.013945198808531623,-0.03179436732948515,0.005473799324904549,-0.007173563718949172,-0.007723384128348276,0.3095992647393848
416,2012-11-16,S&P Reiterates Bullish View on Health Care ETFs,MRK,0.0063084404660369575,0.3544108606103695,-0.005807385245262364,-0.014423014259898337,-0.007723384128348276,-0.0006814485761963418,0.004790444777634129,0.0062686343373528075,-0.44761816597965987
420,2012-12-03,"Merck Begins Phase II/III Study of Investigational BACE Inhibitor, MK-8931",MRK,0.0031600257156456646,-0.22621394830584218,-0.009170055342793582,0.00246679012923523,0.016408081202276437,-0.007239657411278855,-0.001806959042345735,-0.0009001011444151885,-0.13968901773833098
423,2012-12-11,"Benzinga's M&A Chatter for Tuesday December 11, 2012",MRK,0.01596193825337555,0.4531692966033698,-0.0033605257380278086,0.0026959946002358404,0.002703408715475364,-0.00022552657910557272,-0.0009001011444151885,0.0015489882510457686,-0.17178930319873376
424,2012-12-11,"Benzinga's Small Cap Movers for Tuesday December 11, 2012",MRK,0.01596193825337555,0.4531692966033698,-0.0033605257380278086,0.0026959946002358404,0.002703408715475364,-0.00022552657910557272,-0.0009001011444151885,0.0015489882510457686,-0.17178930319873376
429,2012-12-11,Cardiome Reaches Deal with Merck to Retire Debt/Close Line of Credit; Will Pay Merck $20M,MRK,0.01596193825337555,0.4531692966033698,-0.0033605257380278086,0.0026959946002358404,0.002703408715475364,-0.00022552657910557272,-0.0009001011444151885,0.0015489882510457686,-0.17178930319873376
432,2012-12-18,"Merck, GE Healthcare Announce Collaboration on Use of Imaging Biomarkers for Investigational BACE Inhibitor Program",MRK,0.013980942738565094,0.060300266208734854,0.002067434659852596,-0.009328622583760104,-0.019629800660233898,0.0015489882510457686,0.01596193825337555,-0.013109972142855697,-0.16958311264543036
435,2012-12-20,Merck Says HPS2-THRIVE Study of TREDAPTIVE Did Not Achieve Primary Endpoint,MRK,-0.03435667678147214,1.8775944318308024,-0.013109972142855697,0.013980942738565094,0.002067434659852596,-0.009328622583760104,-0.019629800660233898,-0.015180539242253599,-0.14677840044937618
438,2012-12-20,"Mid-Morning Market Update: Rite Aid Rallies, New York Stock Exchange Acquired by ICE",MRK,-0.03435667678147214,1.8775944318308024,-0.013109972142855697,0.013980942738565094,0.002067434659852596,-0.009328622583760104,-0.019629800660233898,-0.015180539242253599,-0.14677840044937618
441,2012-12-20,"Mid-Morning Market Update: Rite Aid Rallys, New York Stock Exchange Acquired by ICE",MRK,-0.03435667678147214,1.8775944318308024,-0.013109972142855697,0.013980942738565094,0.002067434659852596,-0.009328622583760104,-0.019629800660233898,-0.015180539242253599,-0.14677840044937618
443,2013-01-02,"Merck Says FDA Acknowledged Resubmission of NDA for Ezetimibe, Atorvastatin Tablets",MRK,0.009770393754910067,0.11451101609602632,0.007382282277665908,-0.013592420873581812,-0.003386747146015723,-0.001931193917243057,-0.002408361716835561,0.02394755005296534,0.4754369639925202
446,2013-01-07,4 Health Care ETFs Your Broker Forgot to Mention,MRK,0.0035743352598567313,-0.25439283204202,-0.008504560935846506,0.02394755005296534,0.009770393754910067,0.007382282277665908,-0.013592420873581812,0.001423880662839494,0.2822855075323665
450,2013-01-07,Merck Receives FDA Acceptance of Resubmission of NDA for Sugammadex Sodium Injection,MRK,0.0035743352598567313,-0.25439283204202,-0.008504560935846506,0.02394755005296534,0.009770393754910067,0.007382282277665908,-0.013592420873581812,0.001423880662839494,0.2822855075323665
453,2013-01-09,"Microbiotix, Merck Announce Licensing Pact for HCV NS5B",MRK,0.00972014547810951,-0.31711961160604574,0.001423880662839494,0.0035743352598567313,-0.008504560935846506,0.02394755005296534,0.009770393754910067,0.004461601738454668,0.28763734642440575
456,2013-01-11,Three Stocks to Buy for Flu Season,MRK,0.01051900531326333,-0.06402218951931737,0.004461601738454668,0.00972014547810951,0.001423880662839494,0.0035743352598567313,-0.008504560935846506,0.0025441882295165197,-0.08426619088134912
458,2013-01-11,Merck to Suspend Availability of TREDAPTIVE Worldwide,MRK,0.01051900531326333,-0.06402218951931737,0.004461601738454668,0.00972014547810951,0.001423880662839494,0.0035743352598567313,-0.008504560935846506,0.0025441882295165197,-0.08426619088134912
459,2013-01-25,FDA Approves OXYTROL for Women,MRK,0.010697710807272776,0.05369589562467425,0.004203620874919434,-0.008796179606999521,0.005118554165538969,0.005380102801579634,0.00493678699401312,-0.012194965265189261,-0.10004326297001376
462,2013-01-30,Isis and Sanofi's Drug OK'd to Treat Inherited Cholesterol Disease,MRK,-0.0036650473311988785,-0.1938703142737237,0.017004747701759637,-0.012194965265189261,0.010697710807272776,0.004203620874919434,-0.008796179606999521,-0.005747356519754221,0.14730991195240373
464,2013-02-01,US Stock Futures Up; All Eyes On Payroll Data ,MRK,-0.032831887032661156,1.592129007708785,-0.005747356519754221,-0.0036650473311988785,0.017004747701759637,-0.012194965265189261,0.010697710807272776,-0.023428329335598908,-0.21965346047337642
467,2013-02-01,"Earnings Scheduled For February 1, 2013",MRK,-0.032831887032661156,1.592129007708785,-0.005747356519754221,-0.0036650473311988785,0.017004747701759637,-0.012194965265189261,0.010697710807272776,-0.023428329335598908,-0.21965346047337642
469,2013-02-01,"Stocks To Watch For February 1, 2013",MRK,-0.032831887032661156,1.592129007708785,-0.005747356519754221,-0.0036650473311988785,0.017004747701759637,-0.012194965265189261,0.010697710807272776,-0.023428329335598908,-0.21965346047337642
473,2013-02-05,"Merck Serono, Opexa Therapeutics Enter Option, License Agreement for Development of Tcelna",MRK,0.014197651666053579,-0.27550096254656586,-0.023428329335598908,-0.032831887032661156,-0.005747356519754221,-0.0036650473311988785,0.017004747701759637,-0.008206180493402382,-0.1841387726404553
476,2013-02-14,"Merck Resolves Securities Class-Action Suit Related to ENHANCE, to Record $493M Charge",MRK,0.000972503744713693,0.033505661019433974,-0.0072377530761067455,0.0016912354629703419,0.004857163493849681,0.004390288466433079,-0.0021904368192515733,0.005583594700819594,-0.04614637080562023
479,2013-02-27,Still No Herbalife in 13F ETFs,MRK,0.012965605146178838,-0.07091943426039926,-0.0023516557872329535,-0.010472622154323541,0.011058951807431106,-0.0037504439473573514,0.01042164877641194,-0.005585561452948418,0.10019272192366446
481,2013-02-27,Still no Herbalife in 13F ETFs,MRK,0.012965605146178838,-0.07091943426039926,-0.0023516557872329535,-0.010472622154323541,0.011058951807431106,-0.0037504439473573514,0.01042164877641194,-0.005585561452948418,0.10019272192366446
484,2013-02-28,"If The Market Falls, Try These Low Beta ETFs",MRK,-0.005585561452948418,0.10019272192366446,0.012965605146178838,-0.0023516557872329535,-0.010472622154323541,0.011058951807431106,-0.0037504439473573514,-0.002340422008273335,0.04257175742182362
488,2013-03-04,The News of an HIV Cure Is Great News For These Publicly-Traded Companies,MRK,0.016655083434932383,-0.04428226031754534,-0.002340422008273335,-0.005585561452948418,0.012965605146178838,-0.0023516557872329535,-0.010472622154323541,-0.002076656490567208,0.06764733431312497
492,2013-03-04,An HIV Cure Is Great News For These Publicly-Traded Companies,MRK,0.016655083434932383,-0.04428226031754534,-0.002340422008273335,-0.005585561452948418,0.012965605146178838,-0.0023516557872329535,-0.010472622154323541,-0.002076656490567208,0.06764733431312497
496,2013-03-04,An HIV Cure Is Great News For These Drug Manufacturers,MRK,0.016655083434932383,-0.04428226031754534,-0.002340422008273335,-0.005585561452948418,0.012965605146178838,-0.0023516557872329535,-0.010472622154323541,-0.002076656490567208,0.06764733431312497
498,2013-03-06,3 Sector ETFs Outpacing Larger Rivals,MRK,0.009942215935066834,0.2182152491619891,-0.002076656490567208,0.016655083434932383,-0.002340422008273335,-0.005585561452948418,0.012965605146178838,-0.009386158902615072,-0.2543017061029771
502,2013-03-07,"Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire ",MRK,-0.009386158902615072,-0.2543017061029771,0.009942215935066834,-0.002076656490567208,0.016655083434932383,-0.002340422008273335,-0.005585561452948418,-0.006933193230363899,1.131509524927476
505,2013-03-12,"Merck Issues Update on IMPROVE-IT Trial, Says DSMB Recommend Study to Continue",MRK,0.03160708403181678,0.4495407311273092,0.01605799061572144,-0.006933193230363899,-0.009386158902615072,0.009942215935066834,-0.002076656490567208,-0.00044827548959247565,-0.6800214188871243
508,2013-03-14,Embrace These New ETFs,MRK,-0.007176299906522354,0.4448474018308948,-0.00044827548959247565,0.03160708403181678,0.01605799061572144,-0.006933193230363899,-0.009386158902615072,-0.004065711144148887,-0.06030494301669831
512,2013-03-14,Generic Drugs Will Hit Pharmaceuticals Hard in 2013,MRK,-0.007176299906522354,0.4448474018308948,-0.00044827548959247565,0.03160708403181678,0.01605799061572144,-0.006933193230363899,-0.009386158902615072,-0.004065711144148887,-0.06030494301669831
514,2013-03-14,Generics Will Hit Drug Companies Hard in 2013,MRK,-0.007176299906522354,0.4448474018308948,-0.00044827548959247565,0.03160708403181678,0.01605799061572144,-0.006933193230363899,-0.009386158902615072,-0.004065711144148887,-0.06030494301669831
517,2013-03-26,Risk On Rally? These ETFs Say No,MRK,0.01602233979540202,-0.07657178755573779,-0.0047833915317417874,0.002511682776191071,-0.007479373499224451,0.009610562220646601,0.0016046443884385475,-0.0065329448352883235,-0.09426474167940879
519,2013-03-26,The Supreme Court is About to Stick it to Big Pharma,MRK,0.01602233979540202,-0.07657178755573779,-0.0047833915317417874,0.002511682776191071,-0.007479373499224451,0.009610562220646601,0.0016046443884385475,-0.0065329448352883235,-0.09426474167940879
525,2013-03-27,Merck Announces FDA Acceptance of Biologics License App for Investigational Grass Pollen Allergy Immunotherapy Tablet,MRK,-0.0065329448352883235,-0.09426474167940879,0.01602233979540202,-0.0047833915317417874,0.002511682776191071,-0.007479373499224451,0.009610562220646601,0.0022671723342146954,0.5168947553220904
528,2013-04-04,2 New Dividend ETFs to Consider,MRK,-0.0008820887988303383,-0.46013869701430987,0.010020037025853634,0.012627335172670673,0.003393313609361126,0.0022671723342146954,-0.0065329448352883235,-0.004192201247891658,-0.0977919890475607
532,2013-04-10,Merck Announces FDA Acceptance of NDA for NOXAFIL Investigational Tablet Formulation,MRK,0.02922482382523728,0.7675790727206697,0.0006594901139089782,0.007755155675201131,-0.004192201247891658,-0.0008820887988303383,0.010020037025853634,0.007898851862537803,-0.06390146673807195
535,2013-04-11,ETF Showdown: A Pharma Fight,MRK,0.007898851862537803,-0.06390146673807195,0.02922482382523728,0.0006594901139089782,0.007755155675201131,-0.004192201247891658,-0.0008820887988303383,-0.0021182855376528087,-0.42613426244438235
539,2013-04-12,"Benzinga Market Primer, Friday April 12",MRK,-0.0021182855376528087,-0.42613426244438235,0.007898851862537803,0.02922482382523728,0.0006594901139089782,0.007755155675201131,-0.004192201247891658,-0.01379721252184618,0.5249095732814562
540,2013-04-12,"Benzinga Market Primer: Friday, April 12",MRK,-0.0021182855376528087,-0.42613426244438235,0.007898851862537803,0.02922482382523728,0.0006594901139089782,0.007755155675201131,-0.004192201247891658,-0.01379721252184618,0.5249095732814562
543,2013-04-26,Weekly Preview: Focus Shifts from Earnings to Economy,MRK,0.010981982069496965,-0.33478486902320737,-0.012512994280860501,-0.013983456449290221,0.014816610958491738,0.009054819999564145,0.01997378774803016,-0.0010444826527914453,0.07303610817069339
549,2013-04-29,Merck Wins FOSAMAX Federal Bellwether Trial Involving Atypical Femur Fracture Claims ,MRK,-0.0010444826527914453,0.07303610817069339,0.010981982069496965,-0.012512994280860501,-0.013983456449290221,0.014816610958491738,0.009054819999564145,-0.017147723415881555,0.7356605378837997
550,2013-04-29,"Market Wrap for Monday, April 29: Stocks Start Week With a Rally",MRK,-0.0010444826527914453,0.07303610817069339,0.010981982069496965,-0.012512994280860501,-0.013983456449290221,0.014816610958491738,0.009054819999564145,-0.017147723415881555,0.7356605378837997
555,2013-04-29,"Merck, Pfizer Announce Worldwide Collaboration Deal for Development, Commercialization of Ertugliflozin",MRK,-0.0010444826527914453,0.07303610817069339,0.010981982069496965,-0.012512994280860501,-0.013983456449290221,0.014816610958491738,0.009054819999564145,-0.017147723415881555,0.7356605378837997
558,2013-04-30,"Pfizer Tanks on Earnings, Unhealthy Guidance",MRK,-0.017147723415881555,0.7356605378837997,-0.0010444826527914453,0.010981982069496965,-0.012512994280860501,-0.013983456449290221,0.014816610958491738,-0.027872267423334596,1.0127324725167823
559,2013-04-30,"Pfizer Tanks on Ill Earnings, Unhealthy Guidance",MRK,-0.017147723415881555,0.7356605378837997,-0.0010444826527914453,0.010981982069496965,-0.012512994280860501,-0.013983456449290221,0.014816610958491738,-0.027872267423334596,1.0127324725167823
562,2013-05-01,Earnings Trigger Volume Spike in Pharma ETF,MRK,-0.027872267423334596,1.0127324725167823,-0.017147723415881555,-0.0010444826527914453,0.010981982069496965,-0.012512994280860501,-0.013983456449290221,0.0008755981311385774,-0.6415371525571308
566,2013-05-01,Merck Announces New $15B Share Repurchase Program ,MRK,-0.027872267423334596,1.0127324725167823,-0.017147723415881555,-0.0010444826527914453,0.010981982069496965,-0.012512994280860501,-0.013983456449290221,0.0008755981311385774,-0.6415371525571308
567,2013-05-01,"UPDATE: Merck Posts 8.3% Drop In Q1 Profit, Lowers Forecast",MRK,-0.027872267423334596,1.0127324725167823,-0.017147723415881555,-0.0010444826527914453,0.010981982069496965,-0.012512994280860501,-0.013983456449290221,0.0008755981311385774,-0.6415371525571308
570,2013-05-03,UPDATE: Fitch Affirms Ratings on Merck; Outlook Lowered from Positive to Negative,MRK,-0.001311888969840913,-0.09624024131195186,0.0008755981311385774,-0.027872267423334596,-0.017147723415881555,-0.0010444826527914453,0.010981982069496965,-0.015108999185346916,0.0948922226221951
573,2013-05-08,Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet,MRK,-0.006185505408862313,0.26014709763078847,0.006447926590869235,-0.015108999185346916,-0.001311888969840913,0.0008755981311385774,-0.027872267423334596,0.011113992960713803,-0.22572272263371984
576,2013-05-22,Merck Issues Statement on FDA Advisory Committee Meeting Results for Suvorexant ,MRK,-0.013098846776234074,-0.09348649715629953,0.04689201720081693,-0.016960401124017865,-0.00819466443431316,-0.00770394629068083,0.001715159156956858,0.013272703890806037,-0.4702720641706417
577,2013-05-22,"PreMarket Info Recap for May 22, 2013",MRK,-0.013098846776234074,-0.09348649715629953,0.04689201720081693,-0.016960401124017865,-0.00819466443431316,-0.00770394629068083,0.001715159156956858,0.013272703890806037,-0.4702720641706417
579,2013-05-23,Merck Issues Update on Phase III Trial for Preladenant,MRK,0.013272703890806037,-0.4702720641706417,-0.013098846776234074,0.04689201720081693,-0.016960401124017865,-0.00819466443431316,-0.00770394629068083,-0.0035912498037544704,-0.3004304829804617
582,2013-05-28,"PreMarket Info Recap for May 28, 2013",MRK,0.009753650173214057,0.11825144398330623,-0.0035912498037544704,0.013272703890806037,-0.013098846776234074,0.04689201720081693,-0.016960401124017865,-0.01574960693826266,-0.09127086571476406
585,2013-06-03,"ISM Manufacturing Index Drops in May, Shows Contraction",MRK,0.037473123808181574,0.7482336583504741,-0.007860721751785427,0.0042671860113405735,-0.01574960693826266,0.009753650173214057,-0.0035912498037544704,0.020433435762716945,-0.025635610199105874
588,2013-06-03,Benzinga's Top Pre-Market Gainers,MRK,0.037473123808181574,0.7482336583504741,-0.007860721751785427,0.0042671860113405735,-0.01574960693826266,0.009753650173214057,-0.0035912498037544704,0.020433435762716945,-0.025635610199105874
592,2013-06-18,Interesting Similarities Among 2013's Top-Performing ETFs,MRK,-0.0010460279543166306,-0.05353544540138744,-0.0031281542939134432,0.0010440710820176502,0.02306713753400058,-0.006518095881969832,-0.018572463614179413,-0.003560332765890628,0.5227642816064526
596,2013-07-01,FDA Approves New U.S. Labeling for ISENTRESS® (raltegravir) to Include 240-Week Results from STARTMRK Study of ISENTRESS Containing Regimen in Previously Untreated HIV-1 Infected Adult Patients ,MRK,-0.0027984831630183393,-0.19752991542334175,-0.017554931173143107,0.012636578523499198,0.009949806142274698,-0.0038782519760122147,-0.012553113723110632,0.0049652373642810055,-0.1369945943648717
599,2013-07-01,"Merck Receives Complete Response Letter for Suvorexant, Merck's Investigational Medicine for Insomnia; FDA Says Data Does Not Support Approval of Suvorexant 30mg and 40mg",MRK,-0.0027984831630183393,-0.19752991542334175,-0.017554931173143107,0.012636578523499198,0.009949806142274698,-0.0038782519760122147,-0.012553113723110632,0.0049652373642810055,-0.1369945943648717
602,2013-07-02,Pfizer and Novartis Said to be Zeroing in on Onyx,MRK,0.0049652373642810055,-0.1369945943648717,-0.0027984831630183393,-0.017554931173143107,0.012636578523499198,0.009949806142274698,-0.0038782519760122147,0.0,-0.39253615568110234
603,2013-07-02,"Pfizer and Novartis Could Be Eyeing Onyx (PFE, NVS, ONXX)",MRK,0.0049652373642810055,-0.1369945943648717,-0.0027984831630183393,-0.017554931173143107,0.012636578523499198,0.009949806142274698,-0.0038782519760122147,0.0,-0.39253615568110234
606,2013-07-15,Health Care ETFs Looking Healthy Ahead of Earnings,MRK,-0.0004116971625871546,0.09021509899613855,0.004760594417257957,0.0072981089946579925,0.007139648842308111,0.004429802294350527,0.0053010034329847855,-0.005977267595840052,0.5820351852787129
611,2013-07-16,Eli Lilly Tries Again with Alzheimer's Drug as the Race for a Cure Continues,MRK,-0.005977267595840052,0.5820351852787129,-0.0004116971625871546,0.004760594417257957,0.0072981089946579925,0.007139648842308111,0.004429802294350527,-0.002073066859809347,-0.3775010803266351
613,2013-07-16,Eli Lilly Tries Again with Alzheimer's Drug as the Race for a Cure Continues (LLY),MRK,-0.005977267595840052,0.5820351852787129,-0.0004116971625871546,0.004760594417257957,0.0072981089946579925,0.007139648842308111,0.004429802294350527,-0.002073066859809347,-0.3775010803266351
615,2013-07-16,Merck in Talks with FDA to Identify Steps Needed for Review of Sugammadex Sodium Injection,MRK,-0.005977267595840052,0.5820351852787129,-0.0004116971625871546,0.004760594417257957,0.0072981089946579925,0.007139648842308111,0.004429802294350527,-0.002073066859809347,-0.3775010803266351
618,2013-07-16,Life Technologies to Collaborate with Merck Serono for Companion Diagnostics Development and Commercialization ,MRK,-0.005977267595840052,0.5820351852787129,-0.0004116971625871546,0.004760594417257957,0.0072981089946579925,0.007139648842308111,0.004429802294350527,-0.002073066859809347,-0.3775010803266351
621,2013-07-24,"UPDATE: Merck Announces FDA Acceptance of New Drug Application for Vorapaxar, Investigational Anti-Thrombotic Medicine ",MRK,-0.0033382113694127025,-0.03254702643590246,0.004400683588086984,-0.001464859272688579,0.008227987061050213,-0.015167632883354099,-0.002073066859809347,0.008373253702726569,0.12293644930866177
624,2013-07-26,"Weekly Preview: Earnings Season Continues, Fed In Focus, Economic Maelstrom Expected",MRK,0.006643723044125194,-0.019341802236175765,0.008373253702726569,-0.0033382113694127025,0.004400683588086984,-0.001464859272688579,0.008227987061050213,-0.0030938768787169835,0.045235704321948456
628,2013-07-26,"Merck Statement Regarding CHMP Review of Incretin-Based Therapies for Type 2 Diabetes, Including Sitagliptin ",MRK,0.006643723044125194,-0.019341802236175765,0.008373253702726569,-0.0033382113694127025,0.004400683588086984,-0.001464859272688579,0.008227987061050213,-0.0030938768787169835,0.045235704321948456
631,2013-07-30,"Earnings Scheduled For July 30, 2013",MRK,-0.005999302954809327,0.630281012724655,-0.0030938768787169835,0.006643723044125194,0.008373253702726569,-0.0033382113694127025,0.004400683588086984,0.00249740643957308,0.28597819303196603
633,2013-07-30,SLIDESHOW: 8 Stocks to Benefit From a Repatriation Deal In Congress,MRK,-0.005999302954809327,0.630281012724655,-0.0030938768787169835,0.006643723044125194,0.008373253702726569,-0.0033382113694127025,0.004400683588086984,0.00249740643957308,0.28597819303196603
637,2013-07-30,"Benzinga Market Primer: Wednesday, July 30: Futures Higher After Asia Turnaround",MRK,-0.005999302954809327,0.630281012724655,-0.0030938768787169835,0.006643723044125194,0.008373253702726569,-0.0033382113694127025,0.004400683588086984,0.00249740643957308,0.28597819303196603
640,2013-07-30,UPDATE: Merck Posts Drop In Q2 Profit,MRK,-0.005999302954809327,0.630281012724655,-0.0030938768787169835,0.006643723044125194,0.008373253702726569,-0.0033382113694127025,0.004400683588086984,0.00249740643957308,0.28597819303196603
643,2013-07-30,"Benzinga Market Primer, Wednesday July 30",MRK,-0.005999302954809327,0.630281012724655,-0.0030938768787169835,0.006643723044125194,0.008373253702726569,-0.0033382113694127025,0.004400683588086984,0.00249740643957308,0.28597819303196603
645,2013-07-30,US Stock Futures Up Ahead Of Fed Meeting,MRK,-0.005999302954809327,0.630281012724655,-0.0030938768787169835,0.006643723044125194,0.008373253702726569,-0.0033382113694127025,0.004400683588086984,0.00249740643957308,0.28597819303196603
649,2013-07-31,"Benzinga Market Primer: Wednesday, July 31: Futures Higher Heading Into FOMC Decision",MRK,0.00249740643957308,0.28597819303196603,-0.005999302954809327,-0.0030938768787169835,0.006643723044125194,0.008373253702726569,-0.0033382113694127025,0.008511773822575508,-0.3721010113759171
650,2013-07-31,"Benzinga Market Primer, Wednesday July 31",MRK,0.00249740643957308,0.28597819303196603,-0.005999302954809327,-0.0030938768787169835,0.006643723044125194,0.008373253702726569,-0.0033382113694127025,0.008511773822575508,-0.3721010113759171
653,2013-07-31,Bionomics Signs Option and License Agreement With Merck ,MRK,0.00249740643957308,0.28597819303196603,-0.005999302954809327,-0.0030938768787169835,0.006643723044125194,0.008373253702726569,-0.0033382113694127025,0.008511773822575508,-0.3721010113759171
656,2013-08-02,"Three Soaring, But Overlooked Health Care ETFs",MRK,-0.0008233864997674312,-0.341428081825631,0.008511773822575508,0.00249740643957308,-0.005999302954809327,-0.0030938768787169835,0.006643723044125194,-0.0002062398221486239,-0.23907781708419662
659,2013-08-02,S&P: Heaping Praise For Some Health Care ETFs,MRK,-0.0008233864997674312,-0.341428081825631,0.008511773822575508,0.00249740643957308,-0.005999302954809327,-0.0030938768787169835,0.006643723044125194,-0.0002062398221486239,-0.23907781708419662
664,2013-08-12,Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck ,MRK,0.0016536878483657258,0.2594888200246914,-0.0016509576797126835,-0.001647567055766852,0.0022708571502820796,-0.0018543051688770795,-0.0002062398221486239,-0.0008257027288826047,-0.2496200292259353
667,2013-08-13,Mid-Day Market Update: US Stocks Edge Higher; Valspar Shares Decline On Downbeat Results,MRK,-0.0008257027288826047,-0.2496200292259353,0.0016536878483657258,-0.0016509576797126835,-0.001647567055766852,0.0022708571502820796,-0.0018543051688770795,0.0028911153632895648,0.14430384445302002
669,2013-08-13,"Mid-Afternoon Market Update: Apple Rises Sharply On Icahn Stake, NASDAQ Pulled Upward",MRK,-0.0008257027288826047,-0.2496200292259353,0.0016536878483657258,-0.0016509576797126835,-0.001647567055766852,0.0022708571502820796,-0.0018543051688770795,0.0028911153632895648,0.14430384445302002
672,2013-08-13,"Mid-Afternoon Market Update: Apple Rises Sharply on Icahn Stake, NASDAQ Pulled Upward",MRK,-0.0008257027288826047,-0.2496200292259353,0.0016536878483657258,-0.0016509576797126835,-0.001647567055766852,0.0022708571502820796,-0.0018543051688770795,0.0028911153632895648,0.14430384445302002
674,2013-08-13,"Mid-Morning Market Update: Markets Drop, Yum China Same-Store Sales Down 13%",MRK,-0.0008257027288826047,-0.2496200292259353,0.0016536878483657258,-0.0016509576797126835,-0.001647567055766852,0.0022708571502820796,-0.0018543051688770795,0.0028911153632895648,0.14430384445302002
677,2013-08-13,Benzinga's Top Pre-Market Gainers,MRK,-0.0008257027288826047,-0.2496200292259353,0.0016536878483657258,-0.0016509576797126835,-0.001647567055766852,0.0022708571502820796,-0.0018543051688770795,0.0028911153632895648,0.14430384445302002
683,2013-08-30,Plenty Of ETFs With Favorable Risk Traits,MRK,0.004033750563187111,-0.14121131854161972,0.0002125903739540469,-0.00042442440966705686,-0.010710042976903145,-0.0023045230812673845,-0.0016727283539769155,-0.0016913502140204484,0.7069287031045974
687,2013-09-09,USA TD Ameritrade's Investor Movement Index for Aug 5.16 vs 4.87 Prior,MRK,0.005264396054056597,0.09433002150846237,-0.0004208510991122738,-0.0035657873773812243,0.009955313206940763,-0.0016913502140204484,0.004033750563187111,0.005027245118092827,0.055804956369754244
688,2013-09-09,Merck Reports FDA Acceptance of NDA for Investigational Fertility Treatment,MRK,0.005264396054056597,0.09433002150846237,-0.0004208510991122738,-0.0035657873773812243,0.009955313206940763,-0.0016913502140204484,0.004033750563187111,0.005027245118092827,0.055804956369754244
691,2013-09-11,US Stock Futures Flat; Apple Shares Drop In Pre-Market Trading,MRK,0.0033343929657596583,-0.5657348887010551,0.005027245118092827,0.005264396054056597,-0.0004208510991122738,-0.0035657873773812243,0.009955313206940763,0.002934568235474222,-0.2897579303826172
694,2013-09-11,"Merck, AstraZeneca Announce License Agreement for MK-1775",MRK,0.0033343929657596583,-0.5657348887010551,0.005027245118092827,0.005264396054056597,-0.0004208510991122738,-0.0035657873773812243,0.009955313206940763,0.002934568235474222,-0.2897579303826172
695,2013-09-19,Write A Prescription For Health Care ETFs,MRK,-0.002892176834431326,-0.33412809569407453,0.008123241550172189,-0.003735227255988849,0.008369816180909373,-0.0012538476839724089,0.002934568235474222,-0.005180592561822128,1.9975343053173242
697,2013-10-01,Merck Shares Soar After Announcing More Job Cuts,MRK,0.02373457968415038,0.6830337590297579,-0.003766490421515445,0.002306859710245135,0.00021004571257998705,0.0029450008920988147,-0.0031457382926644017,-0.007591036612356383,-0.4888182747405527
698,2013-10-01,Merck Says Interim Data for MK-3475 to be Presented at 15th World Conference on Lung Cancer,MRK,0.02373457968415038,0.6830337590297579,-0.003766490421515445,0.002306859710245135,0.00021004571257998705,0.0029450008920988147,-0.0031457382926644017,-0.007591036612356383,-0.4888182747405527
700,2013-10-01,UPDATE: Merck Announces Global Initiative to Sharpen Commercial and R&D Focus; Cutting 8500 Jobs; Affirms FY Target,MRK,0.02373457968415038,0.6830337590297579,-0.003766490421515445,0.002306859710245135,0.00021004571257998705,0.0029450008920988147,-0.0031457382926644017,-0.007591036612356383,-0.4888182747405527
705,2013-10-07,Merck Says Data Shows Cognigram as Sensitive Assessment,MRK,-0.007050155649311884,-0.20525807017170594,-0.002687520105806196,-0.0002072282411180737,-0.007591036612356383,0.02373457968415038,-0.003766490421515445,-0.0029230888083606743,0.5246852871550425
708,2013-10-14,"Merck, Endocyte Report Vintafolide-PLD Generaly Well Tolerated, Showed Median PFS of Five Months",MRK,-0.011418713490324639,1.016335885307456,-0.004211513955077351,0.00465419253877597,-0.010052461728074724,-0.0029230888083606743,-0.007050155649311884,-0.0038503938964228324,-0.31504994074826476
711,2013-10-16,"Merck Confirms Development of Investigational Dosing ISENTRESS, Will Begin Phase III Trial Early 2014",MRK,0.012883793897172202,-0.21596635960176613,-0.0038503938964228324,-0.011418713490324639,-0.004211513955077351,0.00465419253877597,-0.010052461728074724,-0.00127226492112531,0.25001121555085537
714,2013-10-22,Merck's MK-5172/MK-8742 Receives Breakthrough Therapy Designation from FDA,MRK,-0.0008596347656416592,-0.05015589399208542,-0.002145341678110646,-0.0106135448744481,-0.00127226492112531,0.012883793897172202,-0.0038503938964228324,0.0019365655868535114,-0.390796302011843
717,2013-10-25,Benzinga Weekly Preview: FOMC Meeting Closely Watched,MRK,0.00692360083554644,0.5975216447607339,-0.0073025697126994915,0.0019365655868535114,-0.0008596347656416592,-0.002145341678110646,-0.0106135448744481,-0.025569514858162723,0.5255169437151948
723,2013-10-28,Mid-Afternoon Market Update: Markets Mixed as JC Penney Rises,MRK,-0.025569514858162723,0.5255169437151948,0.00692360083554644,-0.0073025697126994915,0.0019365655868535114,-0.0008596347656416592,-0.002145341678110646,0.005071793290154503,-0.41789754817596614
724,2013-10-28,Mid-Morning Market Update: Markets Mixed; Merck Profit Beats Estimates,MRK,-0.025569514858162723,0.5255169437151948,0.00692360083554644,-0.0073025697126994915,0.0019365655868535114,-0.0008596347656416592,-0.002145341678110646,0.005071793290154503,-0.41789754817596614
727,2013-10-28,Mid-Day Market Update: Burger King Surges On Upbeat Earnings; Sohu Shares Dip,MRK,-0.025569514858162723,0.5255169437151948,0.00692360083554644,-0.0073025697126994915,0.0019365655868535114,-0.0008596347656416592,-0.002145341678110646,0.005071793290154503,-0.41789754817596614
737,2013-10-28,"#PreMarket Primer: Monday, October 28: All Eyes On Apple",MRK,-0.025569514858162723,0.5255169437151948,0.00692360083554644,-0.0073025697126994915,0.0019365655868535114,-0.0008596347656416592,-0.002145341678110646,0.005071793290154503,-0.41789754817596614
738,2013-10-28,"Earnings Scheduled For October 28, 2013",MRK,-0.025569514858162723,0.5255169437151948,0.00692360083554644,-0.0073025697126994915,0.0019365655868535114,-0.0008596347656416592,-0.002145341678110646,0.005071793290154503,-0.41789754817596614
742,2013-10-28,"Stocks To Watch For October 28, 2013",MRK,-0.025569514858162723,0.5255169437151948,0.00692360083554644,-0.0073025697126994915,0.0019365655868535114,-0.0008596347656416592,-0.002145341678110646,0.005071793290154503,-0.41789754817596614
754,2013-10-28,UPDATE: Merck Posts Upbeat Q3 Profit,MRK,-0.025569514858162723,0.5255169437151948,0.00692360083554644,-0.0073025697126994915,0.0019365655868535114,-0.0008596347656416592,-0.002145341678110646,0.005071793290154503,-0.41789754817596614
757,2013-10-29,"#PreMarket Primer: Tuesday, October 29: Fed Meeting Likely Uneventful",MRK,0.005071793290154503,-0.41789754817596614,-0.025569514858162723,0.00692360083554644,-0.0073025697126994915,0.0019365655868535114,-0.0008596347656416592,-0.007459815450088336,-0.37328508495909374
761,2013-10-29,US Stock Futures Flat Ahead Of Fed,MRK,0.005071793290154503,-0.41789754817596614,-0.025569514858162723,0.00692360083554644,-0.0073025697126994915,0.0019365655868535114,-0.0008596347656416592,-0.007459815450088336,-0.37328508495909374
762,2013-10-29,Merck Presents Interim Data from Phase 1B Study of MK-3475 at 15th World Conference on Lung Cancer ,MRK,0.005071793290154503,-0.41789754817596614,-0.025569514858162723,0.00692360083554644,-0.0073025697126994915,0.0019365655868535114,-0.0008596347656416592,-0.007459815450088336,-0.37328508495909374
769,2013-10-31,Market Wrap for October 31: Fed Worries Pull Stocks Lower,MRK,-0.0033152257183682865,0.505668562703157,-0.007459815450088336,0.005071793290154503,-0.025569514858162723,0.00692360083554644,-0.0073025697126994915,0.0031045465270826966,0.39343876086441054
773,2013-11-06,Job Cuts Higher in October; Pharmaceutical & Financial Sectors Took Biggest Hits,MRK,0.013227595084342791,0.18624822401234198,-0.007873690678269152,0.010833442714010433,0.0031045465270826966,-0.0033152257183682865,-0.007459815450088336,-0.0030463055764147207,-0.0554876776988511
777,2013-12-10,Merck Says Data Monitoring Committee Recommending Continuation of Phase II/III EPOCH Study for MK-8931,MRK,-0.0026229899524750078,0.0969725991705841,0.0034414157972395554,0.011882908543976223,-0.01013968595742154,-0.009043384513833463,-0.00837003786851398,-0.009710481671831639,0.4169044068619441
780,2013-12-12,"#PreMarket Primer: Thursday, December, 12th: US Budget Deal Gaining Momentum",MRK,-0.003916831003144439,-0.19941392845564054,-0.009710481671831639,-0.0026229899524750078,0.0034414157972395554,0.011882908543976223,-0.01013968595742154,0.0012417403422677609,-0.2769104142948734
781,2013-12-12,"#PreMarket Primer: Thursday, December 12: US Budget Deal Gaining Momentum",MRK,-0.003916831003144439,-0.19941392845564054,-0.009710481671831639,-0.0026229899524750078,0.0034414157972395554,0.011882908543976223,-0.01013968595742154,0.0012417403422677609,-0.2769104142948734
785,2013-12-18,"Is Amarin's Vascepa Not as Effective as Hoped, or the Target of an Effort to Keep it Off the Market? -- HOLD FOR JOE",MRK,0.020876801869808004,-0.025201411389972006,-0.0039508180117052705,-0.00599424654552605,0.0012417403422677609,-0.003916831003144439,-0.009710481671831639,-0.0022495765833049353,-0.3533141278158456
796,2013-12-18,Merck Collaborates with GlaxoSmithKline on MK-3475,MRK,0.020876801869808004,-0.025201411389972006,-0.0039508180117052705,-0.00599424654552605,0.0012417403422677609,-0.003916831003144439,-0.009710481671831639,-0.0022495765833049353,-0.3533141278158456
797,2013-12-26,Merck Sues to Stop Generic NuvaRing,MRK,0.00627407339018915,0.192080661623109,0.001012818999927445,0.0008110420139428864,0.010862989083817665,-0.0022495765833049353,0.020876801869808004,0.0014078515349547072,-0.16282694823221633
802,2014-01-13,Market Wrap For January 13: Markets Showing Weakness Ahead Of Major Earning Releases,MRK,0.06495589723032746,3.579496597655792,0.0072698987300114926,-0.005422803109166541,-0.006386045647974958,0.007438414541051985,0.00020135675229893124,-0.0022589693634114116,-0.4317521620708348
804,2014-01-13,Market Wrap For January 13: Markets Showing Weakness Ahead of Major Earning Releases,MRK,0.06495589723032746,3.579496597655792,0.0072698987300114926,-0.005422803109166541,-0.006386045647974958,0.007438414541051985,0.00020135675229893124,-0.0022589693634114116,-0.4317521620708348
805,2014-01-13,"Benzinga's M&A Chatter for Monday January 13, 2014",MRK,0.06495589723032746,3.579496597655792,0.0072698987300114926,-0.005422803109166541,-0.006386045647974958,0.007438414541051985,0.00020135675229893124,-0.0022589693634114116,-0.4317521620708348
809,2014-01-13,Mid-Afternoon Market Update: Markets Dip Despite Large Amount of M&A,MRK,0.06495589723032746,3.579496597655792,0.0072698987300114926,-0.005422803109166541,-0.006386045647974958,0.007438414541051985,0.00020135675229893124,-0.0022589693634114116,-0.4317521620708348
810,2014-01-13,Morning Market Movers ,MRK,0.06495589723032746,3.579496597655792,0.0072698987300114926,-0.005422803109166541,-0.006386045647974958,0.007438414541051985,0.00020135675229893124,-0.0022589693634114116,-0.4317521620708348
812,2014-01-13,Merck Initiates Rolling Submission to FDA of US Biologics License Application for MK-3475,MRK,0.06495589723032746,3.579496597655792,0.0072698987300114926,-0.005422803109166541,-0.006386045647974958,0.007438414541051985,0.00020135675229893124,-0.0022589693634114116,-0.4317521620708348
813,2014-01-13,Benzinga's Top #PreMarket Gainers,MRK,0.06495589723032746,3.579496597655792,0.0072698987300114926,-0.005422803109166541,-0.006386045647974958,0.007438414541051985,0.00020135675229893124,-0.0022589693634114116,-0.4317521620708348
815,2014-01-13,Mid-Morning Market Update: Markets Open Lower; Lululemon Lowers Q4 Outlook,MRK,0.06495589723032746,3.579496597655792,0.0072698987300114926,-0.005422803109166541,-0.006386045647974958,0.007438414541051985,0.00020135675229893124,-0.0022589693634114116,-0.4317521620708348
823,2014-01-13,Mid-Day Market Update: SodaStream Drops After Weak Outlook; Beam Shares Spike Higher,MRK,0.06495589723032746,3.579496597655792,0.0072698987300114926,-0.005422803109166541,-0.006386045647974958,0.007438414541051985,0.00020135675229893124,-0.0022589693634114116,-0.4317521620708348
825,2014-01-13,id-Morning Market Update: Markets Open Lower; Lululemon Lowers Q4 Outlook,MRK,0.06495589723032746,3.579496597655792,0.0072698987300114926,-0.005422803109166541,-0.006386045647974958,0.007438414541051985,0.00020135675229893124,-0.0022589693634114116,-0.4317521620708348
829,2014-01-15,Market Wrap For January 15: Bulls Take Over as Economic Growth Remains Healthy,MRK,-0.009056737637857748,-0.5050659104657298,-0.0022589693634114116,0.06495589723032746,0.0072698987300114926,-0.005422803109166541,-0.006386045647974958,-0.00038071152264218533,-0.2591914387071229
832,2014-01-15,Merck Pleased with FDA Advisory Committee Recommendation for Approval of Vorapaxar,MRK,-0.009056737637857748,-0.5050659104657298,-0.0022589693634114116,0.06495589723032746,0.0072698987300114926,-0.005422803109166541,-0.006386045647974958,-0.00038071152264218533,-0.2591914387071229
833,2014-01-15,Market Wrap For January 15: Bulls Take Over As Economic Growth Remains Healthy,MRK,-0.009056737637857748,-0.5050659104657298,-0.0022589693634114116,0.06495589723032746,0.0072698987300114926,-0.005422803109166541,-0.006386045647974958,-0.00038071152264218533,-0.2591914387071229
835,2014-01-24,Merck Shares Higher Following Bristol-Myers' Phase 3 Disappointment,MRK,0.0073645531255714936,0.15011525887061805,0.004868360709516573,-0.009260873910470258,-0.0023099473814544025,-0.010476091965480494,-0.00038071152264218533,0.010580890422861478,0.6976885899674581
839,2014-01-27,"Market Wrap For January 27: China Concerns, Declining Home Sales, Tomorrow's Fed Meeting and Obama's Speech Keep Markets Lower",MRK,0.010580890422861478,0.6976885899674581,0.0073645531255714936,0.004868360709516573,-0.009260873910470258,-0.0023099473814544025,-0.010476091965480494,0.006472383893453504,-0.513637817505987
843,2014-01-27,US Stock Futures Gain Ahead Of Home-Sales Data,MRK,0.010580890422861478,0.6976885899674581,0.0073645531255714936,0.004868360709516573,-0.009260873910470258,-0.0023099473814544025,-0.010476091965480494,0.006472383893453504,-0.513637817505987
848,2014-01-27,Winter's Stock Knockdown May Give Way to a Spring Thaw,MRK,0.010580890422861478,0.6976885899674581,0.0073645531255714936,0.004868360709516573,-0.009260873910470258,-0.0023099473814544025,-0.010476091965480494,0.006472383893453504,-0.513637817505987
850,2014-01-27,Winter's Stock Knockdown May Give Way To A Spring Thaw,MRK,0.010580890422861478,0.6976885899674581,0.0073645531255714936,0.004868360709516573,-0.009260873910470258,-0.0023099473814544025,-0.010476091965480494,0.006472383893453504,-0.513637817505987
853,2014-01-27,Winter's Stock Knockdown May Give Way To a Spring Thaw,MRK,0.010580890422861478,0.6976885899674581,0.0073645531255714936,0.004868360709516573,-0.009260873910470258,-0.0023099473814544025,-0.010476091965480494,0.006472383893453504,-0.513637817505987
855,2014-01-27,Stocks Hitting 52-Week Highs,MRK,0.010580890422861478,0.6976885899674581,0.0073645531255714936,0.004868360709516573,-0.009260873910470258,-0.0023099473814544025,-0.010476091965480494,0.006472383893453504,-0.513637817505987
858,2014-01-27,UPDATE: Merck Upgraded by Morgan Stanley on Oncology Optimism,MRK,0.010580890422861478,0.6976885899674581,0.0073645531255714936,0.004868360709516573,-0.009260873910470258,-0.0023099473814544025,-0.010476091965480494,0.006472383893453504,-0.513637817505987
862,2014-01-31,Market Wrap For January 31: Markets End January On Sour Note,MRK,-0.010091919094943114,-0.06227331894732002,0.02489971481240283,-0.01248363431213817,0.006472383893453504,0.010580890422861478,0.0073645531255714936,-0.016801461537308437,-0.04919581394477013
863,2014-01-31,Market Wrap For January 31: Markets End January on Sour Note,MRK,-0.010091919094943114,-0.06227331894732002,0.02489971481240283,-0.01248363431213817,0.006472383893453504,0.010580890422861478,0.0073645531255714936,-0.016801461537308437,-0.04919581394477013
866,2014-02-03,"Earnings Expectations For The Week Of February 3: GM, Twitter, Disney And More",MRK,-0.016801461537308437,-0.04919581394477013,-0.010091919094943114,0.02489971481240283,-0.01248363431213817,0.006472383893453504,0.010580890422861478,0.02745759347240817,0.17388915622688028
871,2014-02-05,Market Wrap For February 5: Markets Unsure of Which Direction to Take,MRK,0.0003734686292327094,0.34784042787288816,0.02745759347240817,-0.016801461537308437,-0.010091919094943114,0.02489971481240283,-0.01248363431213817,0.004484032162460183,-0.5003407365032562
873,2014-02-05,"Earnings Scheduled For February 5, 2014",MRK,0.0003734686292327094,0.34784042787288816,0.02745759347240817,-0.016801461537308437,-0.010091919094943114,0.02489971481240283,-0.01248363431213817,0.004484032162460183,-0.5003407365032562
874,2014-02-05,US Stock Futures Flat; All Eyes On ADP Report,MRK,0.0003734686292327094,0.34784042787288816,0.02745759347240817,-0.016801461537308437,-0.010091919094943114,0.02489971481240283,-0.01248363431213817,0.004484032162460183,-0.5003407365032562
877,2014-02-05,UPDATE: Merck Posts Drop In Q4 Profit,MRK,0.0003734686292327094,0.34784042787288816,0.02745759347240817,-0.016801461537308437,-0.010091919094943114,0.02489971481240283,-0.01248363431213817,0.004484032162460183,-0.5003407365032562
879,2014-02-05,"Stocks To Watch For February 5, 2014",MRK,0.0003734686292327094,0.34784042787288816,0.02745759347240817,-0.016801461537308437,-0.010091919094943114,0.02489971481240283,-0.01248363431213817,0.004484032162460183,-0.5003407365032562
884,2014-02-05,Market Wrap For February 5: Markets Unsure Of Which Direction To Take,MRK,0.0003734686292327094,0.34784042787288816,0.02745759347240817,-0.016801461537308437,-0.010091919094943114,0.02489971481240283,-0.01248363431213817,0.004484032162460183,-0.5003407365032562
887,2014-02-05,Stocks Hitting 52-Week Highs,MRK,0.0003734686292327094,0.34784042787288816,0.02745759347240817,-0.016801461537308437,-0.010091919094943114,0.02489971481240283,-0.01248363431213817,0.004484032162460183,-0.5003407365032562
889,2014-02-05,Top Trending Tickers On StockTwits For February 5,MRK,0.0003734686292327094,0.34784042787288816,0.02745759347240817,-0.016801461537308437,-0.010091919094943114,0.02489971481240283,-0.01248363431213817,0.004484032162460183,-0.5003407365032562
890,2014-02-05,Benzinga's Top #PreMarket Gainers,MRK,0.0003734686292327094,0.34784042787288816,0.02745759347240817,-0.016801461537308437,-0.010091919094943114,0.02489971481240283,-0.01248363431213817,0.004484032162460183,-0.5003407365032562
897,2014-02-06,#PreMarket Primer: Thursday February 6: Taking a Breather,MRK,0.004484032162460183,-0.5003407365032562,0.0003734686292327094,0.02745759347240817,-0.016801461537308437,-0.010091919094943114,0.02489971481240283,0.01859720638526352,0.18393935733739597
899,2014-02-06,"#PreMarket Primer: Thursday, February 6: Markets Taking A Breather After Twitter Earnings",MRK,0.004484032162460183,-0.5003407365032562,0.0003734686292327094,0.02745759347240817,-0.016801461537308437,-0.010091919094943114,0.02489971481240283,0.01859720638526352,0.18393935733739597
901,2014-02-07,"Market Wrap For February 7: Jobs Report Not Great, But Not Too Bad",MRK,0.01859720638526352,0.18393935733739597,0.004484032162460183,0.0003734686292327094,0.02745759347240817,-0.016801461537308437,-0.010091919094943114,0.0021910131874318672,-0.2681570761617831
902,2014-02-07,Market Wrap For February 7: Jobs Report Not That Great But Not So Bad,MRK,0.01859720638526352,0.18393935733739597,0.004484032162460183,0.0003734686292327094,0.02745759347240817,-0.016801461537308437,-0.010091919094943114,0.0021910131874318672,-0.2681570761617831
905,2014-02-20,"FDA Accepts for Review Merck's Biologics License Application for V503, Investigational 9-valent Human Papillomavirus Vaccine",MRK,0.013989984414369161,-0.015926814050609583,-0.011671972529195052,0.004509590449519152,0.006170496190142538,0.0018184027356560328,-0.012567415649711311,0.00394171720413472,0.1513357186960691
908,2014-03-14,UPDATE: FDA Approves Merck Noxafi Injection for IV Use,MRK,-0.0016133748414183247,0.19741102947832112,-0.010288982291014492,0.0021168069849555327,-0.010991228010640786,-0.0026101416633338426,0.00366767519668576,0.010054176504692203,-0.2152535849179028
911,2014-03-21,Benzinga's Volume Movers,MRK,-0.016729526963976005,1.7686390017365672,-0.007144343273761455,-0.006564807844968823,0.0017771613710084733,0.010054176504692203,-0.0016133748414183247,-0.016099477819998875,-0.3382768018389123
914,2014-03-21,Mid-Morning Market Update: Markets Open Higher; Tiffany Posts Downbeat Earnings,MRK,-0.016729526963976005,1.7686390017365672,-0.007144343273761455,-0.006564807844968823,0.0017771613710084733,0.010054176504692203,-0.0016133748414183247,-0.016099477819998875,-0.3382768018389123
917,2014-03-21,Benzinga's Top #PreMarket Gainers,MRK,-0.016729526963976005,1.7686390017365672,-0.007144343273761455,-0.006564807844968823,0.0017771613710084733,0.010054176504692203,-0.0016133748414183247,-0.016099477819998875,-0.3382768018389123
920,2014-03-21,Mid-Day Market Update: Nike Drops On Cautious Forecast; Endocyte Shares Spike Higher,MRK,-0.016729526963976005,1.7686390017365672,-0.007144343273761455,-0.006564807844968823,0.0017771613710084733,0.010054176504692203,-0.0016133748414183247,-0.016099477819998875,-0.3382768018389123
925,2014-03-24,Google Honors Activist Dorothy Height and Her Contributions,MRK,-0.016099477819998875,-0.3382768018389123,-0.016729526963976005,-0.007144343273761455,-0.006564807844968823,0.0017771613710084733,0.010054176504692203,0.026218042308694844,-0.08935663131882265
927,2014-03-24,Google Honors Activist Dorothy Height & Her Contributions,MRK,-0.016099477819998875,-0.3382768018389123,-0.016729526963976005,-0.007144343273761455,-0.006564807844968823,0.0017771613710084733,0.010054176504692203,0.026218042308694844,-0.08935663131882265
929,2014-03-27,"Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007",MRK,-0.005176679851112587,-0.14914029372607363,0.015038773267026295,0.026218042308694844,-0.016099477819998875,-0.016729526963976005,-0.007144343273761455,0.0044861060229672844,-0.19449289579405682
932,2014-04-08,Biotechs Struggling To Find A Bottom,MRK,-0.0027180953154749554,-0.05771772332510661,-0.016571529849209843,-0.0016011317423803018,-0.004427915441594155,0.0015965870934038229,-0.0070462738663326085,0.03742746826002308,0.4961270359847729
938,2014-04-10,US Stock Futures Edge Lower Ahead Of Jobless Claims Data,MRK,-0.0218914270785997,0.11857094080764807,0.03742746826002308,-0.0027180953154749554,-0.016571529849209843,-0.0016011317423803018,-0.004427915441594155,0.0012534675339221923,-0.24346086623862206
941,2014-04-11,Top 40 Upcoming Earnings Releases  ,MRK,0.0012534675339221923,-0.24346086623862206,-0.0218914270785997,0.03742746826002308,-0.0027180953154749554,-0.016571529849209843,-0.0016011317423803018,-0.006259302477319428,-0.208682724974104
955,2014-04-11,US Stock Futures Slip Ahead Of Consumer Sentiment Report,MRK,0.0012534675339221923,-0.24346086623862206,-0.0218914270785997,0.03742746826002308,-0.0027180953154749554,-0.016571529849209843,-0.0016011317423803018,-0.006259302477319428,-0.208682724974104
958,2014-04-11,Google Honors Chemist Percy Julian & His Contributions ,MRK,0.0012534675339221923,-0.24346086623862206,-0.0218914270785997,0.03742746826002308,-0.0027180953154749554,-0.016571529849209843,-0.0016011317423803018,-0.006259302477319428,-0.208682724974104
976,2014-04-14,Markets Falling? Get Your Defense Ready,MRK,-0.006259302477319428,-0.208682724974104,0.0012534675339221923,-0.0218914270785997,0.03742746826002308,-0.0027180953154749554,-0.016571529849209843,0.008637972957709295,0.03299340031151443
982,2014-04-14,"Market Wrap For April 14: Markets Surge on Positive Retail Data, Citi Earnings",MRK,-0.006259302477319428,-0.208682724974104,0.0012534675339221923,-0.0218914270785997,0.03742746826002308,-0.0027180953154749554,-0.016571529849209843,0.008637972957709295,0.03299340031151443
986,2014-04-23,Bill Ackman Talks Partnership With Valeant For Allergan Deal ,MRK,-0.004673685493918223,-0.446321983688166,0.009083136188760665,0.013812616172635517,0.0037324336367734468,0.0037468903668520515,0.008637972957709295,0.0005217981307046315,-0.13201749555007114
988,2014-04-23,Ackman Talks Partnership With Valeant For Allergan Deal ,MRK,-0.004673685493918223,-0.446321983688166,0.009083136188760665,0.013812616172635517,0.0037324336367734468,0.0037468903668520515,0.008637972957709295,0.0005217981307046315,-0.13201749555007114
991,2014-04-24,Market Wrap For April 24: Apple's Smashing Earnings Overshadowed By Ukraine Concerns,MRK,0.0005217981307046315,-0.13201749555007114,-0.004673685493918223,0.009083136188760665,0.013812616172635517,0.0037324336367734468,0.0037468903668520515,-0.00504098905742123,-0.07254114259973199
995,2014-04-25,3 Ways To Profit From Merger Activity In The Pharmaceutical Sector,MRK,-0.00504098905742123,-0.07254114259973199,0.0005217981307046315,-0.004673685493918223,0.009083136188760665,0.013812616172635517,0.0037324336367734468,-0.009783305266524489,1.7284871365467325
996,2014-04-25,3 Ways to Profit from Merger Activity in the Pharmaceutical Sector,MRK,-0.00504098905742123,-0.07254114259973199,0.0005217981307046315,-0.004673685493918223,0.009083136188760665,0.013812616172635517,0.0037324336367734468,-0.009783305266524489,1.7284871365467325
1003,2014-04-25,Benzinga Weekly Preview: Earnings Season Continues As Biotech & Pharmaceutical Companies Report,MRK,-0.00504098905742123,-0.07254114259973199,0.0005217981307046315,-0.004673685493918223,0.009083136188760665,0.013812616172635517,0.0037324336367734468,-0.009783305266524489,1.7284871365467325
1004,2014-04-25,Benzinga Weekly Preview: Earnings Season Continues As Biotech and Pharmaceutical Companies Report,MRK,-0.00504098905742123,-0.07254114259973199,0.0005217981307046315,-0.004673685493918223,0.009083136188760665,0.013812616172635517,0.0037324336367734468,-0.009783305266524489,1.7284871365467325
1007,2014-04-28,Market Wrap For April 28: Apple Hits New 52-Week Highs In a Volatile Start To the Trading Week,MRK,-0.009783305266524489,1.7284871365467325,-0.00504098905742123,0.0005217981307046315,-0.004673685493918223,0.009083136188760665,0.013812616172635517,0.03599159052754186,-0.19601348306076216
1011,2014-04-29,Mid-Day Market Update: Coach Slips After Q3 Results; Orbital Shares Spike Higher,MRK,0.03599159052754186,-0.19601348306076216,-0.009783305266524489,-0.00504098905742123,0.0005217981307046315,-0.004673685493918223,0.009083136188760665,-0.002724713439968496,-0.007400372641342079
1013,2014-04-29,Mid-Morning Market Update: Markets Rise; Merck Earnings Beat Street View,MRK,0.03599159052754186,-0.19601348306076216,-0.009783305266524489,-0.00504098905742123,0.0005217981307046315,-0.004673685493918223,0.009083136188760665,-0.002724713439968496,-0.007400372641342079
1017,2014-04-29,Mid-Afternoon Market Update: Markets Show Strength as Prothena Shares Plummet,MRK,0.03599159052754186,-0.19601348306076216,-0.009783305266524489,-0.00504098905742123,0.0005217981307046315,-0.004673685493918223,0.009083136188760665,-0.002724713439968496,-0.007400372641342079
1021,2014-04-29,"#PreMarket Primer: Tuesday, April 29: US Steps Up Sanctions Against Russia",MRK,0.03599159052754186,-0.19601348306076216,-0.009783305266524489,-0.00504098905742123,0.0005217981307046315,-0.004673685493918223,0.009083136188760665,-0.002724713439968496,-0.007400372641342079
1025,2014-04-29,UPDATE: Merck Posts Upbeat Q1 Profit,MRK,0.03599159052754186,-0.19601348306076216,-0.009783305266524489,-0.00504098905742123,0.0005217981307046315,-0.004673685493918223,0.009083136188760665,-0.002724713439968496,-0.007400372641342079
1032,2014-04-29,Market Wrap For April 29: Dow Approaches Record Highs Despite Ongoing Ukraine Tension and Upcoming Fed Meeting ,MRK,0.03599159052754186,-0.19601348306076216,-0.009783305266524489,-0.00504098905742123,0.0005217981307046315,-0.004673685493918223,0.009083136188760665,-0.002724713439968496,-0.007400372641342079
1037,2014-04-30,"#PreMarket Primer: Wednesday, April 30: No BOJ Stimulus On The Horizon ",MRK,-0.002724713439968496,-0.007400372641342079,0.03599159052754186,-0.009783305266524489,-0.00504098905742123,0.0005217981307046315,-0.004673685493918223,0.01810085009594653,-0.13538684957652358
1039,2014-05-01,"Benzinga's M&A Chatter for Thursday May 1, 2014",MRK,0.01810085009594653,-0.13538684957652358,-0.002724713439968496,0.03599159052754186,-0.009783305266524489,-0.00504098905742123,0.0005217981307046315,-0.023482168681046245,0.03026138584337157
1042,2014-05-02,Market Wrap For May 2: Markets Slip On Ukraine Tensions Despite Positive Jobs Data ,MRK,-0.023482168681046245,0.03026138584337157,0.01810085009594653,-0.002724713439968496,0.03599159052754186,-0.009783305266524489,-0.00504098905742123,0.007042355220368224,-0.32653380104408636
1045,2014-05-02,Market Wrap For May 2: Markets Slip on Ukraine Tensions Despite Positive Jobs Data ,MRK,-0.023482168681046245,0.03026138584337157,0.01810085009594653,-0.002724713439968496,0.03599159052754186,-0.009783305266524489,-0.00504098905742123,0.007042355220368224,-0.32653380104408636
1047,2014-05-06,"Market Wrap For May 6: Dow Suffers Triple-Digit Point Loss, Nasdaq Underperforms Once Again",MRK,-0.025925373425092046,0.7010816986257666,0.007042355220368224,-0.023482168681046245,0.01810085009594653,-0.002724713439968496,0.03599159052754186,-0.022237590277422226,0.6555429815112361
1051,2014-05-06,US Stock Futures Flat Ahead Of International Trade Data ,MRK,-0.025925373425092046,0.7010816986257666,0.007042355220368224,-0.023482168681046245,0.01810085009594653,-0.002724713439968496,0.03599159052754186,-0.022237590277422226,0.6555429815112361
1053,2014-05-06,UPDATE: Merck Highlights Strategic Initiative,MRK,-0.025925373425092046,0.7010816986257666,0.007042355220368224,-0.023482168681046245,0.01810085009594653,-0.002724713439968496,0.03599159052754186,-0.022237590277422226,0.6555429815112361
1057,2014-05-07,Market Wrap For May 7: Dow Banks Triple-Digit Point Gain While Nasdaq Closes Lower,MRK,-0.022237590277422226,0.6555429815112361,-0.025925373425092046,0.007042355220368224,-0.023482168681046245,0.01810085009594653,-0.002724713439968496,-0.018087197068260674,-0.3726991419048442
1061,2014-05-12,UPDATE: Merck Reports FDA Okay of Zontivity,MRK,0.0014490173183860922,-0.3471941865159467,0.006930169804060471,-0.018087197068260674,-0.022237590277422226,-0.025925373425092046,0.007042355220368224,0.008319531048112339,0.1081014223871366
1064,2014-05-13,US Stock Futures Up Ahead Of Retail Sales Report,MRK,0.008319531048112339,0.1081014223871366,0.0014490173183860922,0.006930169804060471,-0.018087197068260674,-0.022237590277422226,-0.025925373425092046,0.01112132643244279,-0.12964616586672617
1067,2014-05-14,The 5 Most Overvalued Dow Stocks,MRK,0.01112132643244279,-0.12964616586672617,0.008319531048112339,0.0014490173183860922,0.006930169804060471,-0.018087197068260674,-0.022237590277422226,-0.008514912282923448,0.14376402693170887
1071,2014-06-04,ASCO Meeting Day 4: Risks and Rewards of Immunotherapy,MRK,0.0003454330788470461,-0.028637681894036926,-0.00034531379603919277,0.0012097405085131907,0.0027730639529455203,0.023049695426860417,-0.005115498883334069,0.002934573943659702,0.11129540141940386
1073,2014-06-04,ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy,MRK,0.0003454330788470461,-0.028637681894036926,-0.00034531379603919277,0.0012097405085131907,0.0027730639529455203,0.023049695426860417,-0.005115498883334069,0.002934573943659702,0.11129540141940386
1075,2014-06-09,Morning Market Movers ,MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1076,2014-06-09,"Market Wrap For June 9: Markets Higher On St. Louis Fed Comments, Low Volume",MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1077,2014-06-09,Hepatitis C Stocks Move After Idenix Up 235%,MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1078,2014-06-09,Hepatitis C Stocks Move After Idenix Rockets Up 235%,MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1083,2014-06-09,Benzinga's Top #PreMarket Gainers,MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1084,2014-06-09,Benzinga's Top #PreMarket Losers,MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1088,2014-06-09,UPDATE: Merck Announces Will Purchase Idenix for $3.85Bn,MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1092,2014-06-09,Benzinga's Volume Movers,MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1095,2014-06-09,Stocks Hitting 52-Week Highs,MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1097,2014-06-09,Mid-Day Market Update: Idenix Pharma Surges On Merck Buyout; Pilgrim's Pride Shares Slide,MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1101,2014-06-09,Mid-Morning Market Update: Markets Edge Higher; Tyson Wins Bidding Battle To Buy Hillshire Brands For $63/Share,MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1107,2014-06-09,"Mid-Afternoon Update; Icahn's 9% Stake In Family Dollar, Tyson Foods Wins Bid For Hillshire Brands",MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1108,2014-06-09,"Mid-Afternoon Market Update; Icahn's 9% Stake In Family Dollar, Tyson Foods Wins Bid For Hillshire Brands",MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1112,2014-06-09,"Benzinga's M&A Chatter for Monday June 9, 2014",MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1114,2014-06-09,Are Gilead Shares Overreacting to Merck's Idenix Acquisition?,MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1116,2014-06-09,Are Gilead Shares Overreacting To Merck's Idenix Acquisition?,MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1120,2014-06-09,"Market Wrap For June 9: Markets Higher on St. Louis Fed Comments, Low Volume",MRK,0.001556289632209884,0.20582697053959365,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.00034531379603919277,0.0012097405085131907,0.009492250219468534,-0.05186250446972507
1122,2014-06-11,Takeover Whispers Add To Achillion Pharmaceuticals' Momentum,MRK,0.005470856258527057,0.5262600357240774,0.009492250219468534,0.001556289632209884,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.0011991903015293737,-0.18234900816968436
1127,2014-06-11,What Happens When All The Good News Is Out?,MRK,0.005470856258527057,0.5262600357240774,0.009492250219468534,0.001556289632209884,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.0011991903015293737,-0.18234900816968436
1129,2014-06-11,When News And Rumors Add To A Stock's Momentum,MRK,0.005470856258527057,0.5262600357240774,0.009492250219468534,0.001556289632209884,-0.004303019039441747,0.002934573943659702,0.0003454330788470461,-0.0011991903015293737,-0.18234900816968436
1131,2014-06-18,5-Star Biotech Stock Watch: Synta Pharmaceuticals,MRK,0.006028145628615977,0.2505783782022448,-0.00017199136446088836,-0.0029192827116464315,-0.0010289571775569106,-0.0011991903015293737,0.005470856258527057,-0.0018832283416385653,-0.23288250489213913
1134,2014-06-20,"Market Wrap For June 20: Yet Again, Dow And S&P 500 Indices Hit New Highs",MRK,0.010634718041427238,1.3982435598862373,-0.0018832283416385653,0.006028145628615977,-0.00017199136446088836,-0.0029192827116464315,-0.0010289571775569106,-0.00712860001916904,-0.5107227209626644
1138,2014-06-27,Exclusive: Hepatitis C Stock Valuation With Enanta CEO Jay Luly,MRK,-0.017085128389983772,1.3880885419454243,-0.005606670474650355,0.016229447693882015,-0.009914556568245692,-0.00712860001916904,0.010634718041427238,0.005562681935944003,-0.49466901501671445
1141,2014-06-30,Endocyte Spikes Sharply On Rumored Resumption Of Cancer Drug Trial,MRK,0.005562681935944003,-0.49466901501671445,-0.017085128389983772,-0.005606670474650355,0.016229447693882015,-0.009914556568245692,-0.00712860001916904,0.011408565768768586,0.011791642816256331
1143,2014-06-30,US Stock Futures Fall Ahead Of Home Sales Report,MRK,0.005562681935944003,-0.49466901501671445,-0.017085128389983772,-0.005606670474650355,0.016229447693882015,-0.009914556568245692,-0.00712860001916904,0.011408565768768586,0.011791642816256331
1146,2014-07-01,"Stock Market News for July 01, 2014 - Market News",MRK,0.011408565768768586,0.011791642816256331,0.005562681935944003,-0.017085128389983772,-0.005606670474650355,0.016229447693882015,-0.009914556568245692,0.009229081226122648,-0.21464132156596516
1148,2014-07-02,Markets Little Changed Ahead of Vacation,MRK,0.009229081226122648,-0.21464132156596516,0.011408565768768586,0.005562681935944003,-0.017085128389983772,-0.005606670474650355,0.016229447693882015,0.002540165364943059,-0.24793254706242696
1150,2014-07-02,Markets Little Changed Ahead of 4th Of July Break,MRK,0.009229081226122648,-0.21464132156596516,0.011408565768768586,0.005562681935944003,-0.017085128389983772,-0.005606670474650355,0.016229447693882015,0.002540165364943059,-0.24793254706242696
1153,2014-07-02,Markets Little Changed Ahead Of 4th Of July Break,MRK,0.009229081226122648,-0.21464132156596516,0.011408565768768586,0.005562681935944003,-0.017085128389983772,-0.005606670474650355,0.016229447693882015,0.002540165364943059,-0.24793254706242696
1154,2014-07-07,Markets Marginally Lower Ahead of Earnings Season,MRK,-0.01148644623281092,0.777015774133492,0.002540165364943059,0.009229081226122648,0.011408565768768586,0.005562681935944003,-0.017085128389983772,-0.005980672542707732,-0.10846037703397993
1155,2014-07-07,Markets Marginally Lower Ahead Of Earnings Season,MRK,-0.01148644623281092,0.777015774133492,0.002540165364943059,0.009229081226122648,0.011408565768768586,0.005562681935944003,-0.017085128389983772,-0.005980672542707732,-0.10846037703397993
1158,2014-07-15,Companies Leading In Healthy Work Places,MRK,-0.004640940734301879,0.21231396683200665,-0.0044493890082920595,-0.0023896929540656586,0.0005123714488628472,0.0065325551841848295,-0.005980672542707732,0.004144635940062091,-0.33009126980883996
1160,2014-07-28,Markets Little Changed Ahead Of The Federal Reserve's Policy Decision,MRK,-0.003095466117340351,0.556659623284093,-0.0010309986630827606,0.001720896802730243,-0.005476460113908899,0.0074137831341523075,-0.005827839353433895,0.010522788737739708,0.20083243708849374
1167,2014-07-29,Mid-Afternoon Market Update: Indeces Remain Mixed; Merck Beats Expectations,MRK,0.010522788737739708,0.20083243708849374,-0.003095466117340351,-0.0010309986630827606,0.001720896802730243,-0.005476460113908899,0.0074137831341523075,-0.008535449620733826,-0.22039120659173017
1169,2014-07-29,Tuesday Morning Earnings Releases,MRK,0.010522788737739708,0.20083243708849374,-0.003095466117340351,-0.0010309986630827606,0.001720896802730243,-0.005476460113908899,0.0074137831341523075,-0.008535449620733826,-0.22039120659173017
1172,2014-07-29,Mid-Day Market Update: Herbalife Falls On Downbeat Results; Windstream Shares Spike Higher,MRK,0.010522788737739708,0.20083243708849374,-0.003095466117340351,-0.0010309986630827606,0.001720896802730243,-0.005476460113908899,0.0074137831341523075,-0.008535449620733826,-0.22039120659173017
1173,2014-07-29,Indices Remain Mixed; Merck Beats Expectations,MRK,0.010522788737739708,0.20083243708849374,-0.003095466117340351,-0.0010309986630827606,0.001720896802730243,-0.005476460113908899,0.0074137831341523075,-0.008535449620733826,-0.22039120659173017
1175,2014-07-29,Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties,MRK,0.010522788737739708,0.20083243708849374,-0.003095466117340351,-0.0010309986630827606,0.001720896802730243,-0.005476460113908899,0.0074137831341523075,-0.008535449620733826,-0.22039120659173017
1180,2014-07-29,"Earnings Scheduled For July 29, 2014",MRK,0.010522788737739708,0.20083243708849374,-0.003095466117340351,-0.0010309986630827606,0.001720896802730243,-0.005476460113908899,0.0074137831341523075,-0.008535449620733826,-0.22039120659173017
1181,2014-07-29,"UPDATE: Merck Q2 Profit Beats Street View, Shares Rise",MRK,0.010522788737739708,0.20083243708849374,-0.003095466117340351,-0.0010309986630827606,0.001720896802730243,-0.005476460113908899,0.0074137831341523075,-0.008535449620733826,-0.22039120659173017
1184,2014-07-29,"US Stock Futures Rise Ahead Of Earnings, Consumer Confidence Data",MRK,0.010522788737739708,0.20083243708849374,-0.003095466117340351,-0.0010309986630827606,0.001720896802730243,-0.005476460113908899,0.0074137831341523075,-0.008535449620733826,-0.22039120659173017
1188,2014-07-29,"Stocks To Watch For July 29, 2014",MRK,0.010522788737739708,0.20083243708849374,-0.003095466117340351,-0.0010309986630827606,0.001720896802730243,-0.005476460113908899,0.0074137831341523075,-0.008535449620733826,-0.22039120659173017
1192,2014-07-29,Mid-Morning Market Update: Markets Open Higher; Merck Posts Upbeat Profit,MRK,0.010522788737739708,0.20083243708849374,-0.003095466117340351,-0.0010309986630827606,0.001720896802730243,-0.005476460113908899,0.0074137831341523075,-0.008535449620733826,-0.22039120659173017
1194,2014-07-29,Markets Open Higher; Merck Posts Upbeat Profit,MRK,0.010522788737739708,0.20083243708849374,-0.003095466117340351,-0.0010309986630827606,0.001720896802730243,-0.005476460113908899,0.0074137831341523075,-0.008535449620733826,-0.22039120659173017
1196,2014-07-29,Herbalife Falls On Downbeat Results; Windstream Shares Spike Higher,MRK,0.010522788737739708,0.20083243708849374,-0.003095466117340351,-0.0010309986630827606,0.001720896802730243,-0.005476460113908899,0.0074137831341523075,-0.008535449620733826,-0.22039120659173017
1199,2014-08-04,"Glaxo, Sanofi Trend Up On Potential Deal For Established Brands",MRK,0.004577395911805837,-0.14707622522433683,0.001057524602501081,-0.02307151864447521,-0.008535449620733826,0.010522788737739708,-0.003095466117340351,-0.01805111962140049,0.044129762608172696
1201,2014-08-04,"Glaxo, Sanofi, Trend Up On Potential Deal For Established Brands",MRK,0.004577395911805837,-0.14707622522433683,0.001057524602501081,-0.02307151864447521,-0.008535449620733826,0.010522788737739708,-0.003095466117340351,-0.01805111962140049,0.044129762608172696
1203,2014-08-05,Ukraine Tension Prominent As Dow Suffers Triple Digit Loss; S&P 500 & NASDAQ Also Lower,MRK,-0.01805111962140049,0.044129762608172696,0.004577395911805837,0.001057524602501081,-0.02307151864447521,-0.008535449620733826,0.010522788737739708,-0.0017847817707594693,0.3592655571260699
1204,2014-08-05,Ukraine Tension Prominent As Dow Suffers Triple Point Digit Loss; S&P 500 & Nasdaq Also Lower,MRK,-0.01805111962140049,0.044129762608172696,0.004577395911805837,0.001057524602501081,-0.02307151864447521,-0.008535449620733826,0.010522788737739708,-0.0017847817707594693,0.3592655571260699
1205,2014-08-05,Ukraine Tension Takes Center Stage As Dow Suffers Triple Point Digit Loss; S&P 500 And Nasdaq Also Lower,MRK,-0.01805111962140049,0.044129762608172696,0.004577395911805837,0.001057524602501081,-0.02307151864447521,-0.008535449620733826,0.010522788737739708,-0.0017847817707594693,0.3592655571260699
1209,2014-08-11,Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments,MRK,0.0019447988949867767,-0.22345545564644576,0.016355228121899268,-0.0051852528174367585,-0.0017847817707594693,-0.01805111962140049,0.004577395911805837,0.006530658823651558,0.28933828001354134
1210,2014-08-11,Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments.,MRK,0.0019447988949867767,-0.22345545564644576,0.016355228121899268,-0.0051852528174367585,-0.0017847817707594693,-0.01805111962140049,0.004577395911805837,0.006530658823651558,0.28933828001354134
1215,2014-08-13,Merck Issues Statement Related to Role of PNEUMOVAX 23 in Updated ACIP Recommendations,MRK,0.014378606546152639,0.503582382414175,0.006530658823651558,0.0019447988949867767,0.016355228121899268,-0.0051852528174367585,-0.0017847817707594693,0.016075615587799463,-0.2559307236556039
1218,2014-08-13,UPDATE: FDA Approves Belsomra Tablets for Use as Sleep Aid,MRK,0.014378606546152639,0.503582382414175,0.006530658823651558,0.0019447988949867767,0.016355228121899268,-0.0051852528174367585,-0.0017847817707594693,0.016075615587799463,-0.2559307236556039
1221,2014-08-25,US Stock Futures Rise Ahead Of Economic Data,MRK,0.009464168410042717,-0.0032386020319666864,0.005437823008693332,-0.010592007459873543,0.00967574503129831,0.008387596734870773,-0.003241668001653708,0.007868953347927476,0.7832058620431306
1224,2014-08-25," Advaxis, Merck to Collaborate on Investigational Combination of Two Novel Immunotherapy Candidates for Advanced Prostate Cancer",MRK,0.009464168410042717,-0.0032386020319666864,0.005437823008693332,-0.010592007459873543,0.00967574503129831,0.008387596734870773,-0.003241668001653708,0.007868953347927476,0.7832058620431306
1225,2014-08-26,"S&P 500 Closes Above 2,000; Dow Hits New All-Time High As Markets Continue To Rally",MRK,0.007868953347927476,0.7832058620431306,0.009464168410042717,0.005437823008693332,-0.010592007459873543,0.00967574503129831,0.008387596734870773,0.001328816531168231,-0.28999194779280424
1228,2014-08-26,"S&P 500 Closes Above 2,000, Dow Hits New All-Time High As Markets Continue To Rally",MRK,0.007868953347927476,0.7832058620431306,0.009464168410042717,0.005437823008693332,-0.010592007459873543,0.00967574503129831,0.008387596734870773,0.001328816531168231,-0.28999194779280424
1231,2014-08-26,"Pfizer, Merck Report Collaboration on Study Evaluating Novel Anti-Cancer Combo Regimen",MRK,0.007868953347927476,0.7832058620431306,0.009464168410042717,0.005437823008693332,-0.010592007459873543,0.00967574503129831,0.008387596734870773,0.001328816531168231,-0.28999194779280424
1235,2014-08-27,Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend,MRK,0.001328816531168231,-0.28999194779280424,0.007868953347927476,0.009464168410042717,0.005437823008693332,-0.010592007459873543,0.00967574503129831,-0.0046451212514035944,-0.1994440413575862
1240,2014-08-27,"Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold",MRK,0.001328816531168231,-0.28999194779280424,0.007868953347927476,0.009464168410042717,0.005437823008693332,-0.010592007459873543,0.00967574503129831,-0.0046451212514035944,-0.1994440413575862
1243,2014-09-05,"Bristol-Myers Squibb Co In Patent Suit Vs. Merck & Co., Inc. Over Skin Cancer Drug",MRK,0.0183093459726138,-0.005994968851939175,-0.006614363483145924,0.011540667832080409,-0.0053236612833714725,0.001833497824180963,-0.0046451212514035944,-0.002125059931373907,-0.21628418029893992
1244,2014-09-05,Bristol-Myers In Patent Suit Vs. Merck Over Skin Cancer Drug,MRK,0.0183093459726138,-0.005994968851939175,-0.006614363483145924,0.011540667832080409,-0.0053236612833714725,0.001833497824180963,-0.0046451212514035944,-0.002125059931373907,-0.21628418029893992
1247,2014-09-17,"Merck Presents First Phase 3 Data In Japanese Patients for Omarigliptin, An Investigational Once-Weekly DPP-4 Inhibitor For Type 2 Diabetes",MRK,-0.001833551464378913,0.13551646122681182,0.007896342256066946,-0.0005035316335109119,-0.009151412001492498,-0.003647472125692719,0.0033027271374541645,0.00718096237495236,-0.2207239764189094
1250,2014-10-02,Markets Little Changed Ahead Of Friday's Jobs Report,MRK,0.0023843511590952993,-0.107724830441293,-0.009615071918575802,-0.0021883983577847266,0.00033662129078337877,-0.004191570469517236,-0.011928457910941881,0.017842088683746482,0.06559964796148288
1255,2014-10-13,Markets Debut Week On Negative Note; S&P 500 Falls Through Key Level,MRK,-0.042959346652978625,0.31213446645736953,-0.009288968039297352,-0.01611801162648141,0.029421374582734527,-0.018797940958435677,-0.005342346204875281,0.0033841921178690004,-0.2614788700174695
1259,2014-10-16,Will Actavis Plc Win Allergan Over In 4-Way Tug Of War?,MRK,-0.02375301118106843,0.16344264421751897,-0.028403889054251397,0.0033841921178690004,-0.042959346652978625,-0.009288968039297352,-0.01611801162648141,0.011042375001925953,-0.09782579558668048
1262,2014-10-20,US FDA Accepts For Review A Biologics License Application For Merck And Sanofi Pasteur's Investigational Pediatric Hexavalent Vaccine,MRK,0.0005552708095379888,-0.38817127035168264,0.011042375001925953,-0.02375301118106843,-0.028403889054251397,0.0033841921178690004,-0.042959346652978625,0.019981547515821596,0.43316944783735933
1265,2014-10-27,Merck Conf Call Highlights,MRK,-0.0201357790382235,0.6853566321613542,0.01730533305927784,0.020176866952934747,0.00689266836361524,0.019981547515821596,0.0005552708095379888,-0.010629025700333972,0.6617911698406334
1267,2014-10-27,Merck Conference Call Highlights,MRK,-0.0201357790382235,0.6853566321613542,0.01730533305927784,0.020176866952934747,0.00689266836361524,0.019981547515821596,0.0005552708095379888,-0.010629025700333972,0.6617911698406334
1269,2014-10-27,Mid-Afternoon Market Update: NQ Mobile Climbs On SEC Filing; Huntsman Shares Slide,MRK,-0.0201357790382235,0.6853566321613542,0.01730533305927784,0.020176866952934747,0.00689266836361524,0.019981547515821596,0.0005552708095379888,-0.010629025700333972,0.6617911698406334
1270,2014-10-27,"Markets Virtually Flat, Oil Continues To Decline Following Bearish Outlook",MRK,-0.0201357790382235,0.6853566321613542,0.01730533305927784,0.020176866952934747,0.00689266836361524,0.019981547515821596,0.0005552708095379888,-0.010629025700333972,0.6617911698406334
1271,2014-10-27,Mid-Day Market Update: Micron Gains On Buyback Announcement; Sarepta Shares Dip,MRK,-0.0201357790382235,0.6853566321613542,0.01730533305927784,0.020176866952934747,0.00689266836361524,0.019981547515821596,0.0005552708095379888,-0.010629025700333972,0.6617911698406334
1282,2014-10-27,US Stock Futures Down Ahead Of Economic Data,MRK,-0.0201357790382235,0.6853566321613542,0.01730533305927784,0.020176866952934747,0.00689266836361524,0.019981547515821596,0.0005552708095379888,-0.010629025700333972,0.6617911698406334
1284,2014-10-27,"Earnings Scheduled For October 27, 2014",MRK,-0.0201357790382235,0.6853566321613542,0.01730533305927784,0.020176866952934747,0.00689266836361524,0.019981547515821596,0.0005552708095379888,-0.010629025700333972,0.6617911698406334
1286,2014-10-27,UPDATE: Merck Q3 Earnings Top Street View,MRK,-0.0201357790382235,0.6853566321613542,0.01730533305927784,0.020176866952934747,0.00689266836361524,0.019981547515821596,0.0005552708095379888,-0.010629025700333972,0.6617911698406334
1289,2014-10-27,"#PreMarket Primer: Monday, October 27: ECB Stress Tests In Line With Expectations",MRK,-0.0201357790382235,0.6853566321613542,0.01730533305927784,0.020176866952934747,0.00689266836361524,0.019981547515821596,0.0005552708095379888,-0.010629025700333972,0.6617911698406334
1290,2014-10-27,"#PreMarket Primer: Monday, October 27: ECB Stress Tests In-Line With Expectations",MRK,-0.0201357790382235,0.6853566321613542,0.01730533305927784,0.020176866952934747,0.00689266836361524,0.019981547515821596,0.0005552708095379888,-0.010629025700333972,0.6617911698406334
1293,2014-10-27,"Keep an Eye on These 7 Stocks for October 27, 2014",MRK,-0.0201357790382235,0.6853566321613542,0.01730533305927784,0.020176866952934747,0.00689266836361524,0.019981547515821596,0.0005552708095379888,-0.010629025700333972,0.6617911698406334
1298,2014-10-27,Mid-Morning Market Update: Markets Down; Merck Posts Upbeat Earnings,MRK,-0.0201357790382235,0.6853566321613542,0.01730533305927784,0.020176866952934747,0.00689266836361524,0.019981547515821596,0.0005552708095379888,-0.010629025700333972,0.6617911698406334
1308,2014-10-28,"#PreMarket Primer: Tuesday, October 28: CDC Warns That Involuntary Quarantines Could Discourage Progress On Ebola",MRK,-0.010629025700333972,0.6617911698406334,-0.0201357790382235,0.01730533305927784,0.020176866952934747,0.00689266836361524,0.019981547515821596,0.006267295585456134,-0.4786196179590271
1320,2014-11-06,"US Stock Futures Edge Lower Ahead Of Earnings, Jobless Claims ",MRK,-0.0052041819231559705,0.053893159690900694,0.003369191455482534,0.007637183046380391,0.016913977808092895,0.010993009225814587,0.019750671151237187,0.0013498788819348295,-0.20573863027342987
1323,2014-11-10,RBC Sees Weak Merck Data as Positive for Gilead,MRK,-0.008931539526942145,0.37553001036464706,0.0013498788819348295,-0.0052041819231559705,0.003369191455482534,0.007637183046380391,0.016913977808092895,0.009521986986195552,-0.08870088085490324
1325,2014-11-10,RBC Sees Weak Merck Data As Positive For Gilead,MRK,-0.008931539526942145,0.37553001036464706,0.0013498788819348295,-0.0052041819231559705,0.003369191455482534,0.007637183046380391,0.016913977808092895,0.009521986986195552,-0.08870088085490324
1327,2014-11-11,Merck Announces Results From Phase 2 Study Of Investigational Chronic Hepatitis C Treatment Grazoprevir/Elbasvir In Genotype 1 Infected Treatment-Naïve And Difficult-To-Cure Patients,MRK,0.009521986986195552,-0.08870088085490324,-0.008931539526942145,0.0013498788819348295,-0.0052041819231559705,0.003369191455482534,0.007637183046380391,-0.0010104678288772595,-0.49872218627612785
1330,2014-11-17,Merck Announces That IMPROVE-IT Achieved Primary Endpoint; Data To Be Presented At American Heart Association Scientific Sessions Today,MRK,0.00660192318158237,0.20204462302229564,-0.007893429728952128,0.0038779929172865213,-0.0010104678288772595,0.009521986986195552,-0.008931539526942145,0.00723203772030101,-0.10596988307107802
1333,2014-12-04,Markets Marginally Lower Ahead Of Friday's Jobs Report,MRK,0.005612215541484167,-0.2688350864971282,-0.0032904304656965477,0.004296177820540814,0.001986558103697522,0.010878768794813976,0.006909494681079931,0.00935639894315976,0.5702638684749577
1337,2014-12-08,Mid-Afternoon Market Update: Dow Slides Over 100 Points; Oil Futures Down 4%,MRK,0.006342694458018494,0.01995209106626339,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,0.001986558103697522,-0.03021994006127915,0.6479766692129376
1341,2014-12-08,Mid-Day Market Update: McDonald's Drops On Weak November Sales; Acceleron Pharma Shares Jump,MRK,0.006342694458018494,0.01995209106626339,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,0.001986558103697522,-0.03021994006127915,0.6479766692129376
1345,2014-12-08,"Benzinga's M&A Chatter for Monday December 8, 2014",MRK,0.006342694458018494,0.01995209106626339,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,0.001986558103697522,-0.03021994006127915,0.6479766692129376
1349,2014-12-08,Pharmaceutical Stocks In Play Following Merck/Cubist Deal,MRK,0.006342694458018494,0.01995209106626339,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,0.001986558103697522,-0.03021994006127915,0.6479766692129376
1350,2014-12-08,Benzinga's Top #PreMarket Gainers,MRK,0.006342694458018494,0.01995209106626339,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,0.001986558103697522,-0.03021994006127915,0.6479766692129376
1353,2014-12-08,"Pharmaceitical Stocks In Play Monday Following Merck, Cubist Deal",MRK,0.006342694458018494,0.01995209106626339,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,0.001986558103697522,-0.03021994006127915,0.6479766692129376
1355,2014-12-08,"Must Watch Stocks for December 8, 2014",MRK,0.006342694458018494,0.01995209106626339,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,0.001986558103697522,-0.03021994006127915,0.6479766692129376
1357,2014-12-08,US Stock Futures Point To Lower Open Monday,MRK,0.006342694458018494,0.01995209106626339,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,0.001986558103697522,-0.03021994006127915,0.6479766692129376
1362,2014-12-08,Mid-Morning Market Update: Markets Mixed; Merck To Buy Cubist Pharmaceuticals For $102/Share,MRK,0.006342694458018494,0.01995209106626339,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,0.001986558103697522,-0.03021994006127915,0.6479766692129376
1364,2014-12-08,Benzinga's Volume Movers,MRK,0.006342694458018494,0.01995209106626339,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,0.001986558103697522,-0.03021994006127915,0.6479766692129376
1368,2014-12-08,Morning Market Movers,MRK,0.006342694458018494,0.01995209106626339,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,0.001986558103697522,-0.03021994006127915,0.6479766692129376
1372,2014-12-08,Stocks Hitting 52-Week Highs,MRK,0.006342694458018494,0.01995209106626339,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,0.001986558103697522,-0.03021994006127915,0.6479766692129376
1375,2014-12-09,Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO,MRK,-0.03021994006127915,0.6479766692129376,0.006342694458018494,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,-0.0004996719356370471,-0.29419752093975304
1379,2014-12-09,Cellceutix Corp Shares Rise On Two Catalysts,MRK,-0.03021994006127915,0.6479766692129376,0.006342694458018494,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,-0.0004996719356370471,-0.29419752093975304
1381,2014-12-09,Merck & Co. Under Pressure Following Patent Ruling,MRK,-0.03021994006127915,0.6479766692129376,0.006342694458018494,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,-0.0004996719356370471,-0.29419752093975304
1385,2014-12-09,Cellceutix Corp. Shares Rise On Two Catalysts,MRK,-0.03021994006127915,0.6479766692129376,0.006342694458018494,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,-0.0004996719356370471,-0.29419752093975304
1387,2014-12-09,Hospira Inc. Ticks Up On Favorable Patent Ruling Vs Cubist Pharmaceuticals Inc,MRK,-0.03021994006127915,0.6479766692129376,0.006342694458018494,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,-0.0004996719356370471,-0.29419752093975304
1389,2014-12-09,"Hospira, Inc. Ticks Up On Favorable Patent Ruling vs. Cubist Pharmaceuticals Inc",MRK,-0.03021994006127915,0.6479766692129376,0.006342694458018494,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,0.004296177820540814,-0.0004996719356370471,-0.29419752093975304
1391,2014-12-10,"Data Investigating KEYTRUDA, Merck's Anti-PD-1 Therapy, In Patients With Advanced Triple-Negative Breast Cancer Presented At 2014 San Antonio Breast Cancer Symposium",MRK,-0.0004996719356370471,-0.29419752093975304,-0.03021994006127915,0.006342694458018494,0.00935639894315976,0.005612215541484167,-0.0032904304656965477,-0.003191767891768782,-0.1463440499621379
1394,2014-12-11,Market Shrugs Off Plan To Spend $300 Million On Ebola Vaccines,MRK,-0.003191767891768782,-0.1463440499621379,-0.0004996719356370471,-0.03021994006127915,0.006342694458018494,0.00935639894315976,0.005612215541484167,-0.02730033893507655,0.07126502370673893
1395,2014-12-11,Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines,MRK,-0.003191767891768782,-0.1463440499621379,-0.0004996719356370471,-0.03021994006127915,0.006342694458018494,0.00935639894315976,0.005612215541484167,-0.02730033893507655,0.07126502370673893
1398,2014-12-22,NewLink Genetics Surges 4% Following Ebola Contract News,MRK,-0.010406138314480562,-0.42382959905563233,0.010172862202721955,0.023425161947039808,0.014612594582916527,-0.00263373288346036,-0.013340159003227603,-0.02968116247097441,0.4150541740332956
1400,2014-12-22,NewLink Genetics Surges 3% Following Ebola Contract News,MRK,-0.010406138314480562,-0.42382959905563233,0.010172862202721955,0.023425161947039808,0.014612594582916527,-0.00263373288346036,-0.013340159003227603,-0.02968116247097441,0.4150541740332956
1402,2014-12-23,"FTC Requests Public Comment on Merck & Co., Inc.'s Application to Approve Sale of Facilities",MRK,-0.02968116247097441,0.4150541740332956,-0.010406138314480562,0.010172862202721955,0.023425161947039808,0.014612594582916527,-0.00263373288346036,0.004369907593334776,-0.6434269368991843
1405,2015-01-12,Biotechs Presenting at the J.P. Morgan Healthcare Conference: Day One,MRK,-0.004155736246848174,-0.08463689694155496,-0.0046141886630503,0.02012652647786295,0.021386045210928906,0.03928323960431124,0.01486270012123736,-0.0017660152624690006,-0.1325784093975807
1407,2015-01-12,Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1,MRK,-0.004155736246848174,-0.08463689694155496,-0.0046141886630503,0.02012652647786295,0.021386045210928906,0.03928323960431124,0.01486270012123736,-0.0017660152624690006,-0.1325784093975807
1414,2015-01-27,White House Budget To Support Biotech Rally,MRK,-0.004138947462696829,0.18623595812986427,0.005281028556381795,-0.001597549806729992,0.006917499474226485,-0.0071875836006835,-0.006663588934176068,-0.017743154586940868,0.11336957205365716
1416,2015-01-30,What Investors Are Watching For In Regulus Therapeutics' Next Data Release,MRK,-0.029151114430698177,0.32950186624616573,0.010415141389221949,-0.017743154586940868,-0.004138947462696829,0.005281028556381795,-0.001597549806729992,0.0099534736487219,-0.23332694669509624
1420,2015-01-30,What Investors Are Watching For In Regulus Therapeutics Next Data Release,MRK,-0.029151114430698177,0.32950186624616573,0.010415141389221949,-0.017743154586940868,-0.004138947462696829,0.005281028556381795,-0.001597549806729992,0.0099534736487219,-0.23332694669509624
1426,2015-02-04,"Gilead Sciences' 'Long Term Story Remains Intact,' Deutsche Bank Says",MRK,-0.032284417861998205,0.6943324227122099,0.0022996109441877355,0.0099534736487219,-0.029151114430698177,0.010415141389221949,-0.017743154586940868,0.0020321429759926346,-0.3489692564458089
1428,2015-02-04,"Earnings Scheduled For February 4, 2015",MRK,-0.032284417861998205,0.6943324227122099,0.0022996109441877355,0.0099534736487219,-0.029151114430698177,0.010415141389221949,-0.017743154586940868,0.0020321429759926346,-0.3489692564458089
1429,2015-02-04,"Keep an Eye on These 10 Stocks for February 4, 2015",MRK,-0.032284417861998205,0.6943324227122099,0.0022996109441877355,0.0099534736487219,-0.029151114430698177,0.010415141389221949,-0.017743154586940868,0.0020321429759926346,-0.3489692564458089
1433,2015-02-04,"UPDATE: Merck Posts Upbeat Q4 Earnings, Sales Decline",MRK,-0.032284417861998205,0.6943324227122099,0.0022996109441877355,0.0099534736487219,-0.029151114430698177,0.010415141389221949,-0.017743154586940868,0.0020321429759926346,-0.3489692564458089
1437,2015-02-25,Heavy News Day For Several Biotech Stocks,MRK,0.0022274503437980098,0.09607085369719903,0.0010292759100740678,-0.0008571719511571985,0.0008579073252530378,-0.008503482874966939,0.00016985225404764215,0.00803558616731248,0.35882056866849865
1439,2015-02-25,News-Heavy Day For Several Biotech Stocks,MRK,0.0022274503437980098,0.09607085369719903,0.0010292759100740678,-0.0008571719511571985,0.0008579073252530378,-0.008503482874966939,0.00016985225404764215,0.00803558616731248,0.35882056866849865
1441,2015-03-11,US Stock Futures Signal Higher Start On Wall Street,MRK,-0.0091901050813461,0.19354663758633217,-0.011875734398908433,0.007389180040197951,-0.019662122900643175,0.0017276395888472518,-0.007884465413744324,0.01007012317654965,-0.17305765392635564
1444,2015-04-08,"Advaxis, Merck Report Initiation of Enrollment in Phase 1/2 Study of ADXS-PSA in Combo with Anti-PD-1 Therapy",MRK,-0.004875497685469465,0.46144239133050546,0.004372181207605186,0.0014010114233413695,0.004220774329175558,-0.010786213907998388,-0.014741262927357446,0.004899384623863412,-0.11458220594450641
1447,2015-04-14,UPDATE: Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone,MRK,0.018156156089900177,0.3983723390686238,-0.009083028201731347,-0.003134274032374429,0.004899384623863412,-0.004875497685469465,0.004372181207605186,0.01194601553032637,-0.17381044861689343
1450,2015-04-17,It's A Big Weekend For Biotech,MRK,-0.016597574405328053,0.8197335408053326,-0.010436076759001933,0.01194601553032637,0.018156156089900177,-0.009083028201731347,-0.003134274032374429,0.01283400236843013,-0.1459265761140477
1452,2015-04-20,CAR-T Therapy Stocks Hit Hard Following AACR Data,MRK,0.01283400236843013,-0.1459265761140477,-0.016597574405328053,-0.010436076759001933,0.01194601553032637,0.018156156089900177,-0.009083028201731347,0.0008678916163913364,-0.07086351543797831
1457,2015-04-20,Morning Market Gainers,MRK,0.01283400236843013,-0.1459265761140477,-0.016597574405328053,-0.010436076759001933,0.01194601553032637,0.018156156089900177,-0.009083028201731347,0.0008678916163913364,-0.07086351543797831
1460,2015-04-24,Analyst: Biogen Inc. To Miss On Tecfidera Sales; No Threat To Gilead Science Inc.'s Harvoni,MRK,0.0015649572314895277,-0.057000719251977916,-0.003120325946552316,0.0005203545919847397,0.0008678916163913364,0.01283400236843013,-0.016597574405328053,-0.008680424134054898,0.3474353512794375
1462,2015-04-28,Morning Market Gainers,MRK,0.05043775879856738,2.276651926144773,-0.008680424134054898,0.0015649572314895277,-0.003120325946552316,0.0005203545919847397,0.0008678916163913364,-0.005001591166575281,-0.5049983930567303
1464,2015-04-28,Benzinga's Top #PreMarket Gainers,MRK,0.05043775879856738,2.276651926144773,-0.008680424134054898,0.0015649572314895277,-0.003120325946552316,0.0005203545919847397,0.0008678916163913364,-0.005001591166575281,-0.5049983930567303
1466,2015-04-28,"Merck Beats Q1 Estimates, Shares Rise",MRK,0.05043775879856738,2.276651926144773,-0.008680424134054898,0.0015649572314895277,-0.003120325946552316,0.0005203545919847397,0.0008678916163913364,-0.005001591166575281,-0.5049983930567303
1471,2015-04-28,"Earnings Scheduled For April 28, 2015",MRK,0.05043775879856738,2.276651926144773,-0.008680424134054898,0.0015649572314895277,-0.003120325946552316,0.0005203545919847397,0.0008678916163913364,-0.005001591166575281,-0.5049983930567303
1474,2015-05-01,Analysts: Gilead Sciences Inc. Soothes Price-War Worry With Q1 Results,MRK,0.005036860930290432,-0.2808782286713458,-0.002010796275840998,-0.005001591166575281,0.05043775879856738,-0.008680424134054898,0.0015649572314895277,0.013030447023960834,-0.03281861510442907
1476,2015-06-01,Merck Announces New Data on Breadth of KEYTRUDA at ASCO: Anti-Tumor Activity Now Shown in 13 Different Tumor Types,MRK,-0.002299563271688121,-0.4100901448579064,0.019933069813733217,0.00403647249849004,0.008309304965375519,-0.006904457099870531,-0.011980294079765419,-0.008395154382618175,-0.23835898289620583
1479,2015-06-03,Merck Announces Results from Investigational IMPROVE-IT Study of VYTORIN Published in NEJoM,MRK,0.002490513364060476,-0.03676194716331527,-0.008395154382618175,-0.002299563271688121,0.019933069813733217,0.00403647249849004,0.008309304965375519,-0.015234685871245657,0.25026549881336546
1482,2015-06-08,"TECOS, Merck's Cardiovascular Safety Trial of JANUVIA, Met Primary Endpoint in Patients with Type 2 Diabetes",MRK,-0.002034316415248205,-0.26043486366250246,-0.008071157225273295,-0.015234685871245657,0.002490513364060476,-0.008395154382618175,-0.002299563271688121,-0.0005097465278854907,-0.19913508196612462
1485,2015-06-08,"Benzinga's M&A Chatter for  Monday June 8, 2015",MRK,-0.002034316415248205,-0.26043486366250246,-0.008071157225273295,-0.015234685871245657,0.002490513364060476,-0.008395154382618175,-0.002299563271688121,-0.0005097465278854907,-0.19913508196612462
1488,2015-06-08,Analyst: Eli Lilly And Co To Post Key Data Thursday On Autoimmune Drug,MRK,-0.002034316415248205,-0.26043486366250246,-0.008071157225273295,-0.015234685871245657,0.002490513364060476,-0.008395154382618175,-0.002299563271688121,-0.0005097465278854907,-0.19913508196612462
1491,2015-06-10,"TECOS, Merck's Cardiovascular Safety Trial of JANUVIA, Met Primary Endpoint in Patients with Type 2 Diabetes",MRK,0.013086592478302128,0.5861726209070304,-0.0005097465278854907,-0.002034316415248205,-0.008071157225273295,-0.015234685871245657,0.002490513364060476,-0.004225789293468063,0.13861600905140725
1494,2015-06-10,US Stock Futures Signal Higher Start On Wall Street,MRK,0.013086592478302128,0.5861726209070304,-0.0005097465278854907,-0.002034316415248205,-0.008071157225273295,-0.015234685871245657,0.002490513364060476,-0.004225789293468063,0.13861600905140725
1497,2015-06-16,"Benzinga's M&A Chatter for Tuesday June 16, 2015",MRK,0.010329379890499313,-0.3104536873140745,-0.012960140179240853,-0.017654147774975426,-0.004225789293468063,0.013086592478302128,-0.0005097465278854907,0.0034654126971034316,0.1360903205859949
1500,2015-06-29,Merck Announces Phase 3 Study of Single-Dose EMEND® (fosaprepitant dimeglumine) for Injection Regimen Met Primary Endpoint,MRK,-0.020515984758912587,-0.2661708766180868,0.010189875120613978,-0.00583793181005432,-0.01338290751524751,0.003399612434663357,0.0136112695585906,-0.006284147396877882,0.2339394187550896
1503,2015-07-22,"European Commission Approves MSD's Anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab), for Both First-line and Previously-treated Patients with Advanced Melanoma",MRK,-0.009203854602213624,0.24304755549940027,-0.005593090278373958,0.00305969393539951,0.0,0.010306397210120721,0.0005152222857391919,-0.001032208658536815,-0.2525237907428859
1506,2015-07-23,RaNA Therapeutics Announces $55 Million in Oversubscribed Series B Financing Led by Merck,MRK,-0.001032208658536815,-0.2525237907428859,-0.009203854602213624,-0.005593090278373958,0.00305969393539951,0.0,0.010306397210120721,-0.011365939686044269,0.21819112617369485
1507,2015-07-28,Merck Q2 Profit Beats Estimates,MRK,0.009299815584848936,0.10076578161078076,-0.007315459886991005,-0.011365939686044269,-0.001032208658536815,-0.009203854602213624,-0.005593090278373958,0.0177329329349174,-0.21426000634342746
1510,2015-07-28,"Earnings Scheduled For July 28, 2015",MRK,0.009299815584848936,0.10076578161078076,-0.007315459886991005,-0.011365939686044269,-0.001032208658536815,-0.009203854602213624,-0.005593090278373958,0.0177329329349174,-0.21426000634342746
1511,2015-07-28,10 Stocks You Should Be Watching Today,MRK,0.009299815584848936,0.10076578161078076,-0.007315459886991005,-0.011365939686044269,-0.001032208658536815,-0.009203854602213624,-0.005593090278373958,0.0177329329349174,-0.21426000634342746
1516,2015-08-04,Morning Market Gainers,MRK,-0.0059272632123007485,0.018921642180198317,0.001526690005512421,0.007518503954818012,-0.0003415148772037968,0.0177329329349174,0.009299815584848936,0.0068143687075543635,-0.17780205532805093
1519,2015-08-07,"ALK's Partner, Torii Pharmaceutical, Reports Positive Phase II/III Trial Results for Japanese Cedar SLIT-tablet",MRK,-0.007872505730730062,0.383591788975574,-0.01133686388372368,0.0068143687075543635,-0.0059272632123007485,0.001526690005512421,0.007518503954818012,0.00759001317753305,-0.47979902923733575
1520,2015-08-13,"US Stock Futures Rise Ahead of Jobless Claims, Retail Sales Data",MRK,0.012358606423794383,0.4560483884261157,0.00865660833426185,-0.01112842581135165,0.00759001317753305,-0.007872505730730062,-0.01133686388372368,0.0033909657972956975,-0.13605670432127226
1524,2015-08-18,"FDA Accepts Supplemental Biologics License Application for KEYTRUDA, Merck's Anti-PD-1 Therapy, for First-Line Treatment of Advanced Melanoma, and Grants Priority Review",MRK,-0.0008373559129255526,0.1118307055952108,0.00895566941489001,0.0033909657972956975,0.012358606423794383,0.00865660833426185,-0.01112842581135165,0.0,0.17490508761278423
1527,2015-08-20,New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN and the TECOS Cardiovascular Safety Trial of JANUVIA  Will Be Presented at the European Society of Cardiology Congress,MRK,-0.045424073733373205,1.9668809012380697,0.0,-0.0008373559129255526,0.00895566941489001,0.0033909657972956975,0.012358606423794383,-0.020719888794032082,-0.2558368162090674
1530,2015-09-01,New Analyses from the IMPROVE-IT Study with VYTORIN (ezetimibe and simvastatin),MRK,-0.024512341209369404,0.21911261633843715,-0.02745175957882684,0.00764332709074389,0.00973900258880378,0.06351378738405877,-0.05223200196208766,0.00856647285794332,-0.16616077717907507
1533,2015-09-01,Organovo's Keith Murphy: 'People Are Missing The Forest For The Trees',MRK,-0.024512341209369404,0.21911261633843715,-0.02745175957882684,0.00764332709074389,0.00973900258880378,0.06351378738405877,-0.05223200196208766,0.00856647285794332,-0.16616077717907507
1536,2015-09-02,FDA Approves Pediatric Indication for EMEND® (aprepitant) Capsules in Combination with Other Antiemetic Agents,MRK,0.00856647285794332,-0.16616077717907507,-0.024512341209369404,-0.02745175957882684,0.00764332709074389,0.00973900258880378,0.06351378738405877,-0.006229099882382738,-0.07476311085512344
1539,2015-09-08,Giant Health Care ETF Eyes a Comeback,MRK,0.021321821278085684,0.03241949203266348,-0.020132537651027627,-0.006229099882382738,0.00856647285794332,-0.024512341209369404,-0.02745175957882684,-0.014423929792584778,-0.2569596994955047
1541,2015-09-16,Merck Offers Highlights for Commitment to Infectious Disease with 40 Presentations of Data at ICAAC/ICC '15,MRK,0.005976064448482088,-0.2638015359162391,0.02311774273591305,0.004799461390547322,-0.003443461859693464,0.015212551124255791,-0.014423929792584778,0.0016705462430417484,1.6262930299676626
1544,2015-09-17,Merck To Submit Applications To U.S. For Approval Of Ertugliflozin By End Of 2016,MRK,0.0016705462430417484,1.6262930299676626,0.005976064448482088,0.02311774273591305,0.004799461390547322,-0.003443461859693464,0.015212551124255791,-0.03391402331029025,0.27184329983370503
1547,2015-09-18,Merck Offers Results from Phase 2 Study of Investigational Beta-Lactamase Inhibitor at ICAAC/ICC '15: Met Primary Endpoint,MRK,-0.03391402331029025,0.27184329983370503,0.0016705462430417484,0.005976064448482088,0.02311774273591305,0.004799461390547322,-0.003443461859693464,-0.022060293002442277,-0.40536039741493524
1550,2015-09-21,ANI Pharmaceuticals to Acquire Two NDAs from Merck for $75M,MRK,-0.022060293002442277,-0.40536039741493524,-0.03391402331029025,0.0016705462430417484,0.005976064448482088,0.02311774273591305,0.004799461390547322,-0.0047079221904718915,-0.2579378382287887
1551,2015-09-21,Data in Nine Difficult-to-Treat Cancers from Merck's KEYTRUDA Development Program to be Presented at European Cancer Congress 2015,MRK,-0.022060293002442277,-0.40536039741493524,-0.03391402331029025,0.0016705462430417484,0.005976064448482088,0.02311774273591305,0.004799461390547322,-0.0047079221904718915,-0.2579378382287887
1554,2015-09-24,"Merck and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab",MRK,-0.008622534892517297,0.04503004508185682,0.005715722748898866,-0.0047079221904718915,-0.022060293002442277,-0.03391402331029025,0.0016705462430417484,-0.01956911743914902,0.4581522166502705
1557,2015-10-05,"Agilent Company Dako, Announces FDA Approval of New Companion Diagnostic for Lung Cancer",MRK,0.02173909323115053,-0.34611060175528774,0.015596414692522265,-0.0004048036426400614,0.015210534211848259,0.0047504299050455945,-0.02379043809172965,-0.027913126189341275,0.038528851111189644
1558,2015-10-09,KEYTRUDA® (pembrolizumab) Receives New Draft Recommendation from National Institute for Health and Care Excellence (NICE) in U.K. for First-Line Treatment for Advanced Melanoma,MRK,-0.0013719930395196256,-0.1292138567086346,0.0013738779905598797,0.023092326839222466,-0.027913126189341275,0.02173909323115053,0.015596414692522265,-0.00471059450339828,0.06701520152631213
1561,2015-10-13,Incyte and Merck Expand Clinical Collaboration to Include Phase 3 Study Investigating the Combination of Epacadostat with Keytruda® (pembrolizumab) as First-line Treatment for Advanced Melanoma,MRK,-0.024452978975974315,0.2791140962106693,-0.00471059450339828,-0.0013719930395196256,0.0013738779905598797,0.023092326839222466,-0.027913126189341275,0.0014152869973682591,-0.07880768303292995
1564,2015-10-14,Biotech ETFs Get More Refined With Debut Of Cancer Immunotherapy Fund,MRK,0.0014152869973682591,-0.07880768303292995,-0.024452978975974315,-0.00471059450339828,-0.0013719930395196256,0.0013738779905598797,0.023092326839222466,0.02381924682440939,0.022306834785492224
1570,2015-10-27,"Earnings Scheduled For October 27, 2015",MRK,0.010583965490233771,0.27167608096324036,0.0005676557991809439,0.016727684709788138,0.02806869704474768,0.003968903875536167,-0.019649898146045897,0.03048414230451657,0.053958988108907535
1573,2015-10-27,These Three Pharma Giants Just Crushed Earnings,MRK,0.010583965490233771,0.27167608096324036,0.0005676557991809439,0.016727684709788138,0.02806869704474768,0.003968903875536167,-0.019649898146045897,0.03048414230451657,0.053958988108907535
1575,2015-10-27,These 3 Pharma Companies Just Crushed Earnings,MRK,0.010583965490233771,0.27167608096324036,0.0005676557991809439,0.016727684709788138,0.02806869704474768,0.003968903875536167,-0.019649898146045897,0.03048414230451657,0.053958988108907535
1577,2015-11-02,Merck Receives Breakthrough Therapy Designation from U.S.FDA for KEYTRUDA(R) (pembrolizumab) in Advanced Colorectal Cancer,MRK,0.00823256290706409,-0.041597802227306135,-0.003826994320130339,-0.00417423986411436,0.03048414230451657,0.010583965490233771,0.0005676557991809439,0.0,-0.127179379387394
1580,2015-11-12,"Merck Issues Statement Regarding CUBICIN Patent Litigation; Says Reviewing Decision, Considering Next Steps",MRK,-0.012844505117478477,0.0038503626179695605,-0.013044095145360979,0.0035028376977588316,-0.006775569094287781,-0.007992511507533107,-0.008643877081786377,0.0,0.3284173710288545
1581,2015-11-13,Merck Issues Update on REVEAL Outcomes Sutdy,MRK,0.0,0.3284173710288545,-0.012844505117478477,-0.013044095145360979,0.0035028376977588316,-0.006775569094287781,-0.007992511507533107,0.012634425003214877,-0.3937601809363631
1584,2015-11-19,US Stock Futures Edge Higher Ahead Of Jobless Claims Report,MRK,0.000921920457577885,-0.3674084297683028,0.009681740799963867,0.00018601589115241346,0.012634425003214877,0.0,-0.012844505117478477,-0.003316135662783548,0.30619065384468347
1586,2015-11-19,Lilly and Merck Expand Immuno-oncology Collaboration with Phase III Nonsquamous Non-Small Cell Lung Cancer Trial,MRK,0.000921920457577885,-0.3674084297683028,0.009681740799963867,0.00018601589115241346,0.012634425003214877,0.0,-0.012844505117478477,-0.003316135662783548,0.30619065384468347
1590,2015-11-25,MITICURE for house Dust Mite Allergic Rhinitis Now Available in Japan,MRK,0.004487748801590197,-0.4214538993888778,-0.009813003233930417,-0.0016634445533876274,-0.003316135662783548,0.000921920457577885,0.009681740799963867,0.004467510971461586,-0.5095164775792627
1591,2015-11-30,"Deere Announces Factory Workforce Adjustments, 220 Employees On Indefinite Leave Starting Feb 2016",MRK,-0.017605818910561344,3.4818887598460915,0.004467510971461586,0.004487748801590197,-0.009813003233930417,-0.0016634445533876274,-0.003316135662783548,0.02942848113433283,-0.027418638716299237
1594,2015-12-04,EXCLUSIVE: Relypsa Being Evaluated By 3-4 Potential Acquirers; Sanofi Seen As 'Natural Buyer',MRK,0.019965800828988245,0.006759774320915124,-0.022853797668271558,-0.013743849454400991,0.02942848113433283,-0.017605818910561344,0.004467510971461586,0.000745554549835381,-0.36465259004895156
1600,2015-12-07,Must Watch Stocks for Today,MRK,0.000745554549835381,-0.36465259004895156,0.019965800828988245,-0.022853797668271558,-0.013743849454400991,0.02942848113433283,-0.017605818910561344,-0.003911738996994041,-0.12911679143521282
1603,2015-12-10,Biothera Announces Clinical Study to Evaluate Combination Therapy of Imprime PGG,MRK,0.01647097070370651,0.10569453009881946,-0.012156633558667362,-0.003911738996994041,0.000745554549835381,0.019965800828988245,-0.022853797668271558,-0.020289101338144544,-0.09203713074374886
1606,2015-12-21,Merck CEO: Using Keytruda Could Extend Patient's Life By 13 Months On Average,MRK,0.00445384744196442,-0.44857308848970323,-0.019369209701805334,-0.025176194266830043,0.021172365886922728,0.013410036249404289,0.000958441927324305,0.004433905688381312,0.1341342539787791
1610,2015-12-21,ALK Sells European Veterinary Business to Fidelio Capital; Terms Not Disclosed,MRK,0.00445384744196442,-0.44857308848970323,-0.019369209701805334,-0.025176194266830043,0.021172365886922728,0.013410036249404289,0.000958441927324305,0.004433905688381312,0.1341342539787791
1611,2016-01-06,Washington University Initiates Clinical Study of Verastem's VS-6063 in Combination with Merck's Pembrolizumab and Gemcitabine in Pancreatic Cancer,MRK,-0.013734514387518937,0.12553833318227658,0.012766828635129013,-0.006436971877589737,-0.008075077185750179,-0.0016874201076567674,0.009462388443106429,-0.008775245980108481,0.020383622099463317
1612,2016-01-15,Write A Prescription For This Healthcare ETF,MRK,-0.012741496370592631,0.14164423548367955,0.022502961968853263,-0.021251947908305646,0.009951045943189518,0.0033281200525430155,-0.016936057615861477,0.003911148078381554,-0.2944339633159888
1618,2016-01-25,Affimed to Collaborate with Merck to Evaluate AFM13 in Combination with KEYTRUDA for Patients with Hodgkin Lymphoma,MRK,-0.00837366806695583,-0.14171164475519982,0.008444378489458337,0.007319315081986577,-0.015387526087512149,0.003911148078381554,-0.012741496370592631,0.010408548552424568,-0.028338990356123084
1619,2016-01-27,ACARIZAX Receives Marketing Authorization in France,MRK,-0.02099112944014314,0.45484892607038474,0.010408548552424568,-0.00837366806695583,0.008444378489458337,0.007319315081986577,-0.015387526087512149,-0.02322831931135083,0.38171822346606255
1620,2016-01-28,"Merck Receives FDA Approval of Hep C Drug ZEPATIER; To Cost $54,600/Patient for 12-Week Course",MRK,-0.02322831931135083,0.38171822346606255,-0.02099112944014314,0.010408548552424568,-0.00837366806695583,0.008444378489458337,0.007319315081986577,0.02987809492346294,-0.06643162593486518
1621,2016-01-28,Adam Feurestein Reminds Twitter Followers 'Today Is Merck's HepC elbasvir/grazoprevir PDUFA',MRK,-0.02322831931135083,0.38171822346606255,-0.02099112944014314,0.010408548552424568,-0.00837366806695583,0.008444378489458337,0.007319315081986577,0.02987809492346294,-0.06643162593486518
1623,2016-01-28,Abbott to Sell ALK's House Dust Mite Sublingual Allergy Immunotherapy Tablet in SE Asia,MRK,-0.02322831931135083,0.38171822346606255,-0.02099112944014314,0.010408548552424568,-0.00837366806695583,0.008444378489458337,0.007319315081986577,0.02987809492346294,-0.06643162593486518
1624,2016-01-29,Gilead Hits New 52-Week Low; Here Are Two Reasons Why,MRK,0.02987809492346294,-0.06643162593486518,-0.02322831931135083,-0.02099112944014314,0.010408548552424568,-0.00837366806695583,0.008444378489458337,0.0015789110343333856,-0.3245049475641092
1625,2016-01-29,Gilead's Shares Hit A New 52-Week Low: Here Are 2 Reasons Why,MRK,0.02987809492346294,-0.06643162593486518,-0.02322831931135083,-0.02099112944014314,0.010408548552424568,-0.00837366806695583,0.008444378489458337,0.0015789110343333856,-0.3245049475641092
1628,2016-01-29,"Merck Confirms FDA Approval Of Hep C Drug At A Cost Of $54,600 Per Patient",MRK,0.02987809492346294,-0.06643162593486518,-0.02322831931135083,-0.02099112944014314,0.010408548552424568,-0.00837366806695583,0.008444378489458337,0.0015789110343333856,-0.3245049475641092
1632,2016-02-01,"Stock Marquee is Crowded in Week Ahead: Oil, Earnings, Labor Data",MRK,0.0015789110343333856,-0.3245049475641092,0.02987809492346294,-0.02322831931135083,-0.02099112944014314,0.010408548552424568,-0.00837366806695583,-0.006699522350147702,0.3033888936283098
1634,2016-02-01,"Earnings: Pharma Tends to Top Street Estimate—Can PFE, MRK Repeat?",MRK,0.0015789110343333856,-0.3245049475641092,0.02987809492346294,-0.02322831931135083,-0.02099112944014314,0.010408548552424568,-0.00837366806695583,-0.006699522350147702,0.3033888936283098
1638,2016-02-02,"Merck, Sanofi Exploring Potential End To Joint Venture In Europe",MRK,-0.006699522350147702,0.3033888936283098,0.0015789110343333856,0.02987809492346294,-0.02322831931135083,-0.02099112944014314,0.010408548552424568,-0.007141397850849995,0.31339060842682676
1640,2016-02-02,Merck & Sanofi Exploring Potential End To Joint Venture In Europe,MRK,-0.006699522350147702,0.3033888936283098,0.0015789110343333856,0.02987809492346294,-0.02322831931135083,-0.02099112944014314,0.010408548552424568,-0.007141397850849995,0.31339060842682676
1642,2016-02-03,Shares Of Merck Dip Lower Following Q4 Print,MRK,-0.007141397850849995,0.31339060842682676,-0.006699522350147702,0.0015789110343333856,0.02987809492346294,-0.02322831931135083,-0.02099112944014314,-0.02917089939048778,0.053177037738591615
1646,2016-02-03,"Earnings Scheduled For February 3, 2016",MRK,-0.007141397850849995,0.31339060842682676,-0.006699522350147702,0.0015789110343333856,0.02987809492346294,-0.02322831931135083,-0.02099112944014314,-0.02917089939048778,0.053177037738591615
1649,2016-02-03,"Keep an Eye on These 10 Stocks for February 3, 2016",MRK,-0.007141397850849995,0.31339060842682676,-0.006699522350147702,0.0015789110343333856,0.02987809492346294,-0.02322831931135083,-0.02099112944014314,-0.02917089939048778,0.053177037738591615
1652,2016-02-04,25 Companies That Could Still Buy Back Mountains Of Stock,MRK,-0.02917089939048778,0.053177037738591615,-0.007141397850849995,-0.006699522350147702,0.0015789110343333856,0.02987809492346294,-0.02322831931135083,0.016258399213404218,-0.18080276345858648
1658,2016-02-05,A Checkup On A Big Healthcare ETF,MRK,0.016258399213404218,-0.18080276345858648,-0.02917089939048778,-0.007141397850849995,-0.006699522350147702,0.0015789110343333856,0.02987809492346294,-0.011138019729916793,-0.20955397791626518
1664,2016-02-10,ALK's Announces Merck Submits BLA to FDA for Investigational House Dust Mite SLIT-tablet,MRK,0.007526268647326972,0.03634109859656465,0.006758288472795915,-0.011138019729916793,0.016258399213404218,-0.02917089939048778,-0.007141397850849995,-0.013728983641167813,0.004738958274773664
1665,2016-02-10,ALK Announces Merck Submits BLA to FDA for Investigational House Dust Mite SLIT-tablet,MRK,0.007526268647326972,0.03634109859656465,0.006758288472795915,-0.011138019729916793,0.016258399213404218,-0.02917089939048778,-0.007141397850849995,-0.013728983641167813,0.004738958274773664
1666,2016-02-24,AureoGen Announces Licensing Agreement with Merck,MRK,0.00039527265000405265,-0.0413696586265726,-0.004529776012846876,0.012968389774577815,-0.003974186187868156,-0.005533783533863801,0.01647260588983035,0.008702658029267507,0.14803173815143045
1669,2016-02-25,EXCLUSIVE: Sanofi In Talks To Buy PTC Therapeutics,MRK,0.008702658029267507,0.14803173815143045,0.00039527265000405265,-0.004529776012846876,0.012968389774577815,-0.003974186187868156,-0.005533783533863801,-0.007058782433132071,0.06413830844875612
1675,2016-03-07,Gilead Versus Merck: What To Know,MRK,0.010752573485960149,-0.17824518127545308,-0.0003838216301353947,-0.003252351806217968,0.010048110712659764,0.03067112164834862,-0.008491266918843943,-0.0036089956519602673,0.10750980039827818
1677,2016-03-07,Gilead Vs. Merck: What To Know,MRK,0.010752573485960149,-0.17824518127545308,-0.0003838216301353947,-0.003252351806217968,0.010048110712659764,0.03067112164834862,-0.008491266918843943,-0.0036089956519602673,0.10750980039827818
1679,2016-03-10,"The Stocks That Moved The S&P, Dow And Nasdaq Today",MRK,0.012986660478537582,0.3406224448840538,-0.0017160527161930172,-0.0036089956519602673,0.010752573485960149,-0.0003838216301353947,-0.003252351806217968,0.011791857362124736,0.26614223021482
1685,2016-03-23,Jury Rules Merck Patents Valid…Bad For Gilead?,MRK,0.0009426886111578714,0.06935923461427596,0.00435608400609766,0.01052646470331653,0.013972389860628542,-0.007893568582594157,-0.00915690216240228,-0.0001884162335165085,-0.2393867422287621
1689,2016-03-24,"Patent Expert: It's Not Over For Gilead, Still Has Strong Defense Against Merck",MRK,-0.0001884162335165085,-0.2393867422287621,0.0009426886111578714,0.00435608400609766,0.01052646470331653,0.013972389860628542,-0.007893568582594157,-0.0045223743909788006,-0.20081423788852037
1693,2016-04-04,"The Stocks That Moved The S&P, Dow And Nasdaq Today",MRK,0.01303528524034303,0.18040791486577468,0.014931301050954637,-0.005825070950260858,-0.0018753092408756444,0.00927514620651837,-0.0045223743909788006,-0.002941144553169406,-0.12183895461943639
1694,2016-04-04,Make A House Call With A Familiar Healthcare ETF,MRK,0.01303528524034303,0.18040791486577468,0.014931301050954637,-0.005825070950260858,-0.0018753092408756444,0.00927514620651837,-0.0045223743909788006,-0.002941144553169406,-0.12183895461943639
1697,2016-04-06,"Home To Hedge Fund Hotels, But This ETF Can Endure",MRK,0.025626724794798994,0.386587896452796,-0.002941144553169406,0.01303528524034303,0.014931301050954637,-0.005825070950260858,-0.0018753092408756444,-0.0037751015762986784,-0.1557322057433721
1699,2016-04-06,SocGen Picks New Favorites In Big Pharma,MRK,0.025626724794798994,0.386587896452796,-0.002941144553169406,0.01303528524034303,0.014931301050954637,-0.005825070950260858,-0.0018753092408756444,-0.0037751015762986784,-0.1557322057433721
1703,2016-04-12,"Baird: Gilead Set For Q1 EPS Miss, But Hep C Trends Still Good Long Term",MRK,0.005267904155991321,-0.1597316803040859,-0.005599450646988968,-0.001082764432942862,-0.0037751015762986784,0.025626724794798994,-0.002941144553169406,0.011203663198054992,0.42235135590365513
1706,2016-04-12,"Notable Imbalances Before Tuesday's Open Led By Under Armour, Boeing, Caterpillar",MRK,0.005267904155991321,-0.1597316803040859,-0.005599450646988968,-0.001082764432942862,-0.0037751015762986784,0.025626724794798994,-0.002941144553169406,0.011203663198054992,0.42235135590365513
1710,2016-04-12,"Baird: Gilead Set For Q1 EPS Miss, But Hep C Trends Still Good Long-Term",MRK,0.005267904155991321,-0.1597316803040859,-0.005599450646988968,-0.001082764432942862,-0.0037751015762986784,0.025626724794798994,-0.002941144553169406,0.011203663198054992,0.42235135590365513
1716,2016-04-13,Merck Says FDA Accepts Its sBLA For Keytruda And Grants Priority Review,MRK,0.011203663198054992,0.42235135590365513,0.005267904155991321,-0.005599450646988968,-0.001082764432942862,-0.0037751015762986784,0.025626724794798994,0.00875600385097508,-0.010397254819185298
1720,2016-04-14,"After-Hours Recap: Big Banks, Liquidity Services's DoD Deal, Haemonetics' CFO & More",MRK,0.00875600385097508,-0.010397254819185298,0.011203663198054992,0.005267904155991321,-0.005599450646988968,-0.001082764432942862,-0.0037751015762986784,-0.00549159286863643,0.009297859673329745
1724,2016-04-25,Pharma Names Under Pressure Amid Perrigo Warning,MRK,-0.009164599779252214,0.16729405535763586,0.002473515607970267,0.00035352186956250087,-0.00492449709370657,0.006193593153126287,0.006590794837397773,-0.003201629130933692,-0.12724332048423248
1728,2016-05-02,"The Market In 5 Minutes: May, She Will Stay",MRK,0.008388265763504155,-0.2683021009101674,-0.016146707437125984,-0.010122186896298513,0.0048177359394177,-0.003201629130933692,-0.009164599779252214,-0.003978391738638232,-0.21466276833597753
1730,2016-05-02,"The Market In 5 Minutes: May, She Will Stay Stay",MRK,0.008388265763504155,-0.2683021009101674,-0.016146707437125984,-0.010122186896298513,0.0048177359394177,-0.003201629130933692,-0.009164599779252214,-0.003978391738638232,-0.21466276833597753
1731,2016-05-05,Mid-Afternoon Market Update: U.S. Stocks Turn Lower; Zynga Shares Rise Following Earnings Beat,MRK,-0.01313632942340115,0.45668315360490386,-0.0049019757954474885,-0.003978391738638232,0.008388265763504155,-0.016146707437125984,-0.010122186896298513,-0.009058993839300866,-0.06226176278326867
1734,2016-05-05,"Earnings Scheduled For May 5, 2016",MRK,-0.01313632942340115,0.45668315360490386,-0.0049019757954474885,-0.003978391738638232,0.008388265763504155,-0.016146707437125984,-0.010122186896298513,-0.009058993839300866,-0.06226176278326867
1736,2016-05-05,Mid-Day Market Update: Fitbit Slides  On Weak Outlook; Atlas Air Worldwide Shares Shares Spike Higher,MRK,-0.01313632942340115,0.45668315360490386,-0.0049019757954474885,-0.003978391738638232,0.008388265763504155,-0.016146707437125984,-0.010122186896298513,-0.009058993839300866,-0.06226176278326867
1738,2016-05-05,Mid-Morning Market Update: Markets Edge Higher; Merck Profit Beats Views,MRK,-0.01313632942340115,0.45668315360490386,-0.0049019757954474885,-0.003978391738638232,0.008388265763504155,-0.016146707437125984,-0.010122186896298513,-0.009058993839300866,-0.06226176278326867
1741,2016-05-05,"12 Stocks To Watch For May 5, 2016",MRK,-0.01313632942340115,0.45668315360490386,-0.0049019757954474885,-0.003978391738638232,0.008388265763504155,-0.016146707437125984,-0.010122186896298513,-0.009058993839300866,-0.06226176278326867
1745,2016-05-05,"Merck's 1Q Adjusted Profit beats, But Revenue Miss, Narrows Adjusted EPS FY16 Forecast",MRK,-0.01313632942340115,0.45668315360490386,-0.0049019757954474885,-0.003978391738638232,0.008388265763504155,-0.016146707437125984,-0.010122186896298513,-0.009058993839300866,-0.06226176278326867
1746,2016-05-05,"Merck's Q1 Adjusted Profit beats, But Revenue Miss, Narrows Adjusted EPS FY16 Forecast",MRK,-0.01313632942340115,0.45668315360490386,-0.0049019757954474885,-0.003978391738638232,0.008388265763504155,-0.016146707437125984,-0.010122186896298513,-0.009058993839300866,-0.06226176278326867
1750,2016-05-06,What's M&A Like In The Biotech Sector Right Now?,MRK,-0.009058993839300866,-0.06226176278326867,-0.01313632942340115,-0.0049019757954474885,-0.003978391738638232,0.008388265763504155,-0.016146707437125984,0.0093282126440426,-0.24233585416099734
1756,2016-05-12,Berenberg Unimpressed With Pfizer; Initiates Coverage At Hold,MRK,-0.0034983750856576457,0.25428651853645534,-0.0067664135268391545,0.01072072883313302,0.0093282126440426,-0.009058993839300866,-0.01313632942340115,-0.004434542647113404,-0.13574218410916816
1758,2016-05-12,Merck To Present Final Stage Data On Investigational Medicines Ertugliflozin And MK-1293,MRK,-0.0034983750856576457,0.25428651853645534,-0.0067664135268391545,0.01072072883313302,0.0093282126440426,-0.009058993839300866,-0.01313632942340115,-0.004434542647113404,-0.13574218410916816
1760,2016-05-12,Merck To Present Final Stage Data On Investigational Medicines Ertugliflozin and MK-1293,MRK,-0.0034983750856576457,0.25428651853645534,-0.0067664135268391545,0.01072072883313302,0.0093282126440426,-0.009058993839300866,-0.01313632942340115,-0.004434542647113404,-0.13574218410916816
1762,2016-05-16,Merck To Present New And Updated Data On KEYTRUDA,MRK,0.014290979531583536,-0.06681920020998477,-0.004434542647113404,-0.0034983750856576457,-0.0067664135268391545,0.01072072883313302,0.0093282126440426,-0.006038203222874405,0.7737738433011296
1766,2016-05-19,JPMorgan's Take On Big Pharma's New ASCO Abstracts,MRK,-0.001646336920768321,0.18166188956384843,0.006443114785254389,-0.006038203222874405,0.014290979531583536,-0.004434542647113404,-0.0034983750856576457,0.00971080013961001,-0.01154119242527718
1768,2016-05-19,J.P. Morgan's Take On Big Pharma's New ASCO Abstracts,MRK,-0.001646336920768321,0.18166188956384843,0.006443114785254389,-0.006038203222874405,0.014290979531583536,-0.004434542647113404,-0.0034983750856576457,0.00971080013961001,-0.01154119242527718
1772,2016-05-23,Chardan Initiates Asterias Biotherapeutics At Buy On Potential Cell Therapy Competitiveness,MRK,-0.0034478602283444237,-0.3547741257270387,0.00971080013961001,-0.001646336920768321,0.006443114785254389,-0.006038203222874405,0.014290979531583536,0.012381514056533538,0.1330091402842981
1774,2016-05-23,"Chardan Intiates Asterias Biotherapeutics At Buy, Says It Could Be Significant Competitor In Cell Therapy",MRK,-0.0034478602283444237,-0.3547741257270387,0.00971080013961001,-0.001646336920768321,0.006443114785254389,-0.006038203222874405,0.014290979531583536,0.012381514056533538,0.1330091402842981
1778,2016-05-26,Celgene Rallies Of Possible Interest From Merck,MRK,-0.0031819077099437543,-0.40363005646484806,0.017446417137950254,0.012381514056533538,-0.0034478602283444237,0.00971080013961001,-0.001646336920768321,0.0015955924101986874,0.31261246714808344
1780,2016-05-27,Merck Gets Favorable Opinion From CHMP For Its ZEPATIER,MRK,0.0015955924101986874,0.31261246714808344,-0.0031819077099437543,0.017446417137950254,0.012381514056533538,-0.0034478602283444237,0.00971080013961001,-0.003895099505273336,0.26098717255657555
1784,2016-06-03,"Ouch! Jobs Report Miss Sends Rate Hike Odds Down, Raises Questions",MRK,-0.0031676470269815793,-0.25475980958668965,0.008698580631820274,0.0012443644495869766,-0.003895099505273336,0.0015955924101986874,-0.0031819077099437543,0.009357265721734898,0.26984131441375214
1787,2016-06-06,4 Key Takeaways From ASCO,MRK,0.009357265721734898,0.26984131441375214,-0.0031676470269815793,0.008698580631820274,0.0012443644495869766,-0.003895099505273336,0.0015955924101986874,-0.0029734906630120017,-0.09438009716681561
1789,2016-06-06,Piper Jaffray's Takeaways From ASCO,MRK,0.009357265721734898,0.26984131441375214,-0.0031676470269815793,0.008698580631820274,0.0012443644495869766,-0.003895099505273336,0.0015955924101986874,-0.0029734906630120017,-0.09438009716681561
1791,2016-06-06,"Merck, Pfizer Offers Results from Pivotal Avelumab Study",MRK,0.009357265721734898,0.26984131441375214,-0.0031676470269815793,0.008698580631820274,0.0012443644495869766,-0.003895099505273336,0.0015955924101986874,-0.0029734906630120017,-0.09438009716681561
1794,2016-06-07,"Merck Says Ruling Reversal in Gilead Case 'Doesn't Reflect the Facts,' Co. Will Appeal Ruling Overturn",MRK,-0.0029734906630120017,-0.09438009716681561,0.009357265721734898,-0.0031676470269815793,0.008698580631820274,0.0012443644495869766,-0.003895099505273336,0.010877206144283669,0.245937628528893
1797,2016-06-13,"Has Cancer Research Become Cancerous? Same Cancer Strategy Targeted By 'Too Many Drugmakers,' Say Regulators",MRK,-0.004259230151245186,-0.34903539034371245,-0.006470745779413756,-0.00763624100367144,0.010877206144283669,-0.0029734906630120017,0.009357265721734898,0.002495258850328863,0.3850891100985294
1798,2016-06-13,"Has Cancer Research Become Cancerous? Same Cancer Strategy Targeted By 'Too Many Drugmakers,' Says Reuters",MRK,-0.004259230151245186,-0.34903539034371245,-0.006470745779413756,-0.00763624100367144,0.010877206144283669,-0.0029734906630120017,0.009357265721734898,0.002495258850328863,0.3850891100985294
1802,2016-06-27,Merck Gets CHMP Positive Opinion for KEYTRUDA for Advanced Non-Small Cell Lung Cancer Treatment,MRK,-0.010200610509695895,-0.24134637377658763,-0.03120650229945976,0.011220326057512997,0.01404409900625292,0.001959606872551811,0.004473012953909006,0.004881654725350293,-0.02544808697531764
1803,2016-06-27,Merck Gets CHMP Positive Opinion For KEYTRUDA For Advanced Non-Small Cell Lung Cancer Treatment,MRK,-0.010200610509695895,-0.24134637377658763,-0.03120650229945976,0.011220326057512997,0.01404409900625292,0.001959606872551811,0.004473012953909006,0.004881654725350293,-0.02544808697531764
1810,2016-06-30,Merck And Premier Join Hands To Prevent Fractures For Osteoporosis Patients,MRK,0.00981588953803536,-0.0546270820162682,0.02644842014474036,0.004881654725350293,-0.010200610509695895,-0.03120650229945976,0.011220326057512997,0.005728130619451655,-0.1519127267940138
1812,2016-06-30,Merck and Premier Join Hands to Prevent Fractures for Osteoporosis Patients,MRK,0.00981588953803536,-0.0546270820162682,0.02644842014474036,0.004881654725350293,-0.010200610509695895,-0.03120650229945976,0.011220326057512997,0.005728130619451655,-0.1519127267940138
1814,2016-07-20,"Benzinga's M&A Chatter for Wednesday July 20, 2016",MRK,0.0022160812606748514,-0.2708274376149732,-0.006099696153242018,-0.010229517384931275,-0.00033525181957017036,0.0016792392010218649,-0.0008390802168283251,0.0,-0.06622912432988037
1817,2016-07-21,The Market In 5 Minutes: Jam-Packed Day Of Earnings And Econmic Data,MRK,0.0,-0.06622912432988037,0.0022160812606748514,-0.006099696153242018,-0.010229517384931275,-0.00033525181957017036,0.0016792392010218649,0.0005104013312953182,0.03677792696360527
1818,2016-07-21,The Market In 5 Minutes: Jam-Packed Day Of Earnings And Economic Data,MRK,0.0,-0.06622912432988037,0.0022160812606748514,-0.006099696153242018,-0.010229517384931275,-0.00033525181957017036,0.0016792392010218649,0.0005104013312953182,0.03677792696360527
1820,2016-07-22,Merck Presents Data On Its Investigational Once-Daily Formulation of ISENTRESS,MRK,0.0005104013312953182,0.03677792696360527,0.0,0.0022160812606748514,-0.006099696153242018,-0.010229517384931275,-0.00033525181957017036,-0.004420189836349175,0.28195236967531523
1822,2016-07-22,Merck Presents Data On Its Investigational Once-Daily Formulation Of ISENTRESS,MRK,0.0005104013312953182,0.03677792696360527,0.0,0.0022160812606748514,-0.006099696153242018,-0.010229517384931275,-0.00033525181957017036,-0.004420189836349175,0.28195236967531523
1824,2016-07-25,Merck Gets Breakthrough Therapy Status From FDA And PRIME Status From EMA For Investigational Ebola Zaire Vaccine,MRK,-0.004420189836349175,0.28195236967531523,0.0005104013312953182,0.0,0.0022160812606748514,-0.006099696153242018,-0.010229517384931275,-0.0034154230306362443,-0.11028725442497467
1826,2016-07-25,Merck Gets Breakthrough Therapy Status from FDA and PRIME Status from EMA for Its Investigational Ebola Zaire Vaccine,MRK,-0.004420189836349175,0.28195236967531523,0.0005104013312953182,0.0,0.0022160812606748514,-0.006099696153242018,-0.010229517384931275,-0.0034154230306362443,-0.11028725442497467
1828,2016-07-27,Can Keytruda Deliver Earnings Growth For Merck?,MRK,0.004112199618282464,0.10320524128647324,-0.0034154230306362443,-0.004420189836349175,0.0005104013312953182,0.0,0.0022160812606748514,-0.002900784601565509,-0.07594301612756127
1830,2016-07-29,Investors Greet Merck Q2 Results As Key Launches Help Beat,MRK,0.003936315583012773,0.1648215889667608,-0.002900784601565509,0.004112199618282464,-0.0034154230306362443,-0.004420189836349175,0.0005104013312953182,0.0,0.04475221204529434
1832,2016-07-29,12 Stocks You Should Be Watching Today,MRK,0.003936315583012773,0.1648215889667608,-0.002900784601565509,0.004112199618282464,-0.0034154230306362443,-0.004420189836349175,0.0005104013312953182,0.0,0.04475221204529434
1833,2016-07-29,Investors Greet Merck 2Q Results As Key Launches Help Beat,MRK,0.003936315583012773,0.1648215889667608,-0.002900784601565509,0.004112199618282464,-0.0034154230306362443,-0.004420189836349175,0.0005104013312953182,0.0,0.04475221204529434
1835,2016-07-29,A Peek Into The Markets: U.S. Stock Futures Mostly Lower Ahead Of GDP Report,MRK,0.003936315583012773,0.1648215889667608,-0.002900784601565509,0.004112199618282464,-0.0034154230306362443,-0.004420189836349175,0.0005104013312953182,0.0,0.04475221204529434
1840,2016-07-29,"Weak GDP Data, Plunging Oil Renew Questions About Strength Of Economy",MRK,0.003936315583012773,0.1648215889667608,-0.002900784601565509,0.004112199618282464,-0.0034154230306362443,-0.004420189836349175,0.0005104013312953182,0.0,0.04475221204529434
1842,2016-07-29,"Earnings Scheduled For July 29, 2016",MRK,0.003936315583012773,0.1648215889667608,-0.002900784601565509,0.004112199618282464,-0.0034154230306362443,-0.004420189836349175,0.0005104013312953182,0.0,0.04475221204529434
1845,2016-08-02,6 Stocks Moving In Tuesday's After-Hours Session,MRK,-0.005625430593614977,-0.23051004096152117,0.0,0.003936315583012773,-0.002900784601565509,0.004112199618282464,-0.0034154230306362443,-0.011657939079036894,0.4117897187600381
1847,2016-08-02,"Benzinga's M&A Chatter for Tuesday August 2, 2016",MRK,-0.005625430593614977,-0.23051004096152117,0.0,0.003936315583012773,-0.002900784601565509,0.004112199618282464,-0.0034154230306362443,-0.011657939079036894,0.4117897187600381
1850,2016-08-02,6 Stocks Moving In After-Hours: Earnings & Takeovers Shake The Market,MRK,-0.005625430593614977,-0.23051004096152117,0.0,0.003936315583012773,-0.002900784601565509,0.004112199618282464,-0.0034154230306362443,-0.011657939079036894,0.4117897187600381
1852,2016-08-03,"Benzinga's M&A Chatter for Wednesday August 3, 2016",MRK,-0.011657939079036894,0.4117897187600381,-0.005625430593614977,0.0,0.003936315583012773,-0.002900784601565509,0.004112199618282464,0.003295552693890258,-0.4250049257962215
1855,2016-08-03,The Market In 5 Minutes: Downtrend Continues,MRK,-0.011657939079036894,0.4117897187600381,-0.005625430593614977,0.0,0.003936315583012773,-0.002900784601565509,0.004112199618282464,0.003295552693890258,-0.4250049257962215
1856,2016-08-03,Why Is Biogen Attractive? Credit Suisse Sees 12-24% Upside Takeout Potential,MRK,-0.011657939079036894,0.4117897187600381,-0.005625430593614977,0.0,0.003936315583012773,-0.002900784601565509,0.004112199618282464,0.003295552693890258,-0.4250049257962215
1859,2016-08-05,25 Biggest Mid-Day Gainers For Friday,MRK,0.10408035323626508,12.15118968307089,0.003295552693890258,-0.011657939079036894,-0.005625430593614977,0.0,0.003936315583012773,-0.015659047322423847,-0.656321699748061
1861,2016-08-05,The Market In 5 Minutes: Blowout Jobs Report Pushes Markets Higher,MRK,0.10408035323626508,12.15118968307089,0.003295552693890258,-0.011657939079036894,-0.005625430593614977,0.0,0.003936315583012773,-0.015659047322423847,-0.656321699748061
1862,2016-08-05,Bristol Mayer's Failure Is Merck & Co's Success In Lung Cancer Market,MRK,0.10408035323626508,12.15118968307089,0.003295552693890258,-0.011657939079036894,-0.005625430593614977,0.0,0.003936315583012773,-0.015659047322423847,-0.656321699748061
1863,2016-08-05,Bristol's Opdivo Misses Endpoint In Late-Stage Trial; Merck Rallies Sharply Amid Keytruda Potential,MRK,0.10408035323626508,12.15118968307089,0.003295552693890258,-0.011657939079036894,-0.005625430593614977,0.0,0.003936315583012773,-0.015659047322423847,-0.656321699748061
1867,2016-08-05,Benzinga's Volume Movers,MRK,0.10408035323626508,12.15118968307089,0.003295552693890258,-0.011657939079036894,-0.005625430593614977,0.0,0.003936315583012773,-0.015659047322423847,-0.656321699748061
1871,2016-08-05,Stocks Hitting 52-Week Highs,MRK,0.10408035323626508,12.15118968307089,0.003295552693890258,-0.011657939079036894,-0.005625430593614977,0.0,0.003936315583012773,-0.015659047322423847,-0.656321699748061
1876,2016-08-08,The Market in 5 Minutes: Can The Momentum Continue?,MRK,-0.015659047322423847,-0.656321699748061,0.10408035323626508,0.003295552693890258,-0.011657939079036894,-0.005625430593614977,0.0,-0.005886220456076008,-0.5115208516211629
1877,2016-08-08,Watch These 5 Huge Put Purchases In Monday Trade,MRK,-0.015659047322423847,-0.656321699748061,0.10408035323626508,0.003295552693890258,-0.011657939079036894,-0.005625430593614977,0.0,-0.005886220456076008,-0.5115208516211629
1881,2016-08-08,"After Roaring To New Highs on Jobs Data, Market Faces Retail Sales, Job Openings",MRK,-0.015659047322423847,-0.656321699748061,0.10408035323626508,0.003295552693890258,-0.011657939079036894,-0.005625430593614977,0.0,-0.005886220456076008,-0.5115208516211629
1885,2016-08-10,"Argus: Bristol-Myers Selloff Is Overdone, Reiterating $90 Target",MRK,0.0024001945920697487,-0.2778231914127127,-0.005886220456076008,-0.015659047322423847,0.10408035323626508,0.003295552693890258,-0.011657939079036894,0.015804798604353243,0.173121785530729
1887,2016-08-11,Biogen Cancels Out Of Citigroup Conference Following Weeks Of Rumors,MRK,0.015804798604353243,0.173121785530729,0.0024001945920697487,-0.005886220456076008,-0.015659047322423847,0.10408035323626508,0.003295552693890258,-0.004400566975903963,-0.39755912992565257
1891,2016-08-24,The 2015 Flash Crash Was One Year Ago Today. Why Did It Happen?,MRK,-0.013368884007219584,0.2905111850581308,0.000472171425637935,0.0029987912571640685,-0.004243503297989282,0.005372118490448496,0.003966153244274517,-0.006536236873694978,0.06211503352618619
1896,2016-09-02,Merck Remains Stable Following Discontinuation Of Odanacatib Development Program,MRK,0.0012719529026170573,0.1632618665005745,0.0017517540463025671,0.0012755709564984397,-0.0047611632397932535,0.00254600786295911,0.00850457123961168,0.004128224430647309,0.041651240049361826
1900,2016-09-15,Seattle Genetics No Longer On Goldman Sachs' Sell List,MRK,0.016788649541290335,-0.13663667045533412,-0.00744208608864072,-0.014665959384321692,0.011201721783894003,-0.011859426405728901,0.005885286611282181,-0.0016030551626856626,0.38170443282677047
1904,2016-09-20,New 5-Year Contraceptive Coming To U.S. Adds To Long-Acting Reversible Contraceptives List,MRK,0.00994620328629714,-0.18392587689599993,-0.015253750729439242,-0.0016030551626856626,0.016788649541290335,-0.00744208608864072,-0.014665959384321692,0.012270111862719535,-0.21631422875052686
1908,2016-09-21,"The Market In 5 Minutes: We're Waiting For You, Mrs. Yellen",MRK,0.012270111862719535,-0.21631422875052686,0.00994620328629714,-0.015253750729439242,-0.0016030551626856626,0.016788649541290335,-0.00744208608864072,0.005103735335301618,0.17021742877415313
1910,2016-10-10,The ESMO Conference Proves Its Ability To Move Stocks,MRK,0.018002182285510315,0.8882154473668598,0.0017556290636440153,-0.0022294695236214634,0.005443766786922266,-0.0009600228274004863,0.0017627399464297255,-0.030829385415172772,-0.3140927685647412
1911,2016-10-10,SunTrust Cuts Target On Bristol-Myers As Opdivo Estimates Revised Lower,MRK,0.018002182285510315,0.8882154473668598,0.0017556290636440153,-0.0022294695236214634,0.005443766786922266,-0.0009600228274004863,0.0017627399464297255,-0.030829385415172772,-0.3140927685647412
1912,2016-10-10,Bristol-Myers Opdivo Vs. Merck's Keytruda In Front Line Lung Treatment,MRK,0.018002182285510315,0.8882154473668598,0.0017556290636440153,-0.0022294695236214634,0.005443766786922266,-0.0009600228274004863,0.0017627399464297255,-0.030829385415172772,-0.3140927685647412
1913,2016-10-13,A Peek Into The Markets: U.S. Stock Futures Tumble Ahead Of Jobless Claims Report,MRK,0.01378543575462321,0.4366374172998593,-0.004359958832207855,-0.030829385415172772,0.018002182285510315,0.0017556290636440153,-0.0022294695236214634,-0.005918991795089368,-0.16073304805698252
1914,2016-10-19,"Fed Speakers And Beige Book, Bank Earnings, Rising Crude Take Center Stage",MRK,-0.003543020668617114,-0.4410592329115549,0.009265171862843813,-0.009977625730080208,-0.005918991795089368,0.01378543575462321,-0.004359958832207855,0.0008080950676672138,0.1326776249557744
1915,2016-10-21,Merck Has An Upcoming PDUFA Date For Bezlotoxumab,MRK,-0.011628040906847548,0.17131615985277038,0.0008080950676672138,-0.003543020668617114,0.009265171862843813,-0.009977625730080208,-0.005918991795089368,-0.007352877204316655,0.342433133193047
1916,2016-10-24,Big News Out Of Merck This Weekend,MRK,-0.007352877204316655,0.342433133193047,-0.011628040906847548,0.0008080950676672138,-0.003543020668617114,0.009265171862843813,-0.009977625730080208,0.019753047306881877,0.5275570753293775
1917,2016-10-25,Epic Earnings: Many US Companies Beating Expectations As Season Continues,MRK,0.019753047306881877,0.5275570753293775,-0.007352877204316655,-0.011628040906847548,0.0008080950676672138,-0.003543020668617114,0.009265171862843813,-0.017433261914321818,-0.3443855799900839
1918,2016-10-25,6 Big Pharma Companies Left To Report September Quarterly Figures,MRK,0.019753047306881877,0.5275570753293775,-0.007352877204316655,-0.011628040906847548,0.0008080950676672138,-0.003543020668617114,0.009265171862843813,-0.017433261914321818,-0.3443855799900839
1919,2016-10-25,"Earnings Scheduled For October 25, 2016",MRK,0.019753047306881877,0.5275570753293775,-0.007352877204316655,-0.011628040906847548,0.0008080950676672138,-0.003543020668617114,0.009265171862843813,-0.017433261914321818,-0.3443855799900839
1920,2016-10-25,12 Stocks You Should Be Watching Today,MRK,0.019753047306881877,0.5275570753293775,-0.007352877204316655,-0.011628040906847548,0.0008080950676672138,-0.003543020668617114,0.009265171862843813,-0.017433261914321818,-0.3443855799900839
1921,2016-10-25,"The Market In 5 Minutes: UA, GM, P&G Earnings On The Street's Mind",MRK,0.019753047306881877,0.5275570753293775,-0.007352877204316655,-0.011628040906847548,0.0008080950676672138,-0.003543020668617114,0.009265171862843813,-0.017433261914321818,-0.3443855799900839
1922,2016-10-25,"Merck's Q3 Results, Guidance Look Strong",MRK,0.019753047306881877,0.5275570753293775,-0.007352877204316655,-0.011628040906847548,0.0008080950676672138,-0.003543020668617114,0.009265171862843813,-0.017433261914321818,-0.3443855799900839
1923,2016-10-25,"A Peek Into The Markets: U.S. Stock Futures Rise; GM, Apple Earnings In Focus",MRK,0.019753047306881877,0.5275570753293775,-0.007352877204316655,-0.011628040906847548,0.0008080950676672138,-0.003543020668617114,0.009265171862843813,-0.017433261914321818,-0.3443855799900839
1924,2016-11-09,Biotech Is Getting A Big Boost Following Clinton's Loss,MRK,0.06065134447894427,2.506767671221619,0.007660042334617145,0.02091142969471349,0.006674565980154368,-0.0069681887001505904,-0.007756924598722348,0.012153006775442954,-0.35865012527600004
1925,2016-11-09,Stocks Hitting 52-Week Highs,MRK,0.06065134447894427,2.506767671221619,0.007660042334617145,0.02091142969471349,0.006674565980154368,-0.0069681887001505904,-0.007756924598722348,0.012153006775442954,-0.35865012527600004
1926,2016-11-14,Gilead Responds To CMS Blog Highlighting High Cost Of Harvoni: Most Payers Receive Substantial Discounts Off The List Price,MRK,-0.006567751280211587,-0.27989219363502127,-0.015547878129505088,0.012153006775442954,0.06065134447894427,0.007660042334617145,0.02091142969471349,0.0018889062320988081,-0.2799249534139656
1927,2016-12-19,Jefferies' 2017 Global Pharma Outlook,MRK,-0.02081999422531622,-0.3202457488711483,0.0011223450108772681,0.0092233206574317,0.00016161581927010005,0.008816625088643448,0.00800258740406834,-0.010467809317810772,-0.13082333605497154
1928,2016-12-19,A Peek Into The Markets: U.S. Stock Futures Rise Ahead Of Yellen Speech,MRK,-0.02081999422531622,-0.3202457488711483,0.0011223450108772681,0.0092233206574317,0.00016161581927010005,0.008816625088643448,0.00800258740406834,-0.010467809317810772,-0.13082333605497154
1929,2016-12-20,What Does Biogen's New CEO Mean For The Buyout Argument?,MRK,-0.010467809317810772,-0.13082333605497154,-0.02081999422531622,0.0011223450108772681,0.0092233206574317,0.00016161581927010005,0.008816625088643448,-0.01768565935971378,0.16142276358846153
1930,2016-12-23,6 Worst Biotech Stocks Of 2016,MRK,-0.00033562813476673004,-0.24836633663366336,0.0025237677911762457,-0.01768565935971378,-0.010467809317810772,-0.02081999422531622,0.0011223450108772681,0.0038614670709882226,-0.2339326627359949
1931,2016-12-23,Where Does Merck's Ebola Vaccine Breakthrough Leave Competitors?,MRK,-0.00033562813476673004,-0.24836633663366336,0.0025237677911762457,-0.01768565935971378,-0.010467809317810772,-0.02081999422531622,0.0011223450108772681,0.0038614670709882226,-0.2339326627359949
1932,2016-12-23,NewLink CFO: 'Ebola Vaccine Highly Unlikely To Drive Future Profit In Company',MRK,-0.00033562813476673004,-0.24836633663366336,0.0025237677911762457,-0.01768565935971378,-0.010467809317810772,-0.02081999422531622,0.0011223450108772681,0.0038614670709882226,-0.2339326627359949
1933,2017-01-09,"Exclusive: Ziopharm CEO Talks Partnerships, Balance Sheet And JPM Healthcare Conference Presentation",MRK,0.013770995497768945,-0.04922547912857467,0.002661915375817392,-0.0003326388174504924,-0.00033260877221585883,0.02174288432399174,-0.0028795474701241996,-0.019312459219088418,0.5719392765692455
1934,2017-01-09,The Year's Biggest Healthcare Conference Commences This Week; Here's What You Need To Know,MRK,0.013770995497768945,-0.04922547912857467,0.002661915375817392,-0.0003326388174504924,-0.00033260877221585883,0.02174288432399174,-0.0028795474701241996,-0.019312459219088418,0.5719392765692455
1935,2017-01-11,15 Biggest Mid-Day Gainers For Wednesday,MRK,0.028538112829044504,1.1377121960083323,-0.019312459219088418,0.013770995497768945,0.002661915375817392,-0.0003326388174504924,-0.00033260877221585883,0.009411033464327812,-0.23925080265476828
1936,2017-01-11,All The Markets Trump Moved During His Speech Today,MRK,0.028538112829044504,1.1377121960083323,-0.019312459219088418,0.013770995497768945,0.002661915375817392,-0.0003326388174504924,-0.00033260877221585883,0.009411033464327812,-0.23925080265476828
1937,2017-01-11,Here's What Merck's Keytruda News Means For Bristol-Myers,MRK,0.028538112829044504,1.1377121960083323,-0.019312459219088418,0.013770995497768945,0.002661915375817392,-0.0003326388174504924,-0.00033260877221585883,0.009411033464327812,-0.23925080265476828
1938,2017-01-11,22 Stocks Moving In Wednesday's Pre-Market Session,MRK,0.028538112829044504,1.1377121960083323,-0.019312459219088418,0.013770995497768945,0.002661915375817392,-0.0003326388174504924,-0.00033260877221585883,0.009411033464327812,-0.23925080265476828
1939,2017-01-12,Favorable News On Keytruda Drives Piper Jaffray's Upgrade Of Merck,MRK,0.009411033464327812,-0.23925080265476828,0.028538112829044504,-0.019312459219088418,0.013770995497768945,0.002661915375817392,-0.0003326388174504924,0.002089626720789939,-0.5993996372455277
1940,2017-01-12,Merck's Leadership Position In Immuno Oncology Is Improving,MRK,0.009411033464327812,-0.23925080265476828,0.028538112829044504,-0.019312459219088418,0.013770995497768945,0.002661915375817392,-0.0003326388174504924,0.002089626720789939,-0.5993996372455277
1941,2017-01-12,"The Market In 5 Minutes: Jobless Claims Lower, Trump Conference Shakes Sectors",MRK,0.009411033464327812,-0.23925080265476828,0.028538112829044504,-0.019312459219088418,0.013770995497768945,0.002661915375817392,-0.0003326388174504924,0.002089626720789939,-0.5993996372455277
1942,2017-01-20,Wall Street's M&A Chatter From January 19,MRK,0.036466079019051634,1.2144693356608904,-0.013732192838096902,-0.005042449619659717,-0.013795157441097161,0.002089626720789939,0.009411033464327812,-0.011514293750393478,-0.5958169856955855
1943,2017-01-26,Merck's Keytruda Gains Momentum At The Expense Of Bristol-Myers,MRK,0.001964394077563325,-0.12705227725492885,-0.00212384443641378,-0.009707223348722649,-0.011514293750393478,0.036466079019051634,-0.013732192838096902,0.00898692350983965,-0.4764351460413623
1944,2017-01-27,A CEO Who's Who Of Trump's Manufacturing Council,MRK,0.00898692350983965,-0.4764351460413623,0.001964394077563325,-0.00212384443641378,-0.009707223348722649,-0.011514293750393478,0.036466079019051634,-0.005182045154423887,0.18042441836950984
1945,2017-01-30,"The Market In 5 Minutes: Walgreens-Rite Aid, Personal Income And Trump's Executive Order",MRK,-0.005182045154423887,0.18042441836950984,0.00898692350983965,0.001964394077563325,-0.00212384443641378,-0.009707223348722649,-0.011514293750393478,0.009116074069374314,0.2505220474929266
1946,2017-02-02,"The Market In 5 Minutes: Facebook Beats, Trump Tweets",MRK,0.033494498885772606,0.7234364031908687,0.00177454115262754,0.009116074069374314,-0.005182045154423887,0.00898692350983965,0.001964394077563325,0.0017136864160818277,-0.3864993646281002
1947,2017-02-15,Deutsche Bank Casts Doubt On Pfizer's Rumored Takeover Approach To Bristol-Myers,MRK,-0.007615214777555224,0.7556763926977152,0.013741036319060207,0.009665004496677732,-0.003727579245502488,0.0010884693770574216,0.0018693060861860733,0.0015348790495073317,-0.30667198941166696
1948,2017-02-15,Merck Still Sees Path Forward For Failed Alzheimer's Drug,MRK,-0.007615214777555224,0.7556763926977152,0.013741036319060207,0.009665004496677732,-0.003727579245502488,0.0010884693770574216,0.0018693060861860733,0.0015348790495073317,-0.30667198941166696
1949,2017-02-16,"After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline?",MRK,0.0015348790495073317,-0.30667198941166696,-0.007615214777555224,0.013741036319060207,0.009665004496677732,-0.003727579245502488,0.0010884693770574216,0.001991742584225964,-0.2671245718924652
1950,2017-02-17,The Market In 5 Minutes,MRK,0.001991742584225964,-0.2671245718924652,0.0015348790495073317,-0.007615214777555224,0.013741036319060207,0.009665004496677732,-0.003727579245502488,0.0013766139759123774,-0.183702960511538
1951,2017-02-21,"Boeing, Pfizer And Others Band Together To Ask Congress For More Taxes",MRK,0.0013766139759123774,-0.183702960511538,0.001991742584225964,0.0015348790495073317,-0.007615214777555224,0.013741036319060207,0.009665004496677732,-0.0029017292144349893,0.17512624613516747
1952,2017-02-21,Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?,MRK,0.0013766139759123774,-0.183702960511538,0.001991742584225964,0.0015348790495073317,-0.007615214777555224,0.013741036319060207,0.009665004496677732,-0.0029017292144349893,0.17512624613516747
1953,2017-02-23,Breaking Down The Multiple Sclerosis 2017 Formularies: 'Stability Fares Well For The Market',MRK,0.008577197899536815,-0.21014792846391928,-0.0029017292144349893,0.0013766139759123774,0.001991742584225964,0.0015348790495073317,-0.007615214777555224,0.004707449792355378,0.23173746765508607
1954,2017-03-02,Why Bermuda Could Be The Next Switzerland,MRK,-0.0019633842312775096,-0.1903433227550514,0.005161571882073224,0.0003038180513417199,-0.004685393537520066,0.004707449792355378,0.008577197899536815,0.007566519656254211,-0.038253010386426256
1955,2017-03-08,Here's Your March PDUFA Date Preview,MRK,-0.002425903308703403,0.010673911305040917,-0.007672726413473385,-0.0016521319681456204,0.007566519656254211,-0.0019633842312775096,0.005161571882073224,0.0013679626506708509,-0.08109201855209547
1956,2017-03-08,Everything We Know About Merck's Keytruda,MRK,-0.002425903308703403,0.010673911305040917,-0.007672726413473385,-0.0016521319681456204,0.007566519656254211,-0.0019633842312775096,0.005161571882073224,0.0013679626506708509,-0.08109201855209547
1957,2017-03-10,"Adam Feuerstein Talks Vulnerable Pharmaceuticals, Drug Pricing Under Trump",MRK,-0.004401253145407624,0.14077567022111248,0.0013679626506708509,-0.002425903308703403,-0.007672726413473385,-0.0016521319681456204,0.007566519656254211,-0.015046833423291495,0.6091071405978321
1958,2017-03-20,Leerink Presents: Your 2017 Biopharma Catalyst Tracker,MRK,0.0032863694527922593,-0.10228939740319498,-0.004362559975450764,-0.008037047440457634,0.0077879971104255485,0.0007794517638350928,-0.015046833423291495,-0.0031196770580578237,-0.18660570562295298
1959,2017-04-10,Cardiovascular Players Could Be Eyeing Esperion,MRK,-0.009187390735440282,-0.06131248105314657,-0.0017393320170505655,-0.005191060540088666,-0.001570504866365341,0.0031510589003234113,-0.001101890188200727,0.00047944912980102394,-0.09698259121411235
1960,2017-04-20,What Would A $5.8 Billion NIH Cut Look Like? Devastation.,MRK,-0.0014365884171495535,-0.13400204336088883,0.00594196082311127,-0.008439843658571533,0.0030346772819771495,-0.006978295041361715,0.0075103081001377525,-0.010551805090193933,0.17139576406256496
1961,2017-04-25,Mark Your Calendar For These Days In May To Play The Volatility Around FDA Decision Dates,MRK,0.0025750185404278536,0.20861830139440274,0.004039417586020555,-0.010551805090193933,-0.0014365884171495535,0.00594196082311127,-0.008439843658571533,0.006420548598482734,-0.1713930362911006
1962,2017-05-01,Feuerstein On Neurotrope: The Study Failed And There Was Never 'A Lot Of Hope Here',MRK,0.0008023658789952925,0.07983763791791376,-0.0039950329154718744,-0.001913976233042347,0.006420548598482734,0.0025750185404278536,0.004039417586020555,0.005129913627525129,0.2745788684420978
1963,2017-05-02,"12 Stocks To Watch For May 2, 2017",MRK,0.005129913627525129,0.2745788684420978,0.0008023658789952925,-0.0039950329154718744,-0.001913976233042347,0.006420548598482734,0.0025750185404278536,0.014832586569926365,-0.12230373443496945
1964,2017-05-02,A Peek Into The Markets: U.S. Stock Futures Mostly Lower; Apple Earnings In Focus,MRK,0.005129913627525129,0.2745788684420978,0.0008023658789952925,-0.0039950329154718744,-0.001913976233042347,0.006420548598482734,0.0025750185404278536,0.014832586569926365,-0.12230373443496945
1965,2017-05-02,"Earnings Scheduled For May 2, 2017",MRK,0.005129913627525129,0.2745788684420978,0.0008023658789952925,-0.0039950329154718744,-0.001913976233042347,0.006420548598482734,0.0025750185404278536,0.014832586569926365,-0.12230373443496945
1966,2017-05-11,"Here's What The FDA Approval Of Keytruda Means For Merck, And For Bristol-Myers",MRK,0.007663247087742464,0.9223717833520209,0.010270332545875727,-0.011248307456694695,0.0006253761887564657,0.009308875686623086,-0.003929032047737202,-0.013347800347731198,-0.44144760462987687
1967,2017-05-12,"Sympathy Moves, Explained: Unsympathetic Earnings Season Continues As Nvidia, Advanced Micro Devices Diverge",MRK,-0.013347800347731198,-0.44144760462987687,0.007663247087742464,0.010270332545875727,-0.011248307456694695,0.0006253761887564657,0.009308875686623086,-0.0009438154234400198,-0.19635280496296492
1968,2017-05-19,The Most Notable Abstracts Released Ahead Of ASCO 2017,MRK,-0.0017217871843618893,-0.22257724022925351,0.014127027430274941,-0.012384297333594918,0.004408658172689872,-0.0009438154234400198,-0.013347800347731198,0.004076601963382442,-0.330030047851095
1969,2017-05-23,"Zymeworks: Early But Compelling Data, Large Biopharma Partners And A Potential June Catalyst",MRK,0.007963702896756297,-0.07900101327556497,0.004076601963382442,-0.0017217871843618893,0.014127027430274941,-0.012384297333594918,0.004408658172689872,0.0058868713813333695,0.21288312658146347
1970,2017-05-30,A Peek Into The Markets: U.S. Stock Futures Down Ahead Of Economic Data,MRK,-0.0006162247559695633,0.3255554399171132,-0.001844893660539526,0.001694134927858526,0.0058868713813333695,0.007963702896756297,0.004076601963382442,0.0035448836978302367,0.5941336405142938
1971,2017-05-30,Tracking The Busy June PDUFA Calendar,MRK,-0.0006162247559695633,0.3255554399171132,-0.001844893660539526,0.001694134927858526,0.0058868713813333695,0.007963702896756297,0.004076601963382442,0.0035448836978302367,0.5941336405142938
1972,2017-06-26,"A Surprisingly Clean, Straightforward Approval Gives Portola Pharma Shares A Shot Of Upside",MRK,-0.003627495478358722,-0.4624188591080778,0.002120640973015453,0.008554618066830777,0.014411816730155014,0.01334820802550607,0.011275204429138652,-0.005764487285120912,0.07196034995674472
1973,2017-06-27,Ransomware Rears Its Head Again As 150 Countries Hit By New Virus,MRK,-0.005764487285120912,0.07196034995674472,-0.003627495478358722,0.002120640973015453,0.008554618066830777,0.014411816730155014,0.01334820802550607,-0.00579805505815878,-0.1709392902749559
1974,2017-06-28,Russia In The Spotlight As Second Wave Of Ransomware Grips Globe,MRK,-0.00579805505815878,-0.1709392902749559,-0.005764487285120912,-0.003627495478358722,0.002120640973015453,0.008554618066830777,0.014411816730155014,-0.012584180256395405,0.2401497173243725
1975,2017-07-06,Merck Falls As FDA Puts Hold On 3 Keytruda Myeloma Studies,MRK,-0.01652111146747892,0.7429394030122984,-0.0017115283398703163,0.00280854859152857,-0.003885753053179175,-0.012584180256395405,-0.00579805505815878,0.0009508709123453585,-0.361404289505895
1976,2017-07-10,The Royalty-Amassing Strategy Of Royalty Pharma,MRK,-0.005224746240335643,-0.07311486384749055,0.0009508709123453585,-0.01652111146747892,-0.0017115283398703163,0.00280854859152857,-0.003885753053179175,-0.00779889173883852,0.024382673148701572
1977,2017-07-24,Ahead Of Earnings: Why You Should Be Buying Merck And Selling Bristol-Myers,MRK,-0.000957930619641556,0.12702719170058407,-0.004925399000664132,0.0051103390862352605,0.0033647672762602276,-0.0031946807009586298,-0.00713605548765206,-0.0033561628563670842,-0.2348241174366379
1978,2017-07-24,What You Need To Know About Dow Components Reporting This Week,MRK,-0.000957930619641556,0.12702719170058407,-0.004925399000664132,0.0051103390862352605,0.0033647672762602276,-0.0031946807009586298,-0.00713605548765206,-0.0033561628563670842,-0.2348241174366379
1979,2017-07-27,Why Is AstraZeneca Sinking Today?,MRK,0.03058242804575695,1.3323367598103646,-0.008980109954400683,-0.0033561628563670842,-0.000957930619641556,-0.004925399000664132,0.0051103390862352605,0.006594663415532942,-0.3892741368588196
1980,2017-07-27,"Samsung, Amazon — Everyone Is Getting Into Pharmaceuticals",MRK,0.03058242804575695,1.3323367598103646,-0.008980109954400683,-0.0033561628563670842,-0.000957930619641556,-0.004925399000664132,0.0051103390862352605,0.006594663415532942,-0.3892741368588196
1981,2017-07-28,A Peek Into The Markets: U.S. Stock Futures Down; Amazon Earnings Miss Views,MRK,0.006594663415532942,-0.3892741368588196,0.03058242804575695,-0.008980109954400683,-0.0033561628563670842,-0.000957930619641556,-0.004925399000664132,-0.0035878047429941384,-0.12195983828667234
1982,2017-07-28,"10 Stocks To Watch For July 28, 2017",MRK,0.006594663415532942,-0.3892741368588196,0.03058242804575695,-0.008980109954400683,-0.0033561628563670842,-0.000957930619641556,-0.004925399000664132,-0.0035878047429941384,-0.12195983828667234
1983,2017-07-28,"Earnings Scheduled For July 28, 2017",MRK,0.006594663415532942,-0.3892741368588196,0.03058242804575695,-0.008980109954400683,-0.0033561628563670842,-0.000957930619641556,-0.004925399000664132,-0.0035878047429941384,-0.12195983828667234
1984,2017-08-01,August PDUFA Dates: Biotech Investors Stay Tuned To A Month Of Plenty,MRK,0.0006263233361687437,-0.4459278427558693,-0.0035878047429941384,0.006594663415532942,0.03058242804575695,-0.008980109954400683,-0.0033561628563670842,-0.007509531175661777,0.08380964365407051
1985,2017-08-14,Merck CEO Quits Manufacturing Council To Stand Against Violence; Trump Promptly Calls Him Out About Drug Pricing,MRK,0.004648692600204063,-0.08981986448520907,0.0032166200179157833,-0.004961018927197802,0.0027282383014113343,-0.008275131116554979,-0.004120592056843231,-0.002712391507770362,0.14679981842941436
1986,2017-08-15,The Market In 5 Minutes,MRK,-0.002712391507770362,0.14679981842941436,0.004648692600204063,0.0032166200179157833,-0.004961018927197802,0.0027282383014113343,-0.008275131116554979,0.0031999211085169676,-0.040341928169824404
1987,2017-08-16,Market Reaction To Bristol-Myers' Mixed Clinical Results: 'A Little Excessive',MRK,0.0031999211085169676,-0.040341928169824404,-0.002712391507770362,0.004648692600204063,0.0032166200179157833,-0.004961018927197802,0.0027282383014113343,-0.013716099046270913,0.509618493804763
1988,2017-08-16,"You Can't Quit, Because You're Fired! Trump Disbands Manufacturing Council, Policy Forum",MRK,0.0031999211085169676,-0.040341928169824404,-0.002712391507770362,0.004648692600204063,0.0032166200179157833,-0.004961018927197802,0.0027282383014113343,-0.013716099046270913,0.509618493804763
1989,2017-09-07,"Wall Street's M&A Chatter From September 6: Cabelas, Merck-Rigontec, Altice-Charter, Amazon-Kohl's",MRK,0.00499992161377083,-0.04088863106756979,0.00597295999091596,-0.003289911964614589,-0.00046977732225728097,0.011723616318672025,0.0,-0.0007773626643817755,0.07429552291856378
1990,2017-10-09,Health Care Sector Back In Focus In Congress Ahead Of Q3 Earnings Result,MRK,-0.0034082782213226137,-0.2720341117935209,-0.0007739424304318288,0.0,0.003573076891049576,-0.002788571230369352,0.008121172098573659,0.002020917197181671,-0.09727948479265225
1991,2017-10-10,5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings,MRK,0.002020917197181671,-0.09727948479265225,-0.0034082782213226137,-0.0007739424304318288,0.0,0.003573076891049576,-0.002788571230369352,-0.010549359849543749,1.0527535441657578
1992,2017-10-19,OncoSec Shares Spike 17% After New Data Defended,MRK,0.0037789802922547633,0.2769530012264274,0.0045873022411513364,-0.0018945616315547698,-0.0007890147948504955,-0.006893150153122085,0.0007840416073077172,0.002039005779502112,0.023135275952194556
1993,2017-10-23,8 Firms To Debut On The Markets This Week,MRK,-0.007513962489667181,0.12400764455168267,0.002039005779502112,0.0037789802922547633,0.0045873022411513364,-0.0018945616315547698,-0.0007890147948504955,-0.00457405338941963,-0.11750127863584059
1994,2017-10-23,The Week Ahead: Earnings Season Starts In Earnest,MRK,-0.007513962489667181,0.12400764455168267,0.002039005779502112,0.0037789802922547633,0.0045873022411513364,-0.0018945616315547698,-0.0007890147948504955,-0.00457405338941963,-0.11750127863584059
1995,2017-10-24,Healthcare ETFs Set To Soar As Q3 Earnings Unfold,MRK,-0.00457405338941963,-0.11750127863584059,-0.007513962489667181,0.002039005779502112,0.0037789802922547633,0.0045873022411513364,-0.0018945616315547698,-0.010457987359438259,0.0778389973667144
1996,2017-10-27,"12 Stocks To Watch For October 27, 2017",MRK,-0.060493665616802694,1.751347288185658,-0.007365859460914503,-0.010457987359438259,-0.00457405338941963,-0.007513962489667181,0.002039005779502112,-0.060611312753165114,0.3189338869593079
1997,2017-10-27,"Earnings Scheduled For October 27, 2017",MRK,-0.060493665616802694,1.751347288185658,-0.007365859460914503,-0.010457987359438259,-0.00457405338941963,-0.007513962489667181,0.002039005779502112,-0.060611312753165114,0.3189338869593079
1998,2017-10-27,"A Peek Into The Markets: U.S. Stock Futures Climb After Amazon, Alphabet Results",MRK,-0.060493665616802694,1.751347288185658,-0.007365859460914503,-0.010457987359438259,-0.00457405338941963,-0.007513962489667181,0.002039005779502112,-0.060611312753165114,0.3189338869593079
1999,2017-10-30,The Bull Thesis For Merck Is Evaporating,MRK,-0.060611312753165114,0.3189338869593079,-0.060493665616802694,-0.007365859460914503,-0.010457987359438259,-0.00457405338941963,-0.007513962489667181,0.006945859990516334,-0.5273279283116954
2000,2017-10-30,30 Stocks Moving In Monday's Pre-Market Session,MRK,-0.060611312753165114,0.3189338869593079,-0.060493665616802694,-0.007365859460914503,-0.010457987359438259,-0.00457405338941963,-0.007513962489667181,0.006945859990516334,-0.5273279283116954
2001,2017-10-30,35 Stocks Moving In Monday's Mid-Day Session,MRK,-0.060611312753165114,0.3189338869593079,-0.060493665616802694,-0.007365859460914503,-0.010457987359438259,-0.00457405338941963,-0.007513962489667181,0.006945859990516334,-0.5273279283116954
2002,2017-10-30,"8 Stocks To Watch For October 30, 2017",MRK,-0.060611312753165114,0.3189338869593079,-0.060493665616802694,-0.007365859460914503,-0.010457987359438259,-0.00457405338941963,-0.007513962489667181,0.006945859990516334,-0.5273279283116954
2003,2017-10-31,"The Market In 5 Minutes: A Halloween Scare For Under Armour, Qualcomm And Other Big Tech Names",MRK,0.006945859990516334,-0.5273279283116954,-0.060611312753165114,-0.060493665616802694,-0.007365859460914503,-0.010457987359438259,-0.00457405338941963,0.004537899233873155,-0.10910948553785527
2004,2017-10-31,Attention Biotech Investors: Here Are November PDUFA Catalysts On The Horizon,MRK,0.006945859990516334,-0.5273279283116954,-0.060611312753165114,-0.060493665616802694,-0.007365859460914503,-0.010457987359438259,-0.00457405338941963,0.004537899233873155,-0.10910948553785527
2005,2017-10-31,"A Peek Into The Markets: U.S. Stock Futures Rise Ahead Of Mastercard, Kellogg Earnings",MRK,0.006945859990516334,-0.5273279283116954,-0.060611312753165114,-0.060493665616802694,-0.007365859460914503,-0.010457987359438259,-0.00457405338941963,0.004537899233873155,-0.10910948553785527
2006,2017-10-31,40 Biggest Movers From Yesterday,MRK,0.006945859990516334,-0.5273279283116954,-0.060611312753165114,-0.060493665616802694,-0.007365859460914503,-0.010457987359438259,-0.00457405338941963,0.004537899233873155,-0.10910948553785527
2007,2017-11-06,"Pharma Stock Roundup: Pfizer, Teva, Novartis, And More",MRK,-0.0032108017510571463,-0.11133645174862805,0.012461652204232676,0.0005420673956746391,0.004537899233873155,0.006945859990516334,-0.060611312753165114,-0.0051897721328667545,0.6426105626930887
2008,2017-11-09,Pharma ETFs Down Post Q3 Earnings,MRK,-0.006539398743529379,-0.06560537840339398,0.017808972306777582,-0.0051897721328667545,-0.0032108017510571463,0.012461652204232676,0.0005420673956746391,-0.01298691106236416,0.1841429398079808
2009,2017-12-11,3 Stocks In Focus As Biotech M&A Hopes For 2018 Rise,MRK,0.013856157643541644,-0.06266663847115128,0.01460669204106635,0.00772778924988704,-0.02546189544392674,-0.008004075612122241,0.006264551806276941,0.012957028809674975,0.4117111054899958
2010,2017-12-13,Merck's Keytruda Gets FDA Priority Review For Rare Lymphoma,MRK,-0.0028033886026228583,-0.03264048150262022,0.012957028809674975,0.013856157643541644,0.01460669204106635,0.00772778924988704,-0.02546189544392674,-0.0074430131929965615,-0.24022487402506199
2011,2017-12-20,3 Biotech Pipeline Areas To Keep An Eye On In 2018,MRK,-0.0021339363551453605,0.38753150852575935,0.00017778295370196595,-0.0003557739375268376,0.004106606503842869,-0.0074430131929965615,-0.0028033886026228583,0.00873263354348941,-0.24163553597038245
2012,2017-12-26,7 Stocks Moving In Tuesday's After-Hours Session,MRK,-0.00035468275963879137,-0.6117310401621179,-0.004240388925444094,0.00873263354348941,-0.0021339363551453605,0.00017778295370196595,-0.0003557739375268376,0.0,0.28488414154187125
2013,2017-12-26,Merck's Diabetes Drugs Get FDA Nod As Adjunct Therapies,MRK,-0.00035468275963879137,-0.6117310401621179,-0.004240388925444094,0.00873263354348941,-0.0021339363551453605,0.00017778295370196595,-0.0003557739375268376,0.0,0.28488414154187125
2014,2018-01-02,4 Reasons To Consider Adding Celldex To Your Portfolio,MRK,-0.0008886263847225351,0.19396436623097046,-0.005830191981329502,0.00461476593192911,0.0,-0.00035468275963879137,-0.004240388925444094,-0.0014229329301467253,0.05058076044872428
2015,2018-01-05,"Lower Jobs Growth in December, But Some Positive Signs For Economy",MRK,-0.0010515085858635587,-0.3679990985071405,0.01620934520431816,-0.0014229329301467253,-0.0008886263847225351,-0.005830191981329502,0.00461476593192911,-0.00579078785713949,0.16951073208320144
2016,2018-01-08,Alzheimer's Takes Another Hit As Pfizer Ends Research In The Area,MRK,-0.00579078785713949,0.16951073208320144,-0.0010515085858635587,0.01620934520431816,-0.0014229329301467253,-0.0008886263847225351,-0.005830191981329502,0.0024709616761033892,-0.04299094029776651
2017,2018-01-11,Key Takeaways From The J.P. Morgan Healthcare Conference,MRK,0.005235671286886845,-0.21584792461511815,0.00880285072450615,0.0024709616761033892,-0.00579078785713949,-0.0010515085858635587,0.01620934520431816,0.018402562432759506,0.7369236950012903
2018,2018-01-19,Will Johnson & Johnson's Pharma Segment Pull Up Its Q4 Earnings?,MRK,0.0024537806927447114,-0.38902731654311884,-0.014508996950566622,-0.0006444876527759158,0.05813181311427873,0.018402562432759506,0.005235671286886845,-0.0004896930361505403,0.007038389740328332
2019,2018-01-23,Biotech M&A Off To A Strong Start In 2018: More Deals To Follow?,MRK,0.007347074493614381,-0.08703817105531741,-0.0004896930361505403,0.0024537806927447114,-0.014508996950566622,-0.0006444876527759158,0.05813181311427873,-0.008427895850429912,0.2057505872056249
2020,2018-01-29,"PFE, LLY, MRK Write Up 'Scripts For Q4",MRK,-0.006608415627690656,-0.16835806477920356,0.012071907691505013,0.001961281922340685,-0.008427895850429912,0.007347074493614381,-0.0004896930361505403,-0.0159016437857481,0.48579802267641536
2021,2018-01-29,"The Week Ahead: Big Tech Earnings, Fed Rate Decision Likely To Dominate Headlines",MRK,-0.006608415627690656,-0.16835806477920356,0.012071907691505013,0.001961281922340685,-0.008427895850429912,0.007347074493614381,-0.0004896930361505403,-0.0159016437857481,0.48579802267641536
2022,2018-01-29,"Fed, Earnings Are Meaty Filling Between Slices Of Job, Price Data",MRK,-0.006608415627690656,-0.16835806477920356,0.012071907691505013,0.001961281922340685,-0.008427895850429912,0.007347074493614381,-0.0004896930361505403,-0.0159016437857481,0.48579802267641536
2023,2018-01-30,Hang On: Rate Fears In Focus As Futures Point Lower After Monday's Big Losses,MRK,-0.0159016437857481,0.48579802267641536,-0.006608415627690656,0.012071907691505013,0.001961281922340685,-0.008427895850429912,0.007347074493614381,-0.023083104542931276,0.14019949579465463
2024,2018-02-02,"12 Stocks To Watch For February 2, 2018",MRK,-0.021717233585195506,-0.08257778345005273,0.010295247002892305,-0.023083104542931276,-0.0159016437857481,-0.006608415627690656,0.012071907691505013,-0.03688527783192652,0.5986252620737138
2025,2018-02-02,"Earnings Scheduled For February 2, 2018",MRK,-0.021717233585195506,-0.08257778345005273,0.010295247002892305,-0.023083104542931276,-0.0159016437857481,-0.006608415627690656,0.012071907691505013,-0.03688527783192652,0.5986252620737138
2026,2018-02-08,The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease,MRK,-0.02057995751185704,0.5241920759539893,0.007573364932061066,-0.016667018317916726,-0.03688527783192652,-0.021717233585195506,0.010295247002892305,0.002558097544076876,-0.10970292285577388
2027,2018-02-23,"Pharma Stock Roundup: AstraZeneca, Merck, AbbVie And More",MRK,0.0054972522788787614,-0.16195745939243889,0.0003669686167679931,-0.007821103067940594,-0.023272467360163307,0.005358085377043853,0.0198544653570234,0.021687491004655834,0.3395924720636325
2028,2018-03-05,7 Biotech Stocks With Clinical Trial Outcomes In March,MRK,0.0007358968038198022,0.469004797713823,0.012290436539103444,-0.009590492768548953,-0.00913746127039794,-0.023902826116613873,0.021687491004655834,-0.0018383459140682845,-0.2929823873362808
2029,2018-03-09,'Pharma Bro' Martin Shkreli Gets 7 Years In Prison For Securities Fraud,MRK,0.00693982410797811,0.19922190795302952,0.00532393725257907,0.0031309091633555663,-0.0018383459140682845,0.0007358968038198022,0.012290436539103444,0.003989621916127506,0.2195921734249957
2030,2018-03-12,"The Market In 5 Minutes: Coincheck, Gun Violence, Oil And More",MRK,0.003989621916127506,0.2195921734249957,0.00693982410797811,0.00532393725257907,0.0031309091633555663,-0.0018383459140682845,0.0007358968038198022,0.0001802898350262705,0.08900856585907646
2031,2018-03-20,Checking In On The Healthcare Sector Ahead Of Q1 Earnings Season,MRK,0.00018333434474482324,-0.3420273888410704,-0.018681347766066225,0.00760148093511237,0.008211602363053183,-0.0016393054095295012,0.0001802898350262705,0.000914796986324129,0.28654236739339467
2032,2018-03-26,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",MRK,0.011795470678242381,-0.15794357380514246,-0.013119066956849834,-0.01042222350487465,0.000914796986324129,0.00018333434474482324,-0.018681347766066225,-0.005366200726779291,0.622825940278138
2033,2018-04-02,"The Week Ahead: Switch's Lockup Expires, Spotify Debuts, And More",MRK,-0.02203050063576517,0.37408338033946986,-0.011254295932570213,0.024930143566237906,-0.005366200726779291,0.011795470678242381,-0.013119066956849834,0.015393239130979008,-0.3100014785162193
2034,2018-04-03,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,MRK,0.015393239130979008,-0.3100014785162193,-0.02203050063576517,-0.011254295932570213,0.024930143566237906,-0.005366200726779291,0.011795470678242381,0.008319305187850734,-0.03698373127040011
2035,2018-04-06,Incyte Falls 20% After Cancer Drug Fails Phase 3 Trial,MRK,-0.021456103684577843,0.002003879572038736,-0.00018312394053998649,0.008319305187850734,0.015393239130979008,-0.02203050063576517,-0.011254295932570213,0.05247359123545681,0.8588410909286872
2036,2018-04-09,31 Stocks Moving In Monday's Mid-Day Session,MRK,0.05247359123545681,0.8588410909286872,-0.021456103684577843,-0.00018312394053998649,0.008319305187850734,0.015393239130979008,-0.02203050063576517,0.005876159207839793,-0.4463829319980933
2037,2018-04-09,20 Stocks Moving In Monday's Pre-Market Session,MRK,0.05247359123545681,0.8588410909286872,-0.021456103684577843,-0.00018312394053998649,0.008319305187850734,0.015393239130979008,-0.02203050063576517,0.005876159207839793,-0.4463829319980933
2038,2018-04-09,A Peek Into The Markets: U.S. Stock Futures Signal Higher Start On Wall Street,MRK,0.05247359123545681,0.8588410909286872,-0.021456103684577843,-0.00018312394053998649,0.008319305187850734,0.015393239130979008,-0.02203050063576517,0.005876159207839793,-0.4463829319980933
2039,2018-04-10,40 Biggest Movers From Yesterday,MRK,0.005876159207839793,-0.4463829319980933,0.05247359123545681,-0.021456103684577843,-0.00018312394053998649,0.008319305187850734,0.015393239130979008,-0.005133878438890904,-0.29936876065827855
2040,2018-04-13,"The Week Ahead In Biotech: PDUFA Dates, IPOs And More",MRK,0.007578298843290199,-0.15790394907531324,0.009608969843132087,-0.005133878438890904,0.005876159207839793,0.05247359123545681,-0.021456103684577843,0.02588751611302298,1.2425374501318207
2041,2018-04-17,Stock Market Gets Lift From Earnings As Geopolitical Fears Wane,MRK,0.010571172782535276,-0.31985557980832735,0.02588751611302298,0.007578298843290199,0.009608969843132087,-0.005133878438890904,0.005876159207839793,-0.005905004176558704,-0.26699443593711214
2042,2018-04-26,Earnings Preview: Oil Giants Chevron And ExxonMobil Report Friday Morning,MRK,-0.003689448855002553,0.006478678219032474,-0.007655142258435332,-0.0026557852501570833,0.02413740000740261,0.003240219368019659,-0.004752317538253337,0.0010100892771371939,-0.4321449409655922
2043,2018-04-27,Upcoming Earnings: McDonald's Reports On Monday As It Continues On New Growth Plan,MRK,0.0010100892771371939,-0.4321449409655922,-0.003689448855002553,-0.007655142258435332,-0.0026557852501570833,0.02413740000740261,0.003240219368019659,-0.0100892889764862,0.7090045111613996
2044,2018-04-30,"The Week Ahead: Tesla And Apple Earnings, Dropbox Quiet Period Expires, Fed Rate Decision And More",MRK,-0.0100892889764862,0.7090045111613996,0.0010100892771371939,-0.003689448855002553,-0.007655142258435332,-0.0026557852501570833,0.02413740000740261,-0.015118129494625099,0.00193113506095699
2045,2018-04-30,Pharmaceutical Earnings: Pfizer And Merck Are Slated To Report Tuesday Morning,MRK,-0.0100892889764862,0.7090045111613996,0.0010100892771371939,-0.003689448855002553,-0.007655142258435332,-0.0026557852501570833,0.02413740000740261,-0.015118129494625099,0.00193113506095699
2046,2018-04-30,Upcoming Earnings: Tech Giant Apple Reports After Tuesday's Close,MRK,-0.0100892889764862,0.7090045111613996,0.0010100892771371939,-0.003689448855002553,-0.007655142258435332,-0.0026557852501570833,0.02413740000740261,-0.015118129494625099,0.00193113506095699
2047,2018-04-30,"McDonald's Strong Results Start Busy Earnings Week As Fed, Jobs Report Also Loom",MRK,-0.0100892889764862,0.7090045111613996,0.0010100892771371939,-0.003689448855002553,-0.007655142258435332,-0.0026557852501570833,0.02413740000740261,-0.015118129494625099,0.00193113506095699
2048,2018-05-01,"Apple Results, Fed Decision, Jobs Report In Focus; Merck, Pfizer Reports Mixed",MRK,-0.015118129494625099,0.00193113506095699,-0.0100892889764862,0.0010100892771371939,-0.003689448855002553,-0.007655142258435332,-0.0026557852501570833,-0.011728010834145541,-0.20607617391916222
2049,2018-05-01,Benzinga Pro's 5 Stocks To Watch Today,MRK,-0.015118129494625099,0.00193113506095699,-0.0100892889764862,0.0010100892771371939,-0.003689448855002553,-0.007655142258435332,-0.0026557852501570833,-0.011728010834145541,-0.20607617391916222
2050,2018-05-01,"Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings",MRK,-0.015118129494625099,0.00193113506095699,-0.0100892889764862,0.0010100892771371939,-0.003689448855002553,-0.007655142258435332,-0.0026557852501570833,-0.011728010834145541,-0.20607617391916222
2051,2018-05-01,"Earnings Scheduled For May 1, 2018",MRK,-0.015118129494625099,0.00193113506095699,-0.0100892889764862,0.0010100892771371939,-0.003689448855002553,-0.007655142258435332,-0.0026557852501570833,-0.011728010834145541,-0.20607617391916222
2052,2018-05-01,"15 Stocks To Watch For May 1, 2018",MRK,-0.015118129494625099,0.00193113506095699,-0.0100892889764862,0.0010100892771371939,-0.003689448855002553,-0.007655142258435332,-0.0026557852501570833,-0.011728010834145541,-0.20607617391916222
2053,2018-05-18,"Merck, Bristol Myers Shares Move On Alleged FDA Alert On Keytruda",MRK,0.0011849045481280296,0.23458412010705398,-0.011380663594229845,0.009290340507984496,-0.008042749029150253,-0.00016763659199026115,0.028074465624578382,-0.009638001750615133,-0.12501159956584618
2054,2018-05-25,"Benzinga's Daily Biotech Pulse: Biomarin Gets FDA Nod, Amarin Settles with Teva, Merck's Cancer Drug Review Extended",MRK,-0.0006765815567021383,-0.03801521528546492,-0.0006761241036036258,0.012318315869549012,-0.002048912461116714,-0.009638001750615133,0.0011849045481280296,-0.011676960877998854,0.3210910737474588
2055,2018-05-30,Mid-Morning Market Update: Markets Open Higher; Michael Kors Beats Q4 Estimates,MRK,0.02260268755571926,0.2539747161683301,-0.011676960877998854,-0.0006765815567021383,-0.0006761241036036258,0.012318315869549012,-0.002048912461116714,-0.0031813095836775718,0.10490851378013999
2056,2018-05-30,30 Stocks Moving In Wednesday's Mid-Day Session,MRK,0.02260268755571926,0.2539747161683301,-0.011676960877998854,-0.0006765815567021383,-0.0006761241036036258,0.012318315869549012,-0.002048912461116714,-0.0031813095836775718,0.10490851378013999
2057,2018-05-30,"Benzinga's Daily Biotech Pulse: Chinese Cheer For Gilead, Immutep Presents Positive Phase 1 Data, FDA Accepts Exelixis sNDA",MRK,0.02260268755571926,0.2539747161683301,-0.011676960877998854,-0.0006765815567021383,-0.0006761241036036258,0.012318315869549012,-0.002048912461116714,-0.0031813095836775718,0.10490851378013999
2058,2018-05-31,41 Biggest Movers From Yesterday,MRK,-0.0031813095836775718,0.10490851378013999,0.02260268755571926,-0.011676960877998854,-0.0006765815567021383,-0.0006761241036036258,0.012318315869549012,0.017301931897762524,-0.09612796602288798
2059,2018-06-01,Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates,MRK,0.017301931897762524,-0.09612796602288798,-0.0031813095836775718,0.02260268755571926,-0.011676960877998854,-0.0006765815567021383,-0.0006761241036036258,0.024108405827988122,0.7660869132576356
2060,2018-06-05,"Benzinga's Daily Biotech Pulse: Mylan's Neulasta Biosimilar Approved, Portola's CEO To Retire, Regenxbio To Join S&P SmallCap Index",MRK,-0.010158176634509686,-0.3582618661520566,0.024108405827988122,0.017301931897762524,-0.0031813095836775718,0.02260268755571926,-0.011676960877998854,0.00879646121209876,-0.39593385909442036
2061,2018-06-08,"Pharma Stock Roundup: Merck, Eli Lilly, AbbVie And More",MRK,0.009517498415730907,0.28211855668604446,0.0009689875059337716,0.00879646121209876,-0.010158176634509686,0.024108405827988122,0.017301931897762524,-0.003994841635405422,-0.2563493110451067
2062,2018-06-14,"Benzinga's Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma's Q4 Miss, Sage Inks Deal With Japan's Shionogi",MRK,-0.008855397255489894,0.2688425207408911,0.00240223434901643,0.0017647773452589277,-0.003994841635405422,0.009517498415730907,0.0009689875059337716,0.00763496365387506,0.3766145062531274
2063,2018-06-15,Mid-Day Market Update: Dow Down Over 200 Points; Affimed Shares Plummet,MRK,0.00763496365387506,0.3766145062531274,-0.008855397255489894,0.00240223434901643,0.0017647773452589277,-0.003994841635405422,0.009517498415730907,-0.016766096068360214,-0.42073695227853836
2064,2018-06-15,Affimed Shares Slide On Updated Hodgkin Lymphoma Drug Combo Data,MRK,0.00763496365387506,0.3766145062531274,-0.008855397255489894,0.00240223434901643,0.0017647773452589277,-0.003994841635405422,0.009517498415730907,-0.016766096068360214,-0.42073695227853836
2065,2018-06-15,Mid-Afternoon Market Update: Crude Oil Down Over 3%; Canada Goose Shares Gain Following Strong Q4 Results,MRK,0.00763496365387506,0.3766145062531274,-0.008855397255489894,0.00240223434901643,0.0017647773452589277,-0.003994841635405422,0.009517498415730907,-0.016766096068360214,-0.42073695227853836
2066,2018-06-15,30 Stocks Moving In Friday's Mid-Day Session,MRK,0.00763496365387506,0.3766145062531274,-0.008855397255489894,0.00240223434901643,0.0017647773452589277,-0.003994841635405422,0.009517498415730907,-0.016766096068360214,-0.42073695227853836
2067,2018-06-15,"Benzinga's Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid Addiction Drug",MRK,0.00763496365387506,0.3766145062531274,-0.008855397255489894,0.00240223434901643,0.0017647773452589277,-0.003994841635405422,0.009517498415730907,-0.016766096068360214,-0.42073695227853836
2068,2018-06-18,40 Biggest Movers From Friday,MRK,-0.016766096068360214,-0.42073695227853836,0.00763496365387506,-0.008855397255489894,0.00240223434901643,0.0017647773452589277,-0.003994841635405422,0.0006560763342691178,0.051181699793899416
2069,2018-07-05,A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year,MRK,0.015318943189705614,0.8636894679228213,0.004134968126972893,-0.003953892445892948,0.006633457305093904,0.007014104088120865,-0.013833989685316794,0.009084830913842046,-0.10233234963010784
2070,2018-07-09,Health Care Sector Outlook: Checking In Ahead Of Q2 Earnings Reports,MRK,-0.0028938687652608763,0.02123433738049396,0.009084830913842046,0.015318943189705614,0.004134968126972893,-0.003953892445892948,0.006633457305093904,0.0045147710362920535,0.29135135135135126
2071,2018-07-25,"Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile",MRK,0.016871463741199744,0.11001244781774511,0.011644717865872067,0.002719125865532135,0.00016003078038839824,-0.006832031202904987,0.00655694326215106,-0.007443054605502986,0.059294342917802334
2072,2018-07-26,Merck Q2 Earnings Preview,MRK,-0.007443054605502986,0.059294342917802334,0.016871463741199744,0.011644717865872067,0.002719125865532135,0.00016003078038839824,-0.006832031202904987,-0.00812377485581628,-0.2450818194546911
2073,2018-07-27,"Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter",MRK,-0.00812377485581628,-0.2450818194546911,-0.007443054605502986,0.016871463741199744,0.011644717865872067,0.002719125865532135,0.00016003078038839824,0.02079078971331616,0.14903230805059842
2074,2018-07-27,Benzinga Pro's 5 Stocks To Watch Today,MRK,-0.00812377485581628,-0.2450818194546911,-0.007443054605502986,0.016871463741199744,0.011644717865872067,0.002719125865532135,0.00016003078038839824,0.02079078971331616,0.14903230805059842
2075,2018-07-27,"12 Stocks To Watch For July 27, 2018",MRK,-0.00812377485581628,-0.2450818194546911,-0.007443054605502986,0.016871463741199744,0.011644717865872067,0.002719125865532135,0.00016003078038839824,0.02079078971331616,0.14903230805059842
2076,2018-07-27,"Earnings Scheduled For July 27, 2018",MRK,-0.00812377485581628,-0.2450818194546911,-0.007443054605502986,0.016871463741199744,0.011644717865872067,0.002719125865532135,0.00016003078038839824,0.02079078971331616,0.14903230805059842
2077,2018-07-30,Benzinga Pro's 5 Stocks To Watch Today,MRK,0.02079078971331616,0.14903230805059842,-0.00812377485581628,-0.007443054605502986,0.016871463741199744,0.011644717865872067,0.002719125865532135,0.0163555528648347,0.597835450823516
2078,2018-07-31,Benzinga Pro's 5 Stocks To Watch Today,MRK,0.0163555528648347,0.597835450823516,0.02079078971331616,-0.00812377485581628,-0.007443054605502986,0.016871463741199744,0.011644717865872067,-0.005768934393306946,-0.5088192953794646
2079,2018-07-31,"A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings, Economic Data",MRK,0.0163555528648347,0.597835450823516,0.02079078971331616,-0.00812377485581628,-0.007443054605502986,0.016871463741199744,0.011644717865872067,-0.005768934393306946,-0.5088192953794646
2080,2018-08-07,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",MRK,0.005436382847570753,-0.014988485154185938,0.004398821731396385,0.010886022714325483,-0.004122735764734542,-0.005768934393306946,0.0163555528648347,0.001652312939286471,-0.19472246165817797
2081,2018-08-08,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings Report, Paratek Awaits Adcom Verdict",MRK,0.001652312939286471,-0.19472246165817797,0.005436382847570753,0.004398821731396385,0.010886022714325483,-0.004122735764734542,-0.005768934393306946,-0.01034641472162312,0.09870493565723493
2082,2018-08-16,"Benzinga's Daily Biotech Pulse: No Anxiety For Biohaven; Strongbridge's About-Face, Bristol-Myers Squibb's FDA Wait",MRK,0.021968353181532452,0.6977898737790407,0.013692256526622648,-0.0038967299299857983,0.00983808592324742,0.001060418772174332,-0.01034641472162312,0.003049973763666447,-0.5756213710160583
2083,2018-08-17,"The Daily Biotech Pulse: Aveo Slips On Stock Offering, FDA Greenlights Generic EpiPen, Pfenex Exec Resigns",MRK,0.003049973763666447,-0.5756213710160583,0.021968353181532452,0.013692256526622648,-0.0038967299299857983,0.00983808592324742,0.001060418772174332,0.016073083456031423,0.32778980322993334
2084,2018-08-21,"The Daily Biotech Pulse: Merck's Keytruda Secures Approval For Expanded Label, ProPhase Labs Q2 Loss Narrows",MRK,-0.014251245811933488,-0.05803647554367786,0.016073083456031423,0.003049973763666447,0.021968353181532452,0.013692256526622648,-0.0038967299299857983,-0.001879354096199215,-0.39953747440257115
2085,2018-08-22,"The Daily Biotech Pulse: FDA Snub For Allergan, Myriad's Q4 Beat, Mallinckrodt's Stannsoporfin",MRK,-0.001879354096199215,-0.39953747440257115,-0.014251245811933488,0.016073083456031423,0.003049973763666447,0.021968353181532452,0.013692256526622648,-0.001013994192152201,-0.05983052949574963
2086,2018-08-24,30 Stocks Moving In Friday's Pre-Market Session,MRK,0.0010150234200050345,-0.10549207857055032,-0.001013994192152201,-0.001879354096199215,-0.014251245811933488,0.016073083456031423,0.003049973763666447,-0.0007240039165776757,0.025745374846604774
2087,2018-08-30,"The Daily Biotech Pulse: Verastem Gets New CFO, Mesoblast Earnings, Vertex's Precision Medicine Collaboration",MRK,-0.003923751776975015,-0.13572693207926156,0.0026226725222449065,-0.005218308552286444,-0.0007240039165776757,0.0010150234200050345,-0.001013994192152201,0.0007294205025825118,0.21049179853111433
2088,2018-08-31,"The Daily Biotech Pulse: FDA Blessings for Merck's HIV Drug Combo, Veracyte's Test Gets Medicare Coverage",MRK,0.0007294205025825118,0.21049179853111433,-0.003923751776975015,0.0026226725222449065,-0.005218308552286444,-0.0007240039165776757,0.0010150234200050345,-0.009330788979497573,0.004352898448872988
2089,2018-09-04,Benzinga Pro's 5 Stocks To Watch Today,MRK,-0.009330788979497573,0.004352898448872988,0.0007294205025825118,-0.003923751776975015,0.0026226725222449065,-0.005218308552286444,-0.0007240039165776757,0.009860261214801103,0.1024219634227479
2090,2018-09-05,"The Daily Biotech Pulse: Biohaven In-Licenses Drug, Retrophin's Debt Offering, ProQR And Bluebird Report Positive Trial Results",MRK,0.009860261214801103,0.1024219634227479,-0.009330788979497573,0.0007294205025825118,-0.003923751776975015,0.0026226725222449065,-0.005218308552286444,0.011075681678312632,0.5155288515571768
2091,2018-09-10,A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street,MRK,-0.0015786976564531319,-0.2361800574211813,0.004179616818662746,0.011075681678312632,0.009860261214801103,-0.009330788979497573,0.0007294205025825118,-0.006900486823594898,-0.19983762122446047
2092,2018-09-11,"A Peek Into The Markets: US Stock Futures Down Ahead Of Job Openings, Wholesale Inventories Data",MRK,-0.006900486823594898,-0.19983762122446047,-0.0015786976564531319,0.004179616818662746,0.011075681678312632,0.009860261214801103,-0.009330788979497573,0.011290879378597518,0.04720144441578533
2093,2018-09-11,"The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet",MRK,-0.006900486823594898,-0.19983762122446047,-0.0015786976564531319,0.004179616818662746,0.011075681678312632,0.009860261214801103,-0.009330788979497573,0.011290879378597518,0.04720144441578533
2094,2018-09-14,"The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut",MRK,-0.0052595189434268,-0.27511651914303525,0.013885237841947395,0.011290879378597518,-0.006900486823594898,-0.0015786976564531319,0.004179616818662746,0.006287489227577936,-0.099341094900402
2095,2018-09-20,Merck Or Pfizer: Which Is The Better Large-Cap Pharma Stock?,MRK,0.01143191799647747,-0.22702096036741004,-0.006248203714034117,0.0,0.006287489227577936,-0.0052595189434268,0.013885237841947395,0.004521017625352508,1.7738041480834141
2096,2018-09-21,"The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping, Opiant Gets BARDA Funding",MRK,0.004521017625352508,1.7738041480834141,0.01143191799647747,-0.006248203714034117,0.0,0.006287489227577936,-0.0052595189434268,-0.00450067001688037,-0.6219831066464717
2097,2018-09-26,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,MRK,-0.004529271858566553,0.07244133704177491,-0.001836754715623723,-0.00450067001688037,0.004521017625352508,0.01143191799647747,-0.006248203714034117,0.0055451942281679045,-0.13021757582293148
2098,2018-10-02,"The Daily Biotech Pulse: TransEnterix's Positive Pre-Announcement, Merit Medical Opens Wallet, GW Pharma To Offer ADS Shares",MRK,0.003075718585337839,0.36273188580188687,0.008316750814971074,0.0031109465444598694,0.0055451942281679045,-0.004529271858566553,-0.001836754715623723,-0.005296076121662829,-0.07868713542107919
2099,2018-10-03,"The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares",MRK,-0.005296076121662829,-0.07868713542107919,0.003075718585337839,0.008316750814971074,0.0031109465444598694,0.0055451942281679045,-0.004529271858566553,-0.0021018022853179774,0.07967551115461546
2100,2018-10-04,"The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut",MRK,-0.0021018022853179774,0.07967551115461546,-0.005296076121662829,0.003075718585337839,0.008316750814971074,0.0031109465444598694,0.0055451942281679045,-0.0026677440111750883,-0.28114153532869723
2101,2018-10-04,"A Peek Into The Markets: US Stock Futures Drop Ahead Of Jobless Claims, Factory Orders Data",MRK,-0.0021018022853179774,0.07967551115461546,-0.005296076121662829,0.003075718585337839,0.008316750814971074,0.0031109465444598694,0.0055451942281679045,-0.0026677440111750883,-0.28114153532869723
2102,2018-10-10,"The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares",MRK,-0.026126679793259333,0.6073457272179996,0.012314733801577438,0.0060535632036213816,-0.0026677440111750883,-0.0021018022853179774,-0.005296076121662829,-0.02952456298876982,0.01755469093099271
2103,2018-10-11,"The Daily Biotech Pulse: Clinical Hold Lifted Off Crispr's Gene-Edited Therapy, Endra To Offer Shares",MRK,-0.02952456298876982,0.01755469093099271,-0.026126679793259333,0.012314733801577438,0.0060535632036213816,-0.0026677440111750883,-0.0021018022853179774,0.021062019306582247,-0.2107192495200102
2104,2018-10-12,"The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program",MRK,0.021062019306582247,-0.2107192495200102,-0.02952456298876982,-0.026126679793259333,0.012314733801577438,0.0060535632036213816,-0.0026677440111750883,-0.005013840841839201,-0.3523501592365361
2105,2018-10-19,"The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut",MRK,0.0019386121634563658,0.18709306471129605,0.005430408817653998,0.00842446496062177,0.02533857310918397,-0.005013840841839201,0.021062019306582247,0.0030409226863479244,-0.17908279417750494
2106,2018-10-22,"Benzinga's Week Ahead: Can Tech Earnings Restore The Rally? Amazon, Google To Report",MRK,0.0030409226863479244,-0.17908279417750494,0.0019386121634563658,0.005430408817653998,0.00842446496062177,0.02533857310918397,-0.005013840841839201,-0.00647667721141032,-0.02957788711460807
2107,2018-10-22,11 Stocks That Moved From ESMO 2018,MRK,0.0030409226863479244,-0.17908279417750494,0.0019386121634563658,0.005430408817653998,0.00842446496062177,0.02533857310918397,-0.005013840841839201,-0.00647667721141032,-0.02957788711460807
2108,2018-10-23,"The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares",MRK,-0.00647667721141032,-0.02957788711460807,0.0030409226863479244,0.0019386121634563658,0.005430408817653998,0.00842446496062177,0.02533857310918397,-0.02163651531329769,0.2666776761096161
2109,2018-10-24,Merck's Q3 Earnings Preview,MRK,-0.02163651531329769,0.2666776761096161,-0.00647667721141032,0.0030409226863479244,0.0019386121634563658,0.005430408817653998,0.00842446496062177,-0.008222212782835192,0.4043167361320601
2110,2018-10-25,"The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price",MRK,-0.008222212782835192,0.4043167361320601,-0.02163651531329769,-0.00647667721141032,0.0030409226863479244,0.0019386121634563658,0.005430408817653998,0.006289220590428135,-0.17581502974061247
2111,2018-10-25,"Snapping Back, But Can Rally Attempt Last? Strong Earnings Might Power Market",MRK,-0.008222212782835192,0.4043167361320601,-0.02163651531329769,-0.00647667721141032,0.0030409226863479244,0.0019386121634563658,0.005430408817653998,0.006289220590428135,-0.17581502974061247
2112,2018-10-25,"Earnings Scheduled For October 25, 2018",MRK,-0.008222212782835192,0.4043167361320601,-0.02163651531329769,-0.00647667721141032,0.0030409226863479244,0.0019386121634563658,0.005430408817653998,0.006289220590428135,-0.17581502974061247
2113,2018-10-25,"A Peek Into The Markets: US Stock Futures Rise Ahead Of Earnings, Economic Reports",MRK,-0.008222212782835192,0.4043167361320601,-0.02163651531329769,-0.00647667721141032,0.0030409226863479244,0.0019386121634563658,0.005430408817653998,0.006289220590428135,-0.17581502974061247
2114,2018-10-29,"Benzinga's Week Ahead: Can Facebook, Apple Earnings Rescue The Stock Market?",MRK,0.014914877877909571,0.11144148164268763,0.006289220590428135,-0.008222212782835192,-0.02163651531329769,-0.00647667721141032,0.0030409226863479244,0.019874111524155857,0.0051699509635911856
2115,2018-10-30,Earnings Preview: Automaker GM to Report Q3 Results Wednesday Morning,MRK,0.019874111524155857,0.0051699509635911856,0.014914877877909571,0.006289220590428135,-0.008222212782835192,-0.02163651531329769,-0.00647667721141032,0.010155077415729075,-0.16232242747849746
2116,2018-10-30,"The Daily Biotech Pulse: Pfizer And Allergan Earnings, CFO Departures At Acadia And Assertio",MRK,0.019874111524155857,0.0051699509635911856,0.014914877877909571,0.006289220590428135,-0.008222212782835192,-0.02163651531329769,-0.00647667721141032,0.010155077415729075,-0.16232242747849746
2117,2018-10-31,"The Daily Biotech Pulse: KemPharm, FDA Nod For Merck, Clovis Q3 Miss, 3 Stocks To Debut",MRK,0.010155077415729075,-0.16232242747849746,0.019874111524155857,0.014914877877909571,0.006289220590428135,-0.008222212782835192,-0.02163651531329769,-0.006656937263203266,-0.12731434376276163
2118,2018-11-01,"The Daily Biotech Pulse: AbbVie's Leukemia Drug Trial Meets Endpoint, Denali Strikes Collaboration Deal",MRK,-0.006656937263203266,-0.12731434376276163,0.010155077415729075,0.019874111524155857,0.014914877877909571,0.006289220590428135,-0.008222212782835192,-0.011624557635351973,-0.06824860897320839
2119,2018-11-01,Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates,MRK,-0.006656937263203266,-0.12731434376276163,0.010155077415729075,0.019874111524155857,0.014914877877909571,0.006289220590428135,-0.008222212782835192,-0.011624557635351973,-0.06824860897320839
2120,2018-11-08,"The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering",MRK,0.005327626472291014,-0.3031680789652452,0.024144025772082633,0.0025986124266921262,0.011761277280969873,-0.011624557635351973,-0.006656937263203266,-0.008213910421811299,0.12652374201393646
2121,2018-11-09,"The Daily Biotech Pulse: SITC Presentations Pick Up Pace, Sandoz' Voluntary Recall",MRK,-0.008213910421811299,0.12652374201393646,0.005327626472291014,0.024144025772082633,0.0025986124266921262,0.011761277280969873,-0.011624557635351973,-0.0022711667231961608,-0.04432218592401127
2122,2018-11-14,"The Daily Biotech Pulse: Mallinckrodt Faces FDA Panel, Reshape's Earnings, Vapotherm To Debut",MRK,-0.006969561609517783,-0.40098056178684705,-0.0010709168457219143,-0.0022711667231961608,-0.008213910421811299,0.005327626472291014,0.024144025772082633,0.010122645179006184,0.2629757694924002
2123,2018-11-20,"The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings",MRK,-0.020563277956161974,-0.17260572290162934,0.003812745226108083,0.016301619600137984,0.010122645179006184,-0.006969561609517783,-0.0010709168457219143,0.00013384944236149998,-0.3336301495209204
2124,2018-11-26,"Data Dive, Trade Talks And Powell: Busy Post-Holiday Week On The Way",MRK,0.010311988901087199,2.090635859637601,-0.001604626515405494,0.00013384944236149998,-0.020563277956161974,0.003812745226108083,0.016301619600137984,0.011929912154442057,0.3435128469988895
2125,2018-11-27,"The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial",MRK,0.011929912154442057,0.3435128469988895,0.010311988901087199,-0.001604626515405494,0.00013384944236149998,-0.020563277956161974,0.003812745226108083,0.011658634563537884,-0.17616731502910865
2126,2018-11-29,"The Daily Biotech Pulse: Twist In Protagonist Tale, Catalyst's Autoimmune Disorder Drug Approved",MRK,0.008804810340079516,-0.09476728966966119,0.011658634563537884,0.011929912154442057,0.010311988901087199,-0.001604626515405494,0.00013384944236149998,0.018354521397800028,0.9582052911260255
2127,2018-11-29,Merck Is Up 40% In 2018: What's Driving The Rally?,MRK,0.008804810340079516,-0.09476728966966119,0.011658634563537884,0.011929912154442057,0.010311988901087199,-0.001604626515405494,0.00013384944236149998,0.018354521397800028,0.9582052911260255
2128,2018-11-30,Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates,MRK,0.018354521397800028,0.9582052911260255,0.008804810340079516,0.011658634563537884,0.011929912154442057,0.010311988901087199,-0.001604626515405494,-0.001512488455922556,-0.41096014600814657
2129,2018-11-30,"The Daily Biotech Pulse: EC Nod For Shire, Mirati Gets FDA Clearance For Cancer Drug Trials, PhaseBio's First Earnings",MRK,0.018354521397800028,0.9582052911260255,0.008804810340079516,0.011658634563537884,0.011929912154442057,0.010311988901087199,-0.001604626515405494,-0.001512488455922556,-0.41096014600814657
2130,2018-12-04,"Ahead of Mid-Week Pause, Investors Fret Over Trade Pact Details",MRK,-0.012749278460939428,0.17445327375809616,-0.001512488455922556,0.018354521397800028,0.008804810340079516,0.011658634563537884,0.011929912154442057,0.00204578838241809,0.11926518874771985
2131,2018-12-04,"The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO",MRK,-0.012749278460939428,0.17445327375809616,-0.001512488455922556,0.018354521397800028,0.008804810340079516,0.011658634563537884,0.011929912154442057,0.00204578838241809,0.11926518874771985
2132,2018-12-06,"The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering",MRK,0.00204578838241809,0.11926518874771985,-0.012749278460939428,-0.001512488455922556,0.018354521397800028,0.008804810340079516,0.011658634563537884,-0.021054061778690847,-0.23663202865769262
2133,2018-12-11,"The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings",MRK,-0.004004280064777932,-0.14204480704753109,0.009124091635665188,-0.021054061778690847,0.00204578838241809,-0.012749278460939428,-0.001512488455922556,0.011671721392958911,-0.1909465620010874
2134,2018-12-14,A Peek Into The Markets: US Stock Futures Tumble Ahead Of Economic Reports,MRK,-0.02523595232699738,0.23276801645917344,0.012818959995890333,0.011671721392958911,-0.004004280064777932,0.009124091635665188,-0.021054061778690847,-0.016343918712006023,0.13927711363575024
2135,2018-12-20,"The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum",MRK,-0.0037952299337479234,0.028122605371738496,-0.007533827226226419,-0.011963527120654405,-0.016343918712006023,-0.02523595232699738,0.012818959995890333,-0.00802848290077085,0.8660079145911508
2136,2018-12-21,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",MRK,-0.00802848290077085,0.8660079145911508,-0.0037952299337479234,-0.007533827226226419,-0.011963527120654405,-0.016343918712006023,-0.02523595232699738,-0.024005626597504826,-0.6949938072247586
2137,2018-12-31,Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates,MRK,0.013798669008809439,-0.26502348586144464,-0.0001326467747763127,0.018648532857794997,0.04005615926098316,-0.024005626597504826,-0.00802848290077085,-0.010731547893536364,0.5607867745472466
2138,2019-01-03,"The Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen",MRK,-0.020505120574851876,-0.07999252651681121,-0.010731547893536364,0.013798669008809439,-0.0001326467747763127,0.018648532857794997,0.04005615926098316,0.03011853106879392,0.06056426783895019
2139,2019-01-09,How 7 New Laws Affected Stocks In The Last Week,MRK,-0.007632473776696291,0.0016473495223796597,0.007423958827996291,-0.011013265282371565,0.03011853106879392,-0.020505120574851876,-0.010731547893536364,-0.012332812680607042,0.6057077860849909
2140,2019-01-24,Bristol-Myers Squibb Withdraws Regulatory Application For Lung Cancer Combo Drug,MRK,-0.030090193997217685,0.530117926266489,-0.005143065855351958,-0.0005272805741980413,0.0035712811072281525,0.013269084087362826,0.0014765945521286739,-0.0030064324294285516,-0.3607885904796376
2141,2019-01-29,How To Approach Q4 Earnings: The Technical Perspective,MRK,0.004251084206088773,-0.1054058139423617,-0.00041125834418409557,-0.0030064324294285516,-0.030090193997217685,-0.005143065855351958,-0.0005272805741980413,0.0019116392061591103,0.16500272882407874
2142,2019-01-31,Merck's Q4 Earnings Preview,MRK,0.014447680998447954,0.2048906732045881,0.0019116392061591103,0.004251084206088773,-0.00041125834418409557,-0.0030064324294285516,-0.030090193997217685,0.027139335070165194,-0.05095359126849708
2143,2019-02-01,"The Daily Biotech Pulse: Merck Earnings, Positive Relaunch Of  Titan's Opioid Disorder Treatment Implant",MRK,0.027139335070165194,-0.05095359126849708,0.014447680998447954,0.0019116392061591103,0.004251084206088773,-0.00041125834418409557,-0.0030064324294285516,0.00549378653888577,-0.25828972302111997
2144,2019-02-01,Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates,MRK,0.027139335070165194,-0.05095359126849708,0.014447680998447954,0.0019116392061591103,0.004251084206088773,-0.00041125834418409557,-0.0030064324294285516,0.00549378653888577,-0.25828972302111997
2145,2019-02-01,"12 Stocks To Watch For February 1, 2019",MRK,0.027139335070165194,-0.05095359126849708,0.014447680998447954,0.0019116392061591103,0.004251084206088773,-0.00041125834418409557,-0.0030064324294285516,0.00549378653888577,-0.25828972302111997
2146,2019-02-01,"Earnings Scheduled For February 1, 2019",MRK,0.027139335070165194,-0.05095359126849708,0.014447680998447954,0.0019116392061591103,0.004251084206088773,-0.00041125834418409557,-0.0030064324294285516,0.00549378653888577,-0.25828972302111997
2147,2019-02-05,"The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results",MRK,0.003642354854367591,0.09569597514919659,0.00549378653888577,0.027139335070165194,0.014447680998447954,0.0019116392061591103,0.004251084206088773,0.003111076933997481,-0.3535102337274202
2148,2019-02-20,"The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering",MRK,0.002397690679242448,-0.06837176014163504,-0.007141814811663538,0.011021044843473993,-0.0010124073904237418,0.006367809740106756,0.023595109093989652,0.005035907485467117,-0.13930968274146815
2149,2019-02-21,Mid-Day Market Update: Immune Design Jumps Following Acquisition News; Carbon Black Shares Slide,MRK,0.005035907485467117,-0.13930968274146815,0.002397690679242448,-0.007141814811663538,0.011021044843473993,-0.0010124073904237418,0.006367809740106756,0.01177522727251934,0.0771042884994031
2150,2019-02-21,Mid-Afternoon Market Update: Dow Falls 150 Points; Delphi Technologies Shares Spike Higher,MRK,0.005035907485467117,-0.13930968274146815,0.002397690679242448,-0.007141814811663538,0.011021044843473993,-0.0010124073904237418,0.006367809740106756,0.01177522727251934,0.0771042884994031
2151,2019-02-21,50 Stocks Moving In Thursday's Mid-Day Session,MRK,0.005035907485467117,-0.13930968274146815,0.002397690679242448,-0.007141814811663538,0.011021044843473993,-0.0010124073904237418,0.006367809740106756,0.01177522727251934,0.0771042884994031
2152,2019-02-21,31 Stocks Moving In Thursday's Pre-Market Session,MRK,0.005035907485467117,-0.13930968274146815,0.002397690679242448,-0.007141814811663538,0.011021044843473993,-0.0010124073904237418,0.006367809740106756,0.01177522727251934,0.0771042884994031
2153,2019-02-21,Merck To Buy Immune Design For $300M,MRK,0.005035907485467117,-0.13930968274146815,0.002397690679242448,-0.007141814811663538,0.011021044843473993,-0.0010124073904237418,0.006367809740106756,0.01177522727251934,0.0771042884994031
2154,2019-02-21,Mid-Morning Market Update: Markets Open Lower; Domino's Pizza Misses Q4 Views,MRK,0.005035907485467117,-0.13930968274146815,0.002397690679242448,-0.007141814811663538,0.011021044843473993,-0.0010124073904237418,0.006367809740106756,0.01177522727251934,0.0771042884994031
2155,2019-02-22,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",MRK,0.01177522727251934,0.0771042884994031,0.005035907485467117,0.002397690679242448,-0.007141814811663538,0.011021044843473993,-0.0010124073904237418,-0.004828620691447627,0.16837196036351076
2156,2019-02-22,65 Biggest Movers From Yesterday,MRK,0.01177522727251934,0.0771042884994031,0.005035907485467117,0.002397690679242448,-0.007141814811663538,0.011021044843473993,-0.0010124073904237418,-0.004828620691447627,0.16837196036351076
2157,2019-02-22,"The Daily Biotech Pulse: BioMarin Slips On Earnings, TherapeuticsMD Posts In-Line Results, Orchard To Present Immunodeficiency Drug Data",MRK,0.01177522727251934,0.0771042884994031,0.005035907485467117,0.002397690679242448,-0.007141814811663538,0.011021044843473993,-0.0010124073904237418,-0.004828620691447627,0.16837196036351076
2158,2019-02-25,"Pharma M&A Wave: Spark Therapeutics, Clementia Pharma Among The Rare Disease Biotechs Acquired",MRK,-0.004828620691447627,0.16837196036351076,0.01177522727251934,0.005035907485467117,0.002397690679242448,-0.007141814811663538,0.011021044843473993,0.004478919645156454,-0.08349562402829613
2159,2019-02-26,"The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote",MRK,0.004478919645156454,-0.08349562402829613,-0.004828620691447627,0.01177522727251934,0.005035907485467117,0.002397690679242448,-0.007141814811663538,-0.0014865422146336238,-0.12040150037321151
2160,2019-02-26,Sellas Reviews Strategic Options To Fund Clinical Development Programs,MRK,0.004478919645156454,-0.08349562402829613,-0.004828620691447627,0.01177522727251934,0.005035907485467117,0.002397690679242448,-0.007141814811663538,-0.0014865422146336238,-0.12040150037321151
2161,2019-02-26,It Could Be Time For This Pharma ETF,MRK,0.004478919645156454,-0.08349562402829613,-0.004828620691447627,0.01177522727251934,0.005035907485467117,0.002397690679242448,-0.007141814811663538,-0.0014865422146336238,-0.12040150037321151
2162,2019-02-27,"The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings",MRK,-0.0014865422146336238,-0.12040150037321151,0.004478919645156454,-0.004828620691447627,0.01177522727251934,0.005035907485467117,0.002397690679242448,0.008310651042321204,0.47566502796773413
2163,2019-02-28,"The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems",MRK,0.008310651042321204,0.47566502796773413,-0.0014865422146336238,0.004478919645156454,-0.004828620691447627,0.01177522727251934,0.005035907485467117,0.004428556046182752,-0.08320069310899336
2164,2019-03-06,"The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split",MRK,-0.011505486186892289,-0.061049597674918576,0.004055500286986424,-0.0034293452374098976,0.004428556046182752,0.008310651042321204,-0.0014865422146336238,-0.003838738186889512,0.3377346544439084
2165,2019-03-21,FedEx's Struggles May Be Less About Global Demand And More About 'NotPetya',MRK,0.010599672073749788,-0.2035630484110844,0.0020751255434905413,0.006883944268714082,-0.0026969384091998228,0.0009814448844494006,0.005428929743814814,-0.007956757243547496,0.1230723304076693
2166,2019-03-22,"The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback",MRK,-0.007956757243547496,0.1230723304076693,0.010599672073749788,0.0020751255434905413,0.006883944268714082,-0.0026969384091998228,0.0009814448844494006,0.0007290931064456441,-0.2594686945652165
2167,2019-03-27,"The Daily Biotech Pulse: FDA Nod For Novartis, Jazz Positive Late-Stage Data For Sleep Disorder Drug, Genfit IPO",MRK,-0.0075977505331807915,0.08417804218255398,0.006921778562973824,0.0007290931064456441,-0.007956757243547496,0.010599672073749788,0.0020751255434905413,0.0041318581077731675,-0.28535423339892374
2168,2019-03-29,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,MRK,0.006535166083623478,0.4170607060340179,0.0041318581077731675,-0.0075977505331807915,0.006921778562973824,0.0007290931064456441,-0.007956757243547496,0.0015629871050020228,-0.13083492166037936
2169,2019-04-01,"Biotech Winners, Losers In Q1",MRK,0.0015629871050020228,-0.13083492166037936,0.006535166083623478,0.0041318581077731675,-0.0075977505331807915,0.006921778562973824,0.0007290931064456441,-0.0010801617119077234,-0.3339115461387743
2170,2019-04-01,Advaxis Shares Surge After Positive Clinical Trial Updates,MRK,0.0015629871050020228,-0.13083492166037936,0.006535166083623478,0.0041318581077731675,-0.0075977505331807915,0.006921778562973824,0.0007290931064456441,-0.0010801617119077234,-0.3339115461387743
2171,2019-04-01,AstraZeneca's Rare Pediatric Genetic Disorder Drug Granted Breakthrough Therapy Designation,MRK,0.0015629871050020228,-0.13083492166037936,0.006535166083623478,0.0041318581077731675,-0.0075977505331807915,0.006921778562973824,0.0007290931064456441,-0.0010801617119077234,-0.3339115461387743
2172,2019-04-02,"The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial",MRK,-0.0010801617119077234,-0.3339115461387743,0.0015629871050020228,0.006535166083623478,0.0041318581077731675,-0.0075977505331807915,0.006921778562973824,-0.0003607337745521466,0.11500185188715473
2173,2019-04-11,"The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug",MRK,-0.01212590362945909,0.5100251397247684,0.00024762487132079514,-0.0018532407579024968,-0.0024644511853775253,-0.008552363859414935,-0.015989292008035116,-0.005135020389402167,-0.023606510262025426
2174,2019-04-12,"The Daily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug",MRK,-0.005135020389402167,-0.023606510262025426,-0.01212590362945909,0.00024762487132079514,-0.0018532407579024968,-0.0024644511853775253,-0.008552363859414935,-0.011330633204733709,0.35984403766659767
2175,2019-04-16,"The Daily Biotech Pulse: J&J Earnings, FDA Nod For Mediconova, Proteon To Explore Strategic Alternatives",MRK,-0.012351938588021305,-0.09341594073022008,-0.011330633204733709,-0.005135020389402167,-0.01212590362945909,0.00024762487132079514,-0.0018532407579024968,-0.046931500143536975,1.7276977955112218
2176,2019-04-26,"The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug",MRK,0.003798846962246527,-0.3648638567218855,0.0215442050684318,0.0017424203711278174,0.015518628790408329,0.0036892820500689094,-0.009875731800562781,0.0019574805783997284,-0.16796169930153404
2177,2019-04-29,"This Week, Market Eyes China Talks, Fed Meeting As Earnings Continue",MRK,0.0019574805783997284,-0.16796169930153404,0.003798846962246527,0.0215442050684318,0.0017424203711278174,0.015518628790408329,0.0036892820500689094,0.025136824426442494,0.5238074311080918
2178,2019-04-30,Alphabet Revenue Disappoints Ahead Of Apple Earnings After The Bell,MRK,0.025136824426442494,0.5238074311080918,0.0019574805783997284,0.003798846962246527,0.0215442050684318,0.0017424203711278174,0.015518628790408329,0.00012704244046801705,0.35669447944940114
2179,2019-04-30,"The Daily Biotech Pulse: Earnings Deluge, G1 Therapeutics Positive FDA Meeting, Mustang Bio Offering",MRK,0.025136824426442494,0.5238074311080918,0.0019574805783997284,0.003798846962246527,0.0215442050684318,0.0017424203711278174,0.015518628790408329,0.00012704244046801705,0.35669447944940114
2180,2019-04-30,"Earnings Scheduled For April 30, 2019",MRK,0.025136824426442494,0.5238074311080918,0.0019574805783997284,0.003798846962246527,0.0215442050684318,0.0017424203711278174,0.015518628790408329,0.00012704244046801705,0.35669447944940114
2181,2019-04-30,"15 Stocks To Watch For April 30, 2019",MRK,0.025136824426442494,0.5238074311080918,0.0019574805783997284,0.003798846962246527,0.0215442050684318,0.0017424203711278174,0.015518628790408329,0.00012704244046801705,0.35669447944940114
2182,2019-04-30,"A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings, Fed Meeting",MRK,0.025136824426442494,0.5238074311080918,0.0019574805783997284,0.003798846962246527,0.0215442050684318,0.0017424203711278174,0.015518628790408329,0.00012704244046801705,0.35669447944940114
2183,2019-05-15,"The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi",MRK,0.0016790702875755237,-0.10220616020111839,0.0032396771342255715,-0.01304508787993297,-0.0017872228036759363,0.0019186715640373553,0.003594292424230039,0.020373655745539176,0.3605288622772904
2184,2019-05-16,"Iovance Issues Cancer Trial Updates Ahead Of ASCO Meeting, Sending Stock Skyward",MRK,0.020373655745539176,0.3605288622772904,0.0016790702875755237,0.0032396771342255715,-0.01304508787993297,-0.0017872228036759363,0.0019186715640373553,-0.005181094863884406,-0.1665979371457348
2185,2019-05-16,5 ASCO Abstracts That Moved Stocks,MRK,0.020373655745539176,0.3605288622772904,0.0016790702875755237,0.0032396771342255715,-0.01304508787993297,-0.0017872228036759363,0.0019186715640373553,-0.005181094863884406,-0.1665979371457348
2186,2019-05-16,"The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenics",MRK,0.020373655745539176,0.3605288622772904,0.0016790702875755237,0.0032396771342255715,-0.01304508787993297,-0.0017872228036759363,0.0019186715640373553,-0.005181094863884406,-0.1665979371457348
2187,2019-05-20,"Argus Questions Logic Behind Bristol-Myers' Proposed Celgene Buy, Steps To Sidelines",MRK,0.0020324208437840774,0.0026010607882338554,-0.005181094863884406,0.020373655745539176,0.0016790702875755237,0.0032396771342255715,-0.01304508787993297,0.00785988650125291,0.3130640266599334
2188,2019-05-21,"The Daily Biotech Pulse: Setback For Merck In Breast Cancer Study, Arrowhead to Join S&P SmallCap 600 Index, Ocular's Glaucoma Trial Fails",MRK,0.00785988650125291,0.3130640266599334,0.0020324208437840774,-0.005181094863884406,0.020373655745539176,0.0016790702875755237,0.0032396771342255715,0.01861658606519101,0.24077405240922767
2189,2019-05-21,Merck To Buy Clinical-Stage Biopharma Peloton Therapeutics For More Than $1B,MRK,0.00785988650125291,0.3130640266599334,0.0020324208437840774,-0.005181094863884406,0.020373655745539176,0.0016790702875755237,0.0032396771342255715,0.01861658606519101,0.24077405240922767
2190,2019-05-31,Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates,MRK,-0.005898646453831868,-0.04556782091588085,0.004032518319113887,-0.0112134618471319,-0.011211382377151247,0.001851415875493867,0.0004940369084640572,0.013255596042297313,0.29055395898693903
2191,2019-06-04,"The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-tender Offer",MRK,0.010216975753941426,0.016348591461822437,0.013255596042297313,-0.005898646453831868,0.004032518319113887,-0.0112134618471319,-0.011211382377151247,0.007523513285144556,0.0483684900722674
2192,2019-06-07,Sanofi's Leadership Transition: What You Need To Know,MRK,0.012524613807153306,-0.22788607052455245,-0.003060422282120445,0.007523513285144556,0.010216975753941426,0.013255596042297313,-0.005898646453831868,0.00024274985452055198,-0.14335574592415334
2193,2019-06-10,Merck Strikes $773M Deal For Privately Held Tilos Therapeutics: What You Need to Know,MRK,0.00024274985452055198,-0.14335574592415334,0.012524613807153306,-0.003060422282120445,0.007523513285144556,0.010216975753941426,0.013255596042297313,0.006061667900089107,0.03362484347369055
2194,2019-06-10,A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street,MRK,0.00024274985452055198,-0.14335574592415334,0.012524613807153306,-0.003060422282120445,0.007523513285144556,0.010216975753941426,0.013255596042297313,0.006061667900089107,0.03362484347369055
2195,2019-06-11,"FDA Greenlights Merck's Blockbuster Drug Keytruda For First-Line Treatment Of Head, Neck Cancer",MRK,0.006061667900089107,0.03362484347369055,0.00024274985452055198,0.012524613807153306,-0.003060422282120445,0.007523513285144556,0.010216975753941426,0.008797527405895789,0.41954013766164167
2196,2019-06-12,"The Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For Aratana",MRK,0.008797527405895789,0.41954013766164167,0.006061667900089107,0.00024274985452055198,0.012524613807153306,-0.003060422282120445,0.007523513285144556,-0.009676222821598968,-0.07811354594175568
2197,2019-06-13,"IBM, Walmart, Merck Included In FDA Program To Test Blockchain Usage In US Drug Supply Chain",MRK,-0.009676222821598968,-0.07811354594175568,0.008797527405895789,0.006061667900089107,0.00024274985452055198,0.012524613807153306,-0.003060422282120445,0.0052217125432427736,-0.21621039668330422
2198,2019-06-19,Report: Merck Searching Internally For Next CEO,MRK,0.010297115268598889,-0.14001356313641755,0.014285592275472991,0.006281720966568205,0.0052217125432427736,-0.009676222821598968,0.008797527405895789,-0.008903572327216502,0.2712417658727837
2199,2019-06-19,"The Daily Biotech Pulse: Positive Readouts From Adamas And Ironwood, Sesen Bio To Offer Shares, Stoke Therapeutics Debut",MRK,0.010297115268598889,-0.14001356313641755,0.014285592275472991,0.006281720966568205,0.0052217125432427736,-0.009676222821598968,0.008797527405895789,-0.008903572327216502,0.2712417658727837
2200,2019-06-20,"The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge",MRK,-0.008903572327216502,0.2712417658727837,0.010297115268598889,0.014285592275472991,0.006281720966568205,0.0052217125432427736,-0.009676222821598968,-0.00035447547104250354,0.20365993853079978
2201,2019-06-21,"The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy",MRK,-0.00035447547104250354,0.20365993853079978,-0.008903572327216502,0.010297115268598889,0.014285592275472991,0.006281720966568205,0.0052217125432427736,0.011114989598365765,-0.4751040521091313
2202,2019-06-27,"The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO",MRK,0.003471476232790094,-0.07003355415302959,-0.019943525918607152,-0.0031578023911211783,0.011114989598365765,-0.00035447547104250354,-0.008903572327216502,0.00023859502871514948,2.982780354676424
2203,2019-07-01,Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates,MRK,0.010733355952030843,-0.780209942684388,0.00023859502871514948,0.003471476232790094,-0.019943525918607152,-0.0031578023911211783,0.011114989598365765,0.008967658284327662,0.011766066850322332
2204,2019-07-05,"The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight",MRK,-0.014959751010382938,0.3419633651460716,0.016255352303387482,0.008967658284327662,0.010733355952030843,0.00023859502871514948,0.003471476232790094,-0.01822422748633279,0.5618471379861527
2205,2019-07-09,Judge Rules Against Trump Proposal Forcing Pharma Companies To Disclose Drug Prices In Commercials,MRK,0.009757201553925565,-0.379929765513329,-0.01822422748633279,-0.014959751010382938,0.016255352303387482,0.008967658284327662,0.010733355952030843,-0.0004713981156597713,-0.29380760873751344
2206,2019-07-12,Stock Market Eyes Records On Dovish Commentary From Federal Reserve,MRK,-0.015679070035825582,-0.14609733548883452,-0.04503646033679565,-0.0004713981156597713,0.009757201553925565,-0.01822422748633279,-0.014959751010382938,0.01542697726869946,-0.42241128220119095
2207,2019-07-12,"Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug",MRK,-0.015679070035825582,-0.14609733548883452,-0.04503646033679565,-0.0004713981156597713,0.009757201553925565,-0.01822422748633279,-0.014959751010382938,0.01542697726869946,-0.42241128220119095
2208,2019-07-17,"Merck's Novel Antibiotic For Abdominal, Urinary Tract Infections Receives FDA Nod",MRK,0.004044845845854184,0.16574659987581475,0.007781673972588221,0.01542697726869946,-0.015679070035825582,-0.04503646033679565,-0.0004713981156597713,0.009399256049339888,-0.13974394758289654
2209,2019-07-23,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",MRK,0.0100973316008941,0.021864310780248752,-0.002211620478932863,-0.015721397087716138,0.009399256049339888,0.004044845845854184,0.007781673972588221,-0.003413408419828623,0.040392056081630434
2210,2019-07-23,Eisai's Cancer Drug Combo Gets Breakthrough Therapy Designation For Liver Cancer,MRK,0.0100973316008941,0.021864310780248752,-0.002211620478932863,-0.015721397087716138,0.009399256049339888,0.004044845845854184,0.007781673972588221,-0.003413408419828623,0.040392056081630434
2211,2019-07-24,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",MRK,-0.003413408419828623,0.040392056081630434,0.0100973316008941,-0.002211620478932863,-0.015721397087716138,0.009399256049339888,0.004044845845854184,0.0,0.2525724408327923
2212,2019-07-29,Merck Q2 Earnings Preview,MRK,0.01301713595360754,0.45617430187314345,-0.003914431113106742,0.0,-0.003413408419828623,0.0100973316008941,-0.002211620478932863,0.009455602000947305,0.28437373524342036
2213,2019-07-29,Merck's Keytruda Gets A Double Dose Of Positive News,MRK,0.01301713595360754,0.45617430187314345,-0.003914431113106742,0.0,-0.003413408419828623,0.0100973316008941,-0.002211620478932863,0.009455602000947305,0.28437373524342036
2214,2019-07-30,"Apple On Today's Menu, With Starring Roles From China Talks, Fed Meeting",MRK,0.009455602000947305,0.28437373524342036,0.01301713595360754,-0.003914431113106742,0.0,-0.003413408419828623,0.0100973316008941,-0.003362038693023761,-0.12903629287255902
2215,2019-07-30,"Earnings Scheduled For July 30, 2019",MRK,0.009455602000947305,0.28437373524342036,0.01301713595360754,-0.003914431113106742,0.0,-0.003413408419828623,0.0100973316008941,-0.003362038693023761,-0.12903629287255902
2216,2019-07-30,"15 Stocks To Watch For July 30, 2019",MRK,0.009455602000947305,0.28437373524342036,0.01301713595360754,-0.003914431113106742,0.0,-0.003413408419828623,0.0100973316008941,-0.003362038693023761,-0.12903629287255902
2217,2019-07-30,"A Peek Into The Markets: US Stock Futures Down Ahead of Fed Meeting, Apple Earnings",MRK,0.009455602000947305,0.28437373524342036,0.01301713595360754,-0.003914431113106742,0.0,-0.003413408419828623,0.0100973316008941,-0.003362038693023761,-0.12903629287255902
2218,2019-07-30,33 Healthcare Stocks Moving In Today's Pre-Market Session,MRK,0.009455602000947305,0.28437373524342036,0.01301713595360754,-0.003914431113106742,0.0,-0.003413408419828623,0.0100973316008941,-0.003362038693023761,-0.12903629287255902
2219,2019-07-30,Merck Reports Q2 Earnings Beat,MRK,0.009455602000947305,0.28437373524342036,0.01301713595360754,-0.003914431113106742,0.0,-0.003413408419828623,0.0100973316008941,-0.003362038693023761,-0.12903629287255902
2220,2019-07-30,"The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings",MRK,0.009455602000947305,0.28437373524342036,0.01301713595360754,-0.003914431113106742,0.0,-0.003413408419828623,0.0100973316008941,-0.003362038693023761,-0.12903629287255902
2221,2019-08-06,"The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering",MRK,0.014797795103502098,-0.07238217611293285,-0.015981810129634955,0.009320019102315946,0.008434589717674301,-0.003362038693023761,0.009455602000947305,-0.001185407160615104,0.043934146217137204
2222,2019-08-14,"The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering",MRK,-0.031133637648736667,0.35626477805491974,0.01246780198029862,-0.0058468952506033345,0.009324026666678087,0.005696985205924543,-0.001185407160615104,0.0007190435759412139,-0.163658906185425
2223,2019-08-21,"The Daily Biotech Pulse: Ra Medical Earns Milestone, Aimmune Doses Patient In Egg Allergy Trial, Cara In-Licenses Platform",MRK,0.01471134520866113,0.05010428070598083,-0.006265360000643594,0.013284678148002937,0.01917114860289182,0.0007190435759412139,-0.031133637648736667,-0.0021861692311342384,0.015834545160769098
2224,2019-08-22,"The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study",MRK,-0.0021861692311342384,0.015834545160769098,0.01471134520866113,-0.006265360000643594,0.013284678148002937,0.01917114860289182,0.0007190435759412139,-0.02052603993967339,0.6101160519040258
2225,2019-08-28,Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates,MRK,0.011225398633281314,-0.05624517297173659,-0.004191669825650335,0.011066574384250183,-0.02052603993967339,-0.0021861692311342384,0.01471134520866113,0.002775301101060723,0.026149306145163198
2226,2019-08-29,Stocks That Hit 52-Week Highs On Thursday,MRK,0.002775301101060723,0.026149306145163198,0.011225398633281314,-0.004191669825650335,0.011066574384250183,-0.02052603993967339,-0.0021861692311342384,-0.0028833054175922967,0.07500618571836282
2227,2019-09-12,Oracle Reports Early In Surprise Move As Trump Surprises With Positive Trade Tweet,MRK,0.004703500180448517,-0.20613642625203055,0.015056946681572647,-0.02132524502394406,-0.03580901318694696,0.0054586858780389935,0.0005812558894806585,-0.0018126847721832151,-0.10636023770842196
2228,2019-09-18,NewLink Genetics Rallies After Ebola Vaccine Granted Priority Review Status,MRK,0.0061809773961221115,-0.058528446912406884,0.00585157896114441,-0.007020678676434744,-0.0018126847721832151,0.004703500180448517,0.015056946681572647,0.01144291012633425,-0.003018548809617383
2229,2019-09-18,"The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts",MRK,0.0061809773961221115,-0.058528446912406884,0.00585157896114441,-0.007020678676434744,-0.0018126847721832151,0.004703500180448517,0.015056946681572647,0.01144291012633425,-0.003018548809617383
2230,2019-09-20,"The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering",MRK,0.014171698536954214,2.413551706295771,0.01144291012633425,0.0061809773961221115,0.00585157896114441,-0.007020678676434744,-0.0018126847721832151,-0.009394076596853318,-0.6229749534588673
2231,2019-09-25,"Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company",MRK,-0.0059808580439223435,-0.22247308198656623,-0.00900902525046754,-0.009394076596853318,0.014171698536954214,0.01144291012633425,0.0061809773961221115,0.00938623347399914,0.11164300440985908
2232,2019-09-30,"Movers And Shakers At ESMO 2019: Immunomedics, G1 Therapeutics, Seattle Genetics And More",MRK,0.015317739509085548,0.252952277429181,-0.01156396292663342,0.00938623347399914,-0.0059808580439223435,-0.00900902525046754,-0.009394076596853318,-0.0067711367675256096,-0.2811237186924326
2233,2019-09-30,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,MRK,0.015317739509085548,0.252952277429181,-0.01156396292663342,0.00938623347399914,-0.0059808580439223435,-0.00900902525046754,-0.009394076596853318,-0.0067711367675256096,-0.2811237186924326
2234,2019-10-01,"The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines",MRK,-0.0067711367675256096,-0.2811237186924326,0.015317739509085548,-0.01156396292663342,0.00938623347399914,-0.0059808580439223435,-0.00900902525046754,-0.023801157551756158,0.24289812157473456
2235,2019-10-03,What's Behind PDS Biotech's Rally?,MRK,0.013722054547558926,-0.33921377772588956,-0.023801157551756158,-0.0067711367675256096,0.015317739509085548,-0.01156396292663342,0.00938623347399914,0.027314489493150518,0.2960958326245078
2236,2019-10-15,"The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings",MRK,0.004132717670407571,-0.05588609475344142,0.004149548365362188,0.006924928460776636,-0.004989560712485908,0.010685636907890261,-0.013034817748528549,-0.006937782558497307,0.09241548004246614
2237,2019-10-21,Exclusive: Plus Products Hires The Wonderful Company's Mackler As Chief Scientific Officer,MRK,-0.0018895916840216964,-0.3210582291943632,0.010501250644538329,-0.007696752037590571,-0.006937782558497307,0.004132717670407571,0.004149548365362188,-0.038097512281095036,2.480673510538596
2238,2019-10-22,"The Daily Biotech Pulse: Biogen Alzheimer's Program Back On Track, Novartis Reports Strong Quarter, Takeda In-Licenses Autoimmune Disorder Drug",MRK,-0.038097512281095036,2.480673510538596,-0.0018895916840216964,0.010501250644538329,-0.007696752037590571,-0.006937782558497307,0.004132717670407571,0.01931122650249195,-0.5430810222191828
2239,2019-10-22,8 Healthcare Stocks Moving In Tuesday's Pre-Market Session,MRK,-0.038097512281095036,2.480673510538596,-0.0018895916840216964,0.010501250644538329,-0.007696752037590571,-0.006937782558497307,0.004132717670407571,0.01931122650249195,-0.5430810222191828
2240,2019-10-28,More Earnings And A Fed Decision In Week Four Of The WeTrader Competition,MRK,-0.0007293073450798104,0.9772376386307531,-0.0038751800088334676,-0.0034995413039146106,0.01931122650249195,-0.038097512281095036,-0.0018895916840216964,0.03527989882807736,0.11655695118772647
2241,2019-10-29,"12 Stocks To Watch For October 29, 2019",MRK,0.03527989882807736,0.11655695118772647,-0.0007293073450798104,-0.0038751800088334676,-0.0034995413039146106,0.01931122650249195,-0.038097512281095036,0.013160917081270984,-0.4227831424282018
2242,2019-10-29,"Earnings Scheduled For October 29, 2019",MRK,0.03527989882807736,0.11655695118772647,-0.0007293073450798104,-0.0038751800088334676,-0.0034995413039146106,0.01931122650249195,-0.038097512281095036,0.013160917081270984,-0.4227831424282018
2243,2019-10-29,28 Healthcare Stocks Moving In Tuesday's Pre-Market Session,MRK,0.03527989882807736,0.11655695118772647,-0.0007293073450798104,-0.0038751800088334676,-0.0034995413039146106,0.01931122650249195,-0.038097512281095036,0.013160917081270984,-0.4227831424282018
2244,2019-10-29,"Alphabet Misses On Earnings, But Drugmakers, Mastercard Beat Expectations",MRK,0.03527989882807736,0.11655695118772647,-0.0007293073450798104,-0.0038751800088334676,-0.0034995413039146106,0.01931122650249195,-0.038097512281095036,0.013160917081270984,-0.4227831424282018
2245,2019-10-29,"The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study",MRK,0.03527989882807736,0.11655695118772647,-0.0007293073450798104,-0.0038751800088334676,-0.0034995413039146106,0.01931122650249195,-0.038097512281095036,0.013160917081270984,-0.4227831424282018
2246,2019-10-29,"Pharma Earnings: Merck, Pfizer Trade Higher On Q3 Beats",MRK,0.03527989882807736,0.11655695118772647,-0.0007293073450798104,-0.0038751800088334676,-0.0034995413039146106,0.01931122650249195,-0.038097512281095036,0.013160917081270984,-0.4227831424282018
2247,2019-10-30,"Decision Day: Fed On Tap Later, Followed by Apple, Facebook After Close",MRK,0.013160917081270984,-0.4227831424282018,0.03527989882807736,-0.0007293073450798104,-0.0038751800088334676,-0.0034995413039146106,0.01931122650249195,0.005103201228179977,0.23861783043419948
2248,2019-11-08,"The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut",MRK,0.008566509860990612,-0.2808464733430076,-0.004444270118604821,0.003979802352019224,-0.01168062985939844,-0.01224401367556438,-0.019847506813095994,-0.003708489659766334,-0.4400793431896569
2249,2019-11-11,NextCure Shares Give Back Some Gains After Data Readout,MRK,-0.003708489659766334,-0.4400793431896569,0.008566509860990612,-0.004444270118604821,0.003979802352019224,-0.01168062985939844,-0.01224401367556438,0.010086319273351796,1.3130590104587085
2250,2019-11-13,"The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher",MRK,0.00832122807560487,-0.24368769044511007,0.010086319273351796,-0.003708489659766334,0.008566509860990612,-0.004444270118604821,0.003979802352019224,-0.0031830416098919123,0.21396179738074173
2251,2019-11-27,Stocks That Hit 52-Week Highs On Wednesday,MRK,0.0030913037773416807,-0.6861027315994763,0.019136489890132724,0.0029256856987520674,-0.00011682532823364955,0.0022281942425550483,0.007324102693849754,-0.00490817417370748,-0.19165728888224876
2252,2019-11-27,"The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen",MRK,0.0030913037773416807,-0.6861027315994763,0.019136489890132724,0.0029256856987520674,-0.00011682532823364955,0.0022281942425550483,0.007324102693849754,-0.00490817417370748,-0.19165728888224876
2253,2019-12-02,Stocks That Hit 52-Week Highs On Monday,MRK,-0.0016058516252205335,0.1470783501242361,-0.00490817417370748,0.0030913037773416807,0.019136489890132724,0.0029256856987520674,-0.00011682532823364955,0.003906330298388383,0.33372025744208145
2254,2019-12-03,"The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial",MRK,0.003906330298388383,0.33372025744208145,-0.0016058516252205335,-0.00490817417370748,0.0030913037773416807,0.019136489890132724,0.0029256856987520674,0.014763074744387872,-0.02309031065760425
2255,2019-12-04,Stocks That Hit 52-Week Highs On Wednesday,MRK,0.014763074744387872,-0.02309031065760425,0.003906330298388383,-0.0016058516252205335,-0.00490817417370748,0.0030913037773416807,0.019136489890132724,0.0009020799799184243,0.13349701649326295
2256,2019-12-05,Stocks That Hit 52-Week Highs On Thursday,MRK,0.0009020799799184243,0.13349701649326295,0.014763074744387872,0.003906330298388383,-0.0016058516252205335,-0.00490817417370748,0.0030913037773416807,0.0011267601090632073,-0.12356754709002593
2257,2019-12-05,"The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission",MRK,0.0009020799799184243,0.13349701649326295,0.014763074744387872,0.003906330298388383,-0.0016058516252205335,-0.00490817417370748,0.0030913037773416807,0.0011267601090632073,-0.12356754709002593
2258,2019-12-06,Stocks That Hit 52-Week Highs On Friday,MRK,0.0011267601090632073,-0.12356754709002593,0.0009020799799184243,0.014763074744387872,0.003906330298388383,-0.0016058516252205335,-0.00490817417370748,-0.0014628978830018013,0.11164301549903177
2259,2019-12-06,"The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend",MRK,0.0011267601090632073,-0.12356754709002593,0.0009020799799184243,0.014763074744387872,0.003906330298388383,-0.0016058516252205335,-0.00490817417370748,-0.0014628978830018013,0.11164301549903177
2260,2019-12-09,Mid-Day Market Update: Synthorx Jumps Following Acquisition News; Biocept Shares Plunge,MRK,-0.0014628978830018013,0.11164301549903177,0.0011267601090632073,0.0009020799799184243,0.014763074744387872,0.003906330298388383,-0.0016058516252205335,0.004282994028109721,0.07559297082009131
2261,2019-12-09,48 Stocks Moving In Monday's Mid-Day Session,MRK,-0.0014628978830018013,0.11164301549903177,0.0011267601090632073,0.0009020799799184243,0.014763074744387872,0.003906330298388383,-0.0016058516252205335,0.004282994028109721,0.07559297082009131
2262,2019-12-09,Mid-Afternoon Market Update: Dow Falls 90 Points; XBiotech Shares Spike Higher,MRK,-0.0014628978830018013,0.11164301549903177,0.0011267601090632073,0.0009020799799184243,0.014763074744387872,0.003906330298388383,-0.0016058516252205335,0.004282994028109721,0.07559297082009131
2263,2019-12-09,ArQule To Be Acquired By Merck For $2.7B,MRK,-0.0014628978830018013,0.11164301549903177,0.0011267601090632073,0.0009020799799184243,0.014763074744387872,0.003906330298388383,-0.0016058516252205335,0.004282994028109721,0.07559297082009131
2264,2019-12-09,20 Stocks Moving In Monday's Pre-Market Session,MRK,-0.0014628978830018013,0.11164301549903177,0.0011267601090632073,0.0009020799799184243,0.014763074744387872,0.003906330298388383,-0.0016058516252205335,0.004282994028109721,0.07559297082009131
2265,2019-12-09,A Peek Into The Markets: US Stock Futures Down; Crude Oil Falls 1%,MRK,-0.0014628978830018013,0.11164301549903177,0.0011267601090632073,0.0009020799799184243,0.014763074744387872,0.003906330298388383,-0.0016058516252205335,0.004282994028109721,0.07559297082009131
2266,2019-12-09,Mid-Morning Market Update: Markets Mixed; Merck To Acquire ArQule For $20/Share,MRK,-0.0014628978830018013,0.11164301549903177,0.0011267601090632073,0.0009020799799184243,0.014763074744387872,0.003906330298388383,-0.0016058516252205335,0.004282994028109721,0.07559297082009131
2267,2019-12-09,KalVista Shares Sink On Failed Mid-Stage Study Of Daibetic Macular Edema Drug,MRK,-0.0014628978830018013,0.11164301549903177,0.0011267601090632073,0.0009020799799184243,0.014763074744387872,0.003906330298388383,-0.0016058516252205335,0.004282994028109721,0.07559297082009131
2268,2019-12-10,Stocks That Hit 52-Week Highs On Tuesday,MRK,0.004282994028109721,0.07559297082009131,-0.0014628978830018013,0.0011267601090632073,0.0009020799799184243,0.014763074744387872,0.003906330298388383,-0.001346840832912699,-0.2126069302173168
2269,2019-12-10,80 Biggest Movers From Yesterday,MRK,0.004282994028109721,0.07559297082009131,-0.0014628978830018013,0.0011267601090632073,0.0009020799799184243,0.014763074744387872,0.003906330298388383,-0.001346840832912699,-0.2126069302173168
2270,2019-12-10,"The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares",MRK,0.004282994028109721,0.07559297082009131,-0.0014628978830018013,0.0011267601090632073,0.0009020799799184243,0.014763074744387872,0.003906330298388383,-0.001346840832912699,-0.2126069302173168
2271,2019-12-11,"The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint",MRK,-0.001346840832912699,-0.2126069302173168,0.004282994028109721,-0.0014628978830018013,0.0011267601090632073,0.0009020799799184243,0.014763074744387872,0.006630680354053231,0.006175838267798328
2272,2019-12-12,Stocks That Hit 52-Week Highs On Thursday,MRK,0.006630680354053231,0.006175838267798328,-0.001346840832912699,0.004282994028109721,-0.0014628978830018013,0.0011267601090632073,0.0009020799799184243,0.0025856612657895184,0.10313764409496917
2273,2019-12-13,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer",MRK,0.0025856612657895184,0.10313764409496917,0.006630680354053231,-0.001346840832912699,0.004282994028109721,-0.0014628978830018013,0.0011267601090632073,0.0011209374113059223,0.3675985895031564
2274,2019-12-17,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",MRK,-0.0030237990208054066,0.12895590546299385,0.0011209374113059223,0.0025856612657895184,0.006630680354053231,-0.001346840832912699,0.004282994028109721,0.006740266288926877,-0.00960998824263537
2275,2019-12-18,"The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data",MRK,0.006740266288926877,-0.00960998824263537,-0.0030237990208054066,0.0011209374113059223,0.0025856612657895184,0.006630680354053231,-0.001346840832912699,0.004128520500133792,-0.34335936012155255
2276,2019-12-19,Stocks That Hit 52-Week Highs On Thursday,MRK,0.004128520500133792,-0.34335936012155255,0.006740266288926877,-0.0030237990208054066,0.0011209374113059223,0.0025856612657895184,0.006630680354053231,0.017668628476281256,1.3477979448397126
2277,2019-12-19,"The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic",MRK,0.004128520500133792,-0.34335936012155255,0.006740266288926877,-0.0030237990208054066,0.0011209374113059223,0.0025856612657895184,0.006630680354053231,0.017668628476281256,1.3477979448397126
2278,2019-12-20,Stocks That Hit 52-Week Highs On Friday,MRK,0.017668628476281256,1.3477979448397126,0.004128520500133792,0.006740266288926877,-0.0030237990208054066,0.0011209374113059223,0.0025856612657895184,0.0017470628978542013,-0.5576411872933467
2279,2019-12-20,"The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering",MRK,0.017668628476281256,1.3477979448397126,0.004128520500133792,0.006740266288926877,-0.0030237990208054066,0.0011209374113059223,0.0025856612657895184,0.0017470628978542013,-0.5576411872933467
2280,2019-12-20,FDA Approves First Ebola Vaccine,MRK,0.017668628476281256,1.3477979448397126,0.004128520500133792,0.006740266288926877,-0.0030237990208054066,0.0011209374113059223,0.0025856612657895184,0.0017470628978542013,-0.5576411872933467
2281,2019-12-30,Merck-AstraZeneca's Lynparza Snags FDA Nod For Pancreatic Cancer,MRK,-0.005136720589706156,0.04628081232977377,0.001751945525291898,-0.0010936469847457886,-0.0032702115831252376,0.0017470628978542013,0.017668628476281256,-0.0008789557400641357,0.19777245181332814
2282,2020-01-07,"The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering",MRK,-0.026625778910589815,0.4797726640420803,0.004273958261014288,-0.008583247665290394,0.01198463439274322,-0.0008789557400641357,-0.005136720589706156,-0.006726663766023266,0.36544470919017
2283,2020-01-09,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV, Applied Genetic Soars On Trial Results, Globus Medical Slips On Guidance",MRK,0.008803883661053336,-0.3608929860624377,-0.006726663766023266,-0.026625778910589815,0.004273958261014288,-0.008583247665290394,0.01198463439274322,0.001678130061491645,-0.3880126611595769
2284,2020-01-17,"Cannabis Media Company The Fresh Toast Expands Again, Says It's Cash Positive",MRK,-0.002303353519793494,0.3969337911449251,-0.003932537210110665,0.01790262150822164,0.004692357782974943,-0.00022349491261264287,0.001678130061491645,-0.010992486392103706,-0.01076839071599034
2285,2020-01-24,"The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study",MRK,-0.029132782763168774,0.13311521596339704,-0.012158126106625589,-0.0035569493093492444,-0.010992486392103706,-0.002303353519793494,-0.003932537210110665,0.0013956129081327262,-0.2746530916832943
2286,2020-01-27,A Peek Into The Markets: US Stock Futures Down; Dow Futures Tumble Over 400 Points,MRK,0.0013956129081327262,-0.2746530916832943,-0.029132782763168774,-0.012158126106625589,-0.0035569493093492444,-0.010992486392103706,-0.002303353519793494,0.0017423686492525903,-0.12456167457045997
2287,2020-01-28,Turnaround Tuesday? Stocks Look To Bounce Back As Apple Earnings Loom Later,MRK,0.0017423686492525903,-0.12456167457045997,0.0013956129081327262,-0.029132782763168774,-0.012158126106625589,-0.0035569493093492444,-0.010992486392103706,0.011477941857442886,-0.10373673160848063
2288,2020-01-29,"February Market Outlook: Coronavirus, D.C. Proceedings, Earnings Season Could Mean Volatility",MRK,0.011477941857442886,-0.10373673160848063,0.0017423686492525903,0.0013956129081327262,-0.029132782763168774,-0.012158126106625589,-0.0035569493093492444,-0.008482100071914855,0.2943458093645017
2289,2020-01-31,"Position Scrimmage: Coronavirus, End-Of-Month Profit Taking Influencing Markets",MRK,-0.01225450493088176,-0.12661840620285747,-0.008482100071914855,0.011477941857442886,0.0017423686492525903,0.0013956129081327262,-0.029132782763168774,0.022237888280919105,0.0111972219124441
2290,2020-02-03,Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates,MRK,0.022237888280919105,0.0111972219124441,-0.01225450493088176,-0.008482100071914855,0.011477941857442886,0.0017423686492525903,0.0013956129081327262,0.011678551427468431,0.5511164297435853
2291,2020-02-03,"Surprise, Surprise: Stocks Wearing Their Rally Hats Despite China Market Tanking",MRK,0.022237888280919105,0.0111972219124441,-0.01225450493088176,-0.008482100071914855,0.011477941857442886,0.0017423686492525903,0.0013956129081327262,0.011678551427468431,0.5511164297435853
2292,2020-02-05,"Merck To Spin Off Slow-Growing Women's Health, Legacy, Biosimilars Businesses: What You Need to Know",MRK,-0.02863288898220573,0.9408615093260655,0.011678551427468431,0.022237888280919105,-0.01225450493088176,-0.008482100071914855,0.011477941857442886,-0.0017476425666184126,-0.4499796228306645
2293,2020-02-05,Merck Reports Mixed Q4 Earnings,MRK,-0.02863288898220573,0.9408615093260655,0.011678551427468431,0.022237888280919105,-0.01225450493088176,-0.008482100071914855,0.011477941857442886,-0.0017476425666184126,-0.4499796228306645
2294,2020-02-05,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data",MRK,-0.02863288898220573,0.9408615093260655,0.011678551427468431,0.022237888280919105,-0.01225450493088176,-0.008482100071914855,0.011477941857442886,-0.0017476425666184126,-0.4499796228306645
2295,2020-02-05,"10 Stocks To Watch For February 5, 2020",MRK,-0.02863288898220573,0.9408615093260655,0.011678551427468431,0.022237888280919105,-0.01225450493088176,-0.008482100071914855,0.011477941857442886,-0.0017476425666184126,-0.4499796228306645
2296,2020-02-05,"Earnings Scheduled For February 5, 2020",MRK,-0.02863288898220573,0.9408615093260655,0.011678551427468431,0.022237888280919105,-0.01225450493088176,-0.008482100071914855,0.011477941857442886,-0.0017476425666184126,-0.4499796228306645
2297,2020-02-05,"Earnings Bonanza: Results Keep Pouring In, With Investors Looking Over Merck, Disney",MRK,-0.02863288898220573,0.9408615093260655,0.011678551427468431,0.022237888280919105,-0.01225450493088176,-0.008482100071914855,0.011477941857442886,-0.0017476425666184126,-0.4499796228306645
2298,2020-02-06,"Twitter Up, Tesla Down: Strong User Numbers Help TWTR, But TSLA Selling Continues",MRK,-0.0017476425666184126,-0.4499796228306645,-0.02863288898220573,0.011678551427468431,0.022237888280919105,-0.01225450493088176,-0.008482100071914855,-0.007003016077589241,-0.2911665736612339
2299,2020-02-07,"The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns",MRK,-0.007003016077589241,-0.2911665736612339,-0.0017476425666184126,-0.02863288898220573,0.011678551427468431,0.022237888280919105,-0.01225450493088176,0.006817115170888011,-0.07254689749319299
2300,2020-02-11,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",MRK,-0.004786045877207545,-0.031941699840326465,0.006817115170888011,-0.007003016077589241,-0.0017476425666184126,-0.02863288898220573,0.011678551427468431,-0.023460502862341026,0.9147099848634832
2301,2020-02-19,"The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA",MRK,-0.0055785258434055685,0.17199351362661508,-0.00229886737994911,0.008295756083178674,-0.015375420246544591,-0.023460502862341026,-0.004786045877207545,0.0059754143976864516,-0.06804727679719802
2302,2020-02-20,"The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study",MRK,0.0059754143976864516,-0.06804727679719802,-0.0055785258434055685,-0.00229886737994911,0.008295756083178674,-0.015375420246544591,-0.023460502862341026,-0.0018180815475117296,-0.15038025541684608
2303,2020-02-26,"The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates",MRK,-0.004110974960455427,-0.09348843272344165,-0.013033394112139662,-0.012266319401693093,-0.0018180815475117296,0.0059754143976864516,-0.0055785258434055685,-0.0232674974722048,0.3177454001718385
2304,2020-02-27,"The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy",MRK,-0.0232674974722048,0.3177454001718385,-0.004110974960455427,-0.013033394112139662,-0.012266319401693093,-0.0018180815475117296,0.0059754143976864516,-0.019467242263389695,0.8587547181299298
2305,2020-03-02,A Peek Into The Markets: US Stock Futures Down Ahead Of Manufacturing Reports,MRK,0.06282655857097552,-0.35579396745215786,-0.019467242263389695,-0.0232674974722048,-0.004110974960455427,-0.013033394112139662,-0.012266319401693093,-0.027528873393847908,-0.07674552593412343
2306,2020-03-02,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,MRK,0.06282655857097552,-0.35579396745215786,-0.019467242263389695,-0.0232674974722048,-0.004110974960455427,-0.013033394112139662,-0.012266319401693093,-0.027528873393847908,-0.07674552593412343
2307,2020-03-12,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",MRK,-0.060567949571900925,0.5878168544754834,-0.03377236523444527,0.038754098412308036,-0.039416295566711224,0.007600137013977548,-0.01675328954730826,0.03940983556863009,0.1408490052981759
2308,2020-03-13,"Intec Pharma Posts Q4 Net Loss Of $6.6M, Down By Nearly Half Year-Over-Year",MRK,0.03940983556863009,0.1408490052981759,-0.060567949571900925,-0.03377236523444527,0.038754098412308036,-0.039416295566711224,0.007600137013977548,-0.08899031805860103,-0.19525550705736694
2309,2020-03-16,Stocks That Hit 52-Week Lows On Monday,MRK,-0.08899031805860103,-0.19525550705736694,0.03940983556863009,-0.060567949571900925,-0.03377236523444527,0.038754098412308036,-0.039416295566711224,0.06521727348841355,0.18922404914872182
2310,2020-03-17,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment",MRK,0.06521727348841355,0.18922404914872182,-0.08899031805860103,0.03940983556863009,-0.060567949571900925,-0.03377236523444527,0.038754098412308036,-0.03826525601789177,-0.25003387444210223
2311,2020-03-24,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",MRK,0.039909611720986504,0.08309854425601992,-0.06950667343322336,0.008907040323919979,-0.012564486060873459,-0.03826525601789177,0.06521727348841355,-0.012020297009580183,-0.07991407269412287
2312,2020-03-25,UPS Seeks To Accelerate Growth Of Drone-Delivery,MRK,-0.012020297009580183,-0.07991407269412287,0.039909611720986504,-0.06950667343322336,0.008907040323919979,-0.012564486060873459,-0.03826525601789177,0.07783658748025046,-0.014124789599363141
2313,2020-04-15,"The Daily Biotech Pulse: Applied DNA Ships Vaccine Constructs For Animal Testing, Herceptin Biosimilar Now Available In US",MRK,-0.009295052740969867,-0.11075476089383973,0.02855718253159778,-0.023638936493566964,0.010658894641465855,0.038951295820822684,-0.021790615257007873,0.011331686889294534,-0.1539460556835961
2314,2020-04-15,Every Member Of Trump's 'Great American Economic Revival' Industry Groups,MRK,-0.009295052740969867,-0.11075476089383973,0.02855718253159778,-0.023638936493566964,0.010658894641465855,0.038951295820822684,-0.021790615257007873,0.011331686889294534,-0.1539460556835961
2315,2020-04-16,Gilead's Encouraging Remdesivir Data: Rapid Reaction On The Stock,MRK,0.011331686889294534,-0.1539460556835961,-0.009295052740969867,0.02855718253159778,-0.023638936493566964,0.010658894641465855,0.038951295820822684,0.005542264972927757,0.6875958577846089
2316,2020-04-16,"Next 45 Days Will Be 'Most Critical Period' For US, Says Alan Lancz Who Predicted 1987 and 2008 Crises",MRK,0.011331686889294534,-0.1539460556835961,-0.009295052740969867,0.02855718253159778,-0.023638936493566964,0.010658894641465855,0.038951295820822684,0.005542264972927757,0.6875958577846089
2317,2020-04-27,"Apple And Amazon Earnings, Fed Meeting Among Highlights In Busy Week Ahead",MRK,0.0313156189690611,0.6635444628476783,0.006799983830834799,0.011252961573885223,0.018075319890288988,-0.05463303880855319,-0.004313499737929494,-0.03334151473791369,0.5855127568351401
2318,2020-04-28,"Earnings Scheduled For April 28, 2020",MRK,-0.03334151473791369,0.5855127568351401,0.0313156189690611,0.006799983830834799,0.011252961573885223,0.018075319890288988,-0.05463303880855319,-0.005050257788613899,-0.32487466434114187
2319,2020-04-28,"Earnings Feast: Bring a Plate With Healthcare and Caterpillar in Morning, GOOGL And AMD Later",MRK,-0.03334151473791369,0.5855127568351401,0.0313156189690611,0.006799983830834799,0.011252961573885223,0.018075319890288988,-0.05463303880855319,-0.005050257788613899,-0.32487466434114187
2320,2020-04-28,"The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update",MRK,-0.03334151473791369,0.5855127568351401,0.0313156189690611,0.006799983830834799,0.011252961573885223,0.018075319890288988,-0.05463303880855319,-0.005050257788613899,-0.32487466434114187
2321,2020-04-29,"Merck Analysts Focus On Fundamentals, Keytruda Strength Following Guidance Cut",MRK,-0.005050257788613899,-0.32487466434114187,-0.03334151473791369,0.0313156189690611,0.006799983830834799,0.011252961573885223,0.018075319890288988,-0.01770468808950798,-0.14965200317902994
2322,2020-04-29,"The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda",MRK,-0.005050257788613899,-0.32487466434114187,-0.03334151473791369,0.0313156189690611,0.006799983830834799,0.011252961573885223,0.018075319890288988,-0.01770468808950798,-0.14965200317902994
2323,2020-04-30,"ServiceNow CEO Bill McDermott Says Company 'Hungry And Humble,' With $10B Ambitions",MRK,-0.01770468808950798,-0.14965200317902994,-0.005050257788613899,-0.03334151473791369,0.0313156189690611,0.006799983830834799,0.011252961573885223,-0.02104871484726001,-0.1821750343976456
2324,2020-05-05,Why Are Shares Of Gene Therapy Company Genprex AreSurging Higher,MRK,0.01496241195470338,-0.16370827733212212,-0.010428646117455309,-0.02104871484726001,-0.01770468808950798,-0.005050257788613899,-0.03334151473791369,-0.011409140778067761,0.6773759541275666
2325,2020-05-13,"AbbVie's Potential Is 'Underappreciated,"" Says Morgan Stanley Analyst",MRK,0.009068369767823325,0.1456820882042944,-0.009241326062763289,0.019764371786901158,0.010582122831050755,-0.01970943487080934,-0.011409140778067761,0.027731437844317863,0.043203721285477226
2326,2020-05-13,"The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter",MRK,0.009068369767823325,0.1456820882042944,-0.009241326062763289,0.019764371786901158,0.010582122831050755,-0.01970943487080934,-0.011409140778067761,0.027731437844317863,0.043203721285477226
2327,2020-05-20,Why Surface Oncology's Stock Is Surging Higher,MRK,-0.008510710347441997,0.041150899250383954,-0.02721999166733824,-0.0007523356537069148,-0.003372825711944971,0.027731437844317863,0.009068369767823325,-0.004421907916535517,-0.18384239303171968
2328,2020-05-20,Mid-Afternoon Market Update: Crude Oil Up 5%; Surface Oncology Shares Spike Higher,MRK,-0.008510710347441997,0.041150899250383954,-0.02721999166733824,-0.0007523356537069148,-0.003372825711944971,0.027731437844317863,0.009068369767823325,-0.004421907916535517,-0.18384239303171968
2329,2020-05-20,"The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test",MRK,-0.008510710347441997,0.041150899250383954,-0.02721999166733824,-0.0007523356537069148,-0.003372825711944971,0.027731437844317863,0.009068369767823325,-0.004421907916535517,-0.18384239303171968
2330,2020-05-21,"The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive",MRK,-0.004421907916535517,-0.18384239303171968,-0.008510710347441997,-0.02721999166733824,-0.0007523356537069148,-0.003372825711944971,0.027731437844317863,-0.002351434869133695,-0.2936389325323552
2331,2020-05-21,Mid-Day Market Update: Crude Oil Rises Over 1%; Aurora Cannabis Shares Jump,MRK,-0.004421907916535517,-0.18384239303171968,-0.008510710347441997,-0.02721999166733824,-0.0007523356537069148,-0.003372825711944971,0.027731437844317863,-0.002351434869133695,-0.2936389325323552
2332,2020-05-21,51 Stocks Moving In Thursday's Mid-Day Session,MRK,-0.004421907916535517,-0.18384239303171968,-0.008510710347441997,-0.02721999166733824,-0.0007523356537069148,-0.003372825711944971,0.027731437844317863,-0.002351434869133695,-0.2936389325323552
2333,2020-05-21,Mid-Afternoon Market Update: Dow Falls 50 Points; L Brands Shares Spike Higher,MRK,-0.004421907916535517,-0.18384239303171968,-0.008510710347441997,-0.02721999166733824,-0.0007523356537069148,-0.003372825711944971,0.027731437844317863,-0.002351434869133695,-0.2936389325323552
2334,2020-05-21,Mid-Morning Market Update: Markets Mixed; Best Buy Tops Q1 Expectations,MRK,-0.004421907916535517,-0.18384239303171968,-0.008510710347441997,-0.02721999166733824,-0.0007523356537069148,-0.003372825711944971,0.027731437844317863,-0.002351434869133695,-0.2936389325323552
2335,2020-05-22,64 Biggest Movers From Yesterday,MRK,-0.002351434869133695,-0.2936389325323552,-0.004421907916535517,-0.008510710347441997,-0.02721999166733824,-0.0007523356537069148,-0.003372825711944971,0.011653801528584973,2.0115723489268236
2336,2020-05-26,"Merck's Coronavirus Plan Of Attack: 2 Partnerships, M&A Deal Aimed At Treatment, Vaccine Development",MRK,0.011653801528584973,2.0115723489268236,-0.002351434869133695,-0.004421907916535517,-0.008510710347441997,-0.02721999166733824,-0.0007523356537069148,0.0037536589591702363,-0.32993964227651107
2337,2020-06-01,Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates,MRK,-0.014370500859952728,-0.5361993959652895,0.021255041996100843,0.019213216958739565,0.0037536589591702363,0.011653801528584973,-0.002351434869133695,0.01608830134550998,0.8109024680978127
2338,2020-06-04,"The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic",MRK,-0.00621518756657502,-0.32046658477299883,0.015091858295425808,0.01608830134550998,-0.014370500859952728,0.021255041996100843,0.019213216958739565,0.008706188637293,0.12056660278297593
2339,2020-06-05,"The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid",MRK,0.008706188637293,0.12056660278297593,-0.00621518756657502,0.015091858295425808,0.01608830134550998,-0.014370500859952728,0.021255041996100843,0.007780228289306468,-0.04383883491062002
2340,2020-06-10,"The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset",MRK,-0.005956574916929691,0.026537140149271332,-0.007720163653650247,0.007780228289306468,0.008706188637293,-0.00621518756657502,0.015091858295425808,-0.054054135610284604,0.5751529580703276
2341,2020-06-11,Johnson & Johnson To Start Coronavirus Vaccine Human Trials Ahead Of Schedule In July,MRK,-0.054054135610284604,0.5751529580703276,-0.005956574916929691,-0.007720163653650247,0.007780228289306468,0.008706188637293,-0.00621518756657502,-0.005733594413191767,0.18853806929301076
2342,2020-06-16,"The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO",MRK,0.039854207566649924,0.2122174632872058,-0.029881982086761183,-0.005733594413191767,-0.054054135610284604,-0.005956574916929691,-0.007720163653650247,-0.008834921680657026,-0.3477159870411274
2343,2020-06-17,"The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked",MRK,-0.008834921680657026,-0.3477159870411274,0.039854207566649924,-0.029881982086761183,-0.005733594413191767,-0.054054135610284604,-0.005956574916929691,-0.0009174963786053869,-0.4456927657745505
2344,2020-06-25,"The Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy",MRK,0.00922656118469467,-0.06203823646078044,-0.01620863283661278,0.004820964411597739,-0.014762843667256553,0.022041740719167535,-0.0009174963786053869,-0.018022943273926728,0.6257877807738239
2345,2020-06-30,"The Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Merck's Keytruda, OncoCyte Stalls Lung Nodule Malignancy Test",MRK,0.015895866950547344,0.37475006880109096,0.012368803912138793,-0.018022943273926728,0.00922656118469467,-0.01620863283661278,0.004820964411597739,0.010215973681479307,0.0008012430382895452
2346,2020-07-02,"The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts",MRK,0.008448576550829756,-0.31370152427903397,0.010215973681479307,0.015895866950547344,0.012368803912138793,-0.018022943273926728,0.00922656118469467,0.010155011978506101,0.18021214662062945
2347,2020-07-08,"The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy",MRK,-0.010162640227342479,0.18040616904054296,-0.010806805850919754,0.010155011978506101,0.008448576550829756,0.010215973681479307,0.015895866950547344,-0.015785384743296937,-0.029877509226813426
2348,2020-07-16,"The Daily Biotech Pulse: Mallinckrodt Gets FDA Panel Backing, Regulatory Setback For Tricida, Relay Therapeutics IPO",MRK,-0.000503730156476645,-0.24111689183922058,0.015207644514521945,0.011635481340176446,0.008080332278668445,0.0005215652703880469,-0.015785384743296937,0.005919527503686739,0.4000503181288493
2349,2020-07-27,3 ETFs For This Week's Earnings Parade,MRK,0.023735370217095264,0.2083574132436805,-0.01229810006775034,-0.009139333214437939,-0.0013943893063572688,-0.0065485428256358835,-0.005759137315995977,0.009628726829695733,-0.2248287988281401
2350,2020-07-28,"Moderna Looking To Price Its Coronavirus Vaccine At $50-$60, Significantly Above Rivals: FT",MRK,0.009628726829695733,-0.2248287988281401,0.023735370217095264,-0.01229810006775034,-0.009139333214437939,-0.0013943893063572688,-0.0065485428256358835,-0.004266463978177093,-0.2468077231509469
2351,2020-07-28,"The Daily Biotech Pulse: Spectrum's Positive Dementia Readout, Pfizer, BioNTech Start Late-Stage Coronavirus Trial, resTORbio Receives COVID-19 Funding",MRK,0.009628726829695733,-0.2248287988281401,0.023735370217095264,-0.01229810006775034,-0.009139333214437939,-0.0013943893063572688,-0.0065485428256358835,-0.004266463978177093,-0.2468077231509469
2352,2020-07-29,"The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More",MRK,-0.004266463978177093,-0.2468077231509469,0.009628726829695733,0.023735370217095264,-0.01229810006775034,-0.009139333214437939,-0.0013943893063572688,-0.004536840342356463,0.11793611793611802
2353,2020-07-31,Merck's Debt Overview,MRK,0.01582468745102239,0.7184176383413026,-0.004536840342356463,-0.004266463978177093,0.009628726829695733,0.023735370217095264,-0.01229810006775034,0.028664103356434323,-0.13747212019310795
2354,2020-07-31,"Four-For-Four: Perfect Day At The Plate For FAANGs As Apple, Amazon, Facebook Up Big Early",MRK,0.01582468745102239,0.7184176383413026,-0.004536840342356463,-0.004266463978177093,0.009628726829695733,0.023735370217095264,-0.01229810006775034,0.028664103356434323,-0.13747212019310795
2355,2020-07-31,"Earnings Scheduled For July 31, 2020",MRK,0.01582468745102239,0.7184176383413026,-0.004536840342356463,-0.004266463978177093,0.009628726829695733,0.023735370217095264,-0.01229810006775034,0.028664103356434323,-0.13747212019310795
2356,2020-07-31,"10 Stocks To Watch For July 31, 2020",MRK,0.01582468745102239,0.7184176383413026,-0.004536840342356463,-0.004266463978177093,0.009628726829695733,0.023735370217095264,-0.01229810006775034,0.028664103356434323,-0.13747212019310795
2357,2020-07-31,A Peek Into The Markets: US Stock Futures Up Following Upbeat Results From Tech Giants,MRK,0.01582468745102239,0.7184176383413026,-0.004536840342356463,-0.004266463978177093,0.009628726829695733,0.023735370217095264,-0.01229810006775034,0.028664103356434323,-0.13747212019310795
2358,2020-08-24,Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week,MRK,0.005177745212177731,0.10039699615194553,-0.0005881392466964286,0.0,0.005558307534179852,-0.002359638586217905,0.015332989607260927,0.0030437468238864174,0.3513062034111112
2359,2020-08-31,Pharmaceutical Companies Are Doing Much More Than Battling COVID-19,MRK,-0.004436481964325889,0.292665415616993,-0.001981062041186643,0.0032732272395465944,-0.0016337866799701617,0.0030437468238864174,0.005177745212177731,-0.009851083339254552,-0.14274196385973847
2360,2020-09-02,A Look Into Merck's Price Over Earnings,MRK,0.02961024695036052,0.7023480775757553,-0.009851083339254552,-0.004436481964325889,-0.001981062041186643,0.0032732272395465944,-0.0016337866799701617,-0.016564976074399218,0.12202939663384416
2361,2020-09-04,The Dow Jones Index: The Story Of COVID-19 Winners,MRK,-0.002924361758940952,-0.279118572927597,-0.016564976074399218,0.02961024695036052,-0.009851083339254552,-0.004436481964325889,-0.001981062041186643,-0.022407262159387598,-0.028216325159556632
2362,2020-09-04,Return On Capital Employed Overview: Merck & Co,MRK,-0.002924361758940952,-0.279118572927597,-0.016564976074399218,0.02961024695036052,-0.009851083339254552,-0.004436481964325889,-0.001981062041186643,-0.022407262159387598,-0.028216325159556632
2363,2020-09-08,"As Political Pressure Mounts, COVID-19 Vaccine Developers Pledge To Put Safety First",MRK,-0.022407262159387598,-0.028216325159556632,-0.002924361758940952,-0.016564976074399218,0.02961024695036052,-0.009851083339254552,-0.004436481964325889,0.018600703273321306,-0.025648138131085907
2364,2020-09-09,"The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment",MRK,0.018600703273321306,-0.025648138131085907,-0.022407262159387598,-0.002924361758940952,-0.016564976074399218,0.02961024695036052,-0.009851083339254552,-0.015433595809662748,-0.22056660867198574
2365,2020-09-14,Checkpoint Therapeutics To Release Significant Drug Data At This Week's ESMO Congress,MRK,0.003457839853953537,0.19588484803355177,0.010889152642203248,-0.015433595809662748,0.018600703273321306,-0.022407262159387598,-0.002924361758940952,0.0005939506349568191,0.2624400156996378
2366,2020-09-18,"The Daily Biotech Pulse: Roche's COVID Combo Therapy Reduces Need For Ventilation, ESMO Presentations",MRK,0.0019848776726902884,0.5213539905975622,0.0008182756547219228,0.016150010961825778,0.0005939506349568191,0.003457839853953537,0.010889152642203248,-0.031231758007409738,-0.15137044920211695
2367,2020-09-22,Vaccinex Plummets After Lead Drug Flunks Midstage Huntingon's Disease Study,MRK,-0.0022855832633075224,-0.2203994691972312,-0.031231758007409738,0.0019848776726902884,0.0008182756547219228,0.016150010961825778,0.0005939506349568191,-0.0037377293618545693,-0.1298423095674044
2368,2020-09-23,"The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma",MRK,-0.0037377293618545693,-0.1298423095674044,-0.0022855832633075224,-0.031231758007409738,0.0019848776726902884,0.0008182756547219228,0.016150010961825778,0.00629329258185396,0.10703569173571759
2369,2020-09-24,"The Daily Biotech Pulse: Gilead's $7.25B Debt Offering, Lexicon Deleverages, Taysha Gene Therapies Prices IPO",MRK,0.00629329258185396,0.10703569173571759,-0.0037377293618545693,-0.0022855832633075224,-0.031231758007409738,0.0019848776726902884,0.0008182756547219228,-0.002646003869211766,-0.11628587964733539
2370,2020-09-29,"The Daily Biotech Pulse: FDA Nod For Pfizer, Sorrento's COVID-19 Antibody Animal Data, Orphazyme's Wall Street Debut",MRK,-0.010391725131460583,0.10104048647919539,-0.002049635659285509,-0.002646003869211766,0.00629329258185396,-0.0037377293618545693,-0.0022855832633075224,0.012820438090807018,0.7195038334198751
2371,2020-09-30,Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates,MRK,0.012820438090807018,0.7195038334198751,-0.010391725131460583,-0.002049635659285509,-0.002646003869211766,0.00629329258185396,-0.0037377293618545693,-0.015792505455605177,-0.27457378442684566
2372,2020-10-08,"The Daily Biotech Pulse: Gilead, Lilly COVID-19 Treatment Supply Agreements, CareDx's Positive Preannouncement, Aziyo Biologics Debuts On Wall Street",MRK,0.005497197505027973,-0.06379396470939314,0.005149011552848082,-0.019817884741108016,0.005445599648683519,-0.010289119615095488,-0.015792505455605177,-0.0014912450423948398,-0.3538033407253427
2373,2020-10-08,Moderna: Coronavirus Vaccine Patents Will Go Unenforced During Pandemic,MRK,0.005497197505027973,-0.06379396470939314,0.005149011552848082,-0.019817884741108016,0.005445599648683519,-0.010289119615095488,-0.015792505455605177,-0.0014912450423948398,-0.3538033407253427
2374,2020-10-14,Regeneron's Inmazeb Becomes First Ebola Treatment To Get FDA Approval,MRK,-0.002478325540238968,0.00442132360498948,0.004355663480441585,0.0,-0.0014912450423948398,0.005497197505027973,0.005149011552848082,-0.01800999442406359,-0.0015435098943696879
2375,2020-10-20,"The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger",MRK,-0.005084521172467382,0.29372618465126354,-0.014530895222703455,0.009739453801435705,-0.01800999442406359,-0.002478325540238968,0.004355663480441585,-0.002555252823314813,-0.1305492292063004
2376,2020-10-26,"FAANGs In Focus: Amazon, Facebook, Apple, Alphabet, All Set To Report Later This Week",MRK,-0.012401341229767993,0.248100215326031,0.007827258122328207,0.014602320250207246,-0.002555252823314813,-0.005084521172467382,-0.014530895222703455,-0.010781364617848843,0.3418380679700619
2377,2020-10-27,"Earnings Scheduled For October 27, 2020",MRK,-0.010781364617848843,0.3418380679700619,-0.012401341229767993,0.007827258122328207,0.014602320250207246,-0.002555252823314813,-0.005084521172467382,-0.02320793959518519,-0.26560907296844294
2378,2020-10-27,"The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings",MRK,-0.010781364617848843,0.3418380679700619,-0.012401341229767993,0.007827258122328207,0.014602320250207246,-0.002555252823314813,-0.005084521172467382,-0.02320793959518519,-0.26560907296844294
2379,2020-10-27,"7 Stocks To Watch For October 27, 2020",MRK,-0.010781364617848843,0.3418380679700619,-0.012401341229767993,0.007827258122328207,0.014602320250207246,-0.002555252823314813,-0.005084521172467382,-0.02320793959518519,-0.26560907296844294
2380,2020-10-27,Recap: Merck & Co Q3 Earnings,MRK,-0.010781364617848843,0.3418380679700619,-0.012401341229767993,0.007827258122328207,0.014602320250207246,-0.002555252823314813,-0.005084521172467382,-0.02320793959518519,-0.26560907296844294
2381,2020-10-29,"The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal",MRK,-0.0038068913027254903,0.036079828662082036,-0.02320793959518519,-0.010781364617848843,-0.012401341229767993,0.007827258122328207,0.014602320250207246,-0.008960572451852555,0.19136554398554484
2382,2020-11-03,Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates,MRK,0.0027377937858326096,-0.05547828702439084,0.019944124368519667,-0.008960572451852555,-0.0038068913027254903,-0.02320793959518519,-0.010781364617848843,0.04810183831606718,0.9147686551042962
2383,2020-11-04,"Rich Saperstein And Joe Terranova Share Their Recent Purchases: Visa, Adobe And More",MRK,0.04810183831606718,0.9147686551042962,0.0027377937858326096,0.019944124368519667,-0.008960572451852555,-0.0038068913027254903,-0.02320793959518519,-0.001984551227433018,-0.3702434157408565
2384,2020-11-05,"The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping",MRK,-0.001984551227433018,-0.3702434157408565,0.04810183831606718,0.0027377937858326096,0.019944124368519667,-0.008960572451852555,-0.0038068913027254903,-0.0012429592700521352,-0.2513358003106537
2385,2020-11-10,"The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies",MRK,0.007577723719895735,-0.23159167979101658,0.0017422221876586264,-0.0012429592700521352,-0.001984551227433018,0.04810183831606718,0.0027377937858326096,-0.0006164991920554197,-0.3318902190550196
2386,2020-11-11,"The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap",MRK,-0.0006164991920554197,-0.3318902190550196,0.007577723719895735,0.0017422221876586264,-0.0012429592700521352,-0.001984551227433018,0.04810183831606718,-0.014803823003876615,0.3001075643740383
2387,2020-11-16,Warren Buffett's Berkshire Bets On These Four Drugmakers Amid Pandemic,MRK,-0.011221963021469605,0.2351468104701122,0.015401784671079444,-0.014803823003876615,-0.0006164991920554197,0.007577723719895735,0.0017422221876586264,0.016462907821702677,0.0005954664578446955
2388,2020-11-17,"Q3 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios",MRK,0.016462907821702677,0.0005954664578446955,-0.011221963021469605,0.015401784671079444,-0.014803823003876615,-0.0006164991920554197,0.007577723719895735,-0.015337237427115125,-0.0873853588965472
2389,2020-11-17,Not Good Enough? Impressive Earnings From Walmart And Home Depot Fail To Lift Market,MRK,0.016462907821702677,0.0005954664578446955,-0.011221963021469605,0.015401784671079444,-0.014803823003876615,-0.0006164991920554197,0.007577723719895735,-0.015337237427115125,-0.0873853588965472
2390,2020-11-19,Has Warren Buffett Invested In Tesla? Here's Why People Are Speculating,MRK,0.0017442854021687548,-0.1891024540415991,-0.015337237427115125,0.016462907821702677,-0.011221963021469605,0.015401784671079444,-0.014803823003876615,0.0007465114302949161,0.19586591654812846
2391,2020-11-20,"The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger",MRK,0.0007465114302949161,0.19586591654812846,0.0017442854021687548,-0.015337237427115125,0.016462907821702677,-0.011221963021469605,0.015401784671079444,-0.002113142340624985,0.12870485678704857
2392,2020-11-23,FDA Approves Eiger Biopharma's Progeria Treatment: What Investors Should Know,MRK,-0.002113142340624985,0.12870485678704857,0.0007465114302949161,0.0017442854021687548,-0.015337237427115125,0.016462907821702677,-0.011221963021469605,-0.0017438500606817842,0.3466100292381531
2393,2020-11-23,Merck To Buy Late-Stage COVID-19 Treatment Company OncoImmune For $425M In Cash,MRK,-0.002113142340624985,0.12870485678704857,0.0007465114302949161,0.0017442854021687548,-0.015337237427115125,0.016462907821702677,-0.011221963021469605,-0.0017438500606817842,0.3466100292381531
2394,2020-12-02,Merck Cashes Out Direct Investment In Moderna After 600% Year-To-Date Stock Gain,MRK,0.0034335980872326477,-0.2951581476614027,0.014429783063605539,0.006636460951231049,-0.0024982301086436953,-0.0009981646161474345,-0.0017438500606817842,-0.004643786172845554,-0.011261260946955676
2395,2020-12-16,"The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal",MRK,-0.008076645686513229,-0.05949629643140586,0.001992332169441946,-0.02417691366780994,-0.00036166648973801063,-0.005750579518989829,0.003486628607634934,-0.00012546034940541517,0.23424022115489307
2396,2020-12-23,"The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut",MRK,0.004281276261216105,-0.33099856016306806,0.0016394858129356038,-0.0030177506847843816,-0.0036330884877250336,-0.00012546034940541517,-0.008076645686513229,0.004764227170012347,-0.5116549027274748
2397,2020-12-23,"COVID News Flow: Pfizer-BioNTech's US Vaccine Supply Deal, Merck Strikes $356M Contract, Sorrento Files For EUA Of Rapid Test",MRK,0.004281276261216105,-0.33099856016306806,0.0016394858129356038,-0.0030177506847843816,-0.0036330884877250336,-0.00012546034940541517,-0.008076645686513229,0.004764227170012347,-0.5116549027274748
2398,2020-12-23,Merck's Debt Overview,MRK,0.004281276261216105,-0.33099856016306806,0.0016394858129356038,-0.0030177506847843816,-0.0036330884877250336,-0.00012546034940541517,-0.008076645686513229,0.004764227170012347,-0.5116549027274748
2399,2021-01-07,Moderna Has Big Plans For 2021,MRK,0.019907658054852062,-0.0069824384520836835,0.015783024769326914,0.0017292701388649245,-0.01026896862985427,0.015014137999829646,-0.01019378094429213,-0.01178272361238053,-0.08468911213138752
2400,2021-01-07,"The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration",MRK,0.019907658054852062,-0.0069824384520836835,0.015783024769326914,0.0017292701388649245,-0.01026896862985427,0.015014137999829646,-0.01019378094429213,-0.01178272361238053,-0.08468911213138752
2401,2021-01-12,Moderna's Coronavirus Vaccine Secures Swiss Regulatory Approval,MRK,-0.022470667010732637,-0.24907535702187822,0.023726212852304585,-0.01178272361238053,0.019907658054852062,0.015783024769326914,0.0017292701388649245,-0.009026149487205704,-0.0034352209968478986
2402,2021-01-12,"The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue",MRK,-0.022470667010732637,-0.24907535702187822,0.023726212852304585,-0.01178272361238053,0.019907658054852062,0.015783024769326914,0.0017292701388649245,-0.009026149487205704,-0.0034352209968478986
2403,2021-01-15,Novavax Hires Regulatory Expert As Coronavirus Vaccine Inches Closer To Emergency Use Filing,MRK,0.014725440707840765,-0.10230681698810828,-0.002064672430792225,-0.009026149487205704,-0.022470667010732637,0.023726212852304585,-0.01178272361238053,-0.0022788477606995317,-0.17015882138136795
2404,2021-01-20,"The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study",MRK,-0.008774928255857017,0.310675189162658,-0.0022788477606995317,0.014725440707840765,-0.002064672430792225,-0.009026149487205704,-0.022470667010732637,-0.015522613703487398,-0.18509671333344924
2405,2021-01-25,ROCE Insights For Merck & Co,MRK,0.0020992411466578265,0.05518227015873611,-0.0024637667168826427,-0.015522613703487398,-0.008774928255857017,-0.0022788477606995317,0.014725440707840765,-0.011090360769416718,-0.22187845619013347
2406,2021-01-25,Merck Drops COVID-19 Vaccine Studies After Phase 1 Data Churn Out Inferior Efficacy Results,MRK,0.0020992411466578265,0.05518227015873611,-0.0024637667168826427,-0.015522613703487398,-0.008774928255857017,-0.0022788477606995317,0.014725440707840765,-0.011090360769416718,-0.22187845619013347
2407,2021-01-26,"The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market",MRK,-0.011090360769416718,-0.22187845619013347,0.0020992411466578265,-0.0024637667168826427,-0.015522613703487398,-0.008774928255857017,-0.0022788477606995317,-0.039626095332447986,1.0947061432836152
2408,2021-02-01,A Preview Of The Busy Earnings Week Ahead,MRK,0.0037627225421763555,-0.2292909036899321,-0.010908511780189145,0.011028819790798616,-0.039626095332447986,-0.011090360769416718,0.0020992411466578265,0.005299761940411152,0.19965848790925866
2409,2021-02-02,Upcoming Earnings Look To Cut Through The Market's Volatility,MRK,0.005299761940411152,0.19965848790925866,0.0037627225421763555,-0.010908511780189145,0.011028819790798616,-0.039626095332447986,-0.011090360769416718,-0.005786292530562287,0.017037087337116397
2410,2021-02-02,"FAANGs' Final Fling: Amazon, Alphabet Wrap Up Earnings Season For ""Mega-Caps"" Later Today",MRK,0.005299761940411152,0.19965848790925866,0.0037627225421763555,-0.010908511780189145,0.011028819790798616,-0.039626095332447986,-0.011090360769416718,-0.005786292530562287,0.017037087337116397
2411,2021-02-03,"Pfizer Is Ready, Even For Covid-19 Variants",MRK,-0.005786292530562287,0.017037087337116397,0.005299761940411152,0.0037627225421763555,-0.010908511780189145,0.011028819790798616,-0.039626095332447986,-0.016683932179890837,0.8802112845185908
2412,2021-02-04,"The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs",MRK,-0.016683932179890837,0.8802112845185908,-0.005786292530562287,0.005299761940411152,0.0037627225421763555,-0.010908511780189145,0.011028819790798616,-0.00302494029633682,-0.2631891569674366
2413,2021-02-04,Recap: Merck & Co Q4 Earnings,MRK,-0.016683932179890837,0.8802112845185908,-0.005786292530562287,0.005299761940411152,0.0037627225421763555,-0.010908511780189145,0.011028819790798616,-0.00302494029633682,-0.2631891569674366
2414,2021-02-04,Citius Pharmaceuticals Says It Is Addressing Several Unmet Needs In The Medical Field,MRK,-0.016683932179890837,0.8802112845185908,-0.005786292530562287,0.005299761940411152,0.0037627225421763555,-0.010908511780189145,0.011028819790798616,-0.00302494029633682,-0.2631891569674366
2415,2021-02-04,Merck Posts Mixed Q4 Earnings; Kenneth Frazier To Step Down As CEO,MRK,-0.016683932179890837,0.8802112845185908,-0.005786292530562287,0.005299761940411152,0.0037627225421763555,-0.010908511780189145,0.011028819790798616,-0.00302494029633682,-0.2631891569674366
2416,2021-02-04,"Earnings Scheduled For February 4, 2021",MRK,-0.016683932179890837,0.8802112845185908,-0.005786292530562287,0.005299761940411152,0.0037627225421763555,-0.010908511780189145,0.011028819790798616,-0.00302494029633682,-0.2631891569674366
2417,2021-02-10,FDA Casts Doubt On Merck's Keytruda Trial Data In Early-Stage Breast Cancer,MRK,-0.0019988188641126836,-0.13074528781538908,0.0,-0.01002647383552957,-0.00302494029633682,-0.016683932179890837,-0.005786292530562287,-0.0020031671199091106,-0.25086955104804254
2418,2021-02-11,Merck In Talks To Possibly Produce COVID-19 Shots: WSJ,MRK,-0.0020031671199091106,-0.25086955104804254,-0.0019988188641126836,0.0,-0.01002647383552957,-0.00302494029633682,-0.016683932179890837,0.0034788183493841274,-0.232646644760233
2419,2021-02-11,"The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts",MRK,-0.0020031671199091106,-0.25086955104804254,-0.0019988188641126836,0.0,-0.01002647383552957,-0.00302494029633682,-0.016683932179890837,0.0034788183493841274,-0.232646644760233
2420,2021-02-16,"Warren Buffett's Berkshire Cuts Apple Stake And Buys These Drugmaker, Telecom Stocks Instead",MRK,-0.010000113675495026,0.44468468634259195,0.0034788183493841274,-0.0020031671199091106,-0.0019988188641126836,0.0,-0.01002647383552957,0.01737376057045359,0.42550002552788535
2421,2021-02-16,Merck/Eisai's Keytruda-Lenvima Combo Tops Standard Of Care In Late-Stage Kidney Cancer Study,MRK,-0.010000113675495026,0.44468468634259195,0.0034788183493841274,-0.0020031671199091106,-0.0019988188641126836,0.0,-0.01002647383552957,0.01737376057045359,0.42550002552788535
2422,2021-02-17,AstraZeneca/Merck's PARP Inhibitor In Late-Stage Breast Cancer Study To Enter Early Analysis,MRK,0.01737376057045359,0.42550002552788535,-0.010000113675495026,0.0034788183493841274,-0.0020031671199091106,-0.0019988188641126836,0.0,-0.0017207601030814201,-0.2790218227800557
2423,2021-02-17,Nektar Therapeutics Secures $150M From SFJ Pharma For New Study With BEMPEG/Pembrolizumab Combo In Head & Neck Cancer,MRK,0.01737376057045359,0.42550002552788535,-0.010000113675495026,0.0034788183493841274,-0.0020031671199091106,-0.0019988188641126836,0.0,-0.0017207601030814201,-0.2790218227800557
2424,2021-02-17,Shortage Of Giant Sterile Liners Threatens Global Vaccines Rollout: FT,MRK,0.01737376057045359,0.42550002552788535,-0.010000113675495026,0.0034788183493841274,-0.0020031671199091106,-0.0019988188641126836,0.0,-0.0017207601030814201,-0.2790218227800557
2425,2021-02-17,"The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal",MRK,0.01737376057045359,0.42550002552788535,-0.010000113675495026,0.0034788183493841274,-0.0020031671199091106,-0.0019988188641126836,0.0,-0.0017207601030814201,-0.2790218227800557
2426,2021-02-17,"Q4 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios",MRK,0.01737376057045359,0.42550002552788535,-0.010000113675495026,0.0034788183493841274,-0.0020031671199091106,-0.0019988188641126836,0.0,-0.0017207601030814201,-0.2790218227800557
2427,2021-02-18,Pfizer Says South African Variant Could Significantly Reduce Vaccine Protection: Reuters,MRK,-0.0017207601030814201,-0.2790218227800557,0.01737376057045359,-0.010000113675495026,0.0034788183493841274,-0.0020031671199091106,-0.0019988188641126836,-0.014587036011991406,0.2382468631764083
2428,2021-02-22,Sanofi/GlaxoSmithKline Initiate COVID-19 Vaccine Development After Setback,MRK,0.008343494948010566,-0.3047847636920237,-0.014587036011991406,-0.0017207601030814201,0.01737376057045359,-0.010000113675495026,0.0034788183493841274,-0.0052049949470587276,0.26566079115105734
2429,2021-02-22,Lantern Pharma CEO Discusses The Addition Of Its New ADC Program And The Resurgence Of ADC Therapy For Cancer Treatment,MRK,0.008343494948010566,-0.3047847636920237,-0.014587036011991406,-0.0017207601030814201,0.01737376057045359,-0.010000113675495026,0.0034788183493841274,-0.0052049949470587276,0.26566079115105734
2430,2021-02-23,Veru Files US Application For TADFIN Combo For Prostate Enlargement,MRK,-0.0052049949470587276,0.26566079115105734,0.008343494948010566,-0.014587036011991406,-0.0017207601030814201,0.01737376057045359,-0.010000113675495026,0.00040239914459849757,-0.09739260497127733
2431,2021-02-23,FDA Says Conduct Smaller Trials To Test Vaccine Efficacy Against COVID Variants,MRK,-0.0052049949470587276,0.26566079115105734,0.008343494948010566,-0.014587036011991406,-0.0017207601030814201,0.01737376057045359,-0.010000113675495026,0.00040239914459849757,-0.09739260497127733
2432,2021-02-25,Why Pandion Therapeutics Stock Shot Up 133% Today,MRK,0.0006707419320417518,0.10856174623944259,0.00040239914459849757,-0.0052049949470587276,0.008343494948010566,-0.014587036011991406,-0.0017207601030814201,-0.026802576286146462,0.6177624277353304
2433,2021-02-25,Moderna To Test New COVID-19 Vaccine Targeting South Africa Strain,MRK,0.0006707419320417518,0.10856174623944259,0.00040239914459849757,-0.0052049949470587276,0.008343494948010566,-0.014587036011991406,-0.0017207601030814201,-0.026802576286146462,0.6177624277353304
2434,2021-02-25,"The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants",MRK,0.0006707419320417518,0.10856174623944259,0.00040239914459849757,-0.0052049949470587276,0.008343494948010566,-0.014587036011991406,-0.0017207601030814201,-0.026802576286146462,0.6177624277353304
2435,2021-02-25,Moderna Raises 2021 Base COVID-19 Vaccine Production Plan To 700M Doses,MRK,0.0006707419320417518,0.10856174623944259,0.00040239914459849757,-0.0052049949470587276,0.008343494948010566,-0.014587036011991406,-0.0017207601030814201,-0.026802576286146462,0.6177624277353304
2436,2021-02-25,Why Merck Is Buying Autoimmune Disease Drug Company Pandion For $1.85B,MRK,0.0006707419320417518,0.10856174623944259,0.00040239914459849757,-0.0052049949470587276,0.008343494948010566,-0.014587036011991406,-0.0017207601030814201,-0.026802576286146462,0.6177624277353304
2437,2021-02-26,"The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida",MRK,-0.026802576286146462,0.6177624277353304,0.0006707419320417518,0.00040239914459849757,-0.0052049949470587276,0.008343494948010566,-0.014587036011991406,-0.003304779585503237,-0.28620218168892453
2438,2021-02-26,"FDA Requires Additional Data On Merck COVID-19 Drug, EUA Moved Back",MRK,-0.026802576286146462,0.6177624277353304,0.0006707419320417518,0.00040239914459849757,-0.0052049949470587276,0.008343494948010566,-0.014587036011991406,-0.003304779585503237,-0.28620218168892453
2439,2021-02-26,Johnson & Johnson's COVID-19 Vaccine Likely To Get EU Approval Early March: Bloomberg,MRK,-0.026802576286146462,0.6177624277353304,0.0006707419320417518,0.00040239914459849757,-0.0052049949470587276,0.008343494948010566,-0.014587036011991406,-0.003304779585503237,-0.28620218168892453
2440,2021-03-01,Merck's Cough Drug Gefapixant Application Accepted For US Review,MRK,-0.003304779585503237,-0.28620218168892453,-0.026802576286146462,0.0006707419320417518,0.00040239914459849757,-0.0052049949470587276,0.008343494948010566,0.0064934578198301285,0.2741137974971386
2441,2021-03-02,"Merck To Offer Hand With JNJ COVID-19 Vaccine Production, Biden Administration Says: Report",MRK,0.0064934578198301285,0.2741137974971386,-0.003304779585503237,-0.026802576286146462,0.0006707419320417518,0.00040239914459849757,-0.0052049949470587276,0.006177193666222047,-0.13131924455780386
2442,2021-03-02,"People Allergic To Pfizer, Moderna COVID-19 Vaccine Might Be Allowed To Get JNJ Shot: CNBC",MRK,0.0064934578198301285,0.2741137974971386,-0.003304779585503237,-0.026802576286146462,0.0006707419320417518,0.00040239914459849757,-0.0052049949470587276,0.006177193666222047,-0.13131924455780386
2443,2021-03-02,European Officials Seek To Garner Support For AstraZeneca COVID-19 Shot: CNBC,MRK,0.0064934578198301285,0.2741137974971386,-0.003304779585503237,-0.026802576286146462,0.0006707419320417518,0.00040239914459849757,-0.0052049949470587276,0.006177193666222047,-0.13131924455780386
2444,2021-03-02,What's Moving The Market Tuesday? After The Close Update,MRK,0.0064934578198301285,0.2741137974971386,-0.003304779585503237,-0.026802576286146462,0.0006707419320417518,0.00040239914459849757,-0.0052049949470587276,0.006177193666222047,-0.13131924455780386
2445,2021-03-02,What's Moving The Market Tuesday?,MRK,0.0064934578198301285,0.2741137974971386,-0.003304779585503237,-0.026802576286146462,0.0006707419320417518,0.00040239914459849757,-0.0052049949470587276,0.006177193666222047,-0.13131924455780386
2446,2021-03-02,"AstraZeneca, Pfizer/BioNtech Single Shot COVID-19 Jab 80% Effective At Preventing Hospitalizations In Elderly",MRK,0.0064934578198301285,0.2741137974971386,-0.003304779585503237,-0.026802576286146462,0.0006707419320417518,0.00040239914459849757,-0.0052049949470587276,0.006177193666222047,-0.13131924455780386
2447,2021-03-02,Novavax Bullish On Potential FDA EUA Nod For COVID-19 Vaccine By May,MRK,0.0064934578198301285,0.2741137974971386,-0.003304779585503237,-0.026802576286146462,0.0006707419320417518,0.00040239914459849757,-0.0052049949470587276,0.006177193666222047,-0.13131924455780386
2448,2021-03-02,"The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data",MRK,0.0064934578198301285,0.2741137974971386,-0.003304779585503237,-0.026802576286146462,0.0006707419320417518,0.00040239914459849757,-0.0052049949470587276,0.006177193666222047,-0.13131924455780386
2449,2021-03-03,"Medically Necessary: Stimulus Bill Has Billions For Vaccine Distribution, Executive Orders Signal Supply Chain Focus And Merck Helps J&J Produce Vaccine",MRK,0.006177193666222047,-0.13131924455780386,0.0064934578198301285,-0.003304779585503237,-0.026802576286146462,0.0006707419320417518,0.00040239914459849757,-0.015416317828920056,0.14599857158967033
2450,2021-03-03,"The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study",MRK,0.006177193666222047,-0.13131924455780386,0.0064934578198301285,-0.003304779585503237,-0.026802576286146462,0.0006707419320417518,0.00040239914459849757,-0.015416317828920056,0.14599857158967033
2451,2021-03-03,EU Considers Emergency Approvals To Boost COVID-19 Vaccine Rollout: Reuters,MRK,0.006177193666222047,-0.13131924455780386,0.0064934578198301285,-0.003304779585503237,-0.026802576286146462,0.0006707419320417518,0.00040239914459849757,-0.015416317828920056,0.14599857158967033
2452,2021-03-03,Direction Hard To Find As Market Keeps Chopping Ahead Of Key Jobs Data,MRK,0.006177193666222047,-0.13131924455780386,0.0064934578198301285,-0.003304779585503237,-0.026802576286146462,0.0006707419320417518,0.00040239914459849757,-0.015416317828920056,0.14599857158967033
2453,2021-03-04,"Emergent BioSolutions Capable Of Manufacturing 1B COVID-19 Vaccine Doses Annually, CEO Says",MRK,-0.015416317828920056,0.14599857158967033,0.006177193666222047,0.0064934578198301285,-0.003304779585503237,-0.026802576286146462,0.0006707419320417518,0.013302080973530916,-0.23373897070882677
2454,2021-03-04,Novartis Lends Support To Manufacture CureVac's COVID-19 Shots,MRK,-0.015416317828920056,0.14599857158967033,0.006177193666222047,0.0064934578198301285,-0.003304779585503237,-0.026802576286146462,0.0006707419320417518,0.013302080973530916,-0.23373897070882677
2455,2021-03-05,"WHO, SII Warn Of Raw Materials Shortage For COVID-19 Shots, Cites US Law As 'Serious' Limit:' Bloomberg",MRK,0.013302080973530916,-0.23373897070882677,-0.015416317828920056,0.006177193666222047,0.0064934578198301285,-0.003304779585503237,-0.026802576286146462,0.014221035516730929,0.2573434193022821
2456,2021-03-08,Merck/Ridgeback Biotherapeutics' COVID-19 Antiviral Shows Promise,MRK,0.014221035516730929,0.2573434193022821,0.013302080973530916,-0.015416317828920056,0.006177193666222047,0.0064934578198301285,-0.003304779585503237,-0.00040429044820278204,-0.0780586000692467
2457,2021-03-09,"Why AnPac Bio-Medical, Surface Oncology, CorMedix Are Rallying Today",MRK,-0.00040429044820278204,-0.0780586000692467,0.014221035516730929,0.013302080973530916,-0.015416317828920056,0.006177193666222047,0.0064934578198301285,0.008362509696092646,-0.09602661607676433
2458,2021-03-09,New York Times Credits Report On Emergent BioSolutions For Biden's Canceled Vaccine Plant Visit,MRK,-0.00040429044820278204,-0.0780586000692467,0.014221035516730929,0.013302080973530916,-0.015416317828920056,0.006177193666222047,0.0064934578198301285,0.008362509696092646,-0.09602661607676433
2459,2021-03-09,Surface Oncology To Test SRF388 Plus Keytruda Combo In Solid Tumor Settings,MRK,-0.00040429044820278204,-0.0780586000692467,0.014221035516730929,0.013302080973530916,-0.015416317828920056,0.006177193666222047,0.0064934578198301285,0.008362509696092646,-0.09602661607676433
2460,2021-03-10,Johnson And Johnson's Vaccine Could Be A Game Changer,MRK,0.008362509696092646,-0.09602661607676433,-0.00040429044820278204,0.014221035516730929,0.013302080973530916,-0.015416317828920056,0.006177193666222047,-0.0017388285306570994,0.029469467877520694
2461,2021-03-10,Biden Administration Poised To Buy Additional 100M Doses Of J&J's COVID-19 Vaccine: CNBC,MRK,0.008362509696092646,-0.09602661607676433,-0.00040429044820278204,0.014221035516730929,0.013302080973530916,-0.015416317828920056,0.006177193666222047,-0.0017388285306570994,0.029469467877520694
2462,2021-03-10,"Pfizer, BioNTech Predict Increase In Capacity To 3B COVID-19 Vaccine Shots In 2022: Bloomberg",MRK,0.008362509696092646,-0.09602661607676433,-0.00040429044820278204,0.014221035516730929,0.013302080973530916,-0.015416317828920056,0.006177193666222047,-0.0017388285306570994,0.029469467877520694
2463,2021-03-12,Inhibrx's INBRX-105 Shows Dose-Limiting Toxicities In Early-Stage Solid Tumors Study,MRK,0.00838064734780164,-0.12959803182413399,-0.0017388285306570994,0.008362509696092646,-0.00040429044820278204,0.014221035516730929,0.013302080973530916,0.02184990749157989,0.5659812910107413
2464,2021-03-15,"Germany, France Join List Of Countries Suspending AZN's COVID-19 Vaccine; WHO Urges Not To Halt Vaccinations",MRK,0.02184990749157989,0.5659812910107413,0.00838064734780164,-0.0017388285306570994,0.008362509696092646,-0.00040429044820278204,0.014221035516730929,0.007608400955787076,-0.12786100788947563
2465,2021-03-15,IDT Biologika To Make J&J's COVID-19 Vaccine Using Takeda's Manufacturing Capacity,MRK,0.02184990749157989,0.5659812910107413,0.00838064734780164,-0.0017388285306570994,0.008362509696092646,-0.00040429044820278204,0.014221035516730929,0.007608400955787076,-0.12786100788947563
2466,2021-03-15,"Gilead, Merck Team Up To Develop Long-Acting HIV Infection Treatments",MRK,0.02184990749157989,0.5659812910107413,0.00838064734780164,-0.0017388285306570994,0.008362509696092646,-0.00040429044820278204,0.014221035516730929,0.007608400955787076,-0.12786100788947563
2467,2021-03-16,Merck's Belzutifan Wins Priority Review Status In Type Of Kidney Cancer,MRK,0.007608400955787076,-0.12786100788947563,0.02184990749157989,0.00838064734780164,-0.0017388285306570994,0.008362509696092646,-0.00040429044820278204,0.006379297103664916,0.11695784279756882
2468,2021-03-16,Immutep's Lead Candidate To Be Tested In Combination With Keytruda In Second Head & Neck Cancer Study,MRK,0.007608400955787076,-0.12786100788947563,0.02184990749157989,0.00838064734780164,-0.0017388285306570994,0.008362509696092646,-0.00040429044820278204,0.006379297103664916,0.11695784279756882
2469,2021-03-16,Merck & Co's Debt Overview,MRK,0.007608400955787076,-0.12786100788947563,0.02184990749157989,0.00838064734780164,-0.0017388285306570994,0.008362509696092646,-0.00040429044820278204,0.006379297103664916,0.11695784279756882
2470,2021-03-17,"Pfizer/BioNTech COVID-19 Vaccination Could Protect Pregnant Women, Newborns, Study In Israel Suggests: Reuters",MRK,0.006379297103664916,0.11695784279756882,0.007608400955787076,0.02184990749157989,0.00838064734780164,-0.0017388285306570994,0.008362509696092646,-0.00038785454261935914,-0.18590861645096424
2471,2021-03-17,"The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes",MRK,0.006379297103664916,0.11695784279756882,0.007608400955787076,0.02184990749157989,0.00838064734780164,-0.0017388285306570994,0.008362509696092646,-0.00038785454261935914,-0.18590861645096424
2472,2021-03-17,"Amathus Therapeutics, Merck In Agreement For Neurodegenerative Disease-Targeted Therapies",MRK,0.006379297103664916,0.11695784279756882,0.007608400955787076,0.02184990749157989,0.00838064734780164,-0.0017388285306570994,0.008362509696092646,-0.00038785454261935914,-0.18590861645096424
2473,2021-03-18,"The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq",MRK,-0.00038785454261935914,-0.18590861645096424,0.006379297103664916,0.007608400955787076,0.02184990749157989,0.00838064734780164,-0.0017388285306570994,0.0031058079337527023,3.0790579269042375
2474,2021-03-19,"The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs",MRK,0.0031058079337527023,3.0790579269042375,-0.00038785454261935914,0.006379297103664916,0.007608400955787076,0.02184990749157989,0.00838064734780164,0.0,-0.8050177858546925
2475,2021-03-19,Merck' Keytruda Plus Eisai's Lenvima Cuts Risk Of Death By 38% In Endometrial Cancer Trial Compared To Chemo,MRK,0.0031058079337527023,3.0790579269042375,-0.00038785454261935914,0.006379297103664916,0.007608400955787076,0.02184990749157989,0.00838064734780164,0.0,-0.8050177858546925
2476,2021-03-22,AstraZeneca's COVID-19 Shot Shows 79% Efficacy In US Trials,MRK,0.0,-0.8050177858546925,0.0031058079337527023,-0.00038785454261935914,0.006379297103664916,0.007608400955787076,0.02184990749157989,-0.015997835132855243,0.026281086938388043
2477,2021-03-22,"Psyched: Novamind Partners With Merck, Atai Expands To Japan, Australia Funds Psychedelics Research",MRK,0.0,-0.8050177858546925,0.0031058079337527023,-0.00038785454261935914,0.006379297103664916,0.007608400955787076,0.02184990749157989,-0.015997835132855243,0.026281086938388043
2478,2021-03-23,9 Health Care Stocks Showing Unusual Options Activity In Today's Session,MRK,-0.015997835132855243,0.026281086938388043,0.0,0.0031058079337527023,-0.00038785454261935914,0.006379297103664916,0.007608400955787076,-0.0003934281052949684,-0.21592791156653213
2479,2021-03-23,Pfizer Starts Early-Stage Study Of Oral Antiviral COVID-19 Drug,MRK,-0.015997835132855243,0.026281086938388043,0.0,0.0031058079337527023,-0.00038785454261935914,0.006379297103664916,0.007608400955787076,-0.0003934281052949684,-0.21592791156653213
2480,2021-03-23,Merck's Keytruda Wins FDA Approval In Esophageal Cancer Settings,MRK,-0.015997835132855243,0.026281086938388043,0.0,0.0031058079337527023,-0.00038785454261935914,0.006379297103664916,0.007608400955787076,-0.0003934281052949684,-0.21592791156653213
2481,2021-03-23,"The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO",MRK,-0.015997835132855243,0.026281086938388043,0.0,0.0031058079337527023,-0.00038785454261935914,0.006379297103664916,0.007608400955787076,-0.0003934281052949684,-0.21592791156653213
2482,2021-03-29,White House Contemplates Waiving-Off Patent Protections For COVID-19 Treatments,MRK,0.011758554561614787,0.10190748262208382,0.01735242165178219,-0.0022297062079620344,-0.0003934281052949684,-0.015997835132855243,0.0,-0.01711378070976688,-0.11575217918197933
2483,2021-03-30,"The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings",MRK,-0.01711378070976688,-0.11575217918197933,0.011758554561614787,0.01735242165178219,-0.0022297062079620344,-0.0003934281052949684,-0.015997835132855243,0.0016893853687691696,0.3432507527634583
2484,2021-03-30,Merck Lines Up $240M Alydia Health Buyout To Beef Up Women's Health Spin-Off,MRK,-0.01711378070976688,-0.11575217918197933,0.011758554561614787,0.01735242165178219,-0.0022297062079620344,-0.0003934281052949684,-0.015997835132855243,0.0016893853687691696,0.3432507527634583
2485,2021-03-30,FDA Rejects Merck's Keytruda Application In High-Risk Breast Cancer Patients,MRK,-0.01711378070976688,-0.11575217918197933,0.011758554561614787,0.01735242165178219,-0.0022297062079620344,-0.0003934281052949684,-0.015997835132855243,0.0016893853687691696,0.3432507527634583
2486,2021-03-30,What Does Merck & Co's Debt Look Like?,MRK,-0.01711378070976688,-0.11575217918197933,0.011758554561614787,0.01735242165178219,-0.0022297062079620344,-0.0003934281052949684,-0.015997835132855243,0.0016893853687691696,0.3432507527634583
2487,2021-03-31,EMA May Issue Updated Recommendation If AstraZeneca Jab-Clot Link Is Established: Report,MRK,0.0016893853687691696,0.3432507527634583,-0.01711378070976688,0.011758554561614787,0.01735242165178219,-0.0022297062079620344,-0.0003934281052949684,0.0,-0.32922296662526174
2488,2021-03-31,Pfizer-BioNTech's COVID-19 Vaccine Gives 100% Protection In Adolescents,MRK,0.0016893853687691696,0.3432507527634583,-0.01711378070976688,0.011758554561614787,0.01735242165178219,-0.0022297062079620344,-0.0003934281052949684,0.0,-0.32922296662526174
2489,2021-04-06,Is Silicon Valley Replacing Big Pharma In Neuroscience?,MRK,-0.01571431564842729,0.36289191529957243,-0.001167397517458646,0.0,0.0016893853687691696,-0.01711378070976688,0.011758554561614787,0.004354103897236117,-0.3302897907813972
2490,2021-04-07,IMV's Lead Candidate To Be Evaluated With Keytruda In Pretreated B-Cell Lymphoma Patients,MRK,0.004354103897236117,-0.3302897907813972,-0.01571431564842729,-0.001167397517458646,0.0,0.0016893853687691696,-0.01711378070976688,-0.008276476644935582,0.33859825567305335
2491,2021-04-07,Europe's Drug Watchdog Concludes Possible Link Between AstraZeneca COVID-19 Vaccine And Blood Clots,MRK,0.004354103897236117,-0.3302897907813972,-0.01571431564842729,-0.001167397517458646,0.0,0.0016893853687691696,-0.01711378070976688,-0.008276476644935582,0.33859825567305335
2492,2021-04-08,"Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC",MRK,-0.008276476644935582,0.33859825567305335,0.004354103897236117,-0.01571431564842729,-0.001167397517458646,0.0,0.0016893853687691696,0.010862251578042548,-0.3189998421050527
2493,2021-04-08,"The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data",MRK,-0.008276476644935582,0.33859825567305335,0.004354103897236117,-0.01571431564842729,-0.001167397517458646,0.0,0.0016893853687691696,0.010862251578042548,-0.3189998421050527
2494,2021-04-08,Merck's Keytruda Shows Better Disease-Free Survival As Adjuvant Therapy In Kidney Cancer,MRK,-0.008276476644935582,0.33859825567305335,0.004354103897236117,-0.01571431564842729,-0.001167397517458646,0.0,0.0016893853687691696,0.010862251578042548,-0.3189998421050527
2495,2021-04-12,"South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Reports",MRK,-0.001179330240658527,0.2192902936970853,0.010862251578042548,-0.008276476644935582,0.004354103897236117,-0.01571431564842729,-0.001167397517458646,0.0027552436430593463,-0.13472772948503375
2496,2021-04-14,"UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots",MRK,-0.000392269432806569,-0.024549960092014378,0.0027552436430593463,-0.001179330240658527,0.010862251578042548,-0.008276476644935582,0.004354103897236117,0.0034028648246755555,0.727961053027463
2497,2021-04-14,Galectin Therapeutics Stock Is Trading Higher After Belapectin-Pembrolizumab Combo Study Shows Enhanced Tumor Response,MRK,-0.000392269432806569,-0.024549960092014378,0.0027552436430593463,-0.001179330240658527,0.010862251578042548,-0.008276476644935582,0.004354103897236117,0.0034028648246755555,0.727961053027463
2498,2021-04-14,"The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead",MRK,-0.000392269432806569,-0.024549960092014378,0.0027552436430593463,-0.001179330240658527,0.010862251578042548,-0.008276476644935582,0.004354103897236117,0.0034028648246755555,0.727961053027463
2499,2021-04-15,"The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split",MRK,0.0034028648246755555,0.727961053027463,-0.000392269432806569,0.0027552436430593463,-0.001179330240658527,0.010862251578042548,-0.008276476644935582,0.010566068580169397,-0.1395244886201329
2500,2021-04-15,Merck & Co: Debt Overview,MRK,0.0034028648246755555,0.727961053027463,-0.000392269432806569,0.0027552436430593463,-0.001179330240658527,0.010862251578042548,-0.008276476644935582,0.010566068580169397,-0.1395244886201329
2501,2021-04-20,Novel Approach to Cancer From Lixte Biotechnology Could Be a General way to Enhance a Variety of Standard Treatments,MRK,0.011717893358035747,0.2896181437226122,0.0024527113656360733,0.010566068580169397,0.0034028648246755555,-0.000392269432806569,0.0027552436430593463,0.008399871703938633,0.0733833847517722
2502,2021-04-22,"American, Southwest, Alaska Report Today With Focus On Summer Travel Demand",MRK,-0.016029161443642748,0.1280595956012771,0.008399871703938633,0.011717893358035747,0.0024527113656360733,0.010566068580169397,0.0034028648246755555,-0.0010261430501009583,-0.3549528301886793
2503,2021-04-23,"The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs",MRK,-0.0010261430501009583,-0.3549528301886793,-0.016029161443642748,0.008399871703938633,0.011717893358035747,0.0024527113656360733,0.010566068580169397,-0.004494083230697665,-0.08892141265566056
2504,2021-04-27,"Merck Teams Up With Five Indian Generic Players To Expand COVID-19 Drug Access, Production",MRK,-0.0021926064908330822,0.16103494170893096,-0.004494083230697665,-0.0010261430501009583,-0.016029161443642748,0.008399871703938633,0.011717893358035747,-0.003490299903817884,0.27843570033736453
2505,2021-04-28,Sanofi Shares Rise On Q1 Sales Boosted By Dupixent Franchise; Plans To Restart Haemophilia Study With Fitusiran,MRK,-0.003490299903817884,0.27843570033736453,-0.0021926064908330822,-0.004494083230697665,-0.0010261430501009583,-0.016029161443642748,0.008399871703938633,-0.04423420018486568,1.631725625490287
2506,2021-04-29,Bristol-Myers Misses Q1 Profit As Pandemic Hits Cancer Drugs Sales,MRK,-0.04423420018486568,1.631725625490287,-0.003490299903817884,-0.0021926064908330822,-0.004494083230697665,-0.0010261430501009583,-0.016029161443642748,0.011129323466297247,-0.4101147043862361
2507,2021-04-29,"Oncologic Drugs Adcomm Backs Merck's Keytruda, Roche's Tecentriq Accelerated Approvals In Bladder Cancer",MRK,-0.04423420018486568,1.631725625490287,-0.003490299903817884,-0.0021926064908330822,-0.004494083230697665,-0.0010261430501009583,-0.016029161443642748,0.011129323466297247,-0.4101147043862361
2508,2021-04-29,Merck & Co: Q1 Earnings Insights,MRK,-0.04423420018486568,1.631725625490287,-0.003490299903817884,-0.0021926064908330822,-0.004494083230697665,-0.0010261430501009583,-0.016029161443642748,0.011129323466297247,-0.4101147043862361
2509,2021-04-29,"The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx",MRK,-0.04423420018486568,1.631725625490287,-0.003490299903817884,-0.0021926064908330822,-0.004494083230697665,-0.0010261430501009583,-0.016029161443642748,0.011129323466297247,-0.4101147043862361
2510,2021-04-29,Merck Earnings Fall Short of Expectations As Sales Weakened By Widespread Infections,MRK,-0.04423420018486568,1.631725625490287,-0.003490299903817884,-0.0021926064908330822,-0.004494083230697665,-0.0010261430501009583,-0.016029161443642748,0.011129323466297247,-0.4101147043862361
2511,2021-04-30,Intel And Apple Lead The Dow Jones Lower To Close The Week,MRK,0.011129323466297247,-0.4101147043862361,-0.04423420018486568,-0.003490299903817884,-0.0021926064908330822,-0.004494083230697665,-0.0010261430501009583,0.019866049406270125,-0.3051616004640786
2512,2021-05-04,"Sharing A Ride To The Reopening: Uber, Lyft Earnings Could Offer Hints To Life Beyond The Pandemic",MRK,0.00013134360689770475,-0.16939040453622178,0.019866049406270125,0.011129323466297247,-0.04423420018486568,-0.003490299903817884,-0.0021926064908330822,0.022502866936404242,0.6120365458387016
2513,2021-05-05,"Lyft, GM Earnings Impress, Lifting Shares Ahead Of Uber's Report Slated For Later",MRK,0.022502866936404242,0.6120365458387016,0.00013134360689770475,0.019866049406270125,0.011129323466297247,-0.04423420018486568,-0.003490299903817884,0.0010297966434540395,-0.23360932383844546
2514,2021-05-06,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom",MRK,0.0010297966434540395,-0.23360932383844546,0.022502866936404242,0.00013134360689770475,0.019866049406270125,0.011129323466297247,-0.04423420018486568,0.008099618380515317,-0.049266833964682566
2515,2021-05-06,Fusion Pharma Shares Move Higher After Trial Collab With Merck For IGF-1R-Expressing Cancer Study,MRK,0.0010297966434540395,-0.23360932383844546,0.022502866936404242,0.00013134360689770475,0.019866049406270125,0.011129323466297247,-0.04423420018486568,0.008099618380515317,-0.049266833964682566
2516,2021-05-07,"The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs",MRK,0.008099618380515317,-0.049266833964682566,0.0010297966434540395,0.022502866936404242,0.00013134360689770475,0.019866049406270125,0.011129323466297247,-0.0030606533480196374,-0.10604604079135138
2517,2021-05-10,FDA Outlines Plan For Restarting Facility Inspections Halted Due To Pandemic,MRK,-0.0030606533480196374,-0.10604604079135138,0.008099618380515317,0.0010297966434540395,0.022502866936404242,0.00013134360689770475,0.019866049406270125,-0.009082703613849996,0.1104543628844441
2518,2021-05-11,Cannabis Industry Salary Report: Increased Demand For Top Talent As Salaries Continue To Surge,MRK,-0.009082703613849996,0.1104543628844441,-0.0030606533480196374,0.008099618380515317,0.0010297966434540395,0.022502866936404242,0.00013134360689770475,0.006971367534648998,0.10138283330186071
2519,2021-05-13,"The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use",MRK,0.00884606687883105,-0.19053176858603293,0.006971367534648998,-0.009082703613849996,-0.0030606533480196374,0.008099618380515317,0.0010297966434540395,-0.005083334707491005,-0.23612396196612684
2520,2021-05-18,"Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios",MRK,-0.0061348919494587095,-0.36619980613617,0.020181310231884186,-0.005083334707491005,0.00884606687883105,0.006971367534648998,-0.009082703613849996,-0.00025208112108132674,0.14977642247251888
2521,2021-05-20,Immutep Stock Gains on Encouraging Data from Early-Stage Solid Cancer Studies,MRK,0.0037804491058222034,-0.19573129630838138,-0.00025208112108132674,-0.0061348919494587095,0.020181310231884186,-0.005083334707491005,0.00884606687883105,-0.006025573456656108,0.4790549557249597
2522,2021-05-20,Merck's Next-Gen Pneumococcal Conjugate Vaccine Shows Efficacy In Pediatric Trials,MRK,0.0037804491058222034,-0.19573129630838138,-0.00025208112108132674,-0.0061348919494587095,0.020181310231884186,-0.005083334707491005,0.00884606687883105,-0.006025573456656108,0.4790549557249597
2523,2021-05-20,Iovance Shares Jump After Lifileucel Achieves 86% Response Rate In Melanoma Trial,MRK,0.0037804491058222034,-0.19573129630838138,-0.00025208112108132674,-0.0061348919494587095,0.020181310231884186,-0.005083334707491005,0.00884606687883105,-0.006025573456656108,0.4790549557249597
2524,2021-05-20,Oncolytics Pelareorep/Pembrolizumab Combo Therapy Shows Anti-Cancer Activity In Pancreatic Cancer,MRK,0.0037804491058222034,-0.19573129630838138,-0.00025208112108132674,-0.0061348919494587095,0.020181310231884186,-0.005083334707491005,0.00884606687883105,-0.006025573456656108,0.4790549557249597
2525,2021-05-24,Merck's Keytruda/Chemo Combo Therapy Wins EU Backing For Esophageal Cancer,MRK,-0.001894521144471084,-0.19569951620892034,-0.006025573456656108,0.0037804491058222034,-0.00025208112108132674,-0.0061348919494587095,0.020181310231884186,-0.019359887746223547,0.6401764266283356
2526,2021-05-24,NGM Biopharma to Release Mid-Stage NASH Data Monday: What to Expect?,MRK,-0.001894521144471084,-0.19569951620892034,-0.006025573456656108,0.0037804491058222034,-0.00025208112108132674,-0.0061348919494587095,0.020181310231884186,-0.019359887746223547,0.6401764266283356
2527,2021-05-24,NGM Stock Tumbles After Aldafermin Flunks In Mid-Stage NASH Study,MRK,-0.001894521144471084,-0.19569951620892034,-0.006025573456656108,0.0037804491058222034,-0.00025208112108132674,-0.0061348919494587095,0.020181310231884186,-0.019359887746223547,0.6401764266283356
2528,2021-05-27,EXCLUSIVE: eFFECTOR Therapeutics Announces SPAC Deal To Advance Cancer-Fighting Pipeline,MRK,-0.016962239002726087,0.8247285332692438,-0.003483775554838142,-0.019359887746223547,-0.001894521144471084,-0.006025573456656108,0.0037804491058222034,-0.00039512940600494595,-0.2096397603211153
2529,2021-06-02,BriaCell Stock Doubles After Reporting Overall Survival Benefit in Pretreated Breast Cancer Patients,MRK,0.009177770548355557,-0.2511856827627519,-0.009355692354418466,-0.00039512940600494595,-0.016962239002726087,-0.003483775554838142,-0.019359887746223547,0.020926522065433995,0.3502779648420902
2530,2021-06-03,Merck Completes Women's Health Organon Spinoff,MRK,0.020926522065433995,0.3502779648420902,0.009177770548355557,-0.009355692354418466,-0.00039512940600494595,-0.016962239002726087,-0.003483775554838142,0.002705927747364667,-0.20319386017628205
2531,2021-06-03,"The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout",MRK,0.020926522065433995,0.3502779648420902,0.009177770548355557,-0.009355692354418466,-0.00039512940600494595,-0.016962239002726087,-0.003483775554838142,0.002705927747364667,-0.20319386017628205
2532,2021-06-04,"AstraZeneca, Merck Lynparza Earns Win in Early Breast Cancer, Showing Potential in Post-Surgery Setting",MRK,0.002705927747364667,-0.20319386017628205,0.020926522065433995,0.009177770548355557,-0.009355692354418466,-0.00039512940600494595,-0.016962239002726087,-0.017676370485048,0.319432768982991
2533,2021-06-04,Merck's Keytruda Shows Clinical Benefit in Post-Surgery Kidney Cancer Setting,MRK,0.002705927747364667,-0.20319386017628205,0.020926522065433995,0.009177770548355557,-0.009355692354418466,-0.00039512940600494595,-0.016962239002726087,-0.017676370485048,0.319432768982991
2534,2021-06-04,"The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact",MRK,0.002705927747364667,-0.20319386017628205,0.020926522065433995,0.009177770548355557,-0.009355692354418466,-0.00039512940600494595,-0.016962239002726087,-0.017676370485048,0.319432768982991
2535,2021-06-04,Immutep Highlights Encouraging Data from Lead Oncology Candidate at ASCO 2021,MRK,0.002705927747364667,-0.20319386017628205,0.020926522065433995,0.009177770548355557,-0.009355692354418466,-0.00039512940600494595,-0.016962239002726087,-0.017676370485048,0.319432768982991
2536,2021-06-07,Iovance's Lifileucel Shows Meaningful Increase in Response Time with Primary Anti-PD-1 Resistance in Melanoma Trial,MRK,-0.017676370485048,0.319432768982991,0.002705927747364667,0.020926522065433995,0.009177770548355557,-0.009355692354418466,-0.00039512940600494595,-0.005494371469370596,-0.18677059019673226
2537,2021-06-07,Merck/Eisai's Keytruda-Lenvima Combo Results in Better Health-Related Quality of Life Measures Compared to Sunitinib,MRK,-0.017676370485048,0.319432768982991,0.002705927747364667,0.020926522065433995,0.009177770548355557,-0.009355692354418466,-0.00039512940600494595,-0.005494371469370596,-0.18677059019673226
2538,2021-06-07,"The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck",MRK,-0.017676370485048,0.319432768982991,0.002705927747364667,0.020926522065433995,0.009177770548355557,-0.009355692354418466,-0.00039512940600494595,-0.005494371469370596,-0.18677059019673226
2539,2021-06-08,"5 Biogen Analysts On FDA Approval Of Alzheimer's Drug Aduhelm, Broad Label, Pricing",MRK,-0.005494371469370596,-0.18677059019673226,-0.017676370485048,0.002705927747364667,0.020926522065433995,0.009177770548355557,-0.009355692354418466,0.02265178314863947,-0.1024330597391947
2540,2021-06-08,"Vaccinex Initiates Pepinemab Trials for Alzheimer's, Head & Neck Cancer",MRK,-0.005494371469370596,-0.18677059019673226,-0.017676370485048,0.002705927747364667,0.020926522065433995,0.009177770548355557,-0.009355692354418466,0.02265178314863947,-0.1024330597391947
2541,2021-06-09,Merck Inks Molnupiravir Supply Pact With US Government For COVID-19,MRK,0.02265178314863947,-0.1024330597391947,-0.005494371469370596,-0.017676370485048,0.002705927747364667,0.020926522065433995,0.009177770548355557,0.02836301561868071,0.40607894801243205
2542,2021-06-09,"The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US",MRK,0.02265178314863947,-0.1024330597391947,-0.005494371469370596,-0.017676370485048,0.002705927747364667,0.020926522065433995,0.009177770548355557,0.02836301561868071,0.40607894801243205
2543,2021-06-15,Fusion Pharma's Stock Moves Higher As Radiopharmaceutical Candidate Shows Early Promising Action In Solid Tumor Study,MRK,0.0033135008541456124,0.8090774606575357,-0.002248285670161332,0.0017074679469966103,0.02836301561868071,0.02265178314863947,-0.005494371469370596,0.012021182459731827,0.2390576425555313
2544,2021-06-17,Biden Administration Devotes Over $3.2B For Development Of Oral Antiviral Therapies For COVID-19: CNBC,MRK,0.008093013145137329,-0.19023263487873288,0.012021182459731827,0.0033135008541456124,-0.002248285670161332,0.0017074679469966103,0.02836301561868071,-0.008028042094933352,0.35963100356912014
2545,2021-06-23,14 Biotech Stocks To Watch Over The Next 6 Months,MRK,-0.00800639409097803,-0.12944558521560579,-0.007296395851099535,0.0018274851874602316,-0.008028042094933352,0.008093013145137329,0.012021182459731827,0.010320275951092972,-0.0982482624146932
2546,2021-06-24,"The Daily Biotech Pulse: Lily Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO",MRK,0.010320275951092972,-0.0982482624146932,-0.00800639409097803,-0.007296395851099535,0.0018274851874602316,-0.008028042094933352,0.008093013145137329,0.01100049192158159,4.845824759646125
2547,2021-06-29,Moderna's COVID-19 Vaccine Produced Neutralizing Titers Against All Variants Tested,MRK,0.004553483997394414,-0.12500852640913118,-0.0044040203515809395,0.01100049192158159,0.010320275951092972,-0.00800639409097803,-0.007296395851099535,0.007252926594269793,0.7945456435309097
2548,2021-06-29,Price Over Earnings Overview: Merck & Co,MRK,0.004553483997394414,-0.12500852640913118,-0.0044040203515809395,0.01100049192158159,0.010320275951092972,-0.00800639409097803,-0.007296395851099535,0.007252926594269793,0.7945456435309097
2549,2021-06-29,Merck's Keytruda-Chemo Combo Wins European Approval In Esophagus Cancer,MRK,0.004553483997394414,-0.12500852640913118,-0.0044040203515809395,0.01100049192158159,0.010320275951092972,-0.00800639409097803,-0.007296395851099535,0.007252926594269793,0.7945456435309097
2550,2021-06-30,Sellas Life Sciences Reports Encouraging Immune Response From GPS Combo Trial In Ovarian Cancer,MRK,0.007252926594269793,0.7945456435309097,0.004553483997394414,-0.0044040203515809395,0.01100049192158159,0.010320275951092972,-0.00800639409097803,0.002828957869494886,-0.3330389012373388
2551,2021-06-30,Alpine Immune Sciences Initiates Trial Collaboration With Merck,MRK,0.007252926594269793,0.7945456435309097,0.004553483997394414,-0.0044040203515809395,0.01100049192158159,0.010320275951092972,-0.00800639409097803,0.002828957869494886,-0.3330389012373388
2552,2021-07-01,Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates,MRK,0.002828957869494886,-0.3330389012373388,0.007252926594269793,0.004553483997394414,-0.0044040203515809395,0.01100049192158159,0.010320275951092972,0.007821608101085786,-0.16760746851932262
2553,2021-07-01,"NGM Biopharma, Merck Amend Development Pact To Focus On Retinal, Cardiovascular & Metabolic Targets",MRK,0.002828957869494886,-0.3330389012373388,0.007252926594269793,0.004553483997394414,-0.0044040203515809395,0.01100049192158159,0.010320275951092972,0.007821608101085786,-0.16760746851932262
2554,2021-07-02,"The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures",MRK,0.007821608101085786,-0.16760746851932262,0.002828957869494886,0.007252926594269793,0.004553483997394414,-0.0044040203515809395,0.01100049192158159,-0.006234104169783539,-0.12356546687532599
2555,2021-07-02,Merck To Withdraw Keytruda Accelerated Approval In Third-Line Gastric Cancer Setting,MRK,0.007821608101085786,-0.16760746851932262,0.002828957869494886,0.007252926594269793,0.004553483997394414,-0.0044040203515809395,0.01100049192158159,-0.006234104169783539,-0.12356546687532599
2556,2021-07-06,Immutep Shares Are Trading Higher On Green Signal To Start Efti Combo Trial In First-Line Head & Neck Cancer,MRK,-0.006234104169783539,-0.12356546687532599,0.007821608101085786,0.002828957869494886,0.007252926594269793,0.004553483997394414,-0.0044040203515809395,0.005760982256935554,0.23132207425042783
2557,2021-07-07,OncoSec Stock Jumps On Anti-Cancer Gene Therapy Trial Collaboration With Merck In Melanoma,MRK,0.005760982256935554,0.23132207425042783,-0.006234104169783539,0.007821608101085786,0.002828957869494886,0.007252926594269793,0.004553483997394414,-0.005600710916796037,0.015141810975094039
2558,2021-07-07,"The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend",MRK,0.005760982256935554,0.23132207425042783,-0.006234104169783539,0.007821608101085786,0.002828957869494886,0.007252926594269793,0.004553483997394414,-0.005600710916796037,0.015141810975094039
2559,2021-07-09,"Galectin Therapeutics Stock Surges After Robust Data From Belapectin/Keytruda Combo In Melanoma, Head & Neck Cancer",MRK,-0.0016641718390530968,-0.284974525022618,-0.005600710916796037,0.005760982256935554,-0.006234104169783539,0.007821608101085786,0.002828957869494886,-0.005641644217384556,0.8459835178556563
2560,2021-07-09,Why Galectin Is Soaring And Sigilon Is Sinking Today,MRK,-0.0016641718390530968,-0.284974525022618,-0.005600710916796037,0.005760982256935554,-0.006234104169783539,0.007821608101085786,0.002828957869494886,-0.005641644217384556,0.8459835178556563
2561,2021-07-09,Disney And Goldman Sachs Lead The DIA Higher Friday,MRK,-0.0016641718390530968,-0.284974525022618,-0.005600710916796037,0.005760982256935554,-0.006234104169783539,0.007821608101085786,0.002828957869494886,-0.005641644217384556,0.8459835178556563
2562,2021-07-12,"Merck, Ridgeback Highlight Interim Molnupiravir Data In Non-Hospitalized COVID-19 Patients",MRK,-0.005641644217384556,0.8459835178556563,-0.0016641718390530968,-0.005600710916796037,0.005760982256935554,-0.006234104169783539,0.007821608101085786,0.0007735805375135296,-0.4168598201643233
2563,2021-07-15,Merck Touts Encouraging Event-Free Survival For Keytruda Regime Over Placebo-Chemo Regime In Breast Cancer,MRK,0.0036073072188804733,-0.01701753406298856,0.00012893449222439735,0.0007735805375135296,-0.005641644217384556,-0.0016641718390530968,-0.005600710916796037,0.0015404171857806848,0.08477127803104545
2564,2021-07-19,"Merck's Pneumococcal Vaccine Lands FDA Nod, Just Few Weeks After Its Rival",MRK,-0.012432640528546868,0.28703097588437076,0.0015404171857806848,0.0036073072188804733,0.00012893449222439735,0.0007735805375135296,-0.005641644217384556,-0.011421361033119415,0.18279657396293203
2565,2021-07-20,"The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street",MRK,-0.011421361033119415,0.18279657396293203,-0.012432640528546868,0.0015404171857806848,0.0036073072188804733,0.00012893449222439735,0.0007735805375135296,0.0028884879515209683,-0.3610633320719667
2566,2021-07-20,Merck Discloses New Islatravir Data Supporting Safety Profile For PrEP Regime For HIV Infection,MRK,-0.011421361033119415,0.18279657396293203,-0.012432640528546868,0.0015404171857806848,0.0036073072188804733,0.00012893449222439735,0.0007735805375135296,0.0028884879515209683,-0.3610633320719667
2567,2021-07-21,"Merck - Bayer's Heart Failure Treatment, Verquvo Scores European Nod",MRK,0.0028884879515209683,-0.3610633320719667,-0.011421361033119415,-0.012432640528546868,0.0015404171857806848,0.0036073072188804733,0.00012893449222439735,0.0018326423480150567,0.17223695368338876
2568,2021-07-22,Adagene To Test Its Anti-CTLA-4 Monoclonal Antibodies In Combination With Keytruda In Solid Tumors,MRK,0.0018326423480150567,0.17223695368338876,0.0028884879515209683,-0.011421361033119415,-0.012432640528546868,0.0015404171857806848,0.0036073072188804733,0.013197502524322946,-0.2466557200105639
2569,2021-07-22,"The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO",MRK,0.0018326423480150567,0.17223695368338876,0.0028884879515209683,-0.011421361033119415,-0.012432640528546868,0.0015404171857806848,0.0036073072188804733,0.013197502524322946,-0.2466557200105639
2570,2021-07-27,Price Over Earnings Overview: Merck & Co,MRK,0.007897556985427379,0.6041642020584408,-0.003869234699165114,0.013197502524322946,0.0018326423480150567,0.0028884879515209683,-0.011421361033119415,0.00616573058040748,0.356674041297935
2571,2021-07-27,"Mega-Cap Mania: Apple, Alphabet, Microsoft Earnings All Ahead After Close Today",MRK,0.007897556985427379,0.6041642020584408,-0.003869234699165114,0.013197502524322946,0.0018326423480150567,0.0028884879515209683,-0.011421361033119415,0.00616573058040748,0.356674041297935
2572,2021-07-27,"The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts",MRK,0.007897556985427379,0.6041642020584408,-0.003869234699165114,0.013197502524322946,0.0018326423480150567,0.0028884879515209683,-0.011421361033119415,0.00616573058040748,0.356674041297935
2573,2021-07-27,Merck's Keytruda Combo Trial Meets Overall Survival Endpoint In PD-L1 Expressing Breast Cancer Patients,MRK,0.007897556985427379,0.6041642020584408,-0.003869234699165114,0.013197502524322946,0.0018326423480150567,0.0028884879515209683,-0.011421361033119415,0.00616573058040748,0.356674041297935
2574,2021-07-27,FDA Approves Merck's Keytruda/Chemo Combo For Early Breast Cancer,MRK,0.007897556985427379,0.6041642020584408,-0.003869234699165114,0.013197502524322946,0.0018326423480150567,0.0028884879515209683,-0.011421361033119415,0.00616573058040748,0.356674041297935
2575,2021-07-28,The IPO Recap – Party Is Everything But Over,MRK,0.00616573058040748,0.356674041297935,0.007897556985427379,-0.003869234699165114,0.013197502524322946,0.0018326423480150567,0.0028884879515209683,-0.01787305076567125,0.04938439377055426
2576,2021-07-29,"Earnings Scheduled For July 29, 2021",MRK,-0.01787305076567125,0.04938439377055426,0.00616573058040748,0.007897556985427379,-0.003869234699165114,0.013197502524322946,0.0018326423480150567,-0.0007798150931174197,0.12272295605628947
2577,2021-07-29,"The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs",MRK,-0.01787305076567125,0.04938439377055426,0.00616573058040748,0.007897556985427379,-0.003869234699165114,0.013197502524322946,0.0018326423480150567,-0.0007798150931174197,0.12272295605628947
2578,2021-07-29,"Merck Stock Falls As Q2 Earnings Lag Wall Street Estimates, Trimmed FY21 Guidance Below Consensus",MRK,-0.01787305076567125,0.04938439377055426,0.00616573058040748,0.007897556985427379,-0.003869234699165114,0.013197502524322946,0.0018326423480150567,-0.0007798150931174197,0.12272295605628947
2579,2021-07-29,Merck & Co: Q2 Earnings Insights,MRK,-0.01787305076567125,0.04938439377055426,0.00616573058040748,0.007897556985427379,-0.003869234699165114,0.013197502524322946,0.0018326423480150567,-0.0007798150931174197,0.12272295605628947
2580,2021-07-29,"7 Stocks To Watch For July 29, 2021",MRK,-0.01787305076567125,0.04938439377055426,0.00616573058040748,0.007897556985427379,-0.003869234699165114,0.013197502524322946,0.0018326423480150567,-0.0007798150931174197,0.12272295605628947
2581,2021-07-29,"A Peek Into The Markets: US Stock Futures Mostly Higher Ahead Of GDP, Jobless Claims Data",MRK,-0.01787305076567125,0.04938439377055426,0.00616573058040748,0.007897556985427379,-0.003869234699165114,0.013197502524322946,0.0018326423480150567,-0.0007798150931174197,0.12272295605628947
2582,2021-08-02,GlaxoSmithKline Files US Application For Approval Of Its MMR Vaccine,MRK,-0.00897634322335783,-0.30151870506363176,-0.0007798150931174197,-0.01787305076567125,0.00616573058040748,0.007897556985427379,-0.003869234699165114,0.0030192512651245895,0.09566902261267818
2583,2021-08-02,Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates,MRK,-0.00897634322335783,-0.30151870506363176,-0.0007798150931174197,-0.01787305076567125,0.00616573058040748,0.007897556985427379,-0.003869234699165114,0.0030192512651245895,0.09566902261267818
2584,2021-08-05,Exicure Shares Interim Cavrotolimod Data From Early-Stage Trial In Solid Tumor Patients,MRK,0.0014571252816373281,-0.2012043989938862,-0.012171187882823564,0.0030192512651245895,-0.00897634322335783,-0.0007798150931174197,-0.01787305076567125,-0.001984311629666724,-0.0035510710673899437
2585,2021-08-05,"The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO",MRK,0.0014571252816373281,-0.2012043989938862,-0.012171187882823564,0.0030192512651245895,-0.00897634322335783,-0.0007798150931174197,-0.01787305076567125,-0.001984311629666724,-0.0035510710673899437
2586,2021-08-09,Moderna Is Now Valued Higher Than 130-Year Old Vaccine Giant Merck,MRK,-0.001590541326828565,-0.09269147819668544,-0.001984311629666724,0.0014571252816373281,-0.012171187882823564,0.0030192512651245895,-0.00897634322335783,-0.0017258225080281075,0.4291470700394051
2587,2021-08-10,"The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts",MRK,-0.0017258225080281075,0.4291470700394051,-0.001590541326828565,-0.001984311629666724,0.0014571252816373281,-0.012171187882823564,0.0030192512651245895,0.00026584623475267577,-0.38164741041171923
2588,2021-08-12,"The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma",MRK,0.011035646357618223,-0.12587382411323034,0.00026584623475267577,-0.0017258225080281075,-0.001590541326828565,-0.001984311629666724,0.0014571252816373281,0.008942727964843078,0.12066610718928428
2589,2021-08-12,Apple And Salesforce Lead The DIA In A Mixed Day Of Trading,MRK,0.011035646357618223,-0.12587382411323034,0.00026584623475267577,-0.0017258225080281075,-0.001590541326828565,-0.001984311629666724,0.0014571252816373281,0.008942727964843078,0.12066610718928428
2590,2021-08-16,Merck's Belzutifan Wins FDA Approval As First Drug For Rare VHL Tumors,MRK,0.015771738921037892,0.375602020439328,0.008942727964843078,0.011035646357618223,0.00026584623475267577,-0.0017258225080281075,-0.001590541326828565,0.01154878448411134,0.1006788779300627
2591,2021-08-17,"Apple, GM, Kroger, AbbVie, Merck, Bristol Myers Squibb, Biogen — How Warren Buffett's Berkshire Adjusted Its Portfolio In Q2",MRK,0.01154878448411134,0.1006788779300627,0.015771738921037892,0.008942727964843078,0.011035646357618223,0.00026584623475267577,-0.0017258225080281075,-0.013193054928032022,-0.27663020287831186
2592,2021-08-17,"Q2 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios",MRK,0.01154878448411134,0.1006788779300627,0.015771738921037892,0.008942727964843078,0.011035646357618223,0.00026584623475267577,-0.0017258225080281075,-0.013193054928032022,-0.27663020287831186
2593,2021-08-18,Werewolf Therapeutics Inks Solid Tumor Trial Collaboration With Merck,MRK,-0.013193054928032022,-0.27663020287831186,0.01154878448411134,0.015771738921037892,0.008942727964843078,0.011035646357618223,0.00026584623475267577,0.008613015735970064,0.18853480982960402
2594,2021-08-19,Adagene Inks Third Cancer Trial Collaboration With Merck,MRK,0.008613015735970064,0.18853480982960402,-0.013193054928032022,0.01154878448411134,0.015771738921037892,0.008942727964843078,0.011035646357618223,0.002803975840104167,-0.29115437543709255
2595,2021-08-19,"The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck",MRK,0.008613015735970064,0.18853480982960402,-0.013193054928032022,0.01154878448411134,0.015771738921037892,0.008942727964843078,0.011035646357618223,0.002803975840104167,-0.29115437543709255
2596,2021-08-24,Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial,MRK,-0.008420308566729928,0.3396944213412192,-0.0038130707429477884,0.002803975840104167,0.008613015735970064,-0.013193054928032022,0.01154878448411134,-0.008363475917246288,-0.18996102597118913
2597,2021-08-25,"The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug",MRK,-0.008363475917246288,-0.18996102597118913,-0.008420308566729928,-0.0038130707429477884,0.002803975840104167,0.008613015735970064,-0.013193054928032022,-0.006487702759049863,-0.0575378239518578
2598,2021-08-26,"The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO",MRK,-0.006487702759049863,-0.0575378239518578,-0.008363475917246288,-0.008420308566729928,-0.0038130707429477884,0.002803975840104167,0.008613015735970064,-0.0035258780441523863,-0.09493404011806517
2599,2021-09-01,Pfizer Commences Dosing In Pivotal Oral COVID-19 Drug Trial,MRK,-0.001441971981640644,-0.16094798849262526,-0.002745116338583653,0.0026211635857789073,-0.0035258780441523863,-0.006487702759049863,-0.008363475917246288,0.012339290521009794,-0.2860283873214907
2600,2021-09-01,Merck To Test Oral Antiviral Candidate For Post-Exposure Prophylaxis Of COVID-19 Infection,MRK,-0.001441971981640644,-0.16094798849262526,-0.002745116338583653,0.0026211635857789073,-0.0035258780441523863,-0.006487702759049863,-0.008363475917246288,0.012339290521009794,-0.2860283873214907
2601,2021-09-01,"The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering",MRK,-0.001441971981640644,-0.16094798849262526,-0.002745116338583653,0.0026211635857789073,-0.0035258780441523863,-0.006487702759049863,-0.008363475917246288,0.012339290521009794,-0.2860283873214907
2602,2021-09-01,FDA Extends Full Approval For Merck's Keytruda In 1st-Line Bladder Cancer,MRK,-0.001441971981640644,-0.16094798849262526,-0.002745116338583653,0.0026211635857789073,-0.0035258780441523863,-0.006487702759049863,-0.008363475917246288,0.012339290521009794,-0.2860283873214907
2603,2021-09-07,"Illumina, Merck Join Hands For Homologous Recombination Deficiency CDx, Research Assay",MRK,-0.01656729938782342,1.1085854776916348,0.0018151903143213133,0.012339290521009794,-0.001441971981640644,-0.002745116338583653,0.0026211635857789073,-0.008160010918706218,-0.41035087091813016
2604,2021-09-08,Downgrades On Economy And Pandemic Pharmaceuticals,MRK,-0.008160010918706218,-0.41035087091813016,-0.01656729938782342,0.0018151903143213133,0.012339290521009794,-0.001441971981640644,-0.002745116338583653,-0.020435345159721785,0.7746815479801044
2605,2021-09-09,Coca-Cola And Merck Lead The Dow Jones Lower,MRK,-0.020435345159721785,0.7746815479801044,-0.008160010918706218,-0.01656729938782342,0.0018151903143213133,0.012339290521009794,-0.001441971981640644,-0.0050121112528527245,-0.2422771674858326
2606,2021-09-09,Moderna Shares Gain Amid R&D Day Presentations: What You Need To Know,MRK,-0.020435345159721785,0.7746815479801044,-0.008160010918706218,-0.01656729938782342,0.0018151903143213133,0.012339290521009794,-0.001441971981640644,-0.0050121112528527245,-0.2422771674858326
2607,2021-09-10,"Codexis, Merck Extend Supply Pact For Enzyme Used To Manufacture Sitagliptin",MRK,-0.0050121112528527245,-0.2422771674858326,-0.020435345159721785,-0.008160010918706218,-0.01656729938782342,0.0018151903143213133,0.012339290521009794,-0.0036759790148890303,0.014497722044296113
2608,2021-09-13,Why Are Silverback Therapeutics Shares Falling On Monday?,MRK,-0.0036759790148890303,0.014497722044296113,-0.0050121112528527245,-0.020435345159721785,-0.008160010918706218,-0.01656729938782342,0.0018151903143213133,-0.005790740708245035,0.35193682637925505
2609,2021-09-15,"The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs",MRK,0.009707336821354273,-0.17410608572105135,-0.005790740708245035,-0.0036759790148890303,-0.0050121112528527245,-0.020435345159721785,-0.008160010918706218,-0.011536944387398607,0.18023399358070713
2610,2021-09-15,"Hookipa Pharma, Merck Team Up For Phase 2 Head & Neck Cancer Trial",MRK,0.009707336821354273,-0.17410608572105135,-0.005790740708245035,-0.0036759790148890303,-0.0050121112528527245,-0.020435345159721785,-0.008160010918706218,-0.011536944387398607,0.18023399358070713
2611,2021-09-16,Athenex Shares Are Trading Higher On Positive Oral Paclitaxel Data From Solid Tumor Trial,MRK,-0.011536944387398607,0.18023399358070713,0.009707336821354273,-0.005790740708245035,-0.0036759790148890303,-0.0050121112528527245,-0.020435345159721785,-0.004029337599498861,1.9291377902543374
2612,2021-09-16,Silverback Therapeutics Presents Initial Safety Data From Solid Tumor Combo Therapy Trial,MRK,-0.011536944387398607,0.18023399358070713,0.009707336821354273,-0.005790740708245035,-0.0036759790148890303,-0.0050121112528527245,-0.020435345159721785,-0.004029337599498861,1.9291377902543374
2613,2021-09-16,"The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study",MRK,-0.011536944387398607,0.18023399358070713,0.009707336821354273,-0.005790740708245035,-0.0036759790148890303,-0.0050121112528527245,-0.020435345159721785,-0.004029337599498861,1.9291377902543374
2614,2021-09-20,Apple And Disney Lead The Dow Jones Lower,MRK,0.003487727514140948,-0.6316366635488613,-0.004029337599498861,-0.011536944387398607,0.009707336821354273,-0.005790740708245035,-0.0036759790148890303,0.0005559722503523101,-0.2497592154802557
2615,2021-09-20,"Seagen, Genmab Present Tisotumab Vedotin Combo Data In Cervical Cancer",MRK,0.003487727514140948,-0.6316366635488613,-0.004029337599498861,-0.011536944387398607,0.009707336821354273,-0.005790740708245035,-0.0036759790148890303,0.0005559722503523101,-0.2497592154802557
2616,2021-09-20,Merck Backs Up Keytruda Approval In TNBC With Encouraging Overall Survival Data,MRK,0.003487727514140948,-0.6316366635488613,-0.004029337599498861,-0.011536944387398607,0.009707336821354273,-0.005790740708245035,-0.0036759790148890303,0.0005559722503523101,-0.2497592154802557
2617,2021-09-24,Why AstraZeneca Stock Is Trading Higher Today,MRK,0.007666026844900697,0.14837476099426383,0.014019975106118965,0.0009727444696150389,0.0005559722503523101,0.003487727514140948,-0.004029337599498861,-0.0033963905154220653,-0.413470882858638
2618,2021-09-24,AstraZeneca - Merck's Lynparza Delays Disease Progression In Prostate Cancer Patients,MRK,0.007666026844900697,0.14837476099426383,0.014019975106118965,0.0009727444696150389,0.0005559722503523101,0.003487727514140948,-0.004029337599498861,-0.0033963905154220653,-0.413470882858638
2619,2021-09-27,Acceleron In Advanced $11B Buyout Talks: Bloomberg,MRK,-0.0033963905154220653,-0.413470882858638,0.007666026844900697,0.014019975106118965,0.0009727444696150389,0.0005559722503523101,0.003487727514140948,-0.0005451347811921137,0.37142261256459563
2620,2021-09-27,Merck's Keytruda Tops Placebo On Overall Survival Endpoint In Liver Cancer Patients,MRK,-0.0033963905154220653,-0.413470882858638,0.007666026844900697,0.014019975106118965,0.0009727444696150389,0.0005559722503523101,0.003487727514140948,-0.0005451347811921137,0.37142261256459563
2621,2021-09-28,Why Are I-Mab Shares Trading Higher On Tuesday?,MRK,-0.0005451347811921137,0.37142261256459563,-0.0033963905154220653,0.007666026844900697,0.014019975106118965,0.0009727444696150389,0.0005559722503523101,0.024140829786095885,0.35638971967354394
2622,2021-09-28,"A Peek Into The Markets: US Stock Futures Down Ahead Of Economic Data, Fed Speakers",MRK,-0.0005451347811921137,0.37142261256459563,-0.0033963905154220653,0.007666026844900697,0.014019975106118965,0.0009727444696150389,0.0005559722503523101,0.024140829786095885,0.35638971967354394
2623,2021-09-28,Merck Reportedly Lead Bidder In $11B Acceleron Buyout: WSJ,MRK,-0.0005451347811921137,0.37142261256459563,-0.0033963905154220653,0.007666026844900697,0.014019975106118965,0.0009727444696150389,0.0005559722503523101,0.024140829786095885,0.35638971967354394
2624,2021-09-28,Pfizer Begins Late-Stage Study To Test Effectiveness Of Oral Drug Against COVID-19 In Those Exposed To The Virus,MRK,-0.0005451347811921137,0.37142261256459563,-0.0033963905154220653,0.007666026844900697,0.014019975106118965,0.0009727444696150389,0.0005559722503523101,0.024140829786095885,0.35638971967354394
2625,2021-09-28,"5 Stocks To Watch For September 28, 2021",MRK,-0.0005451347811921137,0.37142261256459563,-0.0033963905154220653,0.007666026844900697,0.014019975106118965,0.0009727444696150389,0.0005559722503523101,0.024140829786095885,0.35638971967354394
2626,2021-09-28,"The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive",MRK,-0.0005451347811921137,0.37142261256459563,-0.0033963905154220653,0.007666026844900697,0.014019975106118965,0.0009727444696150389,0.0005559722503523101,0.024140829786095885,0.35638971967354394
2627,2021-09-29,"Merck's COVID-19 Antiviral Pill Effective Against Variants, Lab Studies Show",MRK,0.024140829786095885,0.35638971967354394,-0.0005451347811921137,-0.0033963905154220653,0.007666026844900697,0.014019975106118965,0.0009727444696150389,0.00026639425304764153,0.012090068205176108
2628,2021-09-30,Merck Seals Acceleron Pharma Deal For $180/Share: Highlights,MRK,0.00026639425304764153,0.012090068205176108,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,0.007666026844900697,0.014019975106118965,0.08374370639342188,5.308069618305577
2629,2021-09-30,"A Peek Into The Markets: US Stock Futures Climb Ahead Of GDP, Jobless Claims Data",MRK,0.00026639425304764153,0.012090068205176108,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,0.007666026844900697,0.014019975106118965,0.08374370639342188,5.308069618305577
2630,2021-09-30,"GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact",MRK,0.00026639425304764153,0.012090068205176108,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,0.007666026844900697,0.014019975106118965,0.08374370639342188,5.308069618305577
2631,2021-09-30,"The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug",MRK,0.00026639425304764153,0.012090068205176108,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,0.007666026844900697,0.014019975106118965,0.08374370639342188,5.308069618305577
2632,2021-09-30,"Merck, Sutro Biopharma Extends Cytokine Derivative Research Program",MRK,0.00026639425304764153,0.012090068205176108,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,0.007666026844900697,0.014019975106118965,0.08374370639342188,5.308069618305577
2633,2021-10-01,35 Stocks Moving In Friday's Mid-Day Session,MRK,0.08374370639342188,5.308069618305577,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,0.007666026844900697,0.020884486937767566,-0.4775150174687528
2634,2021-10-01,"Why Moderna, Novavax And Other COVID-19 Vaccine Stocks Are Plummeting",MRK,0.08374370639342188,5.308069618305577,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,0.007666026844900697,0.020884486937767566,-0.4775150174687528
2635,2021-10-01,Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates,MRK,0.08374370639342188,5.308069618305577,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,0.007666026844900697,0.020884486937767566,-0.4775150174687528
2636,2021-10-01,Merck & Co: Debt Overview,MRK,0.08374370639342188,5.308069618305577,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,0.007666026844900697,0.020884486937767566,-0.4775150174687528
2637,2021-10-01,Activist Investor Thinks Merck Undervalues Acceleron Buy,MRK,0.08374370639342188,5.308069618305577,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,0.007666026844900697,0.020884486937767566,-0.4775150174687528
2638,2021-10-01,Merck Announcement Helps Prompt Positive Pre-Market Price Moves,MRK,0.08374370639342188,5.308069618305577,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,0.007666026844900697,0.020884486937767566,-0.4775150174687528
2639,2021-10-01,Why Merck Shares Are Surging Higher Today,MRK,0.08374370639342188,5.308069618305577,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,0.007666026844900697,0.020884486937767566,-0.4775150174687528
2640,2021-10-01,"Merck COVID-19 Oral Antiviral Cuts Risk of Hospitalization, Death By 50%",MRK,0.08374370639342188,5.308069618305577,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,0.007666026844900697,0.020884486937767566,-0.4775150174687528
2641,2021-10-01,"The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO",MRK,0.08374370639342188,5.308069618305577,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,0.007666026844900697,0.020884486937767566,-0.4775150174687528
2642,2021-10-04,Tesla and Merck Give Investors Some Hope,MRK,0.020884486937767566,-0.4775150174687528,0.08374370639342188,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,-0.018050563771877415,-0.4588979577355644
2643,2021-10-04,Why Moderna Shares Continue To Fall Today,MRK,0.020884486937767566,-0.4775150174687528,0.08374370639342188,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,-0.018050563771877415,-0.4588979577355644
2644,2021-10-04,Why BioNTech Shares Are Trading Lower Again Today,MRK,0.020884486937767566,-0.4775150174687528,0.08374370639342188,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,-0.018050563771877415,-0.4588979577355644
2645,2021-10-04,Why Merck Shares Are Rising,MRK,0.020884486937767566,-0.4775150174687528,0.08374370639342188,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,-0.018050563771877415,-0.4588979577355644
2646,2021-10-04,A Glimpse of This Week's Earnings Calendar,MRK,0.020884486937767566,-0.4775150174687528,0.08374370639342188,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,-0.018050563771877415,-0.4588979577355644
2647,2021-10-04,Why This Investor Keeps Buying Moderna Shares As The Stock Falls,MRK,0.020884486937767566,-0.4775150174687528,0.08374370639342188,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,-0.018050563771877415,-0.4588979577355644
2648,2021-10-04,54 Biggest Movers From Friday,MRK,0.020884486937767566,-0.4775150174687528,0.08374370639342188,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.0033963905154220653,-0.018050563771877415,-0.4588979577355644
2649,2021-10-05,Rising Oil Prices and Yields Makes Market Navigation More Complex,MRK,-0.018050563771877415,-0.4588979577355644,0.020884486937767566,0.08374370639342188,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.011519590916795885,-0.39236242916991626
2650,2021-10-05,"The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout",MRK,-0.018050563771877415,-0.4588979577355644,0.020884486937767566,0.08374370639342188,0.00026639425304764153,0.024140829786095885,-0.0005451347811921137,-0.011519590916795885,-0.39236242916991626
2651,2021-10-06,"Merck Keeps M&A Mode On With Mirati, Biogen, mRNA Companies On Radar: FT",MRK,-0.011519590916795885,-0.39236242916991626,-0.018050563771877415,0.020884486937767566,0.08374370639342188,0.00026639425304764153,0.024140829786095885,0.015869016382379808,-0.19408791458427987
2652,2021-10-06,Merck Inks Supply Pact With Singapore For Its Oral COVID-19 Antiviral: Reuters,MRK,-0.011519590916795885,-0.39236242916991626,-0.018050563771877415,0.020884486937767566,0.08374370639342188,0.00026639425304764153,0.024140829786095885,0.015869016382379808,-0.19408791458427987
2653,2021-10-08,A Look Into Merck & Co's Debt,MRK,-0.01598726216071822,-0.1458299566611465,0.015869016382379808,-0.011519590916795885,-0.018050563771877415,0.020884486937767566,0.08374370639342188,-0.008681682751357833,-0.06941614209931446
2654,2021-10-08,Indian Study Shows Merck's COVID-19 Antiviral Candidate Less Effective Against Moderate Infection: Reuters,MRK,-0.01598726216071822,-0.1458299566611465,0.015869016382379808,-0.011519590916795885,-0.018050563771877415,0.020884486937767566,0.08374370639342188,-0.008681682751357833,-0.06941614209931446
2655,2021-10-11,"Merck, Ridgeback File For Emergency Use Nod For COVID-19 Antiviral",MRK,-0.008681682751357833,-0.06941614209931446,-0.01598726216071822,0.015869016382379808,-0.011519590916795885,-0.018050563771877415,0.020884486937767566,-0.004253675486070696,-0.029672774985150308
2656,2021-10-12,Winners and Losers of Rising Energy Prices,MRK,-0.004253675486070696,-0.029672774985150308,-0.008681682751357833,-0.01598726216071822,0.015869016382379808,-0.011519590916795885,-0.018050563771877415,-0.008041329951794296,-0.13544084056646866
2657,2021-10-15,Health Care Sector Appears to Be a Drag on Positive UnitedHealth Earnings,MRK,0.0,-0.11918893201623781,-0.007852944504398884,-0.008041329951794296,-0.004253675486070696,-0.008681682751357833,-0.01598726216071822,-0.015064383392818681,0.01622003917057846
2658,2021-10-19,"WHO-Led Program Intends To Purchase Oral COVID-19 Antivirals For $10, Including Merck's: Reuters",MRK,0.030330402490759578,0.19131964360827491,-0.015064383392818681,0.0,-0.007852944504398884,-0.008041329951794296,-0.004253675486070696,0.019876816043963075,-0.2639515699327859
2659,2021-10-20,"The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review",MRK,0.019876816043963075,-0.2639515699327859,0.030330402490759578,-0.015064383392818681,0.0,-0.007852944504398884,-0.008041329951794296,0.0012334243788520993,-0.13709825127556585
2660,2021-10-20,Merck Recalls One Lot Of Cubicin Antibiotic Over Glass Particles Presence In Vials,MRK,0.019876816043963075,-0.2639515699327859,0.030330402490759578,-0.015064383392818681,0.0,-0.007852944504398884,-0.008041329951794296,0.0012334243788520993,-0.13709825127556585
2661,2021-10-21,PDS Biotech Pauses Recruitment In PDS0101 Combo Cancer Trial,MRK,0.0012334243788520993,-0.13709825127556585,0.019876816043963075,0.030330402490759578,-0.015064383392818681,0.0,-0.007852944504398884,-0.00024653876827063215,-0.2375272903695318
2662,2021-10-21,Bristol Myers Pledges To Offload Acceleron Shares: Bloomberg,MRK,0.0012334243788520993,-0.13709825127556585,0.019876816043963075,0.030330402490759578,-0.015064383392818681,0.0,-0.007852944504398884,-0.00024653876827063215,-0.2375272903695318
2663,2021-10-21,"CDC's Advisory Committee Backs Pneumococcal Vaccine From Pfizer, Merck",MRK,0.0012334243788520993,-0.13709825127556585,0.019876816043963075,0.030330402490759578,-0.015064383392818681,0.0,-0.007852944504398884,-0.00024653876827063215,-0.2375272903695318
2664,2021-10-21,"The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO",MRK,0.0012334243788520993,-0.13709825127556585,0.019876816043963075,0.030330402490759578,-0.015064383392818681,0.0,-0.007852944504398884,-0.00024653876827063215,-0.2375272903695318
2665,2021-10-22,"The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs",MRK,-0.00024653876827063215,-0.2375272903695318,0.0012334243788520993,0.019876816043963075,0.030330402490759578,-0.015064383392818681,0.0,0.006284935143821224,0.24156901214274362
2666,2021-10-22,"Salarius Pharmaceuticals (SLRX) is Developing a Novel LSD1 Inhibitor, Positioning it as a Significant Mover in Epigenetics-Based Cancer Therapies",MRK,-0.00024653876827063215,-0.2375272903695318,0.0012334243788520993,0.019876816043963075,0.030330402490759578,-0.015064383392818681,0.0,0.006284935143821224,0.24156901214274362
2667,2021-10-22,"A-List Executive Team, Big-Name Backers Fail to Lift Abbisko IPO",MRK,-0.00024653876827063215,-0.2375272903695318,0.0012334243788520993,0.019876816043963075,0.030330402490759578,-0.015064383392818681,0.0,0.006284935143821224,0.24156901214274362
2668,2021-10-26,"The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children",MRK,0.007224938732703912,-0.0014307220875729998,0.006284935143821224,-0.00024653876827063215,0.0012334243788520993,0.019876816043963075,0.030330402490759578,-0.008632241444666122,-0.09485164394546908
2669,2021-10-27,Merck Inks Licensing Pact To Broaden Generic Manufacturing Of COVID-19 Antiviral,MRK,-0.008632241444666122,-0.09485164394546908,0.007224938732703912,0.006284935143821224,-0.00024653876827063215,0.0012334243788520993,0.019876816043963075,0.06144238675532687,2.4085453729298085
2670,2021-10-28,"A Peek Into The Markets: US Stock Futures Edge Higher; Apple, Amazon Earnings In Focus",MRK,0.06144238675532687,2.4085453729298085,-0.008632241444666122,0.007224938732703912,0.006284935143821224,-0.00024653876827063215,0.0012334243788520993,0.017330949920397742,-0.352666983195112
2671,2021-10-28,Recap: Merck & Co Q3 Earnings,MRK,0.06144238675532687,2.4085453729298085,-0.008632241444666122,0.007224938732703912,0.006284935143821224,-0.00024653876827063215,0.0012334243788520993,0.017330949920397742,-0.352666983195112
2672,2021-10-28,"Merck's Q3 Earnings Beat Street View, Revises FY21 Outlook Below Consensus",MRK,0.06144238675532687,2.4085453729298085,-0.008632241444666122,0.007224938732703912,0.006284935143821224,-0.00024653876827063215,0.0012334243788520993,0.017330949920397742,-0.352666983195112
2673,2021-10-28,"The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug",MRK,0.06144238675532687,2.4085453729298085,-0.008632241444666122,0.007224938732703912,0.006284935143821224,-0.00024653876827063215,0.0012334243788520993,0.017330949920397742,-0.352666983195112
2674,2021-10-28,"7 Stocks To Watch For October 28, 2021",MRK,0.06144238675532687,2.4085453729298085,-0.008632241444666122,0.007224938732703912,0.006284935143821224,-0.00024653876827063215,0.0012334243788520993,0.017330949920397742,-0.352666983195112
2675,2021-10-28,Cheap Antidepressant Fluvoxamine Shows Potential In Reducing COVID-19 Hospitalization,MRK,0.06144238675532687,2.4085453729298085,-0.008632241444666122,0.007224938732703912,0.006284935143821224,-0.00024653876827063215,0.0012334243788520993,0.017330949920397742,-0.352666983195112
2676,2021-10-28,Market Breadth Could Be a Liability as Stocks Struggle to Maintain Highs,MRK,0.06144238675532687,2.4085453729298085,-0.008632241444666122,0.007224938732703912,0.006284935143821224,-0.00024653876827063215,0.0012334243788520993,0.017330949920397742,-0.352666983195112
2677,2021-10-28,Why Merck Shares Are Making New 52-Week Highs Today,MRK,0.06144238675532687,2.4085453729298085,-0.008632241444666122,0.007224938732703912,0.006284935143821224,-0.00024653876827063215,0.0012334243788520993,0.017330949920397742,-0.352666983195112
2678,2021-10-28,Merck & Company Inc. Looks to Continue to Trade Above its Annual-High Share Price Today,MRK,0.06144238675532687,2.4085453729298085,-0.008632241444666122,0.007224938732703912,0.006284935143821224,-0.00024653876827063215,0.0012334243788520993,0.017330949920397742,-0.352666983195112
2679,2021-10-28,"Earnings Scheduled For October 28, 2021",MRK,0.06144238675532687,2.4085453729298085,-0.008632241444666122,0.007224938732703912,0.006284935143821224,-0.00024653876827063215,0.0012334243788520993,0.017330949920397742,-0.352666983195112
2680,2021-10-29,"The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs",MRK,0.017330949920397742,-0.352666983195112,0.06144238675532687,-0.008632241444666122,0.007224938732703912,0.006284935143821224,-0.00024653876827063215,-0.0023849314225397045,-0.41409420406240294
2681,2021-11-01,Merck Dives Further Into Cytokine Research With Synthekine Deal,MRK,-0.0023849314225397045,-0.41409420406240294,0.017330949920397742,0.06144238675532687,-0.008632241444666122,0.007224938732703912,0.006284935143821224,0.013433344909534739,0.3406006999332962
2682,2021-11-01,ANI Pharma's Purified Cortrophin Gel Scores FDA Approval; Q3 Earnings Beat Estimates,MRK,-0.0023849314225397045,-0.41409420406240294,0.017330949920397742,0.06144238675532687,-0.008632241444666122,0.007224938732703912,0.006284935143821224,0.013433344909534739,0.3406006999332962
2683,2021-11-01,Merck Pushes Acceleron Buyout By Refiling For Antitrust Review,MRK,-0.0023849314225397045,-0.41409420406240294,0.017330949920397742,0.06144238675532687,-0.008632241444666122,0.007224938732703912,0.006284935143821224,0.013433344909534739,0.3406006999332962
2684,2021-11-01,New Data Reaffirms Merck's Keytruda In Extending Survival In Melanoma Patients,MRK,-0.0023849314225397045,-0.41409420406240294,0.017330949920397742,0.06144238675532687,-0.008632241444666122,0.007224938732703912,0.006284935143821224,0.013433344909534739,0.3406006999332962
2685,2021-11-03,"This Company Wants to Revolutionize What Matters for Hospitals, Big Pharma and Health Insurers",MRK,-0.0038191448381433846,-0.2581553226004335,0.013433344909534739,-0.0023849314225397045,0.017330949920397742,0.06144238675532687,-0.008632241444666122,0.020974214889729392,0.7934563897132463
2686,2021-11-03,Evpandpresident And Merck Animal Heallth Of Merck & Co Trades $11M In Company Stock,MRK,-0.0038191448381433846,-0.2581553226004335,0.013433344909534739,-0.0023849314225397045,0.017330949920397742,0.06144238675532687,-0.008632241444666122,0.020974214889729392,0.7934563897132463
2687,2021-11-04,Britain Approves First Oral COVID-19 Antiviral From Merck,MRK,0.020974214889729392,0.7934563897132463,-0.0038191448381433846,0.013433344909534739,-0.0023849314225397045,0.017330949920397742,0.06144238675532687,-0.09863046204356696,0.9274736421479728
2688,2021-11-04,"The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO",MRK,0.020974214889729392,0.7934563897132463,-0.0038191448381433846,0.013433344909534739,-0.0023849314225397045,0.017330949920397742,0.06144238675532687,-0.09863046204356696,0.9274736421479728
2689,2021-11-05,Will Pfizer Outgun Merck With Oral COVID-19 Pill?,MRK,-0.09863046204356696,0.9274736421479728,0.020974214889729392,-0.0038191448381433846,0.013433344909534739,-0.0023849314225397045,0.017330949920397742,0.013111157799007067,-0.5041529453352789
2690,2021-11-05,Pfizer COVID-19 Pill Adds Momentum to the Reopening Trade,MRK,-0.09863046204356696,0.9274736421479728,0.020974214889729392,-0.0038191448381433846,0.013433344909534739,-0.0023849314225397045,0.017330949920397742,0.013111157799007067,-0.5041529453352789
2691,2021-11-05,"Pfizer Touts Encouraging Data For Its COVID-19 Oral Antiviral, With 89% Reduction In Hospitalization, Death",MRK,-0.09863046204356696,0.9274736421479728,0.020974214889729392,-0.0038191448381433846,0.013433344909534739,-0.0023849314225397045,0.017330949920397742,0.013111157799007067,-0.5041529453352789
2692,2021-11-08,Merck Ahead Of Pfizer In Talks With Europe For COVID-19 Pills: Reuters,MRK,0.013111157799007067,-0.5041529453352789,-0.09863046204356696,0.020974214889729392,-0.0038191448381433846,0.013433344909534739,-0.0023849314225397045,0.0004837818828187235,-0.4365261019420338
2693,2021-11-08,"Caterpillar, Fluor, and ChargePoint Among Companies That Could Benefit from Infrastructure Bill",MRK,0.013111157799007067,-0.5041529453352789,-0.09863046204356696,0.020974214889729392,-0.0038191448381433846,0.013433344909534739,-0.0023849314225397045,0.0004837818828187235,-0.4365261019420338
2694,2021-11-08,"The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More",MRK,0.013111157799007067,-0.5041529453352789,-0.09863046204356696,0.020974214889729392,-0.0038191448381433846,0.013433344909534739,-0.0023849314225397045,0.0004837818828187235,-0.4365261019420338
2695,2021-11-09,US Government To Purchase Additional 1.4M Doses Of Merck's COVID-19 Pill,MRK,0.0004837818828187235,-0.4365261019420338,0.013111157799007067,-0.09863046204356696,0.020974214889729392,-0.0038191448381433846,0.013433344909534739,0.015594784301035558,-0.06241438356164386
2696,2021-11-09,ALX Oncology Falls After Updated Data For Solid Tumors Candidate,MRK,0.0004837818828187235,-0.4365261019420338,0.013111157799007067,-0.09863046204356696,0.020974214889729392,-0.0038191448381433846,0.013433344909534739,0.015594784301035558,-0.06241438356164386
2697,2021-11-09,Mirati Posts More Responses For Adagrasib-Keytruda Combo In Lung Cancer Setting,MRK,0.0004837818828187235,-0.4365261019420338,0.013111157799007067,-0.09863046204356696,0.020974214889729392,-0.0038191448381433846,0.013433344909534739,0.015594784301035558,-0.06241438356164386
2698,2021-11-09,"The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data",MRK,0.0004837818828187235,-0.4365261019420338,0.013111157799007067,-0.09863046204356696,0.020974214889729392,-0.0038191448381433846,0.013433344909534739,0.015594784301035558,-0.06241438356164386
2699,2021-11-10,"The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance",MRK,0.015594784301035558,-0.06241438356164386,0.0004837818828187235,0.013111157799007067,-0.09863046204356696,0.020974214889729392,-0.0038191448381433846,0.00011891162703214775,-0.41542629288040667
2700,2021-11-11,"Oncorus, Gaeta Therapeutics Ink Cancer Candidate Licensing Agreement",MRK,0.00011891162703214775,-0.41542629288040667,0.015594784301035558,0.0004837818828187235,0.013111157799007067,-0.09863046204356696,0.020974214889729392,-0.00023798551832399095,0.4244033671786862
2701,2021-11-11,"The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts",MRK,0.00011891162703214775,-0.41542629288040667,0.015594784301035558,0.0004837818828187235,0.013111157799007067,-0.09863046204356696,0.020974214889729392,-0.00023798551832399095,0.4244033671786862
2702,2021-11-15,Iovance's Lifileucel Combo Shows Encouraging Response Rates In Advanced Cancers,MRK,-0.00369041596296682,-0.13385404608429696,-0.00023798551832399095,0.00011891162703214775,0.015594784301035558,0.0004837818828187235,0.013111157799007067,0.005018453953874902,0.4863397203230073
2703,2021-11-16,Dr. Reddy's Ready To Make COVID-19 Antiviral From Pfizer - Reuters,MRK,0.005018453953874902,0.4863397203230073,-0.00369041596296682,-0.00023798551832399095,0.00011891162703214775,0.015594784301035558,0.0004837818828187235,-0.01795267671334899,-0.02639798584030595
2704,2021-11-17,FDA Plans Quick Review of Pfizer/BioNTech COVID-19 Booster For All Adults: NYT,MRK,-0.01795267671334899,-0.02639798584030595,0.005018453953874902,-0.00369041596296682,-0.00023798551832399095,0.00011891162703214775,0.015594784301035558,0.005448084317920987,-0.04400999387534876
2705,2021-11-18,Merck's Keytruda Scores First Approval In Adjuvant Kidney Cancer Setting,MRK,0.005448084317920987,-0.04400999387534876,-0.01795267671334899,0.005018453953874902,-0.00369041596296682,-0.00023798551832399095,0.00011891162703214775,-0.028296450238013304,0.7878599902375529
2706,2021-11-18,"Berkshire Exited Merck Before COVID Pill Boost; Trimmed Holdings In AbbVie, Bristol Myers In Q3",MRK,0.005448084317920987,-0.04400999387534876,-0.01795267671334899,0.005018453953874902,-0.00369041596296682,-0.00023798551832399095,0.00011891162703214775,-0.028296450238013304,0.7878599902375529
2707,2021-11-19,EU Backs Merck's COVID-19 Pill For Adults At Risk Of Severe Illness,MRK,-0.028296450238013304,0.7878599902375529,0.005448084317920987,-0.01795267671334899,0.005018453953874902,-0.00369041596296682,-0.00023798551832399095,0.011648261658081527,-0.38114224934731045
2708,2021-11-19,"The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial",MRK,-0.028296450238013304,0.7878599902375529,0.005448084317920987,-0.01795267671334899,0.005018453953874902,-0.00369041596296682,-0.00023798551832399095,0.011648261658081527,-0.38114224934731045
2709,2021-11-19,Merck Pauses Development Of MK-8507 In HIV Infection,MRK,-0.028296450238013304,0.7878599902375529,0.005448084317920987,-0.01795267671334899,0.005018453953874902,-0.00369041596296682,-0.00023798551832399095,0.011648261658081527,-0.38114224934731045
2710,2021-11-23,Novartis May Have Buyer(s) For Its Sandoz Unit - Report,MRK,0.014208690758311215,0.1149427400231613,0.011648261658081527,-0.028296450238013304,0.005448084317920987,-0.01795267671334899,0.005018453953874902,-0.006280243301786004,-0.29625416295710094
2711,2021-11-23,Merck's Keytruda Conditionally Approved In Canada For Triple-Negative Breast Cancer,MRK,0.014208690758311215,0.1149427400231613,0.011648261658081527,-0.028296450238013304,0.005448084317920987,-0.01795267671334899,0.005018453953874902,-0.006280243301786004,-0.29625416295710094
2712,2021-11-24,"Gilead, Merck Stop Enrollment In Mid-Stage HIV Combination Therapy Trial",MRK,-0.006280243301786004,-0.29625416295710094,0.014208690758311215,0.011648261658081527,-0.028296450238013304,0.005448084317920987,-0.01795267671334899,-0.03791911772502998,1.111046034906876
2713,2021-11-26,"Updated Data Shows Merck's Oral COVID-19 Antiviral Cuts Hospitalization, Death Risk By 30%",MRK,-0.03791911772502998,1.111046034906876,-0.006280243301786004,0.014208690758311215,0.011648261658081527,-0.028296450238013304,0.005448084317920987,-0.05394148619364991,0.8972589057818223
2714,2021-11-29,"FDA's AdComm Meet Tomorrow To Review Safety, Efficacy of Merck's COVID-19 Pill",MRK,-0.05394148619364991,0.8972589057818223,-0.03791911772502998,-0.006280243301786004,0.014208690758311215,0.011648261658081527,-0.028296450238013304,0.0002671056933700733,-0.11735063932335843
2715,2021-11-29,3 Pharma Stocks Morgan Stanley Says Will Be Omicron Variant Beneficiaries,MRK,-0.05394148619364991,0.8972589057818223,-0.03791911772502998,-0.006280243301786004,0.014208690758311215,0.011648261658081527,-0.028296450238013304,0.0002671056933700733,-0.11735063932335843
2716,2021-11-29,Europe Approves Merck-Eisai's Keytruda/Lenvima Combo Therapy For Endometrial Carcinoma,MRK,-0.05394148619364991,0.8972589057818223,-0.03791911772502998,-0.006280243301786004,0.014208690758311215,0.011648261658081527,-0.028296450238013304,0.0002671056933700733,-0.11735063932335843
2717,2021-11-30,"The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout",MRK,0.0002671056933700733,-0.11735063932335843,-0.05394148619364991,-0.03791911772502998,-0.006280243301786004,0.014208690758311215,0.011648261658081527,-0.006274292487155275,-0.2897292568895192
2718,2021-11-30,AstraZeneca-Merck's Lynparza Under FDA Priority Review For Breast Cancer Setting,MRK,0.0002671056933700733,-0.11735063932335843,-0.05394148619364991,-0.03791911772502998,-0.006280243301786004,0.014208690758311215,0.011648261658081527,-0.006274292487155275,-0.2897292568895192
2719,2021-11-30,Adagene Shares Jump After FDA Signs Off ADG116/Keytruda Combo Therapy Trial In Solid Tumors,MRK,0.0002671056933700733,-0.11735063932335843,-0.05394148619364991,-0.03791911772502998,-0.006280243301786004,0.014208690758311215,0.011648261658081527,-0.006274292487155275,-0.2897292568895192
2720,2021-12-01,"AdComm Narrowly Backs Merck's COVID-19 Pill, Despite Efficacy Questions",MRK,-0.006274292487155275,-0.2897292568895192,0.0002671056933700733,-0.05394148619364991,-0.03791911772502998,-0.006280243301786004,0.014208690758311215,-0.007388574318394903,-0.28413082725707806
2721,2021-12-01,2 Biotech Stocks A Congressman Is Betting On With Omicron Variant Emerging,MRK,-0.006274292487155275,-0.2897292568895192,0.0002671056933700733,-0.05394148619364991,-0.03791911772502998,-0.006280243301786004,0.014208690758311215,-0.007388574318394903,-0.28413082725707806
2722,2021-12-01,Merck's Pneumococcal 15-valent Conjugate Vaccine Under Priority FDA Review For Use In Kids,MRK,-0.006274292487155275,-0.2897292568895192,0.0002671056933700733,-0.05394148619364991,-0.03791911772502998,-0.006280243301786004,0.014208690758311215,-0.007388574318394903,-0.28413082725707806
2723,2021-12-01,"The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case",MRK,-0.006274292487155275,-0.2897292568895192,0.0002671056933700733,-0.05394148619364991,-0.03791911772502998,-0.006280243301786004,0.014208690758311215,-0.007388574318394903,-0.28413082725707806
2724,2021-12-02,Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates,MRK,-0.007388574318394903,-0.28413082725707806,-0.006274292487155275,0.0002671056933700733,-0.05394148619364991,-0.03791911772502998,-0.006280243301786004,-0.007443571701102769,-0.05450528826415901
2725,2021-12-02,Vir Biotech - GSK's COVID-19 Antibody Shows Preclinical Activity Against Omicron Variant,MRK,-0.007388574318394903,-0.28413082725707806,-0.006274292487155275,0.0002671056933700733,-0.05394148619364991,-0.03791911772502998,-0.006280243301786004,-0.007443571701102769,-0.05450528826415901
2726,2021-12-03,"The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering",MRK,-0.007443571701102769,-0.05450528826415901,-0.007388574318394903,-0.006274292487155275,0.0002671056933700733,-0.05394148619364991,-0.03791911772502998,0.0010911126544073113,-0.06906795139535049
2727,2021-12-03,Bristol Myers - Merck's Thalassemia Candidate Under FDA Priority Review,MRK,-0.007443571701102769,-0.05450528826415901,-0.007388574318394903,-0.006274292487155275,0.0002671056933700733,-0.05394148619364991,-0.03791911772502998,0.0010911126544073113,-0.06906795139535049
2728,2021-12-06,"Merck's Keytruda Wins Eighth FDA Approval Of 2021, This Time For Adjuvant, Pediatric Melanoma Settings",MRK,0.0010911126544073113,-0.06906795139535049,-0.007443571701102769,-0.007388574318394903,-0.006274292487155275,0.0002671056933700733,-0.05394148619364991,-0.015527129575399812,0.3056460449551337
2729,2021-12-06,"Canada, Merck Ink Supply Pact For 1M Doses Of Molnupiravir For COVID-19",MRK,0.0010911126544073113,-0.06906795139535049,-0.007443571701102769,-0.007388574318394903,-0.006274292487155275,0.0002671056933700733,-0.05394148619364991,-0.015527129575399812,0.3056460449551337
2730,2021-12-06,"The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More",MRK,0.0010911126544073113,-0.06906795139535049,-0.007443571701102769,-0.007388574318394903,-0.006274292487155275,0.0002671056933700733,-0.05394148619364991,-0.015527129575399812,0.3056460449551337
2731,2021-12-07,"Pfizer, Merck COVID-19 Pills US Launch In This Month; Other Countries Will Have to Wait: WSJ",MRK,-0.015527129575399812,0.3056460449551337,0.0010911126544073113,-0.007443571701102769,-0.007388574318394903,-0.006274292487155275,0.0002671056933700733,0.012866417875240899,-0.1873366184484352
2732,2021-12-07,"The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré",MRK,-0.015527129575399812,0.3056460449551337,0.0010911126544073113,-0.007443571701102769,-0.007388574318394903,-0.006274292487155275,0.0002671056933700733,0.012866417875240899,-0.1873366184484352
2733,2021-12-07,Merck Stops Enrollment In Two Islatravir Trials For Prevention Of HIV Infection,MRK,-0.015527129575399812,0.3056460449551337,0.0010911126544073113,-0.007443571701102769,-0.007388574318394903,-0.006274292487155275,0.0002671056933700733,0.012866417875240899,-0.1873366184484352
2734,2021-12-08,"The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom",MRK,0.012866417875240899,-0.1873366184484352,-0.015527129575399812,0.0010911126544073113,-0.007443571701102769,-0.007388574318394903,-0.006274292487155275,-0.00478057705653212,-0.16700392145917353
2735,2021-12-13,Famed Robot-Run ETF Buys Back Into Tesla Heavily After Booking Profits Earlier — Here Are Its Other Bets,MRK,0.011016327682812577,0.5340298978839877,-0.0032940228805116156,-0.00478057705653212,0.012866417875240899,-0.015527129575399812,0.0010911126544073113,0.0136117774964446,0.08370076803861348
2736,2021-12-13,Merck Raises $1 Billion Via Inaugural Sustainability Bond,MRK,0.011016327682812577,0.5340298978839877,-0.0032940228805116156,-0.00478057705653212,0.012866417875240899,-0.015527129575399812,0.0010911126544073113,0.0136117774964446,0.08370076803861348
2737,2021-12-14,"CSL Seals $11.7B Buyout Deal Of Vifor Pharma, Probably the Largest Healthcare Deal In 2021",MRK,0.0136117774964446,0.08370076803861348,0.011016327682812577,-0.0032940228805116156,-0.00478057705653212,0.012866417875240899,-0.015527129575399812,0.021296961381530144,-0.24730206810661914
2738,2021-12-15,"The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO",MRK,0.021296961381530144,-0.24730206810661914,0.0136117774964446,0.011016327682812577,-0.0032940228805116156,-0.00478057705653212,0.012866417875240899,0.008234814487080744,0.16393706970287591
2739,2021-12-15,Famed Robot-Run ETF Says This Is Why It Now Has Tesla As Its Top Holding,MRK,0.021296961381530144,-0.24730206810661914,0.0136117774964446,0.011016327682812577,-0.0032940228805116156,-0.00478057705653212,0.012866417875240899,0.008234814487080744,0.16393706970287591
2740,2021-12-17,EMA's CHMP Backs Approval For Merck's Keytruda In Adjuvant Setting For Kidney Cancer,MRK,-0.0028982864009614584,0.6890197991771927,0.008234814487080744,0.021296961381530144,0.0136117774964446,0.011016327682812577,-0.0032940228805116156,0.00951244340656121,-0.5785111588197114
2741,2021-12-17,EMA Might Not Decide On Merck's COVID-91 Oral Antiviral Before Christmas: Reuters,MRK,-0.0028982864009614584,0.6890197991771927,0.008234814487080744,0.021296961381530144,0.0136117774964446,0.011016327682812577,-0.0032940228805116156,0.00951244340656121,-0.5785111588197114
2742,2021-12-17,"The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx",MRK,-0.0028982864009614584,0.6890197991771927,0.008234814487080744,0.021296961381530144,0.0136117774964446,0.011016327682812577,-0.0032940228805116156,0.00951244340656121,-0.5785111588197114
2743,2021-12-21,IMV's Basket Clinical Study Shows Promising Top Line Data In Bladder Cancer,MRK,-0.011385803967457253,0.26474769012082455,0.00951244340656121,-0.0028982864009614584,0.008234814487080744,0.021296961381530144,0.0136117774964446,0.008207561558548626,-0.38077844231258107
2744,2021-12-22,"FDA To Possibly Authorize Pfizer, Merck COVID-19 Antiviral Pills This Week: Bloomberg",MRK,0.008207561558548626,-0.38077844231258107,-0.011385803967457253,0.00951244340656121,-0.0028982864009614584,0.008234814487080744,0.021296961381530144,-0.005645944083414345,0.0690254969749351
2745,2021-12-22,"UK Calls For Additional Doses Of COVID-19 Antivirals From Merck, Pfizer",MRK,0.008207561558548626,-0.38077844231258107,-0.011385803967457253,0.00951244340656121,-0.0028982864009614584,0.008234814487080744,0.021296961381530144,-0.005645944083414345,0.0690254969749351
2746,2021-12-22,A Look Into Merck & Co's Debt,MRK,0.008207561558548626,-0.38077844231258107,-0.011385803967457253,0.00951244340656121,-0.0028982864009614584,0.008234814487080744,0.021296961381530144,-0.005645944083414345,0.0690254969749351
2747,2021-12-22,Investors Appear Uninterested in Bonds Despite Elevated Uncertainty,MRK,0.008207561558548626,-0.38077844231258107,-0.011385803967457253,0.00951244340656121,-0.0028982864009614584,0.008234814487080744,0.021296961381530144,-0.005645944083414345,0.0690254969749351
2748,2021-12-22,"The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda",MRK,0.008207561558548626,-0.38077844231258107,-0.011385803967457253,0.00951244340656121,-0.0028982864009614584,0.008234814487080744,0.021296961381530144,-0.005645944083414345,0.0690254969749351
2749,2021-12-23,"FDA Approves Another COVID-19 Antiviral Pill, This Time From Merck",MRK,-0.005645944083414345,0.0690254969749351,0.008207561558548626,-0.011385803967457253,0.00951244340656121,-0.0028982864009614584,0.008234814487080744,0.011091934772713863,-0.35980151391120674
2750,2021-12-23,How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?,MRK,-0.005645944083414345,0.0690254969749351,0.008207561558548626,-0.011385803967457253,0.00951244340656121,-0.0028982864009614584,0.008234814487080744,0.011091934772713863,-0.35980151391120674
2751,2021-12-27,Holiday Shopping Saw Growth in Apparel and Jewelry,MRK,0.011091934772713863,-0.35980151391120674,-0.005645944083414345,0.008207561558548626,-0.011385803967457253,0.00951244340656121,-0.0028982864009614584,0.0031342693613829464,-0.09591614441094287
2752,2021-12-30,These 8 Dow Jones Stocks Are Negative For 2021,MRK,0.0024692925342413297,-0.011305917888661976,0.0018226972678019315,0.0031342693613829464,0.011091934772713863,-0.005645944083414345,0.008207561558548626,-0.006481872282302015,0.027376218190507062
2753,2022-01-03,Genprex's Lead Cancer Program Scores Second FDA Fast Track Tag For Lung Cancer Setting,MRK,0.0030011471961979286,0.5684359166043691,-0.006481872282302015,0.0024692925342413297,0.0018226972678019315,0.0031342693613829464,0.011091934772713863,0.0018212743535874765,0.26908655679362803
2754,2022-01-03,Why Genprex Shares Are Soaring Today,MRK,0.0030011471961979286,0.5684359166043691,-0.006481872282302015,0.0024692925342413297,0.0018226972678019315,0.0031342693613829464,0.011091934772713863,0.0018212743535874765,0.26908655679362803
2755,2022-01-04,Financial Stocks Could be Positioned to Kick Off the Q4 Earnings Season,MRK,0.0018212743535874765,0.26908655679362803,0.0030011471961979286,-0.006481872282302015,0.0024692925342413297,0.0018226972678019315,0.0031342693613829464,0.024282413644939327,0.45621239056227414
2756,2022-01-04,Reddy's To Launch Generic Version Of Merck's COVID-19 Drug At $0.50/Pill: Reuters,MRK,0.0018212743535874765,0.26908655679362803,0.0030011471961979286,-0.006481872282302015,0.0024692925342413297,0.0018226972678019315,0.0031342693613829464,0.024282413644939327,0.45621239056227414
2757,2022-01-07,Why Absci Shares Are Soaring Today,MRK,0.018647804575007365,0.33917881540953587,-0.0006338086714073876,0.024282413644939327,0.0018212743535874765,0.0030011471961979286,-0.006481872282302015,0.02577832716279116,0.29087562450696813
2758,2022-01-10,Merck's Keytruda As Adjuvant Treatment Improves Disease-Free Survival In Lung Cancer Setting,MRK,0.02577832716279116,0.29087562450696813,0.018647804575007365,-0.0006338086714073876,0.024282413644939327,0.0018212743535874765,0.0030011471961979286,-0.00849841830901299,-0.4100311659740895
2759,2022-01-12,"The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award",MRK,-0.005754757539380928,0.12705112601531288,-0.00849841830901299,0.02577832716279116,0.018647804575007365,-0.0006338086714073876,0.024282413644939327,0.0014778748444881362,-0.25878073064256724
2760,2022-01-18,"This Robot-Run ETF Retains Tesla As It Largest Holding In January, It Has Bowed Out Of Netflix And Initiated Position In This Chipmaker",MRK,0.0019660762689099887,0.5291306182738975,0.0007378469767580498,0.0014778748444881362,-0.005754757539380928,-0.00849841830901299,0.02577832716279116,-0.003065954091013401,-0.21009307877541727
2761,2022-01-18,"Canada Approves Pfizer's At-Home COVID-19 Antiviral Treatment, But Deliveries Delayed",MRK,0.0019660762689099887,0.5291306182738975,0.0007378469767580498,0.0014778748444881362,-0.005754757539380928,-0.00849841830901299,0.02577832716279116,-0.003065954091013401,-0.21009307877541727
2762,2022-01-19,Seagen's SEA-CD40 Combo Regime Shows Preliminary Antitumor Activity In Pancreatic Cancer,MRK,-0.003065954091013401,-0.21009307877541727,0.0019660762689099887,0.0007378469767580498,0.0014778748444881362,-0.005754757539380928,-0.00849841830901299,-0.0066429757081999385,0.05427927534459576
2763,2022-01-19,Merck's Keytruda Manages To Cross The Finish Line In Liver Cancer Confirmatory Trial,MRK,-0.003065954091013401,-0.21009307877541727,0.0019660762689099887,0.0007378469767580498,0.0014778748444881362,-0.005754757539380928,-0.00849841830901299,-0.0066429757081999385,0.05427927534459576
2764,2022-01-20,Casi Pharma-Partnered BioInvent's Lead Cancer Program Gets FDA Orphan Drug Tag,MRK,-0.0066429757081999385,0.05427927534459576,-0.003065954091013401,0.0019660762689099887,0.0007378469767580498,0.0014778748444881362,-0.005754757539380928,-0.009535402360003498,0.5296033008550407
2765,2022-01-20,"The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug",MRK,-0.0066429757081999385,0.05427927534459576,-0.003065954091013401,0.0019660762689099887,0.0007378469767580498,0.0014778748444881362,-0.005754757539380928,-0.009535402360003498,0.5296033008550407
2766,2022-01-21,Merck Scores Win In Insurance Battle Over Cyberattack - Bloomberg Report,MRK,-0.009535402360003498,0.5296033008550407,-0.0066429757081999385,-0.003065954091013401,0.0019660762689099887,0.0007378469767580498,0.0014778748444881362,-0.014378788966347589,-0.06352069419392581
2767,2022-01-24,Britain To Test Merck - Ridgeback Biotherapeutics' COVID-19 Antiviral Pill In Hospitalized Patients,MRK,-0.014378788966347589,-0.06352069419392581,-0.009535402360003498,-0.0066429757081999385,-0.003065954091013401,0.0019660762689099887,0.0007378469767580498,0.007991858767275595,-0.20976343339695758
2768,2022-01-24,"FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why",MRK,-0.014378788966347589,-0.06352069419392581,-0.009535402360003498,-0.0066429757081999385,-0.003065954091013401,0.0019660762689099887,0.0007378469767580498,0.007991858767275595,-0.20976343339695758
2769,2022-01-24,Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?,MRK,-0.014378788966347589,-0.06352069419392581,-0.009535402360003498,-0.0066429757081999385,-0.003065954091013401,0.0019660762689099887,0.0007378469767580498,0.007991858767275595,-0.20976343339695758
2770,2022-01-24,Merck's Gefapixant For Chronic Cough Slapped With FDA Complete Response Letter,MRK,-0.014378788966347589,-0.06352069419392581,-0.009535402360003498,-0.0066429757081999385,-0.003065954091013401,0.0019660762689099887,0.0007378469767580498,0.007991858767275595,-0.20976343339695758
2771,2022-01-25,eFFECTOR Secures $50M Funding From Lincoln Park Capital,MRK,0.007991858767275595,-0.20976343339695758,-0.014378788966347589,-0.009535402360003498,-0.0066429757081999385,-0.003065954091013401,0.0019660762689099887,-0.004027165906442143,-0.04507260803372759
2772,2022-01-26,Vaccinex Posts Two Complete Responses In Pepinemab Combo Trial In Head & Neck Cancer,MRK,-0.004027165906442143,-0.04507260803372759,0.007991858767275595,-0.014378788966347589,-0.009535402360003498,-0.0066429757081999385,-0.003065954091013401,0.018195723357754323,0.547315009274447
2773,2022-01-27,Jiangsu Recbio Shoots To Become Hong Kong's First HPV Vaccine Stock,MRK,0.018195723357754323,0.547315009274447,-0.004027165906442143,0.007991858767275595,-0.014378788966347589,-0.009535402360003498,-0.0066429757081999385,0.003971190858349294,-0.3106869699611635
2774,2022-01-27,"The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study",MRK,0.018195723357754323,0.547315009274447,-0.004027165906442143,0.007991858767275595,-0.014378788966347589,-0.009535402360003498,-0.0066429757081999385,0.003971190858349294,-0.3106869699611635
2775,2022-01-27,Merck's Keytruda Wins European Approval For Post-Surgery Kidney Cancer,MRK,0.018195723357754323,0.547315009274447,-0.004027165906442143,0.007991858767275595,-0.014378788966347589,-0.009535402360003498,-0.0066429757081999385,0.003971190858349294,-0.3106869699611635
2776,2022-01-27,Cue Pharma Posts Two Responses From CUE-101 Combo In Head & Neck Cancer,MRK,0.018195723357754323,0.547315009274447,-0.004027165906442143,0.007991858767275595,-0.014378788966347589,-0.009535402360003498,-0.0066429757081999385,0.003971190858349294,-0.3106869699611635
2777,2022-01-28,"Merck's COVID-19 Pill works Against Omicron, Lab Studies Show",MRK,0.003971190858349294,-0.3106869699611635,0.018195723357754323,-0.004027165906442143,0.007991858767275595,-0.014378788966347589,-0.009535402360003498,0.007169386232673158,-0.06326130230753202
2778,2022-01-28,"The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron",MRK,0.003971190858349294,-0.3106869699611635,0.018195723357754323,-0.004027165906442143,0.007991858767275595,-0.014378788966347589,-0.009535402360003498,0.007169386232673158,-0.06326130230753202
2779,2022-01-31,"The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News",MRK,0.007169386232673158,-0.06326130230753202,0.003971190858349294,0.018195723357754323,-0.004027165906442143,0.007991858767275595,-0.014378788966347589,0.005399927771294832,-0.1712082853855006
2780,2022-01-31,Veru's Cancer Candidate Sabizabulin Gets FDA Fast Track Tag For COVID-19,MRK,0.007169386232673158,-0.06326130230753202,0.003971190858349294,0.018195723357754323,-0.004027165906442143,0.007991858767275595,-0.014378788966347589,0.005399927771294832,-0.1712082853855006
2781,2022-01-31,Price To Earnings Ratio Insights For Merck & Co,MRK,0.007169386232673158,-0.06326130230753202,0.003971190858349294,0.018195723357754323,-0.004027165906442143,0.007991858767275595,-0.014378788966347589,0.005399927771294832,-0.1712082853855006
2782,2022-02-03,Mid-Morning Market Update: US Stocks Open Lower After Disappointing Earnings From Meta Platforms,MRK,-0.0365809806939944,0.3712557727227235,0.0010988095165498368,0.005399927771294832,0.007169386232673158,0.003971190858349294,0.018195723357754323,-0.005695594214202848,-0.4413233653435099
2783,2022-02-03,"The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation",MRK,-0.0365809806939944,0.3712557727227235,0.0010988095165498368,0.005399927771294832,0.007169386232673158,0.003971190858349294,0.018195723357754323,-0.005695594214202848,-0.4413233653435099
2784,2022-02-03,Mid-Day Market Update: Nasdaq Down 2%; Biophytis Shares Spike Higher,MRK,-0.0365809806939944,0.3712557727227235,0.0010988095165498368,0.005399927771294832,0.007169386232673158,0.003971190858349294,0.018195723357754323,-0.005695594214202848,-0.4413233653435099
2785,2022-02-03,"Earnings Scheduled For February 3, 2022",MRK,-0.0365809806939944,0.3712557727227235,0.0010988095165498368,0.005399927771294832,0.007169386232673158,0.003971190858349294,0.018195723357754323,-0.005695594214202848,-0.4413233653435099
2786,2022-02-03,"7 Stocks To Watch For February 3, 2022",MRK,-0.0365809806939944,0.3712557727227235,0.0010988095165498368,0.005399927771294832,0.007169386232673158,0.003971190858349294,0.018195723357754323,-0.005695594214202848,-0.4413233653435099
2787,2022-02-03,"Merck Clocked $950M Sales In Q4 From COVID-19 Treatment, Issues FY22 Sales",MRK,-0.0365809806939944,0.3712557727227235,0.0010988095165498368,0.005399927771294832,0.007169386232673158,0.003971190858349294,0.018195723357754323,-0.005695594214202848,-0.4413233653435099
2788,2022-02-03,Recap: Merck & Co Q4 Earnings,MRK,-0.0365809806939944,0.3712557727227235,0.0010988095165498368,0.005399927771294832,0.007169386232673158,0.003971190858349294,0.018195723357754323,-0.005695594214202848,-0.4413233653435099
2789,2022-02-03,A Peek Into The Markets: Nasdaq Futures Tumble Following Downbeat Earnings From Meta,MRK,-0.0365809806939944,0.3712557727227235,0.0010988095165498368,0.005399927771294832,0.007169386232673158,0.003971190858349294,0.018195723357754323,-0.005695594214202848,-0.4413233653435099
2790,2022-02-07,NGM Bio Shares Rise After Vision Disorder Candidate Receives FDA Fast Track Tag,MRK,-0.012474361442071702,1.203700938765607,-0.005695594214202848,-0.0365809806939944,0.0010988095165498368,0.005399927771294832,0.007169386232673158,-0.008636271276384777,-0.2595266627991175
2791,2022-02-10,"The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly",MRK,0.000392169824350308,-0.18082605001613639,-0.004941049694433319,-0.008636271276384777,-0.012474361442071702,-0.005695594214202848,-0.0365809806939944,0.001044823854795096,-0.24886634077313952
2792,2022-02-10,Why Are Seagen Shares Sinking Today?,MRK,0.000392169824350308,-0.18082605001613639,-0.004941049694433319,-0.008636271276384777,-0.012474361442071702,-0.005695594214202848,-0.0365809806939944,0.001044823854795096,-0.24886634077313952
2793,2022-02-15,ImmunityBio's Ankitva Shows 100% Survival At Two Years In Bladder Cancer Setting,MRK,0.01752326479062072,0.15630850816204678,-0.002218140267497004,0.001044823854795096,0.000392169824350308,-0.004941049694433319,-0.008636271276384777,-0.0075826031093696455,-0.1264091163702563
2794,2022-02-15,Why Are AstraZeneca Shares Trading Higher Today,MRK,0.01752326479062072,0.15630850816204678,-0.002218140267497004,0.001044823854795096,0.000392169824350308,-0.004941049694433319,-0.008636271276384777,-0.0075826031093696455,-0.1264091163702563
2795,2022-02-15,BioXcel BXCL701 Combo Therapy Shows Encouraging Response Rates In Prostate Cancer,MRK,0.01752326479062072,0.15630850816204678,-0.002218140267497004,0.001044823854795096,0.000392169824350308,-0.004941049694433319,-0.008636271276384777,-0.0075826031093696455,-0.1264091163702563
2796,2022-02-16,"Merck Inks Oncology, Neurology Drug Discovery Pact With British Biotech, Curve Therapeutics",MRK,-0.0075826031093696455,-0.1264091163702563,0.01752326479062072,-0.002218140267497004,0.001044823854795096,0.000392169824350308,-0.004941049694433319,-0.011136885233276383,-0.10940458657689878
2797,2022-02-17,"South Africa Authorizes Merck's COVID-19 Antiviral Pill, But Government Not Buying: Reuters",MRK,-0.011136885233276383,-0.10940458657689878,-0.0075826031093696455,0.01752326479062072,-0.002218140267497004,0.001044823854795096,0.000392169824350308,0.00013084120301631863,-0.012239433926180876
2798,2022-02-18,See Why Did FDA Update Merck's COVID-19 Pill Emergency Use Authorization,MRK,0.00013084120301631863,-0.012239433926180876,-0.011136885233276383,-0.0075826031093696455,0.01752326479062072,-0.002218140267497004,0.001044823854795096,-0.005499595379791611,0.030977734753146136
2799,2022-02-25,Merck-Eisai's Keytruda/Lenvima Combo Scores Japanese Approval For Kidney Cancer Setting,MRK,0.038226012375503826,-0.35341792993811394,-0.03072242585902285,-0.0014482758188677503,-0.005499595379791611,0.00013084120301631863,-0.011136885233276383,0.003406563504907867,0.033675059820428954
2800,2022-02-28,Celyad Stops Early-Stage Colorectal Cancer Trial Amid Reported Fatalities,MRK,0.003406563504907867,0.033675059820428954,0.038226012375503826,-0.03072242585902285,-0.0014482758188677503,-0.005499595379791611,0.00013084120301631863,-0.003133963991771571,-0.3057319429991293
2801,2022-03-02,Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates,MRK,0.004322734841033071,-0.011195741947324978,-0.003133963991771571,0.003406563504907867,0.038226012375503826,-0.03072242585902285,-0.0014482758188677503,0.006260777258493944,-0.15533900489816965
2802,2022-03-03,WHO Conditionally Recommends Merck's COVID-19 Antiviral Pill For High-Risk Patients,MRK,0.006260777258493944,-0.15533900489816965,0.004322734841033071,-0.003133963991771571,0.003406563504907867,0.038226012375503826,-0.03072242585902285,0.008813907794783082,0.49141140994494026
2803,2022-03-04,"The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan",MRK,0.008813907794783082,0.49141140994494026,0.006260777258493944,0.004322734841033071,-0.003133963991771571,0.003406563504907867,0.038226012375503826,-0.0012848204842624833,0.14669744521663675
2804,2022-03-07,Merck's Keytruda Shows Improved Metastasis-Free Survival In Melanoma Patients,MRK,-0.0012848204842624833,0.14669744521663675,0.008813907794783082,0.006260777258493944,0.004322734841033071,-0.003133963991771571,0.003406563504907867,-0.01003481873691181,-0.2730004854230319
2805,2022-03-07,Why Alpine Immune's Shares Are Falling Today,MRK,-0.0012848204842624833,0.14669744521663675,0.008813907794783082,0.006260777258493944,0.004322734841033071,-0.003133963991771571,0.003406563504907867,-0.01003481873691181,-0.2730004854230319
2806,2022-03-14,AstraZeneca-Merck's Lynparza Wins FDA Approval For Early-Stage Breast Cancer,MRK,0.002707301314023969,0.07012573611332162,0.004750306552668171,0.0012853791435256667,0.01091628652119514,-0.01003481873691181,-0.0012848204842624833,0.011056829468145013,0.13064429769766206
2807,2022-03-15,Merck-AstraZeneca Stop Keytruda/Lynparza Combo Trial In Prostate Cancer Patients,MRK,0.011056829468145013,0.13064429769766206,0.002707301314023969,0.004750306552668171,0.0012853791435256667,0.01091628652119514,-0.01003481873691181,-0.006612398532083952,-0.04025256511444353
2808,2022-03-15,"The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial",MRK,0.011056829468145013,0.13064429769766206,0.002707301314023969,0.004750306552668171,0.0012853791435256667,0.01091628652119514,-0.01003481873691181,-0.006612398532083952,-0.04025256511444353
2809,2022-03-16,Adagene Shares Pop After FDA Clears Phase 1b/2 Trial For ADG126/Keytruda Combo Therapy In Solid Tumors,MRK,-0.006612398532083952,-0.04025256511444353,0.011056829468145013,0.002707301314023969,0.004750306552668171,0.0012853791435256667,0.01091628652119514,0.010496713797062185,-0.06072733918128659
2810,2022-03-16,Todos Medical Acquires Lucrative NLC Assets For Pennies On The Dollar,MRK,-0.006612398532083952,-0.04025256511444353,0.011056829468145013,0.002707301314023969,0.004750306552668171,0.0012853791435256667,0.01091628652119514,0.010496713797062185,-0.06072733918128659
2811,2022-03-16,"The Daily Biotech Pulse:  Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study",MRK,-0.006612398532083952,-0.04025256511444353,0.011056829468145013,0.002707301314023969,0.004750306552668171,0.0012853791435256667,0.01091628652119514,0.010496713797062185,-0.06072733918128659
2812,2022-03-18,"The Daily Biotech Pulse: Moderna Files For 2nd COVID Booster Shot Authorization, Lexicon Secures Debt Funding, Amneal Gets Sub-License to Manufacture Generic COVID Pill",MRK,0.0021535416450948475,1.049224662918069,0.010496713797062185,-0.006612398532083952,0.011056829468145013,0.002707301314023969,0.004750306552668171,-0.0006321562160040983,-0.5025682655425164
2813,2022-03-18,Merck Lays Out Keytruda Data In Post Surgery Early-Stage Lung Cancer Setting,MRK,0.0021535416450948475,1.049224662918069,0.010496713797062185,-0.006612398532083952,0.011056829468145013,0.002707301314023969,0.004750306552668171,-0.0006321562160040983,-0.5025682655425164
2814,2022-03-22,FDA Approves Second Indication For Merck's Keytruda In Endometrial Cancer,MRK,0.003035831822193913,-0.044062491052938024,-0.0006321562160040983,0.0021535416450948475,0.010496713797062185,-0.006612398532083952,0.011056829468145013,0.005422447093454075,-0.1543637561647665
2815,2022-03-22,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout",MRK,0.003035831822193913,-0.044062491052938024,-0.0006321562160040983,0.0021535416450948475,0.010496713797062185,-0.006612398532083952,0.011056829468145013,0.005422447093454075,-0.1543637561647665
2816,2022-03-23,AstraZeneca's COVID-19 Vaccine Expected To Win European Approval This Week: Reuters,MRK,0.005422447093454075,-0.1543637561647665,0.003035831822193913,-0.0006321562160040983,0.0021535416450948475,0.010496713797062185,-0.006612398532083952,0.008528616080775597,-0.1021675481677371
2817,2022-03-23,Merck Continues to See Executive Exodus; Here's A Look At All Recent Departures,MRK,0.005422447093454075,-0.1543637561647665,0.003035831822193913,-0.0006321562160040983,0.0021535416450948475,0.010496713797062185,-0.006612398532083952,0.008528616080775597,-0.1021675481677371
2818,2022-03-23,4D Pharma Shares Soar On MRx0518/Keytruda Combo Trial Data In Renal Cell Carcinoma,MRK,0.005422447093454075,-0.1543637561647665,0.003035831822193913,-0.0006321562160040983,0.0021535416450948475,0.010496713797062185,-0.006612398532083952,0.008528616080775597,-0.1021675481677371
2819,2022-03-23,"The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale",MRK,0.005422447093454075,-0.1543637561647665,0.003035831822193913,-0.0006321562160040983,0.0021535416450948475,0.010496713797062185,-0.006612398532083952,0.008528616080775597,-0.1021675481677371
2820,2022-03-24,"The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL",MRK,0.008528616080775597,-0.1021675481677371,0.005422447093454075,0.003035831822193913,-0.0006321562160040983,0.0021535416450948475,0.010496713797062185,0.011565783601412027,-0.06303747534516768
2821,2022-03-25,EMA's Advisory Group Backs Approval For Merck's Keytruda In Various Cancer Settings,MRK,0.011565783601412027,-0.06303747534516768,0.008528616080775597,0.005422447093454075,0.003035831822193913,-0.0006321562160040983,0.0021535416450948475,-0.001598274972285485,-0.007536207477265022
2822,2022-03-25,"The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO",MRK,0.011565783601412027,-0.06303747534516768,0.008528616080775597,0.005422447093454075,0.003035831822193913,-0.0006321562160040983,0.0021535416450948475,-0.001598274972285485,-0.007536207477265022
2823,2022-03-28,FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant,MRK,-0.001598274972285485,-0.007536207477265022,0.011565783601412027,0.008528616080775597,0.005422447093454075,0.003035831822193913,-0.0006321562160040983,0.004432995617233093,0.04621106067676295
2824,2022-03-31,Portage Biotech Shares Encouraging Preliminary Safety Data From Lead iNKT Agonists Program In Cancer Patients,MRK,-0.004247553426585782,0.33669289987776896,0.010175412801040506,0.004432995617233093,-0.001598274972285485,0.011565783601412027,0.008528616080775597,0.017915688701725774,-0.19091507042705425
2825,2022-04-01,Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates,MRK,0.017915688701725774,-0.19091507042705425,-0.004247553426585782,0.010175412801040506,0.004432995617233093,-0.001598274972285485,0.011565783601412027,-0.0003590970403289928,-0.10380996758107208
2826,2022-04-01,Mitt Romney Says Senators Reached Tentative $10B Deal In Additional COVID-19 Relief Funding: CNBC,MRK,0.017915688701725774,-0.19091507042705425,-0.004247553426585782,0.010175412801040506,0.004432995617233093,-0.001598274972285485,0.011565783601412027,-0.0003590970403289928,-0.10380996758107208
2827,2022-04-01,"The Daily Biotech Pulse: SELLA In-licenses Oncology Asset, Merck's Pneumococcal Vaccine Review Extended, Arc Biopharma COVID Drug Flunks Mid-Stage Study",MRK,0.017915688701725774,-0.19091507042705425,-0.004247553426585782,0.010175412801040506,0.004432995617233093,-0.001598274972285485,0.011565783601412027,-0.0003590970403289928,-0.10380996758107208
2828,2022-04-01,FDA Pushes Merck's Pneumococcal Vaccine Decision Date Into July For Expanded Use In Kids,MRK,0.017915688701725774,-0.19091507042705425,-0.004247553426585782,0.010175412801040506,0.004432995617233093,-0.001598274972285485,0.011565783601412027,-0.0003590970403289928,-0.10380996758107208
2829,2022-04-01,Merck - Ridgeback's COVID-19 Antiviral Shows Rapid Elimination Of Infectious SARS-CoV-2 Than Placebo,MRK,0.017915688701725774,-0.19091507042705425,-0.004247553426585782,0.010175412801040506,0.004432995617233093,-0.001598274972285485,0.011565783601412027,-0.0003590970403289928,-0.10380996758107208
2830,2022-04-04,Merck Expands Elkton Manufacturing Facility To Boost HPV Vaccine Supply,MRK,-0.0003590970403289928,-0.10380996758107208,0.017915688701725774,-0.004247553426585782,0.010175412801040506,0.004432995617233093,-0.001598274972285485,0.0027548193806590238,0.33201690340280554
2831,2022-04-05,MindMed Appoints Francois Lilienthal As New CCO,MRK,0.0027548193806590238,0.33201690340280554,-0.0003590970403289928,0.017915688701725774,-0.004247553426585782,0.010175412801040506,0.004432995617233093,0.01493076202236887,0.15641687913694158
2832,2022-04-06,"The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy",MRK,0.01493076202236887,0.15641687913694158,0.0027548193806590238,-0.0003590970403289928,0.017915688701725774,-0.004247553426585782,0.010175412801040506,0.021537032244315357,-0.058889854427152555
2833,2022-04-06,Iovance Outlines Frontline Melanoma Strategy For Lifileucel / Pembrolizumab Combo Therapy,MRK,0.01493076202236887,0.15641687913694158,0.0027548193806590238,-0.0003590970403289928,0.017915688701725774,-0.004247553426585782,0.010175412801040506,0.021537032244315357,-0.058889854427152555
2834,2022-04-11,IMV's MVP-S Doublet Combo Therapy Shows Encouraging Anti Tumor Activity,MRK,-0.01197531147498665,0.2604629556589799,0.01013818742617012,0.021537032244315357,0.01493076202236887,0.0027548193806590238,-0.0003590970403289928,-0.011543357881019234,-0.12780752381614635
2835,2022-04-11,Syros' CDK12 Inhibitor Shows Anti Tumor Activity In Preclinical Studies,MRK,-0.01197531147498665,0.2604629556589799,0.01013818742617012,0.021537032244315357,0.01493076202236887,0.0027548193806590238,-0.0003590970403289928,-0.011543357881019234,-0.12780752381614635
2836,2022-04-13,Japan-Based Shinogi's COVID-19 Drug Associated With Birth Defects: Bloomberg,MRK,0.005838943872215729,0.01600892928326547,-0.011543357881019234,-0.01197531147498665,0.01013818742617012,0.021537032244315357,0.01493076202236887,0.00905624434640595,0.73387058805066
2837,2022-04-13,"Morning Brief: Top Stories Dominating Financial Media on Wednesday, April 13",MRK,0.005838943872215729,0.01600892928326547,-0.011543357881019234,-0.01197531147498665,0.01013818742617012,0.021537032244315357,0.01493076202236887,0.00905624434640595,0.73387058805066
2838,2022-04-18,Merck's Keytruda Regime Approved In Canada For Early Breast Cancer Setting,MRK,-0.009665235483291568,-0.6381669163336516,0.00905624434640595,0.005838943872215729,-0.011543357881019234,-0.01197531147498665,0.01013818742617012,-0.0032530966740887957,0.0624882740678665
2839,2022-04-21,Transportation: Strong Earnings Form Railroad And Airline Stocks Boost the Sector,MRK,-0.002660097160860131,-0.01800582608895107,0.007809735147674246,-0.0032530966740887957,-0.009665235483291568,0.00905624434640595,0.005838943872215729,-0.019018976776387975,-0.07572643184153971
2840,2022-04-22,Will X Mark The Spot For Musk As Streaming Wars Heat Up?,MRK,-0.019018976776387975,-0.07572643184153971,-0.002660097160860131,0.007809735147674246,-0.0032530966740887957,-0.009665235483291568,0.00905624434640595,0.010048503191131486,0.33603740207227695
2841,2022-04-26,"Morning Brief: Top Financial Stories Dominating on Tuesday, April 26",MRK,-0.011235911645967933,-0.14789944577903036,0.010048503191131486,-0.019018976776387975,-0.002660097160860131,0.007809735147674246,-0.0032530966740887957,-0.0008286504858867616,0.19664580003551757
2842,2022-04-26,Biden Administration Working On Wider Availability Of COVID-19 Pills: WSJ,MRK,-0.011235911645967933,-0.14789944577903036,0.010048503191131486,-0.019018976776387975,-0.002660097160860131,0.007809735147674246,-0.0032530966740887957,-0.0008286504858867616,0.19664580003551757
2843,2022-04-27,The S&P 500 And Nasdaq Testing Major Support Levels,MRK,-0.0008286504858867616,0.19664580003551757,-0.011235911645967933,0.010048503191131486,-0.019018976776387975,-0.002660097160860131,0.007809735147674246,0.04940169340575484,0.9563781733186165
2844,2022-04-27,"Nasdaq Loses Nearly 4%, Techs Reel As Global, Fed, And Earnings Fears Mount",MRK,-0.0008286504858867616,0.19664580003551757,-0.011235911645967933,0.010048503191131486,-0.019018976776387975,-0.002660097160860131,0.007809735147674246,0.04940169340575484,0.9563781733186165
2845,2022-04-28,Markets Surge Despite Drop In US GDP,MRK,0.04940169340575484,0.9563781733186165,-0.0008286504858867616,-0.011235911645967933,0.010048503191131486,-0.019018976776387975,-0.002660097160860131,0.0012417412450809184,-0.2454971719537462
2846,2022-04-28,"Earnings Scheduled For April 28, 2022",MRK,0.04940169340575484,0.9563781733186165,-0.0008286504858867616,-0.011235911645967933,0.010048503191131486,-0.019018976776387975,-0.002660097160860131,0.0012417412450809184,-0.2454971719537462
2847,2022-04-28,Are These Global Companies On The Right Side Of History?,MRK,0.04940169340575484,0.9563781733186165,-0.0008286504858867616,-0.011235911645967933,0.010048503191131486,-0.019018976776387975,-0.002660097160860131,0.0012417412450809184,-0.2454971719537462
2848,2022-04-28,Surprise Negative GDP Report Could Hurt Premarket Rally,MRK,0.04940169340575484,0.9563781733186165,-0.0008286504858867616,-0.011235911645967933,0.010048503191131486,-0.019018976776387975,-0.002660097160860131,0.0012417412450809184,-0.2454971719537462
2849,2022-04-28,"The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates",MRK,0.04940169340575484,0.9563781733186165,-0.0008286504858867616,-0.011235911645967933,0.010048503191131486,-0.019018976776387975,-0.002660097160860131,0.0012417412450809184,-0.2454971719537462
2850,2022-04-28,"Merck Clocks 50% Q1 Sales Growth Boosted By COVID-19 Treatment, Tightens FY22 EPS Outlook",MRK,0.04940169340575484,0.9563781733186165,-0.0008286504858867616,-0.011235911645967933,0.010048503191131486,-0.019018976776387975,-0.002660097160860131,0.0012417412450809184,-0.2454971719537462
2851,2022-04-29,"The Nasdaq, S&P 500 And Dow Took A Big Dive In April",MRK,0.0012417412450809184,-0.2454971719537462,0.04940169340575484,-0.0008286504858867616,-0.011235911645967933,0.010048503191131486,-0.019018976776387975,-0.011726215674140894,-0.23810810471151556
2852,2022-04-29,From Big Tech To Big Energy: A Wild Week Of Earnings Ends With Mixed Results,MRK,0.0012417412450809184,-0.2454971719537462,0.04940169340575484,-0.0008286504858867616,-0.011235911645967933,0.010048503191131486,-0.019018976776387975,-0.011726215674140894,-0.23810810471151556
2853,2022-04-29,"The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid",MRK,0.0012417412450809184,-0.2454971719537462,0.04940169340575484,-0.0008286504858867616,-0.011235911645967933,0.010048503191131486,-0.019018976776387975,-0.011726215674140894,-0.23810810471151556
2854,2022-05-16,"Merck, Athenex Join Forces To Evaluate Oraxol/Keytruda Combo In Lung Cancer",MRK,0.021125930428335993,0.35805822605523807,-0.004623967550716257,0.018387696875867166,0.015715740435013004,0.001939760178203187,-0.008485110066084878,0.007365624746197064,0.25600400028573467
2855,2022-05-20,CHMP Supports Approval Of Merck's Keytruda As Adjuvant In Post Surgery Melanoma Setting,MRK,0.015854065073331647,0.05714105884045462,-0.0001085478903564141,-0.009677388549377164,0.007365624746197064,0.021125930428335993,-0.004623967550716257,0.002993071978482975,-0.22880642335269752
2856,2022-05-23,Seagen Posts Encouraging Data From Tucatinib Combo Trial In Colorectal Cancer,MRK,0.002993071978482975,-0.22880642335269752,0.015854065073331647,-0.0001085478903564141,-0.009677388549377164,0.007365624746197064,0.021125930428335993,0.008632613605437989,-0.005073342891805499
2857,2022-05-24,"The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures",MRK,0.008632613605437989,-0.005073342891805499,0.002993071978482975,0.015854065073331647,-0.0001085478903564141,-0.009677388549377164,0.007365624746197064,-0.009404055489067975,0.23907549052211508
2858,2022-05-24,FDA Lifts Partial Hold On Alpine Immune's Davoceticept Combo Trial In Advanced Cancer,MRK,0.008632613605437989,-0.005073342891805499,0.002993071978482975,0.015854065073331647,-0.0001085478903564141,-0.009677388549377164,0.007365624746197064,-0.009404055489067975,0.23907549052211508
2859,2022-05-26,"The Daily Biotech Pulse: Setback For NRx Pharma's COVID Study, Fast Track Tag For Pfizer's NASH Combo Therapy, Reata's Ataxia Drug In FDA Review",MRK,-0.015360067362671592,0.5432065630675362,-0.009404055489067975,0.008632613605437989,0.002993071978482975,0.015854065073331647,-0.0001085478903564141,0.008341557366001728,-0.4317516449752167
2860,2022-05-26,Sellas' Ovarian Cancer Candidate Shows Clinical Benefit In Pretreated Patients,MRK,-0.015360067362671592,0.5432065630675362,-0.009404055489067975,0.008632613605437989,0.002993071978482975,0.015854065073331647,-0.0001085478903564141,0.008341557366001728,-0.4317516449752167
2861,2022-05-31,Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates,MRK,-0.011280652124149748,1.3322587227096512,0.008341557366001728,-0.015360067362671592,-0.009404055489067975,0.008632613605437989,0.002993071978482975,-0.009670757502674765,-0.54102656075028
2862,2022-06-06,Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients,MRK,-0.0007785178719066366,0.18227069033978105,-0.0010000752763611453,-0.012508165400948679,-0.009670757502674765,-0.011280652124149748,0.008341557366001728,0.007123748335634117,0.22867012918470886
2863,2022-06-06,Yumanity Therapeutics Shares Trading Higher Today - Read Here Why,MRK,-0.0007785178719066366,0.18227069033978105,-0.0010000752763611453,-0.012508165400948679,-0.009670757502674765,-0.011280652124149748,0.008341557366001728,0.007123748335634117,0.22867012918470886
2864,2022-06-07,Rising Yields And A Stronger Dollar Pose Risk For Stocks,MRK,0.007123748335634117,0.22867012918470886,-0.0007785178719066366,-0.0010000752763611453,-0.012508165400948679,-0.009670757502674765,-0.011280652124149748,-0.01105209164877985,0.002216082707721112
2865,2022-06-07,"Merck, Ridgeback Announce New Molnupiravir Data From Late-Stage COVID-19 Study",MRK,0.007123748335634117,0.22867012918470886,-0.0007785178719066366,-0.0010000752763611453,-0.012508165400948679,-0.009670757502674765,-0.011280652124149748,-0.01105209164877985,0.002216082707721112
2866,2022-06-13,HC Wainwright Says This Lymphoma Candidate Has Better Response Rates Than Approved Medications,MRK,-0.025005735942883134,0.3559740904577051,-0.009318130118543322,-0.01654013148556488,-0.01105209164877985,0.007123748335634117,-0.0007785178719066366,0.002253636928762459,-0.06567854794816952
2867,2022-06-15,Chardan Sees Over 200% Upside On This Small-Cap Cancer-Focused Stock,MRK,0.001538378365611992,0.011597146140074344,0.002253636928762459,-0.025005735942883134,-0.009318130118543322,-0.01654013148556488,-0.01105209164877985,0.00307221501525734,0.13807221914044954
2868,2022-06-17,Merck Shows Takeover Interest In Seagen: WSJ,MRK,-0.003180443153561918,1.5523086683378207,0.00307221501525734,0.001538378365611992,0.002253636928762459,-0.025005735942883134,-0.009318130118543322,0.04029773195648345,-0.6429547941592829
2869,2022-06-21,SVB Leerink's Pro-forma Analysis Of Speculated Merck/Seagen Deal - What Investors Need To Know,MRK,0.04029773195648345,-0.6429547941592829,-0.003180443153561918,0.00307221501525734,0.001538378365611992,0.002253636928762459,-0.025005735942883134,0.012836526893768907,0.013312278199446359
2870,2022-06-21,Recap of Tuesday's Biotech Catalysts - End of the Day Summary,MRK,0.04029773195648345,-0.6429547941592829,-0.003180443153561918,0.00307221501525734,0.001538378365611992,0.002253636928762459,-0.025005735942883134,0.012836526893768907,0.013312278199446359
2871,2022-06-21,Merck To Start Pivotal Trial For Next-Gen Pneumococcal Vaccine Next Month,MRK,0.04029773195648345,-0.6429547941592829,-0.003180443153561918,0.00307221501525734,0.001538378365611992,0.002253636928762459,-0.025005735942883134,0.012836526893768907,0.013312278199446359
2872,2022-06-23,"The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise",MRK,0.03185282147061197,0.23317190877557525,0.012836526893768907,0.04029773195648345,-0.003180443153561918,0.00307221501525734,0.001538378365611992,0.012282518516647967,0.7154310251114251
2873,2022-06-24,Merck/Seagen Potential Deal Talks Pick Up Speed: WSJ,MRK,0.012282518516647967,0.7154310251114251,0.03185282147061197,0.012836526893768907,0.04029773195648345,-0.003180443153561918,0.00307221501525734,0.01374443993725949,-0.5267422886202691
2874,2022-06-24,"Benzinga Before The Bell: Gun Safety Bill. Bill Gates North Dakota Outrage, Sanofi-GSK's Covid-19 Vaccine's Omicron Efficacy And Other Top Financial Stories Friday, June 24",MRK,0.012282518516647967,0.7154310251114251,0.03185282147061197,0.012836526893768907,0.04029773195648345,-0.003180443153561918,0.00307221501525734,0.01374443993725949,-0.5267422886202691
2875,2022-06-27,"The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies",MRK,0.01374443993725949,-0.5267422886202691,0.012282518516647967,0.03185282147061197,0.012836526893768907,0.04029773195648345,-0.003180443153561918,-0.026692172794076985,0.131751611013474
2876,2022-06-27,EMA's Advisory Committee Backs Approval For AstraZeneca's Targeted Breast Cancer Therapies,MRK,0.01374443993725949,-0.5267422886202691,0.012282518516647967,0.03185282147061197,0.012836526893768907,0.04029773195648345,-0.003180443153561918,-0.026692172794076985,0.131751611013474
2877,2022-06-29,This Analyst Believes Seagen Is Evaluating Strategic Alternatives,MRK,0.006747093926622982,-0.35983820517181453,-0.026692172794076985,0.01374443993725949,0.012282518516647967,0.03185282147061197,0.012836526893768907,-0.014484916650423951,1.1429115985722702
2878,2022-07-01,"Only 8 Of The 30 Dow Jones Stocks Were Positive In The First Half Of 2022: Chevron Leads, But Who Else Was Up?",MRK,0.013710633926458993,-0.38474724279569195,-0.014484916650423951,0.006747093926622982,-0.026692172794076985,0.01374443993725949,0.012282518516647967,0.002380542276430031,-0.1611557938635687
2879,2022-07-07,"The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill",MRK,-0.001288426146278221,-0.22143793100150166,0.005289180699564744,0.002380542276430031,0.013710633926458993,-0.014484916650423951,0.006747093926622982,-0.0024728928068356026,-0.12021965332121232
2880,2022-07-07,"Benzinga Before The Bell: Elon Musk's Kids, Apple's Potential Security Measure, Covid-19 Vaccine Wastage And Other Top Financial Stories Thursday, July 7",MRK,-0.001288426146278221,-0.22143793100150166,0.005289180699564744,0.002380542276430031,0.013710633926458993,-0.014484916650423951,0.006747093926622982,-0.0024728928068356026,-0.12021965332121232
2881,2022-07-07,Senate Finance Committee Probe Reveals How AbbVie Exploits Offshore Subsidiaries To Avoid Tax Bills,MRK,-0.001288426146278221,-0.22143793100150166,0.005289180699564744,0.002380542276430031,0.013710633926458993,-0.014484916650423951,0.006747093926622982,-0.0024728928068356026,-0.12021965332121232
2882,2022-07-07,Merck's Potential Buyout Of Seagen Expected Within Next Few Weeks: Report,MRK,-0.001288426146278221,-0.22143793100150166,0.005289180699564744,0.002380542276430031,0.013710633926458993,-0.014484916650423951,0.006747093926622982,-0.0024728928068356026,-0.12021965332121232
2883,2022-07-13,Merck Makes $290M Bet On Prostate Cancer Candidate,MRK,0.0018161603624791134,-0.18027215230307292,-0.007423091847999608,0.016382861198061205,-0.0024728928068356026,-0.001288426146278221,0.005289180699564744,0.0011732180068013687,-0.022538811646611423
2884,2022-07-18,"PMV Pharma, Merck Ink Clinical Trial Collaboration For Combination Study In Solid Tumors",MRK,-0.02759060262518076,-0.11079028761084675,0.011503942639472076,0.0011732180068013687,0.0018161603624791134,-0.007423091847999608,0.016382861198061205,0.00021663112430370113,-0.0485457087719704
2885,2022-07-19,Merck & AstraZeneca Partnered Lynparza Fails In Late-Stage Colorectal Cancer Study,MRK,0.00021663112430370113,-0.0485457087719704,-0.02759060262518076,0.011503942639472076,0.0011732180068013687,0.0018161603624791134,-0.007423091847999608,-0.02934158907983453,0.4384959191605131
2886,2022-07-20,"The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study",MRK,-0.02934158907983453,0.4384959191605131,0.00021663112430370113,-0.02759060262518076,0.011503942639472076,0.0011732180068013687,0.0018161603624791134,0.0054655847033888705,-0.307919621749409
2887,2022-07-20,"Pfizer (PFE), BioNTech Seek EU Nod For Omicron-Based COVID Jab",MRK,-0.02934158907983453,0.4384959191605131,0.00021663112430370113,-0.02759060262518076,0.011503942639472076,0.0011732180068013687,0.0018161603624791134,0.0054655847033888705,-0.307919621749409
2888,2022-07-20,What's In The Offing For Infosys (INFY) This Earnings Season?,MRK,-0.02934158907983453,0.4384959191605131,0.00021663112430370113,-0.02759060262518076,0.011503942639472076,0.0011732180068013687,0.0018161603624791134,0.0054655847033888705,-0.307919621749409
2889,2022-07-26,"Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate",MRK,0.008395017205522715,0.007793228061905966,0.004660970943332732,-0.0003327909912579363,0.0054655847033888705,-0.02934158907983453,0.00021663112430370113,-0.0006571974780217316,0.08609157948893853
2890,2022-07-26,Seagen Shares Jump On Positive Data From Urothelial Cancer Trial,MRK,0.008395017205522715,0.007793228061905966,0.004660970943332732,-0.0003327909912579363,0.0054655847033888705,-0.02934158907983453,0.00021663112430370113,-0.0006571974780217316,0.08609157948893853
2891,2022-07-27,"Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy",MRK,-0.0006571974780217316,0.08609157948893853,0.008395017205522715,0.004660970943332732,-0.0003327909912579363,0.0054655847033888705,-0.02934158907983453,-0.014140148778458816,0.9967271004694027
2892,2022-07-28,"Earnings Scheduled For July 28, 2022",MRK,-0.014140148778458816,0.9967271004694027,-0.0006571974780217316,0.008395017205522715,0.004660970943332732,-0.0003327909912579363,0.0054655847033888705,-0.006671140327626612,0.07396224244777061
2893,2022-07-28,Meta and Qualcomm Miss— Will Tech Investors Shrug Off These Reports Too?,MRK,-0.014140148778458816,0.9967271004694027,-0.0006571974780217316,0.008395017205522715,0.004660970943332732,-0.0003327909912579363,0.0054655847033888705,-0.006671140327626612,0.07396224244777061
2894,2022-07-28,"Keytruda, Gardasil Boost Merck's Q2 Revenues, Tightens Annual Guidance",MRK,-0.014140148778458816,0.9967271004694027,-0.0006571974780217316,0.008395017205522715,0.004660970943332732,-0.0003327909912579363,0.0054655847033888705,-0.006671140327626612,0.07396224244777061
2895,2022-07-28,Merck & Co: Q2 Earnings Insights,MRK,-0.014140148778458816,0.9967271004694027,-0.0006571974780217316,0.008395017205522715,0.004660970943332732,-0.0003327909912579363,0.0054655847033888705,-0.006671140327626612,0.07396224244777061
2896,2022-07-29,"Seagen Q2 Earnings - Better Than Expected, Mum On M&A, Lifts Outlook",MRK,-0.006671140327626612,0.07396224244777061,-0.014140148778458816,-0.0006571974780217316,0.008395017205522715,0.004660970943332732,-0.0003327909912579363,-0.009066514766942868,-0.5084345253236582
2897,2022-08-01,"Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial",MRK,-0.009066514766942868,-0.5084345253236582,-0.006671140327626612,-0.014140148778458816,-0.0006571974780217316,0.008395017205522715,0.004660970943332732,-0.010391863961181635,0.01357700216523905
2898,2022-08-01,FDA Removes Clinical Hold On Celyad's Colorectal Cancer Trial,MRK,-0.009066514766942868,-0.5084345253236582,-0.006671140327626612,-0.014140148778458816,-0.0006571974780217316,0.008395017205522715,0.004660970943332732,-0.010391863961181635,0.01357700216523905
2899,2022-08-03,"Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial",MRK,0.00011416342810610658,0.10004030632809346,-0.010391863961181635,-0.009066514766942868,-0.006671140327626612,-0.014140148778458816,-0.0006571974780217316,-0.009130341246515239,-0.02366993990913091
2900,2022-08-03,Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary,MRK,0.00011416342810610658,0.10004030632809346,-0.010391863961181635,-0.009066514766942868,-0.006671140327626612,-0.014140148778458816,-0.0006571974780217316,-0.009130341246515239,-0.02366993990913091
2901,2022-08-03,Merck's Two Keytruda Combo Cancer Trials Miss Primary Goal,MRK,0.00011416342810610658,0.10004030632809346,-0.010391863961181635,-0.009066514766942868,-0.006671140327626612,-0.014140148778458816,-0.0006571974780217316,-0.009130341246515239,-0.02366993990913091
2902,2022-08-04,Recap Of Thursday's Biotech Catalysts - End Of the Day Summary,MRK,-0.009130341246515239,-0.02366993990913091,0.00011416342810610658,-0.010391863961181635,-0.009066514766942868,-0.006671140327626612,-0.014140148778458816,0.006795674609634483,0.10100327754009353
2903,2022-08-04,"Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate",MRK,-0.009130341246515239,-0.02366993990913091,0.00011416342810610658,-0.010391863961181635,-0.009066514766942868,-0.006671140327626612,-0.014140148778458816,0.006795674609634483,0.10100327754009353
2904,2022-08-08,Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern,MRK,0.012355453052007581,-0.07405808298868333,0.006795674609634483,-0.009130341246515239,0.00011416342810610658,-0.010391863961181635,-0.009066514766942868,0.011639694526293765,0.6216531278376323
2905,2022-08-09,Merck Re-enters Alzheimer's R&D With Research Pact With Cerevance,MRK,0.011639694526293765,0.6216531278376323,0.012355453052007581,0.006795674609634483,-0.009130341246515239,0.00011416342810610658,-0.010391863961181635,-0.00368614161753944,-0.38404146645983883
2906,2022-08-10,"Benzinga Before The Bell: Elon Musk Sells $6.8B Tesla Shares, Nio Begins ES7 Test Drives, Coinbase Accused Of Misleading Investors And Other Top Financial Stories Wednesday, August 10",MRK,-0.00368614161753944,-0.38404146645983883,0.011639694526293765,0.012355453052007581,0.006795674609634483,-0.009130341246515239,0.00011416342810610658,-0.0029151420266425587,-0.09132453748065161
2907,2022-08-10,"To Avoid Supply Crunch, FDA Temporarily Allows Higher Impurity Levels In Merck's Diabetes Drug: Report",MRK,-0.00368614161753944,-0.38404146645983883,0.011639694526293765,0.012355453052007581,0.006795674609634483,-0.009130341246515239,0.00011416342810610658,-0.0029151420266425587,-0.09132453748065161
2908,2022-08-10,"Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial",MRK,-0.00368614161753944,-0.38404146645983883,0.011639694526293765,0.012355453052007581,0.006795674609634483,-0.009130341246515239,0.00011416342810610658,-0.0029151420266425587,-0.09132453748065161
2909,2022-08-11,Recap Of Thursday's Biotech Catalysts - End Of the Day Summary,MRK,-0.0029151420266425587,-0.09132453748065161,-0.00368614161753944,0.011639694526293765,0.012355453052007581,0.006795674609634483,-0.009130341246515239,0.023501525298923465,0.6652200951762925
2910,2022-08-12,Senate Finance Committee Expands Amgen's Tax Probe: Report,MRK,0.023501525298923465,0.6652200951762925,-0.0029151420266425587,-0.00368614161753944,0.011639694526293765,0.012355453052007581,0.006795674609634483,-0.004614285949205987,-0.48529304311821586
2911,2022-08-15,Seagen Suffers Loss In Arbitration Dispute Over ADC Technology,MRK,-0.004614285949205987,-0.48529304311821586,0.023501525298923465,-0.0029151420266425587,-0.00368614161753944,0.011639694526293765,0.012355453052007581,-0.00011048182552453323,-0.10703807691094358
2912,2022-08-16,"Merck Bets $250M On Next-Gen Approach To mRNA For Infectious Diseases, Cancer",MRK,-0.00011048182552453323,-0.10703807691094358,-0.004614285949205987,0.023501525298923465,-0.0029151420266425587,-0.00368614161753944,0.011639694526293765,0.004967584544500747,0.14569349254575004
2913,2022-08-16,Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary,MRK,-0.00011048182552453323,-0.10703807691094358,-0.004614285949205987,0.023501525298923465,-0.0029151420266425587,-0.00368614161753944,0.011639694526293765,0.004967584544500747,0.14569349254575004
2914,2022-08-16,AstraZeneca-Merck's Prostate Cancer Drug Under FDA Priority Review For Expanded Use,MRK,-0.00011048182552453323,-0.10703807691094358,-0.004614285949205987,0.023501525298923465,-0.0029151420266425587,-0.00368614161753944,0.011639694526293765,0.004967584544500747,0.14569349254575004
2915,2022-08-18,What's In The Cards For Medtronic (MDT) In Q1 Earnings?,MRK,0.003954183939854694,-0.0577243293246994,0.004967584544500747,-0.00011048182552453323,-0.004614285949205987,0.023501525298923465,-0.0029151420266425587,0.007439842974176658,0.4445807971725899
2916,2022-08-19,Looking For Ebola Virus Meds? WHO Recommends These Two Antibody Treatments,MRK,0.007439842974176658,0.4445807971725899,0.003954183939854694,0.004967584544500747,-0.00011048182552453323,-0.004614285949205987,0.023501525298923465,-0.009991306055054494,-0.24653686273177255
2917,2022-08-22,FDA Says Study Needed To Assess Another Round Of Pfizer's COVID-19 Pill As Infection Rebounds,MRK,-0.009991306055054494,-0.24653686273177255,0.007439842974176658,0.003954183939854694,0.004967584544500747,-0.00011048182552453323,-0.004614285949205987,-0.010531010193134627,-0.2169690774341937
2918,2022-08-22,"Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday, August 22",MRK,-0.009991306055054494,-0.24653686273177255,0.007439842974176658,0.003954183939854694,0.004967584544500747,-0.00011048182552453323,-0.004614285949205987,-0.010531010193134627,-0.2169690774341937
2919,2022-08-22,Gilead's Lenacapavir Scores European Approval For Pretreated HIV Patients After Manufacturing Delays,MRK,-0.009991306055054494,-0.24653686273177255,0.007439842974176658,0.003954183939854694,0.004967584544500747,-0.00011048182552453323,-0.004614285949205987,-0.010531010193134627,-0.2169690774341937
2920,2022-08-23,Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary,MRK,-0.010531010193134627,-0.2169690774341937,-0.009991306055054494,0.007439842974176658,0.003954183939854694,0.004967584544500747,-0.00011048182552453323,-0.0021063031885633077,0.06613807402856708
2921,2022-08-23,Merck Gets FDA Fast Track Status For Chronic Kidney Disease Candidate,MRK,-0.010531010193134627,-0.2169690774341937,-0.009991306055054494,0.007439842974176658,0.003954183939854694,0.004967584544500747,-0.00011048182552453323,-0.0021063031885633077,0.06613807402856708
2922,2022-08-25,Back-To-Back Three Japanese Approvals For AstraZeneca's Rare Disease Treatments,MRK,0.0028884116922904823,0.05960419930491789,-0.0021063031885633077,-0.010531010193134627,-0.009991306055054494,0.007439842974176658,0.003954183939854694,-0.011188577595140692,-0.032119368489030076
2923,2022-08-26,Merck's Buyout Of Seagen Hits Speed Braker Over Price Agreement: Report,MRK,-0.011188577595140692,-0.032119368489030076,0.0028884116922904823,-0.0021063031885633077,-0.010531010193134627,-0.009991306055054494,0.007439842974176658,-0.01870937202236167,0.3783646164381156
2924,2022-08-26,"Benzinga Before The Bell: Elon Musk's Demand For Broad Twitter Data Dismissed, Xiaomi Wants To Join EV Race, Bed Bath & Beyond Plans To Share Turnaround Strategy Next Week And Other Top Financial Stories Friday, August 26",MRK,-0.011188577595140692,-0.032119368489030076,0.0028884116922904823,-0.0021063031885633077,-0.010531010193134627,-0.009991306055054494,0.007439842974176658,-0.01870937202236167,0.3783646164381156
2925,2022-08-29,"Bristol Myers-JNJ Partnered Secondary Stroke Drug Misses Endpoint, But Companies See Enough Potential For Phase 3 Trials",MRK,-0.01870937202236167,0.3783646164381156,-0.011188577595140692,0.0028884116922904823,-0.0021063031885633077,-0.010531010193134627,-0.009991306055054494,-0.008106030513962192,-0.13963975440116172
2926,2022-08-30,"With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report",MRK,-0.008106030513962192,-0.13963975440116172,-0.01870937202236167,-0.011188577595140692,0.0028884116922904823,-0.0021063031885633077,-0.010531010193134627,-0.01749532869277337,0.7177968611193366
2927,2022-09-01,"Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash…",MRK,0.020970070923708617,-0.35109463885536973,-0.01749532869277337,-0.008106030513962192,-0.01870937202236167,-0.011188577595140692,0.0028884116922904823,-0.010556415679452313,-0.07054432430996471
2928,2022-09-01,Novartis Appoints Merck Executive As Research Head,MRK,0.020970070923708617,-0.35109463885536973,-0.01749532869277337,-0.008106030513962192,-0.01870937202236167,-0.011188577595140692,0.0028884116922904823,-0.010556415679452313,-0.07054432430996471
2929,2022-09-09,"Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary",MRK,-0.0009151141146052089,-0.07757855275489567,0.006331309704891153,0.005207103324611495,0.0022032762105204107,-0.010556415679452313,0.020970070923708617,0.009388645118907801,-0.15088033582438742
2930,2022-09-09,AstraZeneca-Merck's Lynparza Treatment Shows Long-Term Survival In Ovarian Cancer,MRK,-0.0009151141146052089,-0.07757855275489567,0.006331309704891153,0.005207103324611495,0.0022032762105204107,-0.010556415679452313,0.020970070923708617,0.009388645118907801,-0.15088033582438742
2931,2022-09-12,"BP To $47? Plus UBS Sees $2,260 For This Stock",MRK,0.009388645118907801,-0.15088033582438742,-0.0009151141146052089,0.006331309704891153,0.005207103324611495,0.0022032762105204107,-0.010556415679452313,-0.02132493493799137,0.20443989608753843
2932,2022-09-12,Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer,MRK,0.009388645118907801,-0.15088033582438742,-0.0009151141146052089,0.006331309704891153,0.005207103324611495,0.0022032762105204107,-0.010556415679452313,-0.02132493493799137,0.20443989608753843
2933,2022-09-12,Five-Year Data For Merck's Keytruda Plus Chemo Shows Sustained Survival Benefit In Lung Cancer Patients,MRK,0.009388645118907801,-0.15088033582438742,-0.0009151141146052089,0.006331309704891153,0.005207103324611495,0.0022032762105204107,-0.010556415679452313,-0.02132493493799137,0.20443989608753843
2934,2022-09-13,"Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary",MRK,-0.02132493493799137,0.20443989608753843,0.009388645118907801,-0.0009151141146052089,0.006331309704891153,0.005207103324611495,0.0022032762105204107,0.015889708282694093,0.23120261437908507
2935,2022-09-13,"After FDA Regulatory Setback, Penny Stock ObsEva Cuts 70% Of Its Staff",MRK,-0.02132493493799137,0.20443989608753843,0.009388645118907801,-0.0009151141146052089,0.006331309704891153,0.005207103324611495,0.0022032762105204107,0.015889708282694093,0.23120261437908507
2936,2022-09-14,Immutep Issues Development Update For Its Lead Cancer Candidate,MRK,0.015889708282694093,0.23120261437908507,-0.02132493493799137,0.009388645118907801,-0.0009151141146052089,0.006331309704891153,0.005207103324611495,-0.002300167500790873,-0.1499039145529638
2937,2022-09-14,"Evercore ISI Group Boosts PT On This Stock By Around 400%, Plus This Analyst Predicts $100 For Merck",MRK,0.015889708282694093,0.23120261437908507,-0.02132493493799137,0.009388645118907801,-0.0009151141146052089,0.006331309704891153,0.005207103324611495,-0.002300167500790873,-0.1499039145529638
2938,2022-09-20,Merck To Start New Islatravir HIV Trials With Lower Dose After FDA Hold,MRK,-0.0073868363502184176,-0.2960276695144929,-0.012311892218510367,0.011181558518362111,-0.002300167500790873,0.015889708282694093,-0.02132493493799137,-0.017093101728895332,0.31825181491530397
2939,2022-09-22,Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial,MRK,0.03525378940841106,0.714649274072426,-0.017093101728895332,-0.0073868363502184176,-0.012311892218510367,0.011181558518362111,-0.002300167500790873,-0.008341858915337452,-0.26693269098193795
2940,2022-09-23,Citius Pharma Inks Clinical Collaboration For I/ONTAK Combo Regime in Solid Tumor Settings,MRK,-0.008341858915337452,-0.26693269098193795,0.03525378940841106,-0.017093101728895332,-0.0073868363502184176,-0.012311892218510367,0.011181558518362111,-0.006914019965339913,-0.02185097084693255
2941,2022-09-27,"Corvus Pharma's Partner Secures China Approval For Early-Stage Mupadolimab Trial For Lung, Head & Neck Cancer",MRK,-0.003945365566157322,-0.2611582400180975,-0.006914019965339913,-0.008341858915337452,0.03525378940841106,-0.017093101728895332,-0.0073868363502184176,0.010950726640032382,0.04713644922766025
2942,2022-09-29,Merck Inks Supply Deal With Sinopharm To Commercialize COVID-19 Pills In China,MRK,-0.0016133247938096007,-0.03489766081871348,0.010950726640032382,-0.003945365566157322,-0.006914019965339913,-0.008341858915337452,0.03525378940841106,-0.006001815691836887,0.36876069865026584
2943,2022-09-29,"Vietnam Law May Impact Facebook, Twitter; Amazon Has A Sleep Tracker; India Lures Apple, Dell, HP: Top Financial Media Stories Thursday, Sept. 29",MRK,-0.0016133247938096007,-0.03489766081871348,0.010950726640032382,-0.003945365566157322,-0.006914019965339913,-0.008341858915337452,0.03525378940841106,-0.006001815691836887,0.36876069865026584
2944,2022-09-30,"'Right Now, You've Still Got To Avoid The Stock,' Jim Cramer Says About This Aerospace Company",MRK,-0.006001815691836887,0.36876069865026584,-0.0016133247938096007,0.010950726640032382,-0.003945365566157322,-0.006914019965339913,-0.008341858915337452,0.01660476345526063,0.016744875824516336
2945,2022-10-03,The Short List Of Dow Jones Stocks That Are Actually Up This Year: Hint — It's Very Short,MRK,0.01660476345526063,0.016744875824516336,-0.006001815691836887,-0.0016133247938096007,0.010950726640032382,-0.003945365566157322,-0.006914019965339913,0.009594460475451427,-0.19744418683124887
2946,2022-10-05,AnaptysBio / GSK-Partnered Immuno-Oncology Agent Meets Primary Goal In Lung Cancer Trial,MRK,0.0,-0.17730910077309103,0.009594460475451427,0.01660476345526063,-0.006001815691836887,-0.0016133247938096007,0.010950726640032382,-0.010747754803785536,0.32804128130306487
2947,2022-10-06,"Verve's Stock Price Could Continue To Rise Through Clinical Progress - Despite Worries About ""DeeperPocketed"" Competition",MRK,-0.010747754803785536,0.32804128130306487,0.0,0.009594460475451427,0.01660476345526063,-0.006001815691836887,-0.0016133247938096007,0.0018297689586139754,0.09706411768357026
2948,2022-10-07,"Amazon Halts Delivery Bots; Merck's Covid-19 Pill Didn't Reduce Risk; Samsung Profits Slip; Adidas Reviews Relationship With Kanye: Top Stories Friday, Oct. 7",MRK,0.0018297689586139754,0.09706411768357026,-0.010747754803785536,0.0,0.009594460475451427,0.01660476345526063,-0.006001815691836887,0.03287674570590138,0.6390567361441148
2949,2022-10-07,UK Study Shows Merck's COVID-19 Antiviral Pill Did Not Cut Hospitalization Risk,MRK,0.0018297689586139754,0.09706411768357026,-0.010747754803785536,0.0,0.009594460475451427,0.01660476345526063,-0.006001815691836887,0.03287674570590138,0.6390567361441148
2950,2022-10-10,New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope,MRK,0.03287674570590138,0.6390567361441148,0.0018297689586139754,-0.010747754803785536,0.0,0.009594460475451427,0.01660476345526063,0.006299746281942964,-0.3273386261649983
2951,2022-10-10,Centre Piece Of Merck's $11.5B Acceleron Buyout Aces Late-Stage Cardiovascular Trial,MRK,0.03287674570590138,0.6390567361441148,0.0018297689586139754,-0.010747754803785536,0.0,0.009594460475451427,0.01660476345526063,0.006299746281942964,-0.3273386261649983
2952,2022-10-11,PDS Biotech Highlights Expanded Data From PDS0101 Triple Combination Trial In HPV-Positive Cancers,MRK,0.006299746281942964,-0.3273386261649983,0.03287674570590138,0.0018297689586139754,-0.010747754803785536,0.0,0.009594460475451427,-0.006919319004336955,-0.12534510186278036
2953,2022-10-11,Merck Collaborates Ginkgo Bioworks to Improve Active Pharmaceutical Ingredient Manufacturing,MRK,0.006299746281942964,-0.3273386261649983,0.03287674570590138,0.0018297689586139754,-0.010747754803785536,0.0,0.009594460475451427,-0.006919319004336955,-0.12534510186278036
2954,2022-10-11,"With Meaningful Upside, This Cancer Stock Earns Analyst Upgrade",MRK,0.006299746281942964,-0.3273386261649983,0.03287674570590138,0.0018297689586139754,-0.010747754803785536,0.0,0.009594460475451427,-0.006919319004336955,-0.12534510186278036
2955,2022-10-11,Merck To Rally Over 29%? Here Are 5 Other Price Target Changes For Tuesday,MRK,0.006299746281942964,-0.3273386261649983,0.03287674570590138,0.0018297689586139754,-0.010747754803785536,0.0,0.009594460475451427,-0.006919319004336955,-0.12534510186278036
2956,2022-10-12,Moderna Shares Are Surging After Merck Exercised Personalized Cancer Vaccine Pact,MRK,-0.006919319004336955,-0.12534510186278036,0.006299746281942964,0.03287674570590138,0.0018297689586139754,-0.010747754803785536,0.0,0.022893140371097465,0.10098331416770323
2957,2022-10-12,"Yet Another Good News For Moderna, FDA Approves Its New Omicron Adapted COVID-19 Shot",MRK,-0.006919319004336955,-0.12534510186278036,0.006299746281942964,0.03287674570590138,0.0018297689586139754,-0.010747754803785536,0.0,0.022893140371097465,0.10098331416770323
2958,2022-10-12,Why Moderna Stock Is Moving Higher Today,MRK,-0.006919319004336955,-0.12534510186278036,0.006299746281942964,0.03287674570590138,0.0018297689586139754,-0.010747754803785536,0.0,0.022893140371097465,0.10098331416770323
2959,2022-10-18,Merck Outlicenses Two Preclinical TB Candidates To Bill & Melinda Gates Research Institute,MRK,0.0052061165995271885,-0.21493941365931613,0.021045784072950102,-0.0033516980230952065,0.022893140371097465,-0.006919319004336955,0.006299746281942964,-0.014269032501594281,-0.10328003021908838
2960,2022-10-24,Merck's Antiviral Therapy Shows Efficacy In Prevention of Cytomegalovirus In Kidney Transplant Patients,MRK,0.017769457320540694,0.10854407023268453,0.029373782773280732,-0.0034313259661818973,-0.014269032501594281,0.0052061165995271885,0.021045784072950102,0.003491795650254259,-0.2336419942356044
2961,2022-10-27,"Merck Clocks More Than 50% Drop In COVID-19 Treatment Sales, Revises Annual Guidance",MRK,0.013514753847926109,0.17771116273241638,0.007164120229446791,0.003491795650254259,0.017769457320540694,0.029373782773280732,-0.0034313259661818973,0.010326881984882741,-0.08105807634387485
2962,2022-10-27,"Elon Musk & Philippine Billionaire Come Together For Satellite Internet Service In Southeast Asia, Disney May Track Your Theme Park Preferences, Struggling Credit Suisse Reveals Business Overhaul: Top Stories Thursday, Oct. 27",MRK,0.013514753847926109,0.17771116273241638,0.007164120229446791,0.003491795650254259,0.017769457320540694,0.029373782773280732,-0.0034313259661818973,0.010326881984882741,-0.08105807634387485
2963,2022-10-27,"US Stocks On Track For Mixed Start As Nasdaq Futures Sag Yet Again Amid Big Tech Woes; Traders Look Ahead To Q3 GDP Data, Apple, Amazon Earnings",MRK,0.013514753847926109,0.17771116273241638,0.007164120229446791,0.003491795650254259,0.017769457320540694,0.029373782773280732,-0.0034313259661818973,0.010326881984882741,-0.08105807634387485
2964,2022-10-31,Bristol Myers Touts Positive Reblozyl Data From Late-Stage Blood Disorder Study,MRK,0.004267110708741972,-0.016405415033843962,0.010326881984882741,0.013514753847926109,0.007164120229446791,0.003491795650254259,0.017769457320540694,-0.014229187999572068,0.00321447327912483
2965,2022-11-02,EVP of Merck & Co Sold $2.49M In Stock,MRK,-0.0036086838490002604,-0.1422292022059155,-0.014229187999572068,0.004267110708741972,0.010326881984882741,0.013514753847926109,0.007164120229446791,-0.006539260067458974,0.043057820802862024
2966,2022-11-02,Massive Insider Trade At Merck & Co,MRK,-0.0036086838490002604,-0.1422292022059155,-0.014229187999572068,0.004267110708741972,0.010326881984882741,0.013514753847926109,0.007164120229446791,-0.006539260067458974,0.043057820802862024
2967,2022-11-02,EVP At This Health Care Company Sells $16.42M of Stock,MRK,-0.0036086838490002604,-0.1422292022059155,-0.014229187999572068,0.004267110708741972,0.010326881984882741,0.013514753847926109,0.007164120229446791,-0.006539260067458974,0.043057820802862024
2968,2022-11-04,Merck & Co Executive Chair Trades Company's Stock,MRK,0.004556991367637764,-0.10442160057300232,-0.006539260067458974,-0.0036086838490002604,-0.014229187999572068,0.004267110708741972,0.010326881984882741,0.008770165533951157,-0.02625709651257091
2969,2022-11-07,Control Of Congress Up For Grabs In Midterms: 12 Stocks To Watch,MRK,0.008770165533951157,-0.02625709651257091,0.004556991367637764,-0.006539260067458974,-0.0036086838490002604,-0.014229187999572068,0.004267110708741972,0.014290019845317747,-0.01626467696223033
2970,2022-11-08,Election Day Is Here: Which Politicians Are Profiting (Or Losing) On Stocks?,MRK,0.014290019845317747,-0.01626467696223033,0.008770165533951157,0.004556991367637764,-0.006539260067458974,-0.0036086838490002604,-0.014229187999572068,0.00088662897674463,0.2468279260104187
2971,2022-11-09,Executive Chair At This Health Care Company Sells $23.47M of Stock,MRK,0.00088662897674463,0.2468279260104187,0.014290019845317747,0.008770165533951157,0.004556991367637764,-0.006539260067458974,-0.0036086838490002604,0.0029531163659846094,-0.09873713795282424
2972,2022-11-10,SELLAS Life Sciences' GPS Combo Therapy Shows Overall Survival Of 18 Months In Pretreated Ovarian Cancer Patients,MRK,0.0029531163659846094,-0.09873713795282424,0.00088662897674463,0.014290019845317747,0.008770165533951157,0.004556991367637764,-0.006539260067458974,-0.03857105178770326,0.39627459187944747
2973,2022-11-11,What Does Merck & Co's Debt Look Like?,MRK,-0.03857105178770326,0.39627459187944747,0.0029531163659846094,0.00088662897674463,0.014290019845317747,0.008770165533951157,0.004556991367637764,0.02439766847303293,-0.3286116857031508
2974,2022-11-11,"These 2 Dividend Paying ETFs Have A Track Record For Increasing Payments, Can Help Diversify Against Industry Risk",MRK,-0.03857105178770326,0.39627459187944747,0.0029531163659846094,0.00088662897674463,0.014290019845317747,0.008770165533951157,0.004556991367637764,0.02439766847303293,-0.3286116857031508
2975,2022-11-14,European Medicines Agency's Advisory Committee Backs Approval Of AstraZeneca's Three Cancer Drugs,MRK,0.02439766847303293,-0.3286116857031508,-0.03857105178770326,0.0029531163659846094,0.00088662897674463,0.014290019845317747,0.008770165533951157,-0.007473787183790548,-0.11077002076309972
2976,2022-11-16,"FTX Contagion Spreads To Hong Kong Exchange, Microsoft Outlines New Harassment Policies, Netflix Subscribers Can Terminate Freeloading Account Access: Top Stories Wednesday, Nov. 16",MRK,0.0033132225157508355,0.09939868690292375,-0.007473787183790548,0.02439766847303293,-0.03857105178770326,0.0029531163659846094,0.00088662897674463,0.023816713480972362,-0.02979092684152229
2977,2022-11-16,"Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says",MRK,0.0033132225157508355,0.09939868690292375,-0.007473787183790548,0.02439766847303293,-0.03857105178770326,0.0029531163659846094,0.00088662897674463,0.023816713480972362,-0.02979092684152229
2978,2022-11-17,A Look Into Merck & Co's Debt,MRK,0.023816713480972362,-0.02979092684152229,0.0033132225157508355,-0.007473787183790548,0.02439766847303293,-0.03857105178770326,0.0029531163659846094,0.01876651346379954,0.3683151304020338
2979,2022-11-17,Analyst Expects 'Somewhat Smaller Effect Size' From Gossamer Bio's Upcoming PAH Trial,MRK,0.023816713480972362,-0.02979092684152229,0.0033132225157508355,-0.007473787183790548,0.02439766847303293,-0.03857105178770326,0.0029531163659846094,0.01876651346379954,0.3683151304020338
2980,2022-11-18,Here's How Much You Would Have Made Owning Merck & Co Stock In The Last 5 Years,MRK,0.01876651346379954,0.3683151304020338,0.023816713480972362,0.0033132225157508355,-0.007473787183790548,0.02439766847303293,-0.03857105178770326,0.013239935773906142,-0.23455441542021105
2981,2022-11-18,Credit Suisse Believes In This Pharma Giant's Low Risk Growth Against Uncertain Backdrop,MRK,0.01876651346379954,0.3683151304020338,0.023816713480972362,0.0033132225157508355,-0.007473787183790548,0.02439766847303293,-0.03857105178770326,0.013239935773906142,-0.23455441542021105
2982,2022-11-21,Analyst Says IO Biotech's Cancer Treatment Approach 'Differentiated',MRK,0.013239935773906142,-0.23455441542021105,0.01876651346379954,0.023816713480972362,0.0033132225157508355,-0.007473787183790548,0.02439766847303293,0.012214806195368855,-0.06782555931365386
2983,2022-11-21,Cancer-Focused Imago BioSciences Shares Soar After Merck Deal,MRK,0.013239935773906142,-0.23455441542021105,0.01876651346379954,0.023816713480972362,0.0033132225157508355,-0.007473787183790548,0.02439766847303293,0.012214806195368855,-0.06782555931365386
2984,2022-11-22,"$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today",MRK,0.012214806195368855,-0.06782555931365386,0.013239935773906142,0.01876651346379954,0.023816713480972362,0.0033132225157508355,-0.007473787183790548,-0.0007484480878982014,-0.306918041877117
2985,2022-11-22,Merck's Keytruda Phase 3 Trial Meets Primary Endpoint In Gastric Cancer Patients,MRK,0.012214806195368855,-0.06782555931365386,0.013239935773906142,0.01876651346379954,0.023816713480972362,0.0033132225157508355,-0.007473787183790548,-0.0007484480878982014,-0.306918041877117
2986,2022-11-22,10-Year Phase 3 Trial Shows CEL-SCI's Multikine immunotherapy Extends Lives In Head & Neck Cancer Patients,MRK,0.012214806195368855,-0.06782555931365386,0.013239935773906142,0.01876651346379954,0.023816713480972362,0.0033132225157508355,-0.007473787183790548,-0.0007484480878982014,-0.306918041877117
2987,2022-11-23,Mirati Therapeutics Garners Interest From Large Pharmas Ahead Of Much Awaited Data Next Month,MRK,-0.0007484480878982014,-0.306918041877117,0.012214806195368855,0.013239935773906142,0.01876651346379954,0.023816713480972362,0.0033132225157508355,0.006365922233409815,-0.4497530262974816
2988,2022-11-29,"Cramer Expects Dow's Outperformance To Last 'Longer' As Traders Chase 'Old-Fashioned, Profitable' Companies Amid Uncertainty",MRK,0.0035961265571853307,-0.018069189983726197,0.008837153625647298,0.006365922233409815,-0.0007484480878982014,0.012214806195368855,0.013239935773906142,0.011760441905791508,1.1711860057311494
2989,2022-12-06,"Mirati Experimental Lung Cancer Drug Shows Favorable Tolerability, Promising Efficacy",MRK,-0.00981721177519912,0.07135982993148415,-0.0002726767240337491,0.002185829836017339,-0.002905970505312272,0.011760441905791508,0.0035961265571853307,0.010648974106491904,0.10882593481437786
2990,2022-12-07,A Look Into Merck & Co's Debt,MRK,0.010648974106491904,0.10882593481437786,-0.00981721177519912,-0.0002726767240337491,0.002185829836017339,-0.002905970505312272,0.011760441905791508,0.006903455654555746,-0.11070806732443417
2991,2022-12-07,GSK's Jemperli/Chemo Combo Shows Response Rate Of 46% In Head-To-Head Lung Cancer Trial,MRK,0.010648974106491904,0.10882593481437786,-0.00981721177519912,-0.0002726767240337491,0.002185829836017339,-0.002905970505312272,0.011760441905791508,0.006903455654555746,-0.11070806732443417
2992,2022-12-08,Here's How Much $100 Invested In Merck & Co 5 Years Ago Would Be Worth Today,MRK,0.006903455654555746,-0.11070806732443417,0.010648974106491904,-0.00981721177519912,-0.0002726767240337491,0.002185829836017339,-0.002905970505312272,-0.01867386351863687,0.31448849730788053
2993,2022-12-09,"Stryker, Freeport-McMoRan, Southwest Gas And This Health Care Major Feature On CNBC's 'Final Trades'",MRK,-0.01867386351863687,0.31448849730788053,0.006903455654555746,0.010648974106491904,-0.00981721177519912,-0.0002726767240337491,0.002185829836017339,0.001746647838785531,0.13330850865760557
2994,2022-12-13,"Moderna's Data From Personalized Cancer Vaccine Provides Relief To Investors, Analyst Says",MRK,0.017803068098640962,0.445421024770458,0.001746647838785531,-0.01867386351863687,0.006903455654555746,0.010648974106491904,-0.00981721177519912,0.012434209810704422,-0.3187871363713858
2995,2022-12-13,"Tesla, Amazon, Coinbase, Moderna, Nuwellis: Why These 5 Stocks Are Drawing Investors' Attention Today",MRK,0.017803068098640962,0.445421024770458,0.001746647838785531,-0.01867386351863687,0.006903455654555746,0.010648974106491904,-0.00981721177519912,0.012434209810704422,-0.3187871363713858
2996,2022-12-13,"Moderna-Merck Partnered Cancer Vaccine Meets Primary Efficacy Endpoint, Stock Jumps",MRK,0.017803068098640962,0.445421024770458,0.001746647838785531,-0.01867386351863687,0.006903455654555746,0.010648974106491904,-0.00981721177519912,0.012434209810704422,-0.3187871363713858
2997,2022-12-14,Market Volatility Drops Sharply Ahead Of Fed's Rate Decision,MRK,0.012434209810704422,-0.3187871363713858,0.017803068098640962,0.001746647838785531,-0.01867386351863687,0.006903455654555746,0.010648974106491904,-0.017212101294113435,-0.0849902208874429
2998,2022-12-15,"BioNTech Stock Gets Upgrade, Analyst Sees Multiple Upside Opportunities",MRK,-0.017212101294113435,-0.0849902208874429,0.012434209810704422,0.017803068098640962,0.001746647838785531,-0.01867386351863687,0.006903455654555746,-0.003922296593932617,1.9849768016694695
2999,2022-12-15,"Elon Musk Dumps Another $3.6B Tesla Stock, Facebook's Jobs' Feature To Disappear Next Year, Foxconn Relaxes Covid Restrictions In China Factory: Today's Top Stories",MRK,-0.017212101294113435,-0.0849902208874429,0.012434209810704422,0.017803068098640962,0.001746647838785531,-0.01867386351863687,0.006903455654555746,-0.003922296593932617,1.9849768016694695
3000,2022-12-15,"FDA Extends Review Period For AstraZeneca-Merck Partnered Cancer Drug, Lynparza",MRK,-0.017212101294113435,-0.0849902208874429,0.012434209810704422,0.017803068098640962,0.001746647838785531,-0.01867386351863687,0.006903455654555746,-0.003922296593932617,1.9849768016694695
3001,2022-12-15,"West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies",MRK,-0.017212101294113435,-0.0849902208874429,0.012434209810704422,0.017803068098640962,0.001746647838785531,-0.01867386351863687,0.006903455654555746,-0.003922296593932617,1.9849768016694695
3002,2022-12-20,"Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says",MRK,0.002467098335752871,0.15432764947118494,0.0021978665196216163,-0.003922296593932617,-0.017212101294113435,0.012434209810704422,0.017803068098640962,0.012760926079915969,-0.17216404886561953
3003,2022-12-21,"Europe Approves AstraZeneca's Two Combo Therapies For Prostate, Bile Duct Cancer Settings",MRK,0.012760926079915969,-0.17216404886561953,0.002467098335752871,0.0021978665196216163,-0.003922296593932617,-0.017212101294113435,0.012434209810704422,0.0011699623151963934,0.26092848860847173
3004,2022-12-21,"After Disappointing Phase 2 Data, Merck Drops Eye Disease Related Pact With NGM Biopharm",MRK,0.012760926079915969,-0.17216404886561953,0.002467098335752871,0.0021978665196216163,-0.003922296593932617,-0.017212101294113435,0.012434209810704422,0.0011699623151963934,0.26092848860847173
3005,2022-12-22,"Merck, Kelun-Biotech Ink Licensing Pact For Seven Cancer Candidates",MRK,0.0011699623151963934,0.26092848860847173,0.012760926079915969,0.002467098335752871,0.0021978665196216163,-0.003922296593932617,-0.017212101294113435,0.005573565344224818,-0.4569425701899996
3006,2022-12-23,$100 Invested In Merck & Co 5 Years Ago Would Be Worth This Much Today,MRK,0.005573565344224818,-0.4569425701899996,0.0011699623151963934,0.012760926079915969,0.002467098335752871,0.0021978665196216163,-0.003922296593932617,0.002324373283195902,0.12719356115582525
3007,2022-12-23,"Merck COVID Antiviral Does Not Reduce Risk Of Hospitalization, Death Rates In Vaccinated Individuals",MRK,0.005573565344224818,-0.4569425701899996,0.0011699623151963934,0.012760926079915969,0.002467098335752871,0.0021978665196216163,-0.003922296593932617,0.002324373283195902,0.12719356115582525
3008,2022-12-23,"Meta Settles Cambridge Analytica Scandal Case, Microsoft Files Rebuttal To FTC's Lawsuit Against Activision Deal, US Winter Storm Snaps Holiday Plans: Today's Top Stories",MRK,0.005573565344224818,-0.4569425701899996,0.0011699623151963934,0.012760926079915969,0.002467098335752871,0.0021978665196216163,-0.003922296593932617,0.002324373283195902,0.12719356115582525
3009,2022-12-27,"Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors",MRK,0.002324373283195902,0.12719356115582525,0.005573565344224818,0.0011699623151963934,0.012760926079915969,0.002467098335752871,0.0021978665196216163,-0.009275795363787864,-0.003511646962425341
3010,2022-12-28,"AT&T, Merck And This Leading Payments Processor Stock On CNBC's 'Final Trades'",MRK,-0.009275795363787864,-0.003511646962425341,0.002324373283195902,0.005573565344224818,0.0011699623151963934,0.012760926079915969,0.002467098335752871,-0.0023406949078058625,-0.12541603038490157
3011,2023-01-04,"Merck Vs. Pfizer: Why Analyst Upgrades One Pharmaceutical Stock, While Downgrading Another",MRK,0.008457800237841706,0.07889612403100776,0.0017125013986951654,0.0011730933074340921,-0.0023406949078058625,-0.009275795363787864,0.002324373283195902,0.013918590434612188,0.10120019313452744
3012,2023-01-11,"FAA Technology Glitch Hits US Flights Operations, Coca-Cola & PepsiCo Under FTC Probe, Rivian's Executive Departures: Today's Top Stories",MRK,0.002346398399091232,-0.288406968687102,0.0038955759311578575,-0.038836580362783146,0.010559632822232157,0.013918590434612188,0.008457800237841706,0.006302337336657526,0.03342027473482867
3013,2023-01-11,"Merck, Pfizer Rebuts China's Request For Further Price Cuts For COVID-19 Drugs",MRK,0.002346398399091232,-0.288406968687102,0.0038955759311578575,-0.038836580362783146,0.010559632822232157,0.013918590434612188,0.008457800237841706,0.006302337336657526,0.03342027473482867
3014,2023-01-13,"Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot",MRK,0.004294521412773866,-0.35413021043657733,0.006302337336657526,0.002346398399091232,0.0038955759311578575,-0.038836580362783146,0.010559632822232157,-0.01603565855321476,0.7786480947584147
3015,2023-01-18,Can Cannabinoid CB2 Receptor Antagonist Combined With KEYTRUDA Be Effective In Patients With Advanced Solid Tumors? These Two Companies Aim To Find Out,MRK,-0.015029406797604006,-0.1407661286385251,-0.01603565855321476,0.004294521412773866,0.006302337336657526,0.002346398399091232,0.0038955759311578575,0.010203185948095994,-0.2303085402579692
3016,2023-01-19,"Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects",MRK,0.010203185948095994,-0.2303085402579692,-0.015029406797604006,-0.01603565855321476,0.004294521412773866,0.006302337336657526,0.002346398399091232,0.0003639895180524988,0.3607907986239278
3017,2023-01-20,Seagen's Tukysa Becomes First FDA-Approved Treatment For HER2-Positive Metastatic Colorectal Cancer,MRK,0.0003639895180524988,0.3607907986239278,0.010203185948095994,-0.015029406797604006,-0.01603565855321476,0.004294521412773866,0.006302337336657526,-0.0005458205560591178,-0.02362068030163289
3018,2023-01-31,"February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More",MRK,0.012442303876629035,0.22578204613531794,0.006737551451662105,-0.01394225312129993,-0.01583930539842804,0.0006449933971535149,-0.012377127676049482,-0.004003364222103012,0.27261963244278165
3019,2023-02-02,Central Banks And More Earnings,MRK,-0.03290335001787037,0.6064118299152743,-0.004003364222103012,0.012442303876629035,0.006737551451662105,-0.01394225312129993,-0.01583930539842804,-0.005026033481197567,-0.30925021103025896
3020,2023-02-02,"US Stocks Higher, NASDAQ Adds Over 230 Points",MRK,-0.03290335001787037,0.6064118299152743,-0.004003364222103012,0.012442303876629035,0.006737551451662105,-0.01394225312129993,-0.01583930539842804,-0.005026033481197567,-0.30925021103025896
3021,2023-02-02,"Nasdaq Futures Fly As Meta Keeps Tech Earnings' Buoyancy Intact: Will Apple, Amazon, Alphabet Toe In Line?",MRK,-0.03290335001787037,0.6064118299152743,-0.004003364222103012,0.012442303876629035,0.006737551451662105,-0.01394225312129993,-0.01583930539842804,-0.005026033481197567,-0.30925021103025896
3022,2023-02-02,"Merck Beats On Q4 earnings, Anticipates Almost 80% Decline In COVID-19 Treatment Sales In 2023",MRK,-0.03290335001787037,0.6064118299152743,-0.004003364222103012,0.012442303876629035,0.006737551451662105,-0.01394225312129993,-0.01583930539842804,-0.005026033481197567,-0.30925021103025896
3023,2023-02-03,Why Personalis Shares Are Trading Higher Today,MRK,-0.005026033481197567,-0.30925021103025896,-0.03290335001787037,-0.004003364222103012,0.012442303876629035,0.006737551451662105,-0.01394225312129993,0.01058861239630593,-0.19234131373318586
3024,2023-02-03,Merck's Keytruda Plus Chemo Combo Aces Late-Stage Study In Advanced Endometrial Cancer Patients,MRK,-0.005026033481197567,-0.30925021103025896,-0.03290335001787037,-0.004003364222103012,0.012442303876629035,0.006737551451662105,-0.01394225312129993,0.01058861239630593,-0.19234131373318586
3025,2023-02-03,"Merck's Oral COVID-19 Treatment Might Be Linked To Spreading Mutations, Study Shows",MRK,-0.005026033481197567,-0.30925021103025896,-0.03290335001787037,-0.004003364222103012,0.012442303876629035,0.006737551451662105,-0.01394225312129993,0.01058861239630593,-0.19234131373318586
3026,2023-02-06,"Analyst Upgrades Personalis; Says Biopharma Is Strong, Cash Burn Is Down",MRK,0.01058861239630593,-0.19234131373318586,-0.005026033481197567,-0.03290335001787037,-0.004003364222103012,0.012442303876629035,0.006737551451662105,0.015860839111469183,-0.12698658125793805
3027,2023-02-08,"If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,000 Today",MRK,0.009084001717934775,0.08749225144534267,0.015860839111469183,0.01058861239630593,-0.005026033481197567,-0.03290335001787037,-0.004003364222103012,0.0007502334844173841,-0.07206588881262865
3028,2023-02-08,Analyst Reiterates This Alzheimer's Candidate As Top Idea For 2023,MRK,0.009084001717934775,0.08749225144534267,0.015860839111469183,0.01058861239630593,-0.005026033481197567,-0.03290335001787037,-0.004003364222103012,0.0007502334844173841,-0.07206588881262865
3029,2023-02-09,"Aligos Reprioritizes Pipeline With Focus On NASH, COVID Programs, Cuts Another 10% Of Its Workforce",MRK,0.0007502334844173841,-0.07206588881262865,0.009084001717934775,0.015860839111469183,0.01058861239630593,-0.005026033481197567,-0.03290335001787037,0.01733508136601669,-0.04603349714171101
3030,2023-02-09,"Amazon, Tesla And 2 Other Stocks Insiders Are Selling",MRK,0.0007502334844173841,-0.07206588881262865,0.009084001717934775,0.015860839111469183,0.01058861239630593,-0.005026033481197567,-0.03290335001787037,0.01733508136601669,-0.04603349714171101
3031,2023-02-10,"If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today",MRK,0.01733508136601669,-0.04603349714171101,0.0007502334844173841,0.009084001717934775,0.015860839111469183,0.01058861239630593,-0.005026033481197567,0.009026456183328424,-0.029765033641715677
3032,2023-02-13,"Stellar Opportunity For Merck At Upcoming Data Presentation, Analyst Says While Boosting Price Target",MRK,0.009026456183328424,-0.029765033641715677,0.01733508136601669,0.0007502334844173841,0.009084001717934775,0.015860839111469183,0.01058861239630593,-0.0073939331122409024,-0.05406942883070798
3033,2023-02-13,"Fox, MGM Resorts And 3 Other Stocks Insiders Are Selling",MRK,0.009026456183328424,-0.029765033641715677,0.01733508136601669,0.0007502334844173841,0.009084001717934775,0.015860839111469183,0.01058861239630593,-0.0073939331122409024,-0.05406942883070798
3034,2023-02-13,IMV Stock Falls After Interim Data From Lead Candidate In Blood Cancer Subtype,MRK,0.009026456183328424,-0.029765033641715677,0.01733508136601669,0.0007502334844173841,0.009084001717934775,0.015860839111469183,0.01058861239630593,-0.0073939331122409024,-0.05406942883070798
3035,2023-02-14,Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session,MRK,-0.0073939331122409024,-0.05406942883070798,0.009026456183328424,0.01733508136601669,0.0007502334844173841,0.009084001717934775,0.015860839111469183,-0.00974801903836997,-0.08122968541932163
3036,2023-02-14,BioXcel Therapeutics Unveils Complete Data From BXCL701/Keytruda Combo Study In Prostate Cancer Subtype,MRK,-0.0073939331122409024,-0.05406942883070798,0.009026456183328424,0.01733508136601669,0.0007502334844173841,0.009084001717934775,0.015860839111469183,-0.00974801903836997,-0.08122968541932163
3037,2023-02-15,EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue,MRK,-0.00974801903836997,-0.08122968541932163,-0.0073939331122409024,0.009026456183328424,0.01733508136601669,0.0007502334844173841,0.009084001717934775,-0.010865496997585544,-0.07126827291712123
3038,2023-02-15,"Robinhood, Merck And 2 Other Stocks Insiders Are Selling",MRK,-0.00974801903836997,-0.08122968541932163,-0.0073939331122409024,0.009026456183328424,0.01733508136601669,0.0007502334844173841,0.009084001717934775,-0.010865496997585544,-0.07126827291712123
3039,2023-02-16,Merck Says Keytruda/Chemo Combo Improved Overall Survival Compared To Chemo Alone In Gastric Cancer Settings,MRK,-0.010865496997585544,-0.07126827291712123,-0.00974801903836997,-0.0073939331122409024,0.009026456183328424,0.01733508136601669,0.0007502334844173841,0.028260201119568507,0.5898847180037925
3040,2023-02-21,Merck's COVID-19 Treatment Fails To Prevent Infection In Household Exposure,MRK,-0.004108827135557158,-0.28846600384185084,0.028260201119568507,-0.010865496997585544,-0.00974801903836997,-0.0073939331122409024,0.009026456183328424,0.0008252262856971448,0.07007342579544606
3041,2023-02-22,Jim Cramer Lists 6 Conditions For Market Selloff To End Amid 'Discouraging' Inflation Data,MRK,0.0008252262856971448,0.07007342579544606,-0.004108827135557158,0.028260201119568507,-0.010865496997585544,-0.00974801903836997,-0.0073939331122409024,0.013099975691521326,-0.04035265251805542
3042,2023-02-23,"Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge",MRK,0.013099975691521326,-0.04035265251805542,0.0008252262856971448,-0.004108827135557158,0.028260201119568507,-0.010865496997585544,-0.00974801903836997,-0.006329691649394675,-0.16393655746229852
3043,2023-02-24,European Authority Recommends Against Approval For Merck-Ridgeback Biotherapeutics' COVID-19 Pill,MRK,-0.006329691649394675,-0.16393655746229852,0.013099975691521326,0.0008252262856971448,-0.004108827135557158,0.028260201119568507,-0.010865496997585544,-0.0048229680324914925,-0.022996250799080853
3044,2023-02-24,"US Senators Warren, Sanders Urge 'Close Scrutiny' On Merck's Keytruda-Related Patents",MRK,-0.006329691649394675,-0.16393655746229852,0.013099975691521326,0.0008252262856971448,-0.004108827135557158,0.028260201119568507,-0.010865496997585544,-0.0048229680324914925,-0.022996250799080853
3045,2023-02-27,Analyst Cautions Investors On Overreacting To 'Early-Stage' Pfizer/Seagen Discussions,MRK,-0.0048229680324914925,-0.022996250799080853,-0.006329691649394675,0.013099975691521326,0.0008252262856971448,-0.004108827135557158,0.028260201119568507,-0.028529686583140035,0.8055280469689468
3046,2023-02-27,Here's How Much $1000 Invested In Merck & Co 5 Years Ago Would Be Worth Today,MRK,-0.0048229680324914925,-0.022996250799080853,-0.006329691649394675,0.013099975691521326,0.0008252262856971448,-0.004108827135557158,0.028260201119568507,-0.028529686583140035,0.8055280469689468
3047,2023-02-27,Seagen Stock Soars On Pfizer Takeover Talks: What's Going On?,MRK,-0.0048229680324914925,-0.022996250799080853,-0.006329691649394675,0.013099975691521326,0.0008252262856971448,-0.004108827135557158,0.028260201119568507,-0.028529686583140035,0.8055280469689468
3048,2023-02-28,Merck Discontinues Two Keytruda Combo Therapy Trials In Prostate & Lung Cancer Settings,MRK,-0.028529686583140035,0.8055280469689468,-0.0048229680324914925,-0.006329691649394675,0.013099975691521326,0.0008252262856971448,-0.004108827135557158,0.0038592242575266056,-0.40263861546146384
3049,2023-03-01,"After Shelving Two Keytruda Trials, Merck Touts Encouraging Data From Keytruda Regime Study In Lung Cancer Patients",MRK,0.0038592242575266056,-0.40263861546146384,-0.028529686583140035,-0.0048229680324914925,-0.006329691649394675,0.013099975691521326,0.0008252262856971448,0.0033755179431902427,-0.16420724708968681
3050,2023-03-06,Merck Highlights Promising Data From Two Candidates In Heart Diseases,MRK,0.03948354299505219,1.902870766517522,-0.0012148602637888084,0.0033755179431902427,0.0038592242575266056,-0.028529686583140035,-0.0048229680324914925,0.0015301256980835287,-0.22340042527817472
3051,2023-03-07,Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason,MRK,0.0015301256980835287,-0.22340042527817472,0.03948354299505219,-0.0012148602637888084,0.0033755179431902427,0.0038592242575266056,-0.028529686583140035,-0.0268715454665025,-0.3885826457954553
3052,2023-03-07,Analyst Downgrades Gossamer Bio As Merck's Sotatercept Might Overshadow Seralutinib's Success,MRK,0.0015301256980835287,-0.22340042527817472,0.03948354299505219,-0.0012148602637888084,0.0033755179431902427,0.0038592242575266056,-0.028529686583140035,-0.0268715454665025,-0.3885826457954553
3053,2023-03-07,DocuSign To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Tuesday,MRK,0.0015301256980835287,-0.22340042527817472,0.03948354299505219,-0.0012148602637888084,0.0033755179431902427,0.0038592242575266056,-0.028529686583140035,-0.0268715454665025,-0.3885826457954553
3054,2023-03-08,OPKO Health's Cancer & Infectious Disease Focused Subsidiary Inks Vaccine Development Pact With Merck,MRK,-0.0268715454665025,-0.3885826457954553,0.0015301256980835287,0.03948354299505219,-0.0012148602637888084,0.0033755179431902427,0.0038592242575266056,,
